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This dissertation examines the controversial fates of frozen human embryos left over 
from in vitro fertilization procedures and frozen for future in the United States at the turn of the 
twenty-first century. Stem cell researchers covet human embryos as wellsprings of biovalue for 
curing human diseases and generating new forms of wealth. At the same time, pro-life Christians 
target excess embryos for rescue as adoptable orphans and mobilize the frozen unborn within 
legal strategies to redefine personhood. As a comparative ethnography, this dissertation reveals 
what these putatively opposing solutions share in common by examining why and how frozen 
reproductive remainders are saved.  
Based on twenty-seven months of ethnographic field research in California following the 
global financial crisis (2008-2013), this dissertation draws from in-depth interviews, document 
analysis, and participant observation in two organizations on the vanguard of managing frozen 
biological assets: a Christian embryo adoption program and a university stem cell tissue bank. 
Both solutions for America’s embryo surplus agree about what makes embryos valuable, which 
is their potential.  
This dissertation develops saving as a theoretical framework for examining the processes 
through which frozen IVF embryo potential is produced and valued. First, the lens of saving 
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gives voice to evangelical Christians, IVF patients, and stem cell scientists, whose perspectives 
offer a revision to scholarly understandings about the imbrications between the life sciences and 
finance capital. Perspectives from American embryo savers illuminate how the opposing 
missions of stem cell researchers and Christian adopters belie common efforts within financial 
crises that transform frozen forms of capital—like reproductive remainders—from devalued 
trash into potent treasure. Additionally, the saving framework reveals that stem cell tissue 
bankers and embryo adoption proponents share a commitment to “doing good” today on behalf 
of a better tomorrow. On the one hand, stem cell researchers strive to adhere to and model the 
principles of “good science,” at the heart of which are responsibilities to not be wasteful. Embryo 
adoption proponents, on the other hand, strive to live according to Christian values of equality, 
dignity, and duty by modeling social forms of inclusion through “good family.” This dissertation 
contributes to knowledge about the politics of regenerating value when “life” is in surplus and 
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Saving: Freezing Reproductive Remainders for the Future 
 
Alice is the second child of Adam and Julie Gold, an orthodox Jewish couple living in 
Georgia with their three children.1 At eighteen months old, Alice was diagnosed with 
Mucolipidosis IV (ML4), a rare genetic disorder more common among people of Ashkenazi 
Jewish descent characterized by motor and verbal skill dysfunction, vision trouble, and decreased 
life expectancy. Learning this news was understandably devastating for her parents. To a CNN 
journalist, her father Adam shared what it meant for their family: “It was more than a sad 
moment but the beginning of what became a lot of sad moments.” Her mother Julie echoed a 
similar sentiment: “Anything that we had dreamed and hoped for our family at that point was 
broken. Done.” 
Compounding the devastation of Alice’s diagnosis was their utter surprise. In anticipation 
of getting married, the Golds sought genetic testing in consultation with their rabbi and genetic 
counselors to prevent passing on to their children autosomal recessive diseases more common 
among Jewish families. Adam was screened for two disorders and Julie was screened for six; 
when neither test suggested that they were positive carriers for inheritable diseases, their minds 
were eased about creating a family together. They were unaware at the time they were screened 
in 2003 that there did not exist a standard genetic test that included the nineteen known diseases 
occurring more frequently (though not exclusively) among Jewish individuals.   
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Considerable efforts have been made to protect the confidentiality of individuals and 
organizations participating in this study. All names of individual people (except for public 
figures, such as elected officials and Hollywood actors), ethnographic field sites, and geographic 
locations in this dissertation are pseudonyms or disguised to the best of the author’s ability to 
maintain the anonymity of study participants. 
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Soon after Alice was born, Adam and Julie became concerned about her developmental 
milestones, but were told by doctors to not worry. At nine months old, Alice began physical 
therapy to address low muscle tone and had surgery to correct her crossed eyes. They spent 
months searching for answers and, against their doctor’s advice, took Alice to a specialist who 
did an MRI scan on her brain. When the results were troubling, the neurologist referred the 
Golds to a geneticist who would call Adam and Julie late one August evening in 2009 with tragic 
news about their daughter’s health.   
As carriers of ML4, any children the Golds conceived naturally would have a 25% 
chance of being born with this inheritable genetic disease. Feeling that their family was 
incomplete, they weighed their options for having another child.2 “We looked beyond our current 
sadness and knew that we had more love to give,” Julie explained, but they worried that “the 
clock was against us.” Julie was 39 years old when Alice was diagnosed, which prompted them 
to wonder about time: “How long would it take to get pregnant, and what if we had to terminate? 
What would happen after we terminated? How long would we have to wait to start trying again 
and what happens if we lost twice in a row?”  
Because they did not want to put any future child at risk for ML4, natural conception felt 
like a gamble. The Golds settled on using reproductive and genetic technologies to try for their 
third child. “The best option for us was IVF coupled with PGD [preimplantation genetic 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  The main alternatives to natural conception for people with inheritable genetic conditions are 
assisted reproductive technologies or adoption. ART options include using a sperm, egg, or 
embryo donor, or, using their own gametes, pairing IVF and with PGD, a technique for 
determining which IVF embryos are genetically normal and abnormal. For already established 
pregnancies, genetic screenings like amniocentesis or CVS can provide information for couples 
to determine whether or not to continue a pregnancy. Genetic screening results are typically 
reviewed in consultation with a genetic counselor or obstetrician to discuss risk and options. For 
pregnancies screened positive for genetic abnormalities, pregnancies can be terminated or carried 
to term for adoption placement or parenthood.	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diagnosis] so we could have another healthy child of our own,” Julie explained. “Other carrier 
couples may decide on something different…but we decided we wanted to go this route.” 
Preimplantation genetic diagnosis, or PGD, is a test conducted on embryos in vitro before being 
transferred into the uterus for pregnancy.3 Embryologists remove a cell from the embryo and 
send it to a genetics lab to be tested for disorders associated with a single gene, such as cystic 
fibrosis, Tay Sachs, or muscular dystrophy. When the Golds came to their fertility clinic, no 
PGD test existed for the rare ML4 disease. To address this problem, Adam and Julie 
commissioned Dr. Mark Hughes of Genesis Genetics, a world leader in preimplantation genetic 
testing for single gene disorders, to create a test using DNA from cells from their cheeks to 
screen the Golds’ IVF embryos for the ML4 gene. With the PGD test, they could identify which 
embryos were affected with the disease and not transfer them into Julie’s uterus. Insurance 
covered some portion of the cost to develop the test, but the Golds still paid thousands of dollars 
out of pocket for this genetic screening technology.  
IVF with PGD was a “pretty intense process” for Julie, as it is for many fertility patients 
(Franklin and Roberts 2006). Her eggs were harvested, fertilized, cultured in vitro, genetically 
tested, and transferred into her uterus over the course of three IVF cycles, none of which 
established pregnancy. Although emotionally and financially drained, they committed to one last 
round with a new doctor and medication regimen; this cycle produced one genetically normal 
embryo that led to pregnancy and the birth of their third child. They named her Shai, which 
means “gift” in Hebrew. As Adam recounted the story for me, he remarked with pride and 
surprise that “it just takes one.” Once Shai was born, Julie felt that the emotionally, physically, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  Preimplantation genetic diagnosis (PDG) differs from preimplantation genetic screening (PGS), 
which is a similar biopsy procedure on in vitro embryos that tests for chromosomal 
abnormalities, such as Down syndrome, as well as sex.  	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and financially challenging process was worth it: “It’s definitely not an easy process, but 
knowing that you can have healthy children of your own even if you carry the same disease 
mutation is important to any family.” 
The Golds’ final IVF cycle produced another kind of gift: one extra embryo that screened 
positive for ML4. In IVF clinics, genetically abnormal embryos are typically discarded as 
medical waste because they are of no clinical value to patients trying to become parents. But at 
Adam and Julie’s request, the ML4 embryo was frozen and stored for they considered it anything 
but waste. Rather, it held the potential for a cure. “We always expected [through IVF] that we 
would have an embryo that was affected,” explained Adam, which came as great news because 
the Golds, as he explained, were “working for a cure.” Before starting IVF, they asked their 
geneticist what the possibilities would be for embryos that screened positive for ML4. Dr. 
Hughes introduced the Golds to Dr. Dunn of Sutter University’s REDEEM Biobank, the Director 
of the most active tissue bank in the country receiving donated human embryos for research. Dr. 
Dunn shared information with the Golds about disease-specific stem cell research underway at 
Sutter University and the process entailed in donating frozen embryos to the Biobank.  
After Alice’s diagnosis, Julie and Adam became active with the ML4 Foundation, an 
organization that supports research of the genetic disease in hopes of finding a cure. Based on 
what they learned from Dr. Dunn about research potential at Sutter University for their diseased 
embryo, Adam and Julie decided to donate any ML4 embryos that their IVF procedures 
generated to the REDEEM Biobank. By donating, their hope was 
…to try to produce stem cells that, in theory, would help in research for helping to find a 
cure for ML4. The hope was that the stem cells would provide something that the 
researcher would want in order to start studying ML4 at a different level and at some 
point we would be able to create a drug that would be able to benefit ML4.  
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Fewer than 250 people worldwide are living with ML4, which means that there are very few 
couples like the Golds who are known carriers, want to expand their family, and have the means 
and desire to utilize IVF with genetic testing. At the time of our first conversation in 2012, Adam 
knew of only one other couple in the world attempting to have children, and they were trying via 
natural conception. “For us, we saw this embryo as a once in a lifetime, one-shot deal,” a chance 
at a cure that could save lives, including Alice’s. 
 
The Remainders 
“What becomes the value of this thing, the remainder?”  
- Warwick Anderson, “The Frozen Archive, or Defrosting Derrida”  
 
The Golds’ embryo is one of approximately a half million human embryos left over from 
in vitro fertilization procedures that have accumulated in the 486 fertility clinic freezers across 
the United States.4 Despite the mainstream practice of saving excess embryos in the United 
States since the mid-1980s, what to do with the growing supply of frozen remainders like the 
Golds’ has become the subject of controversy. Fertility clinics quietly banked embryos for fifteen 
years until two events in 1998 thrust the future of frozen embryos into a public debate. In a 
University of Wisconsin lab that year, biologists established the first human embryonic stem cell 
line from a donated leftover embryo (Thomson, et al. 1998). Stem cell researchers responded by 
procuring donated embryos from IVF patients for their invaluable promise to revolutionize 
medicine in the quest for life-saving cures for diseases like diabetes, Alzheimer’s, and cancer 
(Scott 2006). Meanwhile, a Christian adoption agency created the first embryo adoption program 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 A 2003 RAND study reporting 400,000 is the most commonly cited estimate (Hoffman et al. 
2003). More recent estimates suggest increasing numbers, such as the 600,000 figure reported in 
the Department of Health and Human Services website on embryo adoption: 
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/ 
 6 
for placing unwanted embryos with adoptive families and turning extras into born children. They 
decried the devaluing of unborn human life by championing embryo personhood and facilitating 
their chances to be born.  
Controversy about the future of America’s IVF embryos centers on saving, or the 
preservation of something considered valuable. In this dissertation, I enter into the U.S. frozen 
embryo debate to explore why and how such reproductive remains are saved. To do so, I develop 
saving as a conceptual framework for understanding how the preservation of valuables occurs 
through ethical orientations, daily practices, and infrastructures. I explore the circumstances 
within which frozen IVF embryo potential is produced and valued; the kinds of values, for 
whom, and within which contexts; the conditions that propel people to make, store, want, and 
give excess embryos; and what the potentiality attributed to these frozen remains suggests about 
life in uncertain times. 
I addressed these topics during twenty-seven months of field research between 2008 and 
2013 within organizations offering Christian and scientific solutions for the excess embryo 
problem: an embryo adoption program and a stem cell tissue bank. The first program of its kind, 
the Blossom Embryo Adoption Program works with IVF patients and clinics to transfer unused 
embryos from giving to receiving families. As proponents of embryo personhood and Christian 
values, they strive to provide embryos the opportunity to achieve their full potential through birth 
into an adoptive family. By contrast, the REDEEM Biobank within Sutter University’s Stem Cell 
Institute manages a gold mine of donated embryos from across the country that supports stem 
cell biologists whose ambitions to produce exceptional science have collectively positioned 
Sutter at the world’s forefront of regenerative medicine. California, often considered a frontier 
for stem cell and reproductive technologies (Scott 2006; Thompson 2014) and a crucible for the 
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Religious Right (Dochuk 2011; McGirr 2001), offered a coherent historical, legal, and social 
setting for studying the scientific and evangelical pioneers who prospect left over embryo 
treasures for America’s future.  
 
Making Remainders: Freezing for the Future 
Basile Luyet, a Catholic priest, biologist, and physicist, is often regarded as the “Father” 
of cryobiology, or the science of life at the frosty extremes. In the first book on “life and death at 
low temperatures,” Luyet introduced the concept of latent life—a zone where organic life is 
liminal and neither fully alive nor dead (Luyet and Gehenio 1940; Radin 2013). Early twentieth 
century studies of latent forms of life, such as animal hibernation and freeze-resistant plants, took 
interest in pragmatic ways to harness the cold for solving practical problems in medicine, health 
care, and the environment (Fuller, et al. 2004). The field took a pivotal turn in 1949 following 
the chance discovery by a team of British scientists that glycerol—a simple sugar compound—
protects cells from damage during freezing and thawing (Polge, et al. 1949). The ability to 
preserve cellular life in a suspended state with power to stop and start biological time 
revolutionized the biological sciences and industries now common within contemporary life 
(Landecker 2007).  
Cryobiology figured centrally in the late 1940s revolution in domestic animal breeding 
through the freezing of sperm (Bavister 2001; Foote 2002); the post-war 1950s eruption of 
frozen foods and home freezers (Smith 2001); the 1960s cryonics movement to preserve one’s 
brain or body for later revivification (Farman 2013; Sheskin 1979); and the banking of genetic 
materials from exotic or endangered plant and animal species in the 1970s (Watson and Holt 
2001). The first successful pregnancy after cryopreservation occurred in a mouse in 1972 
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(Whittingham, et al. 1972), followed by a cow named Frosty in 1973 (Wilmut and Rowson 
1973). In vitro fertilization technology made its world debut in human fertility with the birth of 
Louise Brown in 1978 to a British couple, followed in 1984 by the birth of Zoe Leyland in 
Melbourne, the first frozen human embryo to be born. Freezing human embryos quickly 
mainstreamed in the United States after the technique’s introduction in 1984.  
While the cryopreservation of extra embryos in the United States has been common 
practice for over thirty years, storing human embryos in liquid nitrogen at -196 Celsius is neither 
customary nor legal in many regions of the world providing IVF (Inhorn and Balen 2002; 
Roberts 2012). Germany and Italy, for instance, have the strictest IVF laws in Europe. Germany 
banned cryopreservation in 1991 with the “Federal Embryo Protection Law” whereas Italy, once 
one of the “wildest” places for assisted reproduction in Europe, took a dramatic turn in 2004 
when lawmakers passed a highly restrictive bill outlawing embryo cryopreservation, gamete 
donation, surrogacy, and usage by same-sex couples. In response to restrictive embryo freezing 
laws in Italy, scientists became experts in egg freezing techniques that are now being offered 
within IVF clinics around the globe.  
Other European countries, like France and the U.K., also highly regulate IVF and 
cryopreservation, but more leniently. A requirement of the U.K.’s Human Fertilisation and 
Embryology Act of 1990 is that embryos cannot be stored for longer than ten years, which 
prevents the growing embryo glut that now burdens U.S. IVF clinics. Also, the U.K. National 
Health System created “interfaces” between IVF and stem cell research, which fosters an 
efficient system of fresh and frozen embryo donations for research (Franklin 2006a; Franklin 
2006b). 
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Scholarship in countries with fewer assisted reproduction regulations reveals other forces 
at play that affect cryopreservation practices. In India, where little national regulation currently 
exists for assisted reproduction (though the Indian government may soon ban international 
surrogacy), patient embryo donations fuel the country’s burgeoning stem cell industry 
(Bharadwaj and Glasner 2009). Similarly, with the exception of Costa Rica where an IVF ban of 
fifteen years was reversed in 2015, Latin America is known for its absence of IVF regulations. In 
Ecuador, this allowed one scholar to discern regional cryopreservation differences between Quito 
and Guayaquil that reveal the power of religion and kinship to regulate assisted reproductive 
technologies in places without formal state-based secular restrictions (Roberts 2007b).  
Religious traditions shape assisted reproduction in other settings as well. In Muslim 
countries practicing IVF, like Egypt, Lebanon, and Iran, freezing embryos is considered halal—
or permissible by Islamic law—and thus a widely accepted practice in line with Sunni fatwas on 
assisted reproduction (Inhorn 2006). The United Arab Emirates is the one exception to the rule; 
they banned embryo freezing in 2010, leaving many international fertility patients who traveled 
there for services not offered in their home countries wondering about the fates their frozen 
remainders stored abroad (Inhorn 2015). The variegated policies and practices in IVF and 
embryo cryopreservation around the world contribute to growing flows of people, gametes, and 
capital that comprise new networks of “cross-border reproductive care” (Inhorn and Gürtin 
2011). As these examples suggest, the presence or absence of regulations is not prescriptive of 
how patients, donors, and doctors will use assisted reproductive technologies, nor are regulatory 
systems guarantees for what will pan out. The growing surplus of frozen embryos in freezers 
across the free-market fertility industry in the United States is one such unforeseen example.    
--- 
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No two of the IVF patients that I met or clinics I visited were alike, though Sandra’s case 
at Harrington Fertility’s Paloma clinic was typical in many ways. Harrington Fertility, discussed 
in greater detail in Chapter 2, began as a small fertility clinic in the late 1980s in Southern 
California and grew to become one of the California’s highest volume providers. Sandra, a white 
banking associate living in Irvine, CA, was thirty-six when she and her husband first went to 
Harrington after two years of multiple miscarriages. After a series of tests, she was diagnosed 
with “unexplained infertility” and encouraged by her physician to consider IVF. On the day of 
Sandra’s first egg retrieval, she produced thirteen eggs that were co-incubated with her partner’s 
sperm in a Petri dish, a procedure that facilitates fertilization. A few days later, ten viable 
embryos showed positive signs of development in the warmed dish. Two were selected for 
transfer into her uterus while the extra eight embryos were frozen for potential later use. Her 
embryologist immersed the leftover embryos in individual droplets of cryoprotectant media, 
carefully packaged them in straws, labeled each with Sandra’s name and birthdate, and plunged 
the straws into liquid nitrogen for storage. When Sandra and her husband’s efforts to build a 
family through IVF came to an end, they had a few options for embryos that remained: they 
could donate them for research or procreation, discard as medical waste, or keep cryopreserved 
indefinitely.  
Derek, an embryologist at Harrington, explained why embryos like Sandra’s are routinely 
saved in fertility clinics across the United States:  
The patient has been through high doses of drugs, a needle into her vagina and ovaries, 
and paid the costs of lab embryology. You’ve got some good embryos – why waste 
them? You don’t bin them. You want to freeze them for the future.  
 
But saving spare embryos for the future has become an increasing burden in the present for 
fertility clinics and patients alike. Charging each patient anywhere from $350-$1000 a year for 
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storage makes freezing embryos seem like easy money for fertility clinics, yet many IVF staff 
feel that the liabilities outweigh the revenue. The accrual of frozen embryos in storage tanks 
represents a growing problem and worry for the hundreds of IVF clinics in the United States.  
“We have embryos from the 1990s in those tanks,” Ken, a senior embryologist at 
Harrington Fertility, explained as he pointed toward the room off the lab where twelve 
cryopreservation tanks are located. For Ken, this is a burden rather than a boon. In addition to his 
daily activities working under the microscope with human eggs, sperm, and embryos, Ken 
manages the physical inventory of frozen embryos preserved at Harrington. This involves 
maintaining expensive equipment stored in a room designed to keep precious materials secure. 
At Harrington, tanks are strapped to the wall to withstand earthquakes and wired with multiple 
monitoring systems for security from theft and risk of exposure to unsafe temperatures. Such 
safeguards are in place to protect embryos as much as fertility clinics for within the litigious U.S. 
legal environment, fertility patients have successfully sued for damages to their frozen embryos 
that are legally considered forms of property (Andrews 1986; Litman and Robertson 1993).  
Part of Ken’s job also involves caring for abandoned embryos that are no longer being 
paid for by fertility patients. Unlike storage units filled with furniture that can be auctioned off to 
the highest bidder, determining what to do with the contents of abandoned embryo accounts is 
more complicated. “We don’t discard them after patients stop payment because we are worried 
about lawsuits,” expressed a concerned embryologist to a panel of lawyers convened at the 2011 
American Society for Reproductive Medicine annual meetings. For the same reason, Harrington 
keeps unclaimed embryos in their tanks rather than discarding old inventory. In the absence of 
legal guidance in U.S. law about how to proceed when patients forego cryostorage payment, 
fertility clinics are stuck caring for a growing glut of reproductive remainders that nobody seems 
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to want. Despite profits gained from storage fees, IVF clinics have come to realize that freezing 
leftover embryos is risky business.  
Saving embryos also poses burdens to IVF patients who agree to keep them on ice. 
Having backup embryos appeals to thousands like Sandra who desire the chance to become a 
parent, yet bearing the responsibility for leftovers comes with unanticipated costs. Beyond the 
financial expense of annual storage fees, many patients report feeling differently about their extra 
embryos at the end of IVF than at the time of freezing (Lyerly, et al. 2010; Nachtigall, et al. 
2005). Some express being overwhelmed by the responsibility of deciding what to do with 
embryos they no longer need but that for various reasons are hard to let go. Other difficulties 
arise for patients in cases of divorce or death, which have thrust leftover embryos into the middle 
of court proceedings that attempt to determine to whom these reproductive leftovers belong. 
Why freeze embryos at all when saving them presents legal, financial, ethical, political and 
emotional burdens on the individuals and institutions tasked with their management?  
 
Saving Embryos 
As any computer user knows when she clicks to save an electronic document, saving is 
fundamentally about preserving something considered valuable. While this dissertation addresses 
the saving of embryos at the turn of the millennium, embryo saving in the United States is 
traceable into the prehistory of the Americas. Saving may be one of the oldest technologies in 
human history evident within the practice of preserving seeds—the embryos of plants. 
Archeologists of North America have unearthed seed deposits stored in birch-lined cache pits, 
ash-filled baskets, and clay pots in locales around the continent. Scientists presume that these 
preserving techniques protected seed reserves from the threat of animals, elements, and time. 
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Whether collected for consumption, trade, or farming, the saving of seeds suggests a desire 
among early humans to preserve valuables with regenerative possibility. When reimagined as the 
twenty-first century’s answer to Pueblo seed pots, contemporary cryopreservation tanks immerse 
IVF techno-seeds into liquid nitrogen to preserve the promise they too contain for the future. 
Today’s IVF remainders, akin to ancient plant seeds, are thought to hold the potential to bring to 
fruition various kinds of tomorrows.  
Saving is a dynamic keyword with a rich etymological history (OED). The earliest 
meaning of saving comes from the fourth century A.D., signifying heroic healing efforts that 
delayed death and rescued bodies from disease. In the tenth century, saving evoked Christian 
notions of rescuing the soul, delivering persons from evil, and offering salvation in the eyes of 
God. By the sixteenth century, saving took on an economic tone through discourses about the 
frugal expenditure of money and the storing of resources for later redemption or use.  
Each of these meanings operates vibrantly within the contemporary American 
controversy concerning the afterlives of excess IVF embryos. In this dissertation, I utilize the 
multiple valences of saving to explore the many ways in which frozen embryo leftovers are 
valued at the turn of the twenty-first century: as resource, orphan, insurance, treasure, burden, 
promise, waste, etc. An advantage of a framework that holds multiple meanings simultaneously 
is the ability to examine the intersections of realms presumed to be incommensurable. Toward 
this end, I develop saving as a conceptual framework for illuminating convergences among 
putatively disparate realms within politics addressing life’s uncertainties; for this project, I direct 
my attention to the imbrications between medico-science, Christianity, and capitalism in the 
United States.  
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Based in California after the 2008 global financial crisis, this project develops saving to 
analyze the politics of regenerating value when “life” is in surplus. The saving framework puts 
into relief ways the Blossom Embryo Adoption program and REDEEM Biobank operate as 
intermediary organizations at the vanguard of managing frozen biological assets, or what may be 
considered “cryocapital.” Like traditional banks, embryo-saving organizations oversee the 
receipt and distribution of reproductive remainders whose values are suspended—or frozen—
until they can be realized. Moreover, saving illuminates how the opposing missions of stem cell 
researchers and Christian adopters belie common efforts evident within financial crises to 
transform frozen forms of capital—like mortgages, as well as biological remains—from 
devalued trash into potent treasure. Why and how each group strives to redeem excess embryos 
reveals a shared faith in what they consider to be most valuable about frozen embryos: their 
potential. Importantly, saving gives voice to evangelical Christians, IVF patients, and stem cell 
scientists, whose perspectives collectively offer a revision to scholarly understandings of 
biocapital (Cooper 2008; Dumit 2012; Franklin 2006c; Hayden 2003; Helmreich 2007; Peterson 
2014; Sunder Rajan 2006; Sunder Rajan 2012). Frozen embryos and other reproductive 
remainders emerge as a new species of speculative biocapital whose valued potential fuels the 
increasing financialization of reproductive health and technology worldwide.  
When viewed through the lens of saving, stem cell tissue bankers and embryo adoption 
proponents also express a shared commitment to “doing good,” which I use to describe ethical 
frameworks guided by duty and desire to improve life in uncertain times. On the one hand, Sutter 
University researchers try to adhere to and model the principles of “good science”; Blossom 
Embryo Adoption proponents, on the other hand, try to live according to Christian values in 
order to foster conditions for “good family.” Saving puts into relief the nuances of these 
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coexisting ethical terrains, futures people envision beyond their horizons, and how they try to 
enact those visions.  
In the following chapters, I demonstrate that saving operates within stem cell research 
and embryo adoption in three main ways: as an ethic, practice, and infrastructure. Saving 
describes a widely felt ethical, moral, or religious obligation to value and preserve potentiality in 
uncertain times. The obligatory quality of saving is especially pronounced within “anticipatory 
regimes” that shape how the present is increasingly felt to be contingent upon unknowable 
“futures” for which each of us are encouraged to prepare (Adams, et al. 2009). Saving operates 
in and through stem cell labs and Christian adoption agencies as a temporal ethic and timely 
politics. Moreover, saving functions as a moral force that cultivates attitudes of responsibility in 
the present and fosters conditions for ethical action on behalf of the future.  
Saving is also practiced and enacted through daily activities, techniques, and ways of 
being that “make things audible, visible, tangible, knowable” (Mol 2002: 33). I consider 
mundane happenings within each program, like waste prevention in labs or treating Blossom 
clients as adoptable parents, to be saving practices that help realize their visions for redeeming 
life in America. Saving practices are informed by diverse notions of “good” and assume various, 
sometimes conflicting, form. The saving practices I examine in the following chapters are 
myriad, from ranking and grading embryos in IVF labs, maximizing the use of precious cells for 
research, rescuing frozen orphans via adoption, sorting for “precious” embryos, to submitting tax 
returns.  
As an infrastructure, saving subtends, suffuses, and surrounds the interpersonal, 
organizational, and social aspects of life in the United States. It inhabits the quiet grammars that 
prop up spaces, including lab standards, classificatory systems, funding grants, California’s 
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economy, and racial logics. An infrastructural view of saving illuminates previously invisible 
connections that crosscut settings and topics (Landecker 2007). In this dissertation, property and 
personhood operate as the main structuring conditions that produce frozen wastes and orphans, 
their potentials, and their savers. These saving conditions predated the frozen embryo 
controversy and will continue operating long after it cools down.  
 Frozen embryos are unsettling entities without simple definition, nor can they be reduced 
to a “singular entity” (Franklin and Roberts 2006). For this reason, my analysis in this 
dissertation is premised on the polysemous—rather than singular—meanings of saving and 
angles from which to understand them. Such an approach is imperative for understanding how 
and why we save embryos because, as Marilyn Strathern reminds, “it matters what ideas one 
uses to think other ideas (with)” (Strathern 1992: 10). 
 
Finding Homes for Embryos 
It became clear to me as I traced the afterlives of frozen embryos from fertility clinic 
freezers to tissue banks, adoption agencies, research labs, and waste bins that they defy simple 
categorization. As biological cells existing outside the human body, frozen embryos are plunged 
into liquid nitrogen where they become fixed developmentally in time and storable for possible 
future use. Yet while suspended in time, they prove to be socially vibrant matters that are 
enlivened and affected by circumstances outside the tank (Bennett 2010). It is unclear if frozen 
embryos are alive or pre-dead, tissue or kin, proto-persons or precious things, and constrained by 
the past or promising of the future. 
A brief review of the philosophical and legal topics that have dominated discussions for 
decades about what should be done with America’s unwanted but un-wastable remainders 
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illustrates the kinds of categories within which embryos are awkwardly pressed. At the first sign 
of controversy over frozen embryos, philosophers and lawyers flock to the scene while 
sociologists, anthropologists, and historians remain cautiously on the sidelines. I suspect part of 
the reason for this is because the terms for the debate are set in ways that make social scientists, 
or at least me, somewhat uneasy. While legal and philosophical scholarship differ in many ways, 
each tradition attends to the ontological status of embryos—what they are—as a method for 
figuring out where they belong. As an ethnographer of the turmoil stirred around leftover 
embryos, my contribution to the debate begins by taking note of how embryos are being 
discussed. I consider this an entry point for understanding the processes of trying to shoehorn 
unprecedented entities into ill-fitting spaces.   
Philosophical considerations about the future of frozen embryos focus on the moral status 
of embryos, a topic of dispute for over two millennia (Maienschein 2003). For example, do they 
accrue status as they develop or is their value inherent to them at any stage? Do embryos bear 
natural rights as biologically human? Are they owed dignities and protections equivalent to 
adults? Contemporary discussions about frozen embryos ask other questions, such as: Are we 
morally obligated to make use of abandoned embryos so that they are not wasted? What are the 
rights of children born through embryo donation, and how are they best respected? Catholic 
theologians, bioethicists, and philosophers of science often situate their arguments within 
longstanding debates about the origins of “life.” As such, thinkers like Aristotle, St. Thomas 
Aquinas, and Kant figure regularly within philosophical literatures striving to resolve what 
embryos are in order to inform what should be done with them. 
Western legal thought can similarly be understood as a “process of categorization” 
(Vandevelde 1980: 327). For this reason, it is not surprising that headline-catching courtroom 
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divorce disputes over frozen embryos in the United States center around their legal definition: 
are they persons, property, or something else? Consider the highly publicized Davis v. Davis 
trials (1989-1992), one of the first divorce cases involving frozen embryos. The disagreement 
between Mary Sue and Junior Davis about the future of their seven frozen IVF embryos pressed 
three Tennessee courts, including the state Supreme Court, to weigh in on the best legal category 
for frozen embryos. 
Mary Sue argued that she be able to use their extra embryos for pregnancy, to which 
Junior objected and, in later trials, argued for their disposal. Judge Young of the Tennessee 
Circuit Court sided with Mary Sue by ruling that embryos are not property but persons whose 
lives began at conception. In his ruling, Judge Young wrote: “By whatever name one chooses to 
call the seven frozen entities—be it preembryo or embryo—those entities are human beings; they 
are not property.”5 Judge Young applied family law to determine which parent would meet the 
frozen “children’s” needs best, which resulted in awarding “custody” to Mary Sue.  
The testimony of Dr. Jérôme Lejeune, the internationally acclaimed French Catholic 
geneticist who “discovered” in 1959 that people with Down’s syndrome have an extra 
chromosome, which was latter called Trisomy 21, contributed influentially to the lower court’s 
judgment. Though a widely regarded geneticist, Lejeune ardently protested the uses of his work 
in expanding biomedical technologies, like amniocentesis (Rapp 1999), that were used to detect 
this condition in established pregnancies. He was brought to stand in Tennessee to wield his 
authority as a scientist and to deliver a moral argument concerning the legal classification of 
human embryos. Lejeune testified that embryos are forms of “human life at the moment of 
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  Davis v. Davis, 15, E-14496 (Tennessee Circuit Court, Blout County, September 26, 1989)	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conception” and expressed feeling “deeply moved that the mother wants to rescue babies from 
this concentration can” (Annas 1989: 21). 
Junior challenged the decision in the Court of Appeals, which rejected the lower court’s 
designation of embryos as persons in favor of a “suspiciously property-like” (Litman and 
Robertson 1993: 260) model instead. The appellate court ruled that the embryos were fated for 
the freezer until the Davises jointly resolved what to do with them, which it based on their 
“shared interest” in the frozen marital possessions.6 The case was taken up by the Tennessee 
Supreme Court, which decided upon review of the two lower court rulings to “side fully with 
neither” (Strathern 1999: 136). The court found the definition of embryos as persons and 
property too extreme, and came up with an alternative: “Pre-embryos are not, strictly speaking, 
either ‘persons’ or ‘property’, but occupy an interim category that entitles them to special respect 
because of their potential for human life.”7 While the Davis case concluded thirteen years ago, 
the jury remains out as to how to categorize frozen embryos—legally, philosophically, or 
morally.  
The confusion about where frozen embryos fit within social schemes continues to 
provoke public debate and, at times, media frenzy. News in April 2015 about the suing of 
Modern Family TV sitcom star Sofía Vergara by her ex-fiancé Nick Loeb over the future of their 
two cryopreserved embryos is such an example. Vergara expressed wishes for their embryos to 
remain frozen indefinitely while Loeb, as he stated in an op-ed letter that the New York Times 
published in April 2015, regarded the embryos as his two daughters that he wishes to save and 
raise (Loeb 2015). The letter from Loeb landed a spot in the New York Times because, 
according to the Op-Ed page editor, his “strong pro-life position…reflects an important debate 
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that is going on around the country [concerning the] so-called personhood movement” and “is 
intended to spark discussions, debate, controversy, and even some yelling” (Sullivan 2015).  
To help his legal suit against Vergara, Loeb used moral language to make a case for 
embryo personhood and his right to parent. In the Op-Ed letter, Loeb questioned what he 
perceived to be a misalignment between the legal and moral classification of frozen embryos: 
“When we create embryos for the purpose of life, should we not define them as life, rather than 
as property?” Bringing frozen embryos to court has occurred only a dozen times in the United 
States, while deciphering what to do with leftover embryos is a challenge facing thousands of 
other modern families within life after IVF. Even though legal scholars and philosophers have 
sought categorical clarity so that the question of what to do with frozen leftovers can better be 
answered, frozen embryos are hard to classify.  
The discussion thus far illustrates how the dominant literature concerning leftover 
embryos is structured around what embryos are and where they fit. In anthropologist Mary 
Douglas’s terms, philosophers and legal scholars seem to consider frozen embryos 
uncomfortable types of “matter out of place” (Douglas 1966) and work hard to find them a 
place—conceptually, if not practically. These literatures provide insight into the predominant 
categories into which embryos are being encouraged, which to date are notions of persons and 
property. Following Foucault’s genealogical method of examining the making of a category, I 
take interest in what notions of property and personhood describe as well as how they produce 
what they are describing. To borrow James Ferguson’s useful distillation of this approach, I ask 
about personhood and property: “not simply ‘what does this concept mean; what does it really 
refer to?’; but, ‘How and to what effect is this concept deployed; what does it do?’” (Ferguson 
1999: 205).  
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While these analyses draw from discursive traditions, I ground my categorical interest 
within ethnography of everyday practices. Finding “homes” for embryos conceptually is also a 
practical matter that staff within fertility clinics, the Blossom Embryo Adoption program, and 
REDEEM Biobank manages each day. Embryologists at Harrington fertility discussed in Chapter 
2 routinely decide where IVF embryos belong clinically: which are ideal for being “put back” 
into a uterus, which should be frozen as “back up,” and which are destined for the garbage. 
Similarly, I trace in Chapter 3 the waste prevention practices among stem cell biologists that 
serve as an organizing framework for turning clinical trash into laboratory treasures for 
experimentation within warm Petri dishes. I illuminate parallel process in Chapter 4, where 
classificatory systems within the Blossom program produce frozen orphans awaiting adoption 
and the chance to be transferred into the warmth of a uterus. Finally, how each program 
addresses the challenge of donated embryos that nobody wants is the topic of Chapter 5. Where 
embryos belong—categorically, materially, and politically—is no simple matter.  
 
Unsettling Things 
If you ask a science studies scholar, novel biological entities are proliferating and frozen 
embryos are in the vanguard. After being confronted with the adoptable embryo in her email, 
Susan Squier took new interest in cultured cells, organ donor recipients, and other “liminal lives” 
in the frontiers of biomedicine that populate the margins of our everyday life (Squier 2004).8 On 
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  In anthropologist Victor Turner’s rendering of liminality, the condition of “being on the 
threshold” and “betwixt and between” occurs within spaces of “potency and potentiality” (Turner 
1977: 33). Turner studied liminality in the context of cultural rituals marking rites of passage, 
within which he maintains the idea of neatly divided natural and cultural worlds. Turner’s notion 
of liminality inspired ideas about how embryos are transformed from clinical waste into 
laboratory treasures and orphaned children, yet I do not sustain in my work the boundary he does 
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page 8 of Bruno Latour’s morning newspaper, frozen embryos feature alongside genetically 
modified foods, endangered species, and other “imbroglios of science, politics, economy, law, 
religion, technology, fiction” (Latour 1993: 2). Latour’s encounter of a “proliferation of hybrids” 
prompted his thinking about the presumptions of modernity that maintain a solid distinction 
between nature and culture. Frozen embryos, likened to cloned transgenic animals and 
genetically modified seeds, exemplify for Sarah Franklin how “new biologicals” are 
defamiliarizing “the very nature of what it means to do or be biological” (Franklin 2001: 303). 
As Levi-Strauss might say, frozen embryos prove to be “good to think” among social scientists 
about the boundaries and dissolutions of our vital taxonomies. Here, I discuss how I approach the 
study of these cool things.  
Despite the heightened prominence of frozen embryos within debates about life itself, 
feminist scholarship reminds us that they should not be considered inherently controversial. In 
the case of embryos and fetuses, cross-cultural and historical studies demonstrate the various 
ways they operate as “actors” conscripted within diverse socio-historical agendas (Addelson 
1999). Across a range of settings, embryos and fetuses have been deemed testable (Rapp 1999), 
tentative (Rothman 1986), dangerous (Reagan 2010), haunting (Gammeltoft 2014), born as well 
as made (Franklin and Roberts 2006). They are put to work as patients (Casper 1998), consumers 
(Taylor 2008), citizens (Berlant 1997), icons (Morgan 2009), persons (Hartouni 1999), and kin 
(Roberts 2012). Sometimes they are lost (Layne 2003) or let go (Scheper-Hughes 1992); other 
times they are made to tell tales about tails (Morgan 2003), race (Tsing 2007), and environmental 
risk (Steingraber 2001). In this dissertation, I consider the controversial status of frozen embryos 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
between nature and culture. Rather, I follow recent rearticulations of Turner’s liminality thesis 
that challenge such dualisms (Squier 2004). 
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in the United States an ethnographic question rather than a natural given. Assuming this 
perspective during field research prepared me for the profoundly naturalizing tropes about 
embryos and their potential, and began drawing forth the hidden forces of their production.      
In addition to denaturalizing the idea that frozen embryos are inherent troublemakers, I 
am intentional about how I “think” them. Specifically, I am cautious about reifying them as 
already fetishized objects within American politics and, arguably, social science. Anthropologist 
Margaret Lock’s insights about brain death in Japan and the United States illustrate why in 
certain controversies it is important to “name the hybrid.” In her study, bioethical controversies 
around definitions of death focus on the technologies in question, like life support machines. At 
the same time, the ways in which brain dead individuals may pose a threat to the moral ordering 
of life remain undiscussed. For this reason, Lock sees the ethnographer’s task as “naming the 
hybrid,” the “ambiguous, technologically created entities—neither alive nor dead, both dead and 
alive” (Lock 2002b: 41). She even gives clues about how to identify it: “Its attributes will be 
suppressed, and it will appear to reside fully either in the domain of society, or that of nature” 
(Lock 2002b: 42).  
The frozen embryo hybrid in this study is already multiply named—as resource, child, 
promise, insurance, surplus, etcetera. And for any reader of American news, frozen embryos are 
simply hard to miss. Rather than name the frozen embryo hybrid in the midst of controversy, I 
decenter it by focusing my analysis on saving—the processes, practices, and props that 
participate in the handling of frozen leftovers. Through the lens of saving, I emphasize 
movements and relations rather than fixate on the saved entity. I distinguish my approach from 
recent scholarship on IVF embryos; rather than examine how embryos became “tools,” as Sarah 
Franklin creatively and successfully argues (Franklin 2013), this project is about the re-tooling 
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processes that transform clinical excesses into precious promises of possibility. Frozen embryos 
are constituted in, as well as constitutive of, the many fields from which I draw my conclusions, 
though I argue that they are minor characters in the dramas that play out in their name.  
Feminist science studies scholar Donna Haraway sets the tone for this mode of inquiry in 
a few ways. Haraway challenges the neat taxonomies and singular meanings that prop up 
America’s social order, especially at the intersections of science, technology, and bodies. In the 
classic essay “A Cyborg Manifesto” (Haraway 1991),9 Haraway describes the binaries that 
organize Western discourse and notions of modernity as “antagonistic dualisms,” such as 
nature/culture, female/male, self/other, civilized/primitive, etcetera. She sees such dualisms as 
artificial, and argues that they “have all been systematic to the logics and practices of domination 
of women, people of color, nature, workers, animals... all [those] constituted as others” (Haraway 
1991: 177).  
Like Haraway, I attend to the ordering of frozen things because these processes—unlike 
embryos—are intrinsically political. Saving, as I demonstrate in this dissertation, provides a lens 
for seeing new vital taxonomies. In the following chapters, I highlight many sites of convergence 
and alignment between stem cell researchers and Christian embryo adopters that challenge the 
way America’s embryo savers are often antagonistically polarized. In disrupting this particular 
form of binaristic thinking, my dissertation makes space for the quieted politics and remaindered 
ideas that do not fit neatly within the dominant trope of saving in the United States during 
uncertain times.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9	  Sociologist Jackie Orr is right: “It is hard to be a feminist graduate student in the U.S. 
humanities or social sciences after 1985 and not be touched in some way by the cyborg 
manifesto” (Orr 2012: 276).  
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If frozen embryos merit any name, I opt for Haraway’s notion of “knots,” or the 
entangled fibers of: 
knowledge-making practices, industry and commerce, popular culture, social struggles, 
psychoanalytic formations, bodily histories, human and nonhuman actions, local and 
global flows, inherited narratives, new stories, syncretic technical/cultural processes, and 
more (Haraway 1997: 128). 
 




Coming to Terms 
“The importance of things for people lies, in part, in the ways they may contribute to new 
futures.”   
- Webb Keane, “On Multiple Ontologies and the Temporality of Things”10 
 
I have touched on two key terms—value and potential—that are central to this study 
about saving embryos and merit some explaining:  
 
Value 
Like saving, value is one of those double-hinged words with multiple meanings. Within 
social theory and everyday discourse, value describes aspects of life presumed to be radically 
opposite, namely with respect to markets and morals. In the singular form, value connotes the 
material ranking and pricing of things within economic markets. In the plural form, values 
represent the practices and spaces associated with morals, ethics, and meaning. Given its 
multivalent meanings, and as David Graeber’s history of the concept thoroughly demonstrates 
(Graeber 2001), there is no shortage of ideas about value or approaches to studying it.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10	  See Material World blog: http://www.materialworldblog.com/2009/07/on-multiple-ontologies-
and-the-temporality-of-things/	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Anthropologists have shown renewed interest in value in recent years, though 
ethnographic attention to value spans the history of the discipline. HAU: Journal of 
Ethnographic Theory dedicated two issues to the study of value, in which commentators 
identified three dominant trends within anthropological inquiry: 1) how value is created through 
exchange, 2) how systems of meaning express value, and 3) how value is enacted at the 
intersection of exchange and meaning (da Col 2013a; da Col 2013b). In this dissertation, my 
questions about value touch on literatures from all three lines of reasoning, though I draw 
inspiration mainly from the latter group due to their emphasis on value in action (Munn 1986) 
and curiosity at the crossroads of morals and markets (Maurer 2005).   
A question guiding this project is how embryos are valued, at the core of which is the 
premise that value is created. The creation of value, as anthropologist Katherine Verdery notes 
with respect to the de- and re-valuation of land in postsocialist Transylvania, is often a highly 
political process and one contingent on context (Verdery 2003). I develop my study of the values 
created around excess embryos from literatures on exchange, within which we learn that the 
value of the thing does not emerge inherently from the thing itself.  
A key figure in this line of thinking is Karl Marx, who challenged classical economic 
theories that the value of commodities was inherent to their qualities. Instead, Marx forwarded a 
labor theory of value in which he described how value accumulates through the alienated 
energies of workers expressed in making a product, or what he called labor (Marx 1981 [1885]). 
Sociologist Georg Simmel also challenged economistic thinking through a theory of value in 
which he located value within the context of exchange and described it as the effect of individual 
desire (Simmel 1900). While Marx and Simmel offer contrasting perspectives about how value is 
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made, what both usefully do is denaturalize the idea that value arises from the essence of a 
commodified thing. Specifically, they show how value is actively produced.  
Economic theories of value continue to garner interest among social theorists seeking to 
understand how value is generated within advance capitalist economies. Biovalue, for example, 
is a concept coined by feminist scholars of tissue economies to make sense of the way biological 
matters—especially the products of women’s reproductive labors, like eggs and embryos—
produce new forms of wealth (Cooper and Waldby 2014; Waldby 2002). Central to the study of 
biovalue is troubling the naturalizing idea that biology itself—given form through embryos, 
marine algae, cancerous cervical cells, etcetera—is inherently generative of surplus value 
(Cooper 2008; Cussins 1998; Franklin 2007; Helmreich 2008). Like feminist scholars of 
biovalue, I too am dedicated to revealing the hidden forces beyond the biological materials that 
transform their cellular matters into valuable workhorses. Even in the new context of biology, 
theorists of value still take interest in its creation.    
An advantage of studying values in production is that it redirects attention focused 
intently on frozen embryos to the broader processes through which they come to matter. As a 
result of intense focus on embryos themselves as “icons of life” (Morgan 2009) within the 
United States, they increasingly appear to be autonomous things detached from their physical 
contexts and social ties (Morgan and Michaels 1999; Petchesky 1987). I am aware that my 
attention to them contributes to naturalizing them as free-floating, potent things, even while I 
endeavor to critique these effects. In response to severing of embryos from their many social ties, 
feminist scholars compensate by addressing the “hidden sources of production” (Morgan 2009) 
and other methods for laying bare how they are made, not born. It is within these efforts that I 
approach my study of the enigmatic excess embryo and the multiple values that condition their 
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possibilities. And as is perhaps becoming clear, not only is the creation of value a highly political 
process—so too is the study of it.    
 
Potential 
Another question guiding this dissertation is why potential is considered valuable and 
worth saving. Over the course of investigating how frozen embryos are saved within embryo 
adoption programs and stem cell tissue banks, participants regularly directed me to the topic of 
potentiality. In answer to Warwick Anderson’s question what becomes the value of this thing, the 
remainder?, study participants across my field sites, in striking agreement, suggested frozen 
embryos are valuable because of their potential. What is potential and how did embryos get it?  
Potential is defined as the latent quality, ability, or capacity to develop into something 
one day (OED). When embryos are said to have or contain potential, one is likely speaking about 
the qualities perceived to be inherent or essential to an embryo. For reasons explained below, I 
explore the idea of potential as a naturalizing concept at the same time that I highlight the many 
ways it is produced and preserved. Similar to how I address the topic of value, my questions 
about potential arise from two intellectual traditions: political economic identifications of forces 
that propel and produce potential, and discursive tracings of what potential—as a concept, 
substance, and process—does. 
Potentiality is a new area of interest within anthropological literatures, as discussed in a 
recent special issue in Current Anthropology on potentiality and biomedicine. The editors 
suggest three definitions of potential: 1) a hidden force determined to bring about a future 
already built in; 2) plasticity to transform into something entirely different; and 3) latent 
possibility available to human modification toward something else (Taussig and Helmreich 
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2013). Similar to the way science studies scholars mobilize frozen embryos to illustrate their 
respective theories about liminal lives, cyborgs, hybrids, and new biologicals, the journal editors 
use the example of an IVF embryo to demonstrate their three definitions of potential. “It is a sign 
of the complexity of the concept of potentiality that an embryo can be understood in terms of all 
three of these articulations” (Taussig and Helmreich 2013: S4), they suggest, though I see it in 
reverse: it is a sign of the complexity of saving embryos that refracted meanings of potentiality 
become intelligible.  
The papers within the Current Anthropology edition approach the study of potential in 
multiple ways: as an analytic, an ethnographic object, and a cultural process, and they gesture 
toward future intellectual work on potential as an imaginary and a method. In broader social 
science literatures, potentiality is one of those “future tense” concepts (Selin 2011) akin to ideas 
about expectations, promise, speculation, vision, hope, and anticipation. Such conceptual 
innovations are evidence that social science scholarship is taking increasing interest in how 
tropes of promise and redemption commingle with anxieties about the uncertain.  
Countless thinkers within Western philosophy and Christian theology have engaged with 
the concept of potentiality since Aristotle first introduced the idea in Book Theta of Metaphysics. 
As a result of musing about potential within Western traditions for multiple millennia, Agamben 
suggests that “the vocabulary of potentiality has penetrated so deeply into us” (Agamben 1999: 
178) so as to seem a natural given. Core features of Aristotle’s argument are that potentiality is in 
a teleological relationship with actuality and actuality is superior to potentiality. Potential in 
Aristotelian thought is construed as amorphous matter that yearns to become an active, specific 
form, and achieves this by moving unidirectionally toward actuality. Aristotelian notions of 
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potential are profuse within social theories that involve teleological premises like progress, 
revolution, becoming, and emergence, as well Christian theologies of redemption and end times.  
In this dissertation, I take interest in the Aristotelian suppositions that subtend Christian 
and scientific ideas about surplus embryos. While IVF embryologists, stem cell researchers, and 
pro-life activists differently mobilize the concept of potentiality for their respective purposes 
(Morgan 2013), they similarly recapitulate Aristotle’s naturalized, linear story of human 
generation from a fertilized egg to adult human. Their renderings reveal slippages between the 
idea of embryos containing potential and embryos being potential. However embryos are cast, 
my analytic work involves unraveling the seams of narratives that presuppose a synchrony 
between embryos and potentiality. In doing so, I bolster a central claim of this dissertation, 
which is that while excess embryos operate as icons of potential within efforts to save in 
America, the equation of embryos with potentiality is a product of social creations rather than a 
natural given.    
Despite the growing ethnographic and theoretical interest in potentiality, the ways in 
which the concept operates as a stand-in for ideas about reproduction remain unexplored. To 
address this lacuna, I situate this dissertation within efforts that began forty years ago among 
feminist scholars to systematically “drag” reproduction to the center of social theory and identify 
the ways that reproductivity is at work within social life (cf. Ginsburg and Rapp 1995). This 
scholarship usefully expands the definition of reproduction beyond the naturalized framework of 
biological procreation. For example, feminists have long critiqued social theory’s overemphasis 
on production with the effect of obscuring and naturalizing reproduction as a social and political 
process (Harding 1981; Harris and Young 1981). Recent scholarship continues the tradition by 
articulating new theories of value that address global hungers for the “biovalue” presumed to be 
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latent within newly circulating reproductive materials, like donated eggs and surplus embryos 
(Cooper and Waldby 2014). Ethnographic insights from the lived experiences of people with and 
wanting leftover embryos contextualize feminist theories of reproduction, and invariably 
reconfigure them. In my examinations of how potential is produced, valued, and preserved 
within embryo remainder economies, I highlight the centrality of reproduction within Christian 
and medico-scientific visions for redeeming life in America.  
In the everyday conversations I had across field sites, I noticed that potential is often 
considered a natural quality of frozen embryos. In the truest sense of the word “resource,” 
coming from the French source meaning a spring of water, the people I spent time with in 
diverse settings thought of embryos as resources, lying in wait of human creativity to transform 
their inherent potency into a product or child for human enrichment. For pro-life Christian 
donors and adopters within the Blossom program, embryos are considered valuable because their 
essential worth as humans is already contained within them and vibrates with possibility that 
many described as potential. For researchers and staff of Sutter University’s Stem Cell Institute, 
embryo potential is also already contained within them, rooted in their cellular potency. In 
current cell biology, it is commonly accepted that embryos contain potent cells described as 
“pluripotent,” which is a kind of cell that could become any one of the 220 cell types in the 
human body.  
But as a group of ethnographers on the timely topic of resources argues, such wellsprings 
of value are better understood as made, not found (Ferry and Limbert 2008). The promising 
qualities that are presumed to be latent in the “nature” of a resource, such as crude oil or mined 
silver, is a product of social, historical, and political processes. In this dissertation, understanding 
how potential is naturalized is key to understanding how and why frozen embryos are saved.  
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At the same time that Blossom and REDEEM program staff and participants conveyed to 
me that embryos are naturally potentiated, and therefore valuable, my experiences within each 
organization suggested instead that embryo potentials are produced, and contingent. In Chapter 
2, I explore the role of embryologists at Harrington Fertility clinic in culturing potential through 
clinical systems of ranking and grading in vitro embryos. In Chapters 3 and 4, I look at how the 
organizing logics of waste and rescue within the respective donation programs transform IVF 
embryo potentiality into new possibilities as research treasures and adoptable orphans. After 
examining how embryo potentials are sorted out within Blossom and REDEEM in Chapter 5, I 
ask what happens to the potential among the donated embryos that nobody wants. And in 
Chapter 6, I return to the story of Adam and Julie Gold’s ML4 embryo to discuss their 
unprecedented tax experiments as a way to open up the question about the “liveliness” of 
potential and the role of embryo givers and receivers in producing it.  
Common to these chapters is an emphasis on the labors and forces that go into making 
embryo potential. As stem cell biologists working at the microscope spoke matter-of-factly about 
the powers unique to stem cells, they detailed in the same breath the intensive hours they work 
around the clock feeding and culturing their cells; described the volatile political and funding 
climate that determines what kinds of research questions they can pursue with their cells; and 
conveyed how lucky they felt to be based in a well-resourced lab in a prestigious university that 
provides an environment abundant with instruments, media, and colleagues key to the success of 
their experiments. If embryonic stem cells are the potent “golden eggs” of stem cell research, I 
take interest in the labors involved in tending the goose.  
The story is much the same within the Blossom Embryo Adoption program. There, all 
embryos are considered precious preborn children whose value is morally fixed and indisputable. 
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This has not precluded Blossom staff members from working intensively to turn IVF remainders 
into adoptable frozen orphans, an outcome good for their moral principles and their business. 
Their efforts include: maintenance of a “special embryos” website to help “find homes” for the 
hardest to match embryos; monthly webinars to reach adoption agency staff, fertility clinic 
professionals, and prospective embryo donors and adopters about the benefits of adopting 
embryos; required adoption parenting education classes for clients receiving embryos; secured 
grant funding from the Department of Health and Human Services to promote awareness of 
embryo donation and adoption; attendance of Blossom families and children at national events in 
opposition to embryonic stem cell research. These labors are the hidden sources of production 
that make embryo potentials, and by extension, make embryos valuable.  
As a future-oriented concept, potentiality provokes thoughts about how frozen embryos, 
regarded by Haraway as materializations of the “future-in-the-present” (Haraway 1997), relate 
to, and are located in, time. Anthropologist Kevin Birth acknowledged the challenge of studying 
time ethnographically by suggesting, “Cultural conceptions of time do not lie by the side of the 
road waiting for an ethnographer to wander by and pick them up” (Birth 2004: 70). Yet potential 
seems to be one of these roadside findings that refracts, like a prism, how embryo savers today 
relate to the unknowns of tomorrow.   
In the following chapters, I demonstrate how frozen embryos are subject to simultaneous 
temporal imaginings that arise in debates about their futures. The stem cell scientists of Sutter 
University express a future-oriented morality toward the natural world, which they consider to be 
available—and proper—for human use in order to realize the potential of left over embryos. 
Otherwise they perceive unused embryos as remainders lying unnecessarily in waste, a 
perspective that echoes John Locke’s treatise on the making of property from inert nature 
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through creative human energies (Locke 1964 [1689]). Embryo potential, in the eyes of stem cell 
biologists, is a promising, positive, and in potentia force.  
By contrast, embryo adoption proponents express a more nostalgic lament about the 
exploitation of embryos as a resource by modern technologies. They challenge the destructive 
effects of treating embryos within IVF as being “cheaper by the dozen” because they believe it 
cheapens human experience more broadly, a view that resonates with Heidegger’s critique of 
transforming nature into a “standing-reserve” (Heidegger 1977: 320). Embryo adoption 
advocates also express longing for a return to white middle-class Christian American values 
premised on the traditional ways we likely never were (Coontz 1992; Stacey 1996). Such 
simultaneous visions of pasts and futures come into relief as I approach frozen embryo 
remainders as timely resources relevant to the embryo saving programs I studied.   
Haunting the margins of this ethnographic consideration about the valuing of frozen 
embryos is the question about the value of the remainder itself, or what Derrida calls the 
“spectral effect” of the commodity and “apparition of the inapparent” (Derrida 1994). 
Anthropologists have attended thoughtfully to the hauntings of various collected matters—such 
as brain tissue of kuru epidemic victims (Anderson 2008), DNA samples of Native Americans 
(TallBear 2013), and unearthed indigenous graves in museum storehouses (Fine-Dare 2002)—
and concluded that the spirits of their “donors” cannot be easily conjured away by the rigors of 
science or law. In the pages that follow, I make space for the hauntings within embryo 
potentialities and my analyses of them. I also keep an eye out for traces of the past within 




Methods: Field Sites and Data Collection 
The Field 
Fieldwork for this project occurred over the course of twenty-seven months (2008-2013) 
in the United States, and primarily in the state of California. Entry into the highly charged 
controversy meant engaging with some of the polarizing terms. By design, this project confronts 
the tensions between secular science and Christian fundamentalism by studying comparatively 
two organizations offering solutions for the problem of what to do with leftover IVF embryos: 1) 
the Blossom Embryo Adoption Program of the Pacific Christian Adoptions agency located in 
Orange County and 2) the REDEEM Biobank within Sutter University’s Stem Cell Institute 
located in the Bay Area. Similar to other comparative ethnographic projects at the crossroads of 
controversy (Ginsburg 1989; Lock 2002b), this research approached the opposition between 
science and Christianity, as well as other dualisms, as an ethnographic starting place—rather 
than a foregone conclusion—for understanding how and why surplus embryos are saved.  
To my surprise, driving in my car countless miles on Interstate 5 and Highway 101 in 
California became a vehicle for understanding the interconnected afterlives of frozen embryos. 
Driving was a fortuitous and unintended method by which I became familiar with tacking back 
and forth between the adoption agency and stem cell institute and their associated systems for 
making embryos matter. The 500-mile stretch of highway between my two field sites turned out 
to be one of many connectors linking these field sites and the activities within them. This 
sensation of moving between realms that blurred ideas about what happens in one place versus 
another is one that I strive to maintain in my analysis and writing. For these reasons, I do not 
treat the cases of embryo adoption and stem cell research as isolated realms for comparison but 
as simultaneous solutions that are actively in conversation. 
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Though I began the project aiming to put the “realms” of stem cell science and pro-life 
Christianity into conversation, I soon realized through field research that the conversations 
between them were already ongoing. This occurred to me at various points, including felicitous 
moments when I learned that some of people I knew so well from each site knew each other too. 
Such an occasion arose when a patient at Sutter’s IVF clinic wanted to use embryos adopted 
from the Blossom program to become pregnant. Over the multi-month saga that ensued between 
the Sutter IVF clinic manager and Blossom staff about whether it would be possible, people from 
both organizations shared their struggles with me about the case. Examples like this were 
reminders for me about the relative smallness of California’s IVF and reproductive remainder 
economy within which these saving programs forward their missions.  
I chose the Blossom program and REDEEM Biobank because they are at the vanguard as 
national leaders in saving embryos in the United States. I provide a more thorough description of 
each organization in Chapters 2 and 3, but introduce some particulars of each to clarify why they 
were ideal primary field sites.  
 
Blossom Embryo Adoption Program: Saving Lives through Adoption and Birth 
Topping the backside of a Blossom Embryo Adoption brochure is a statement explaining 
their mission and name: Like a tiny seed, each embryo is small but contains everything it needs 
to blossom into a beautiful flower. Blossom emphasizes the uniqueness contained within each 
embryo and its value as a pre-born child deserving the chance to be born. The program operates 
within Pacific Christian Adoptions agency that uses adoption as a model to facilitate the transfer 
of remaining IVF embryos from donors to recipients. The first program of its kind, Blossom is a 
leading proponent of extending the rights of persons to frozen embryos.     
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Blossom’s mission is twofold. Their first goal is to extend the dignity and protections of 
personhood to frozen embryos. In their official embryo adoption contract, they define embryos 
as “pre-born children who are endowed by God with unique characteristics and are entitled to the 
rights and protection accorded to all children, legally and morally.” The program’s second goal is 
to recognize all embryos as equally deserving of the opportunity to achieve their full potential 
through birth. “We consider that every embryo is a potential continued life,” said Stacy, one of 
the program’s social workers. “We want to give them all a chance.” For this reason, Blossom 
accepts all frozen embryos into their program for placement with adoptive families, regardless of 
how they are ranked clinically. “We’re not looking at the embryology report saying, ‘Oh this 
one’s not really worth saving.’ That’s just horrible to us,” Stacy explained. Blossom challenges 
the prevailing fertility clinic practice of grading embryos into categories connoting their clinical 
worth. For donors, they offer a life-giving alternative to destructive embryonic stem cell research 
by finding homes for all embryos considered equally valuable and awaiting the chance to be 
born. The Blossom Embryo Adoption program serves a clientele across the United States as well 
as internationally from a modest office building in Southern California. 
The financial means to forward their mission is supported in part through program fees 
paid for by adoptive clients, but the lion’s share of their budget comes from federal grant monies. 
Since 2002, Pacific Christian Adoptions has received multiple millions of dollars in federal 
grants administered by the Office of Population Affairs for increasing awareness around embryo 
donation and adoption. In 2002, the United States Congress began earmarking funds for an 
Embryo Donation and/or Adoption Awareness campaign authorized under Section 301 of the 
Public Health Service Act. The grant program received Congressional approval and backing by 
the George W. Bush administration, though its origins are attributed to Pennsylvania Senator 
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Arlen Specter, a pro-choice, pro-stem cell research Republican. Senator Specter chaired the 
subcommittee responsible for determining appropriations for the Departments of Labor, Health 
and Human Services, and Education.  
In reference to the $123 billion dollar bill Sen. Specter’s subcommittee helped pass, and 
the $2.9 billion dollar increase in funding to the National Institutes of Health that year, he spoke 
about the allocation of $1 million dollars to a new program for embryo adoption awareness 
during the December 20, 2001 Senate session:  
A controversy has arisen because some object to stem cell research because they are 
extracted from embryos and embryos can produce life… If any of those embryos could 
produce life, I think they ought to produce life and not to be used for stem cell 
production. But if they’re not going to produce life, then why throw them away? Why not 
use them for saving lives? We put into this bill $1 million, sort of a test program on 
embryo adoption. Let us try to find people who will adopt embryos and take the 
necessary next steps on implanting them in a woman to produce a life. If that can be done 
and use all of the embryos, that would be marvelous to produce life. But where those 
embryos are going to be discarded, then I think the sensible thing to do is to use them for 
saving lives.11  
 
Since 2002, three to five awardees each year received hundreds of thousands of public grant 
dollars to “educate Americans about the existence of frozen embryos (resulting from in-vitro 
fertilization), which may be available for donation/adoption for family building.”12 The Office of 
Population Affairs within the Office of the Assistant Secretary of Health administers the grant of 
which Pacific Christian Adoptions has been a regular recipient for promoting embryo adoption 
generally and the Blossom program in particular. 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11	  See transcript and archived video of the session here:	  http://www.c-span.org/video/?167943-
1/senate-session&start=5231	  
12	  See the Office of Population Affairs description of the awareness program here: 
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/	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REDEEM Biobank: Saving Lives through Science 
A decade after the Blossom program began and a few hundred miles away, the REDEEM 
Biobank’s first coordinator Tori brainstormed a list of names for the new tissue bank she was 
tasked with launching. Tori searched for words she hoped would capture the intent of newly 
funded embryo and oocyte resource center. She tried words like regrow, revive, strive, pluri, and 
potent, eventually settling on the program name, REDEEM, which she made into an acronym: 
REgenerative Medicine and Discovery through the Ethical Procurement of Embryonic 
Materials.  
The precipitating context for REDEEM Biobank was the limiting of U.S. federal funding 
for research on human embryonic stem cell research (Scott 2006). Soon after the establishment 
of the first human embryonic stem cell line in 1998, President George W. Bush announced to the 
nation on August 9, 2001 during his first Presidential address an executive policy that limited 
federal funding for embryonic stem cell research. This policy restricted federal dollars—though 
not state or private funds—to research on human embryonic stem cell lines that were derived 
before August 2001. Although Bush’s executive order had a cooling effect on the burgeoning 
field of embryonic stem cell research in the United States (Korobkin and Munzer 2007), places 
like California experienced it as a boon. Several states responded by filling gaps in federal 
funding with state tax funds while others went beyond the Bush policy to pass laws prohibiting 
all human embryonic stem cell research at the state level. President Bush remained firm in his 
position and vetoed two bipartisan Congressional bills in 2006 and 2007 that would have freed 
up federal funding for embryonic stem cell research. Soon after entering the White House in 
March 2009, President Barack Obama also announced an executive order on the topic, this time 
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revoking the Bush-era funding restrictions and allowing the National Institutes of Health to 
finance research on a wider range of embryonic stem cell lines.  
In response to the restriction of federal dollars and the hope of curing diseases, California 
voters passed Proposition 71 in 2004, entitled the Stem Cell Research and Cures Initiative. 
Voters agreed to invest $3 billion dollars of taxpayer funds into the promise of human embryo 
stem cell research over a decade’s time. This unprecedented budget quickly surpassed in dollars 
the entire National Institute of Health’s annual funding for human embryonic stem cell research 
in the United States, which in 2003 totaled $24.8 million (Benjamin 2013: 13). California’s $300 
million annual budget for human embryonic stem cell research still dwarfs the NIH’s, which 
totaled $166 million in 201413, as well as all public investments made by other countries 
committed to embryonic stem cell research, including the United Kingdom, Israel, Singapore, 
and Japan (Benjamin 2013). With the passage of Proposition 71, California catapulted onto the 
international scene as a world leader committed to the promise of research with human embryos.  
Proposition 71 established the granting agency, the California Institute for Regenerative 
Medicine (CIRM), that oversees the allocation of funds for human embryonic stem cell research 
within California and the Independent Citizens’ Oversight Committee as CIRM’s governing 
body. REDEEM Biobank was established through a CIRM grant meant to launch a Sutter 
University-based frozen embryo resource center that provides expert management of and access 
to human embryos for scientists around the university and state. 
REDEEM’s mission, according to the current director, Dr. Pat Dunn, is altruistic and 
twofold. An early Biobank brochure describes the first part of its mission in formal terms: “To 
optimize the use of precious resources for an increased knowledge of basic science and the future 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 See NIH “Estimates of Funding for Various Research, Condition, and Disease Categories” 
table, February 5, 2015: https://report.nih.gov/categorical_spending.aspx   
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treatment of human diseases.” The precious resources Sutter scientists needed were embryos in 
order to continue the work of deriving stem cell lines, studying disease development, and testing 
therapies on human tissues that may lead to cures.14 “The situation was that we need 
blastocysts,” Dr. Dunn explained, “so we decided that we’ll take any unwanted embryos.”15 This 
began a multi-year process of grant writing, legal consulting, and protocol development to be 
able to begin receiving the first frozen embryo donations from fertility patients in June 2008. 
REDEEM’s welcoming of all leftover IVF embryos without exception for stage or grade made 
the REDEEM Biobank one of the premier donor sites for fertility patients around the country.  
“By the same token,” Dr. Dunn explained, “the Biobank provides an ethical disposition 
option for patients who have a difficult decision to make.” For IVF patients considering donation 
options, Dr. Dunn feels that REDEEM “provides a way for people to dispose of their embryos in 
an honorable way. It is truly a tremendous savior option for people who spent money and effort 
to get to what they achieved. Now they want to stop paying but don’t want to throw embryos 
away and don’t want to give them to someone else.” Serving also as Sutter University’s IVF 
clinic director, Dr. Dunn is committed to patient satisfaction and maintaining the university’s 
good name. Thus, one of her primary concerns is providing a smooth donation process for 
patients. For researchers and fertility patients, the dual purpose of REDEEM Biobank is to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14	  Embryonic stem cells are considered precious because they provide scientists alternatives and 
complements to traditional disease research based on animal models. Alzheimer’s disease, for 
example, has proven challenging to mimic in animal models. Therapies with promising results in 
animals exhibiting a form of Alzheimer’s have proved ineffective in human trials. Embryonic 
stem cells allow researchers to develop stem cell models in vitro that illuminate how Alzheimer’s 
develops as a disease as well as provide the opportunity to test drugs and therapies on actual 
human cells. Additionally, the ability of embryo cells to become nearly any type of the 220 cells 
that make up human bodies has inspired researchers to try developing therapies, such as 
regenerative tissue transplants, that may replace cells destroyed by degenerative diseases like 
Alzheimer’s.	  
15 Blastocyst describes the developmental stage of a fertilized egg typically 5-6 days after 
fertilization.  
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provide invaluable research opportunities for saving lives and a pleasant donation experience, 
and to serve as a salve for all. 
--- 
Studying the afterlives of frozen embryos in the United States is invariably a multi-sited 
affair. While Pacific Christian Adoptions and Sutter University functioned as my primary field 
sites, I considered them nodes of activity from which to trace flows of people, things, ideas, 
practices, and resources. For this reason, I spent four months conducting field research at 
Harrington Fertility, a private IVF clinic in Los Angeles unaffiliated with either program. I also 
carried out interviews and site visits with other organizations around the country: two embryo 
adoption programs (Washington and Tennessee), two fertility clinics (California, Illinois), and 
two long-term cryostorage businesses (Texas, Nevada). These explorations helped me 
contextualize the themes arising from my research at Pacific and Sutter.    
Excursions beyond my primary field sites introduced new scales that proved important 
for investigating the re-valuation of frozen embryos. This challenged the coherence of “primary” 
sites being located at any one organizational, regional, state, and national level. For example, 
important to understanding Sutter University’s prominence within worldwide regenerative 
medicine research is its position at the center of “Biotech Bay.”16 The San Francisco Bay Area is 
one of the nation’s hotbeds for biotech research and development collaborations between 
industry and academia, fueled by nearby Silicon Valley bust-and-boom startup culture and 
landmark legal cases like Moore v. Regents of the University of California.17 The Bay Area is 
also the seat of power for Proposition 71 grants that fund speculative ventures within stem cell 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
16	  See other biotech hotbed maps around the United States here: 
http://www.biospace.com/hotbed.aspx?regionid=11	  	  
17 See Chapter 3 for more discussion about this case. Moore v. Regents of the University of 
California, 51 Cal 3d 120, (California Supreme Court, July 9, 1990)	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science; San Francisco won the bid as hosting site for the proposition’s oversight and granting 
agency, the California Institute for Regenerative Medicine. 
 Similarly, Southern California’s national significance in the history of Christian 
evangelism and New Right politics makes it a meaningful region for understanding how embryo 
adoption fits within “Sunbelt” society values. The roots of California evangelism originated with 
white Christian migrants moving in massive waves to California from the South from the 1930s 
through the 1960s. The Depression-era migrants carried their plain-folk churches with them, as 
historian Darren Dochuk argues, and over time “forged a vigorous cultural force, one that 
melded traditionalism into an uncentered, unbounded religious culture of entrepreneurialism, 
experimentation, and engagement—in short, into a Sunbelt creed” (Dochuk 2011: xviii). The 
Sunbelt society of Southern California became a crucible for the conservative revolution that 
burst onto the national scene in the 1970s with the election of Jimmy Carter (1976-1980)—the 
first self-professed evangelical Christian elected president—and helped maneuver Christian 
politics into power with Ronald Reagan’s governorship (1967-75) and presidency (1980-1988). 
Characterizations of the Bay Area and Orange County map on to a narrative about a 
cultural and economic divide between Northern and Southern California, a story I am familiar 
with as someone who was raised in the state. The tale of two Californias is an old one, within 
which lingers a story about the divided American nation along North-South lines indicative of 
incommensurable worldviews. While there are notable truths to the differences between the Bay 
Area and Orange County, I remain cautious of the obscuring and othering effects of binaristic 
thinking. For this reason, the state of California as observed within national and international 
contexts serves as another “site” for thinking about the admixture of IVF embryo afterlives 
across shared geographic, historical, political, economic, and social circumstances. 
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Once the Western frontier of the American nation and its manifest imaginaries (Turner 
1920 [1893]), California is still often considered the “Wild West” for reproductive politics. The 
state is well known for laws and policies that smooth the way for all forms of third-party 
reproduction, including sperm, egg, and embryo donation; surrogacy; and adoption. The Johnson 
v. Calvert18 surrogacy case, for example, secured the parenting rights of couples commissioning 
surrogates, which contrasted with the famous “Baby M” case in New Jersey where the woman 
who gave birth—the surrogate—was declared the legal mother (Rose 1996). As a result, 
California ranks as a national leader when it comes to the business of making families. Of the 
486 IVF clinics in the United States, California is home to 75 where clinicians performed over 
25,000 IVF cycles in 2012.19 Also, more adoptions are completed each year in California than 
any other state (Gailey 2009). In this dissertation, I do not consider California a microcosm of 
America, which is the productive angle Faye Ginsburg takes in her comparative study of pro-life 
and pro-choice activism in Fargo, North Dakota (Ginsburg 1989). Rather, I think of California as 
a very large Petri dish where different experiments are underway to cultivate the potential of 




With saving practices situated at the heart of this analysis, I utilized three main 
ethnographic methods—participant observation, interviews, and document analysis—to trace the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
18	  Johnson v. Calvert, 851 P. 2d 776 (California Supreme Court, May 20, 1993). 
19 Official IVF statistics are tracked in the United States per mandate by the Fertility and Clinic 
Success Rate and Fertilization Act of 1992. This Congressional law requires clinics in the United 
States performing IVF to annually submit data to the Centers for Disease Control, which 
compiles and publishes annual reports of reproductive technology trends and outcomes. See the 
Center for Disease Control Assisted Reproductive Technology Success Rates site: 
http://www.cdc.gov/art/reports/index.html  
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making of frozen embryo potentials from IVF clinic freezers to adoption agencies, tissue banks, 
research labs, wombs, and waste bins. 
 
Participant Observation 
My first visit to Pacific Christian Adoptions (June-July 2008) involved exploring the 
feasibility of the project. I later returned to Pacific for research stints lasting two to six weeks at a 
time over a period of two years (February 2011-April 2013). During those visits I learned 
through observations of life within the Blossom Embryo Adoption program how IVF embryos 
were transformed into adoptable orphans and clients into parents. My initial liaison was the 
agency Director of Public Affairs, whom I first contacted by calling with expressed interest in 
conducting a pilot study during Summer 2008. Upon my return in 2011, the Blossom program 
manager Monica became my main contact for the duration of field research. She and I worked 
out the practicalities of being on site for weeks at a time, such as what files I could look at and 
where I should sit. Monica was responsible for my presence in the agency and was consistently 
generous with her time and ideas.  
I commuted to the office most weekdays and finished field notes at a café after work 
while waiting for highway traffic to slow. I became a regular fixture in the “engine room” of the 
Blossom program, a windowless office on the second floor of the agency wherein three staff 
were stationed: the program manager Monica, the social worker Kathy, and the Program 
Assistant Sarah. I set up a table in the middle of the room from where I felt comfortable asking 
questions about files I was looking at or pulling my chair over to look at someone’s screen with 
them. I worked alongside staff with my laptop open and documenting what occurred around me, 
which was intermixed with conversations and activities like team meetings, embryo matching 
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sessions, and parenting education classes for adoption clients. Overhearing half of a phone call 
conversation was sometimes a prompt to ask about why they devised a particular rule for the 
adoption program. Advice they sought from each other about a challenging file allowed me to 
chime in with clarifying questions. Normal outbursts of surprise, worry, and joy were the starting 
points of stories about their experience with a donor or adopter. The Blossom team also shared 
their opinions with me about shifts in agency leadership and personal feelings about their job 
satisfaction. What to them was mundane stuff of an office illuminated for me how IVF leftovers 
became adoptable orphans, a task that involved a dedicated, full-time team. My presence became 
familiar to the Blossom team as well as other agency staff who would greet me with kind smiles 
and questions about how long I would be with them this time.  
Beyond the office, I participated in events with or hosted by Pacific Christian Adoptions, 
such as tabling at conferences, attending annual summer picnics and winter galas, and visiting 
the homes of embryo donors and adopters around the country (CA, IL, OR, WA). Also, as I 
developed working relationships with the Blossom team, I began spending time with them 
beyond the agency. Monica became a primary informant with whom I spent the most time 
debriefing our days on long walks, cooking dinner with her husband, and bonding over one of 
her favorite things: line dancing. Sarah was also an exceptional informant, keeping notes about 
news topics from her day that she knew I would be excited to hear about. She and I kept a 
regular phone dates during the stretches between my visits in which she would update me about 
ongoing cases and program shifts. Spending time in a place where embryo personhood is the 
status quo provided invaluable insight into the making of frozen embryo orphans awaiting 
adoption and deserving a chance to be born.   
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Gaining access to research at Sutter University was a more tumultuous journey. In June 
2009, I visited another university’s Center for Women’s Health through contact with the IVF 
clinic’s staff psychologist. She and I established a research plan with for carrying out future field 
research. Their center maintained an active IVF program, tissue bank, and research lab, which 
seemed like a trifecta for examining the making and movement of excess embryos. When I 
followed up the psychologist in 2010 with positive news of my funding grant, the door that I 
thought was open had closed. She shared that the embryo donation program had not gotten off 
the ground and expressed doubt about convincing the clinic director to allow an outside 
researcher on site. This was my first lesson in the goodwill of gatekeepers in research, as Marcia 
Inhorn notes about research in fertility clinics (Inhorn 2004). At the time, it seemed like the end 
of being able to study the donation of embryos to stem cell research. I would later discover 
through field research at Sutter University that it was actually the beginning: this was my first 
piece of data about the logistical hardships and eventual closure of many research tissue banks 
around the country, on which I elaborate in Chapter 5.  
My first trip to Sutter University was a brief two-day visit in October 2011, from which I 
was able to negotiate returning for the following year for a few weeks in September 2012. The 
Sutter IVF clinic manager was my initial point of contact, whom I initiated communication with 
as a result of an email introduction from a friend of a family friend based in the Bay Area. The 
clinic manager forwarded my requests for lengthier stays to the IVF clinic director, Dr. Dunn, 
whose willingness to have me as “an extra pair of eyes” opened many doors for me at Sutter 
University. Once on campus, I was welcomed to stay the 2012-2013 school year from September 
2012 to April 2013. There I learned through everyday life in a fertility clinic and laboratory how 
IVF trash was transformed into laboratory treasure.     
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I conducted field research at Sutter within two connected sites: the IVF clinic and within 
Dr. Christine Moto’s research lab in the Stem Cell Institute where the REDEEM Biobank was 
housed. Within the IVF clinic, I shadowed doctors, nurses, and embryologists to understand how 
embryos are made, managed, used, stored and planned for within a fertility clinic. Since activity 
in the IVF clinic occurred in differing locations, I spent time documenting, listening, and 
conversing in the embryology lab and main staff office. When based initially in the clinic, I 
walked the oft-traveled path from the IVF clinic to the Stem Cell Institute, where I attended 
weekly lectures and journal clubs, audited a graduate course in stem cell biology, and conducted 
interviews.  
Once based within the REDEEM Biobank office, I was provided a desk across from the 
lab manager and next to the Biobank, which was a choice spot for observing the arrival and 
management of embryos donated to the bank. The office doorway opened into one of two large 
lab spaces where I shadowed stem cell institute faculty, student and postdoc researchers, and 
tissue bank staff as they carried out their everyday desktop and bench top activities. The “embryo 
team” of researchers working most often with donated human embryos became some of my 
closest informants: Dr. Moto’s lab manager Wendy, the German postdoc Luke, the senior 
postdoc Caitlin, the genetics doctoral student Madison, and the Biobank program coordinator 
Donna.  
While much of my field research involved observation, a couple of opportunities to 
participate arose at the Stem Cell Institute. I spent a week in a CIRM funded laboratory crash 
course in deriving stem cells, which allowed me to learn hands-on about what everyone around 
me was constantly doing: working with media and instruments, dissecting mice, following 
detailed protocols, and looking through microscopes. Another participation opportunity involved 
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helping the Biobank staff do inventory, through which I learned about the major organizational 
challenges facing tissue banks. Through these activities, I traced the systems within which 
embryos at REDEEM Biobank are transformed from excess reproductive waste into precious 
resources for research. 
In addition to field research activities within Blossom and REDEEM, I strived to stay 
abreast of the broader contexts for reproductive remainder economies by attending ten national 
and regional conferences that attracted professionals on abortion (National Abortion Federation 
annual meetings), infertility (American Society for Reproductive Medicine annual meetings), 
adoption (Mapping Adoption), Christian politics (Values Voter Summit), and embryo disposition 
(Emerging Issues in Embryo Donation/Adoption). 
 
Interviews 
I interviewed two main groups: relevant professionals (e.g., doctors, nurses, social 
workers, counselors, embryologists, students, study coordinators, lab managers, researchers, 
lawyers, theologians, bioethicists) and embryo program participants (e.g., donors, adopters, and 
stem cell researchers). I recruited interviewees in person at Sutter and Blossom as well as 
through an email posting to Blossom’s client listserv. Interviews with people recruited in person 
were often conducted in person; most of the people recruited by email, who often lived all 
around the country, were conducted over the phone.  
During the period of research, I conducted 200 formal, semi-structured interviews with: 
38 embryo adoption professionals; 65 embryo adopters; 30 embryo donors; 30 fertility clinic 
professionals; 10 tissue bank professionals; 10 stem cell scientists; 10 stem cell biology PhD 
students; and 7 active fertility patients.  
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Document Analysis 
Documents, in anthropologist Annelise Riles’s view (Riles 2006), are intermediaries 
between systems of meaning and material practices; they are storable hybrids of their own kind. 
Given the focus of this study on frozen embryo hybrids at the confluence of meaning and matter, 
documents were essential for my ethnographic study. I gathered documents of countless kinds, 
though generally documents internal to program organization (donation and adoption files, client 
databases, donor consent forms, embryology reports), for embryo program donors and clients 
(applications, letters, contracts, consents, brochures, template emails), for external advertising 
materials from each program (brochures, websites, webinar power points, quarterly newsletters, 
books published by adoptive clients for their children). I also gathered 90 matched embryo 
adoption files (every tenth file in their database counting up to 900), specifically the donor and 
recipient letters, applications, and matching fact sheets. 
--- 
To conclude, I reflect on the effect of my positionality on research and my reception in 
the field. As a feminist ethnographer, I remain mindful that all methodological and analytical 
choices that informed this study come from situated knowledges (Haraway 1988). As a U.S. 
ethnographer studying “at home,” I was regularly confronted with the circumstance of being an 
insider on some occasions, and an outsider on others. My interest in frozen embryos derived 
from an ongoing participation in reproductive politics and advocacy in the United States. 
Leftover embryos came to my attention first in Katherine Verdery’s property course as an entity 
within divorce cases that fit awkwardly within legal categories of property and personhood. As a 
reproductive justice advocate involved in grassroots efforts in New York and Oregon, I remained 
keenly aware of the role that frozen embryos increasingly played in the erosion of abortion 
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access and criminalization of pregnant women. As embryo and fetal personhood gained 
prominence within these politics, the potentiality that frozen embryos contained for partners in 
my advocacy groups was the capacity to dismantle hard won reproductive freedoms. This 
invariably informed my interests in the field and in writing.  
Even though I was at “home” in California—my state of origin—I was an outsider in 
many ways: I have not experienced infertility or IVF, have not participated in adoption, do not 
identify as pro-life or Christian, and am not trained in the biological sciences. Yet in many others 
ways, I passed: at Sutter, I was another doctoral student in training conducting a research study. 
At Pacific, my whiteness, gender presentation, age, and college education were similar to agency 
staff, which tempered the ways in which I stuck out as a non-Christian and an anthropologist.   
My reception as an anthropologist at Sutter involved finding a preexisting category 
within which I could fit, which was as a “visiting student researcher.” Not long after my arrival, 
Dr. Dunn introduced me to others as her “student,” a designation of mentorship that helped 
leverage opportunities for me within the IVF lab, Stem Cell Institute, and beyond. Science at the 
Stem Cell Institute is premised on interdisciplinary collaborations, though I was the first 
anthropologist to ask Dr. Moto to do research in her lab. Like the other 30 students and postdocs 
that Dr. Moto supported, she made room for me to “join” her lab where it was not always clear to 
me who was being researched. Luke teased me when I shadowed him during experiments and 
during coffee breaks about feeling like a mouse being studied. Yet he also regarded me as a 
colleague; Luke wondered if I planned to start my own lab one day as principal investigator, as 
he did. He also warned me to be aware of my data being “scooped,” or stolen and published first, 
by a competitor in my field—an anxiety of many lab scientists who are racing to publish findings 
in journals that are critical for career advancement. Each person I encountered was generous with 
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their time, with some wondering when they would get a turn to be interviewed as I worked my 
way down the bench rows. Others, like the past and current Biobank coordinators, were 
noticeably guarded when I pulled out a tape recorder or laptop. I chalk this up to rapport; they 
did not know me but were told that I would be learning the ins and outs of their daily work, a 
circumstance that could make anyone—myself included—feel cautious. When my recording 
devices for data collection seemed to hamper easy conversation, I relied instead on handwritten 
notes and my recollections.      
My reception at Blossom paralleled what I came to learn about adoption and evangelical 
Christianity. The embrace of “outsiders” is a part of the evangelical process of missionizing, 
which Christian adoption takes to another level within the family structure of welcoming 
outsiders in. As the flagship embryo adoption program with a visible presence in the public eye 
around stem cell research, they were accustomed to talking with journalists about their work. 
They knew that even bad press had been helpful for their program, which is why the agency 
expressed disappointment when we discussed not using the agency’s name in my publications in 
accordance with human subjects protections. Despite their disappointment, Pacific was 
accustomed to participating in research; they had helped various students at the local evangelical 
university and a few M.A. and Ph.D. level researchers by posting recruitment flyers to their 
listservs. But having an ethnographer show up each day was unprecedented at the agency. In 
many ways, I felt adopted into the organizational family; at times, the joke was made that I might 
as well be added to the payroll. The bulk of my time was spent in the company of the Blossom 
team, and the lines between what was on and off the record were often blurred. Although I was 
prepared to discuss the fact I identify neither as Christian nor pro-life, staff and program 
participants never raised it for discussion, which was both surprising and a relief. I expect that all 
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participants used their own perceptive knowledge and evaluations about me to inform how, 
when, and what they shared in our conversations.    
 
Organization of Dissertation 
I organized this dissertation around keywords—saving, value, culture, conversion, 
redemption—that capture, as doubles entendres, the simultaneous meanings words and embryos 
often contain.  
Chapter 2, “Culturing: Making Potentiality within an IVF Laboratory,” argues that IVF 
labs are places where embryo potential is made and born. This chapter establishes how frozen 
embryo potential is produced through clinical grading practices, and how their potentiality is 
suspended in a limbo state once cryopreserved in anticipation of future redemption.   
Chapters 3 and 4 analyze embryo revaluation through processes of wasting and rescuing. 
Through the lens of saving, I examine each program’s respective commitment to prevent waste 
and to rescue. I argue that each serves a parallel role within speculative economies by converting 
IVF potentials into new forms: on the one hand, turning clinical trash into laboratory treasure, 
and on the other, making extra embryos into abandoned orphans waiting for a chance.  
Chapter 3, “Wasting: Making Embryo Trash and Treasure in a Stem Cell Institute 
Biobank,” argues that waste prevention is a paradigmatic feature of stem cell science. Despite 
the common regard for frozen embryos as un-wastable, I argue that the REDEEM Biobank’s 
procurement practices “trash” valued materials in order to ready them for use as precious and 
promising research materials.  
Similarly, Chapter 4, “Rescuing: Making Embryo Orphans in a Christian Adoption 
Program,” explores the centrality of saving ethics within the Blossom Embryo Adoption’s 
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efforts to leave none in the cold. I argue that rescue practices facilitate the making of orphan 
embryos from IVF remainders, which are simultaneously regarded as without origins and 
deserving of a chance to be born. Rescue in the Blossom program, like the waste prevention at 
Sutter, serves as a guiding ethical rubric for doing good during uncertain times.  
At the time of donation, leftover IVF embryos contain “potencies” (Munn 1986) to 
become anything. Chapters 5 and 6 examine efforts to manifest ways for embryos to realize their 
potential, or what I understand through the concept of redemption. Chapter 5, “Sorting: 
Archiving Embryos for Viable Futures” illustrates how once donated, frozen embryos are 
differentiated through valuation systems that render frozen embryos differently viable for 
particular futures. In both settings, various circumstances render some remainders “hot 
commodities” while others as destined to “wait.” I examine what happens when the least viable 
embryos within Blossom and REDEEM embryos appear to be unredeemable. Specifically, I 
analyze the concept of circumstantial viability through two stories about the programs’ most 
logistically burdensome and hardest to match donated embryos. Problem embryo cases reveal 
how powerful potentiality is, once produced.  
Chapter 6, “Redeeming: Claiming Potential Makes Moral Cents,” tells two stories—one 
family’s adoption of nine embryos and another’s donation of a genetically abnormal embryo for 
research—in which both filed tax returns attempting to save money as well as save lives. One 
family filed for an adoption tax credit while another filed for a tax exemption based on their 
charitable donation of “property” to REDEEM Biobank. These accounts suggest that the 
priceless child often has a price and intimate relations are not beyond purchase (Zelizer 1979; 
Zelizer 1985).  
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The Conclusion, “What Remains,” reviews this dissertation’s extended answer to the 
question posed by Anderson—what becomes the value of the remainder?—and makes some 











































Culturing: Making Potentiality in an IVF Laboratory 
 
On my third day at Harrington Fertility’s Paloma clinic, Zhao expressed his frustration 
with the amount of paperwork he and Ken have assumed as senior embryologists within the IVF 
lab. Rather than manage all of the files resulting from the hundreds of IVF cycles they perform 
each year, he prefers working with pipettes and under the microscope. In an ideal scenario, Zhao 
and Ken would like to see the administrative tasks of embryo storage and disposition, inventory 
logs, and shipment delegated to other staff or subcontracted out to other businesses. This would 
allow them to focus on what they consider their real work to be: “An embryologist's job,” Zhao 
explained, “is to make babies.”20  
Over the next few months at the Paloma clinic, I took interest in the work embryologists 
do. I shadowed Zhao, Ken, and other clinic staff while observing the mundane tasks and 
everyday practices that comprise IVF laboratory life. Babies, I learned, are not the only things 
embryologists make. At the bench, embryologists create embryos through processes of 
fertilization, grading, selection, and transfer. They generate reports, manage files, update 
logbooks, and maintain databases. They establish classificatory systems and standardized 
protocols for monitoring lab conditions and cellular matter. And embryologists make 
opportunities for their clients to become parents through the possibility of pregnancy. Within 
Paloma’s IVF lab, the many bench top and desktop activities elucidate what else is produced in 
the process of making IVF babies.   
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 On one level, Zhao’s statement echoes a common trope about IVF as a “baby-making” 
technology. While critics of IVF invoked dystopic images of scientists in laboratory-factories 
where fetuses are made and grown to term in artificial wombs, IVF in the United States was 
quickly mainstreamed as a method for assisting conception. Within the curiously normalized 
context around ARTs, Zhao’s claim to “make babies” suggests a different picture: of helping 
fertility patients become parents. 
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In this chapter, I argue that the IVF clinic is a setting where embryo potential is 
“cultured,” or made and mediated by processes extrinsic to the embryo itself. Like historian of 
science Hannah Landecker, whose history of cellular life in vitro inspired this chapter 
(Landecker 2007), I approach culturing as a way to understand how cellular life forms are 
produced utilizing the whole apparatus supplied by the IVF laboratory. Culturing involves an 
assemblage of protocols, techniques, methods, and infrastructures within the biological sciences 
that manage cells in vitro. Specifically, I focus on the role of embryo grading within the IVF 
embryology lab, which is a technique for sorting out which embryos are perceived to have the 
best chance to establish pregnancy. My analysis of how IVF embryo potential is cultured 
provides the foundation for understanding what is taken up in the next four ethnographic 
chapters: how frozen embryo potential is revalued within REDEEM Biobank and Blossom 
Embryo Adoption program. In order to understand how frozen potential is revalued, we must 
first establish how IVF embryos come to contain potential, and how that potential is deemed 
valuable, a story that involves a mixture of paperwork, Petri dishes, and protocols.  
 
Culturing Embryos 
Zhao’s description of embryologist-as-maker stands in tension with the deeply 
entrenched belief within Western scientific traditions that embryos are naturally occurring 
biological facts. For multiple centuries, the narrative of science as a process of discovery cast 
embryologists as the founders and describers of embryos, rather than their makers and producers. 
Like other feminist social science scholars, I suggest that embryologists have always been 
makers and embryos have always been made.  
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Consider, for instance, the images common to contemporary pregnancy literature and 
prenatal classes depicting embryological growth from zygote to fetus to baby. Today’s expectant 
parents can download a pregnancy app through which they receive weekly images or videos 
explaining, “how your baby is growing” over time (See Figure 1). Historian Nick Hopwood 
(Hopwood 2000) identified the origin of this now common view of embryological 
“development” in 1799 in Frankfurt where biologist Samuel Thomas Soemmerring created the 
first drawing that depicted embryo growth in successive, linear stages (See Figure 2). Hopwood 
argues that Soemmerring’s series did not discover and describe, but produced, the idea of human 
embryological development. This idea contained within it the narrative of a linear march of 
progress from conception to zygote to fetus to baby—a modernist trope that has been naturalized 
as scientific fact since Aristotle’s first philosophical remarks on animal generation over two 
millenia ago.   
Fig. 1. What to Expect Pregnancy app           Fig. 2. Soemmerring’s series21 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
21 Samuel Thomas Soemmerring, Icones embryonum humanorum, accessed at the Making 
Visible Embryos online exhibition directed by Tatjana Buklijas and Nick Hopwood of University 
of Cambridge, http://www.hps.cam.ac.uk/visibleembryos/s2.html. 	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Anthropologist Lynn Morgan utilizes Hopwood’s insight about embryological 
development to examine early twentieth century embryo specimen collecting in Baltimore. Her 
work reveals the “enormous amount of theoretical, methodological, technical and ideological 
work” (Morgan 2009: 111) involved in transforming embryo and fetal remains into specimen 
objects of scientific inquiry. In an illustrative example, Morgan describes the forces that shaped 
how Carnegie embryo specimen #836, the model for Stage 13 of the Carnegie’s 23 
developmental stages, came to be.22 She discusses laws, customs, and social inequalities in 
Baltimore at the turn of the twentieth century that impacted pregnancy, abortion, and miscarriage 
rates. Morgan analyzes cultural norms around mortuary practices and disposal of human remains 
that clarified how embryologist Dr. Franklin Paine Mall was able to collect miscarried fetuses 
without raising many eyebrows. In detail, she describes the laboratory techniques of fixing and 
sectioning fetal remains for display and study. And though little could be learned about the 
source of the specimen, her ethnographic detective work elicited evidence that linked the fetus 
that became specimen #836 to Mrs. R., a married woman in her twenties from West Virginia 
who had a hysterectomy in 1914. It was within her removed uterus that the fetus-turned-
specimen was found. These “hidden sources of production” of the  #836 specimen illuminate 
factors within and beyond the lab that were involved in transforming the dead fetus into a 
scientific specimen. Morgan argues that Dr. Mall’s greatest achievement was shaking “the 
embryo free of its social trappings and reconfiguring it as a naturalized biological specimen, 
where it could eventually be re-presented as an icon of life” (2009: 197). 
The case of Mrs. R echoes the story of another woman seeking medical treatment in 
Baltimore whose biological tissues became one of the most important tools in twentieth century 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
22	  See Carnegie’s Stage 13 embryo on the Virtual Human Embryo site: 
https://www.ehd.org/virtual-human-embryo/intro.php?stage=13	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biology. I am referring to Henrietta Lacks, a poor black tobacco farmer from Clover, Virginia 
whose story journalist Rebecca Skloot uncovered sixty years after Lacks’s cancerous cervical 
cells were removed during treatment at Johns Hopkins Hospital and used for experimentation 
(Skloot 2009). Lacks died a couple of months after the procedure, but her cells were 
immortalized as the first human cell line, which scientists called HeLa (Landecker 2000). HeLa 
has served vitally in medical advances since the 1950s, such as testing and treating numerous 
human diseases like polio. Lacks’s cells are also the basis of a multibillion-dollar industry in 
biological tissue sales that have shipped the HeLa line around the globe and even into space. 
Skloot’s study tells the untold story about the segregated medical wards in Baltimore where 
Lacks received care; the subsequent experiments performed on Lacks’s husband and children 
without their consent; and the countless other forces that made the unusual regenerativity of 
Lacks’s cells the fount of late twentieth century biological research. The immortality of 
Henrietta’s cells produced in vitro, like Mrs. R’s fetus, was a product of culturing forces within 
the lab and beyond.   
 Thus, in response to the presumption that embryos like Mrs. R’s are found entities, 
Hopwood and Morgan highlight the social, and often hidden, dimensions of embryo production. 
Morgan and Hopwood also show how the labor entailed in producing embryos reflects the 
“rational, empirical, laboratory-based vision of the material world” (Morgan 2009: 42) that 
embryologists in each era hold. In this chapter, I explore how the same is true for frozen IVF 
embryos at the turn of the twenty-first century: even when wearing the cloak of nature, they are 
in fact quite cultured.  
The application of IVF technology to human reproduction inspired late twentieth-century 
embryologists to ask a new question about human development, namely: what makes a “good” 
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embryo? As IVF became mainstreamed in the U.S. as a private market unregulated by state or 
federal law, the fertility industry sought ways to improve “take home baby” rates for clients 
(Spar 2006). Fertility research over the past thirty years reflects consistent interest in how to 
identify a so-called good embryo that had “take home baby” potential. In 1986, a team of 
Australian scientists proposed one of the first classificatory schemes for “predicting pregnancy” 
by scoring embryo growth rates based on criteria visible through a microscope (Cummins, et al. 
1986). From papers and discussions like this came standardized agreement about the stages of 
embryological development—from zygote, cleavage, morula, to blastocyst—that are now 
common to fertility professionals and patients. Such developmental categories are as 
fundamental to making IVF embryos as the media, incubators, and embryologists that bring 
these life forms materially to fruition. 
Thirty years ago, the Australian team acknowledged the difficulty of sorting out which 
embryos contain the most promise for pregnancy, a sentiment that remains true for embryologists 
today: “In defining embryo ‘quality,’ it seems impossible at present to arrive at an objective 
definition of a ‘good’ embryo, that is, one that will implant successfully and give rise to a 
normal, healthy term infant” (Cummins, et al. 1986: 284). Nearly the same idea was echoed in a 
2012 workshop on non-invasive embryo selection techniques at the American Society for 
Reproductive Medicine (ASRM) annual conference. I attended this workshop with Ken at which 
he received continuing education units to learn about the current science behind predictive 
technologies for identifying the best embryos for achieving pregnancy. One presenter reported 
that as many as 85% of IVF embryos transferred into uteruses do not establish pregnancy, a rate 
that continues to inspire the search for better embryo selection methods. Despite the limitations 
of current embryo grading systems, none of the new predictive technologies presented at the 
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ASRM workshop—ranging from genomic testing to video technology—were available for 
clinical application. Upon return from the conference, I asked Dr. Frank of the Paloma clinic 
about his perspective on these screening methods for embryos. Dr. Frank, a self-described 
Christian man who regards embryos as valuable lives, considered the current screening 
techniques imperfect. “We have not yet found the holy grail,” he stated, referring to the idea that 
a godsend type of selection and transfer technique may be found one day. To this end, 
embryologists continue to search for improved selection methods for identifying embryos with 
pregnancy potential. 
As I explore the making and grading of IVF embryos in this chapter, I draw attention to 
how potential is stabilized as a “natural fact” of an embryo. IVF embryologists presuppose that 
embryos contain potentiality. Paloma’s embryologists describe embryos as having inherent 
capacities that “speak,” communicating to Ken and Zhao how the embryos should be graded and 
revealing what their destinies may be: for a warm uterus, a cold freezer, or a dry waste bin. I 
argue that examining the evaluative techniques within the IVF lab reveals instead that embryo 
potential is compelled into existence through “culturing” practices. I explore how IVF lab 
protocols, methods, and practices collaborate in the production of embryo potentiality, 
specifically by analyzing the processes of grading in vitro embryos. Grading is a mechanism for 
sorting out the embryos good enough for transfer into uteruses while others are slated for the 
freezer or waste bin.  
 
Harrington Fertility – The Paloma Office 
California is home to 75 fertility clinics, which is the largest concentration in the United 
States. Over a period of twenty-two months (June 2011 – April 2013), I gathered observational 
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data and conducted formal and informal interviews within three California IVF clinics and 
embryology labs: Sutter University IVF, Western Reproductive, and Harrington Fertility. The 
bulk of my time was spent in the Paloma office of Harrington Fertility, the state’s largest fertility 
clinic group representing nine locations around Southern California.23  
Harrington Fertility began as a small “mom and pop” service in the late 1980s in 
Southern California and has since grown to become one of California’s highest volume 
providers. Ken and Zhao joined staff in the late 1980s and have been an integral force in 
Harrington’s development in the competitive IVF market in California. Harrington Fertility 
provides the lion’s share of fertility services in California. Of the 25,500 IVF cycles performed 
across California in 2012, clinics ranged in performing 16 to 1737 cycles, for a state average of 
331 cycles per clinic. Harrington, by comparison, completed 1500 IVF cycles.24 One reason 
Harrington attracts a large number of patients is because it is one of the first clinic groups on the 
West Coast to offer cutting-edge—and controversial—technologies like intracytoplasmic sperm 
injection (ICSI), preimplantation genetic screening (PGS) for chromosomal screening and gender 
selection, and egg freezing. Physicians wanting to offer these services to their patients rely on 
skilled embryologists in the lab able and willing to learn the newest techniques. Zhao, for 
example, traveled to Belgium in 2002 for a training course on ICSI technique and brought new 
technical skills back to Harrington’s Paloma office. As a result, Harrington facilitated the first 
pregnancy on the West Coast resulting from ICSI. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
23 References to Harrington or Harrington Fertility signify the network of nine clinics dispersed 
around Southern California sharing the same name. References to Paloma mean the one 
Harrington clinic where I did field research. 
24 Ken kept an unofficial, handwritten record of every cycle for keeping track of rates over time. 
In 2007 and 2008, Paloma performed twice as many cycles a year than there were when I visited 
in 2011 and 2012. 
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The Paloma clinic is located on the second floor of an office building along a well 
trafficked, palm-tree lined street in old town Paloma, a wealthy city near Los Angeles. Patients 
enter from the elevator into a waiting room of muted earth tones, gold-rimmed mirrors, neatly 
stacked magazines, and soft music on a constant loop. For initial consultation meetings, patients 
meet with their respective physician in their private office along the north hallway. Each of 
Paloma’s reproductive endocrinologists has a large, professionally designed and decorated 
office. Behind Dr. Johnson’s large mahogany desk is mounted a large flat screen TV; all of Dr. 
Lohl’s massive office furniture is made of gray granite; Dr. Frank’s office suggests ‘Captain’ 
with nautically themed furniture, a comfortable couch, and wall-sized aquarium; and Dr. Rupia’s 
office, the only woman reproductive endocrinologist, is furnished modestly with pictures of her 
sons and dog on her desk.  
Procedure rooms with bright windows run along the south and west hallways with the 
IVF lab positioned in between. To enter the lab, you need a special access card to unlock the 
door, which brings you into a small entry room with a sticky pad on the floor and stacks of blue 
booties for covering one’s shoes. In conjunction with a special air filtration system, these 
measures help limit extraneous dust and debris from entering the lab. Across a hallway from the 
entry room is Ken and Zhao’s bright office filled with a couple of computers, dozens of binders, 
stacks of papers, and family photos. To the left of the entry way is a storage room with eight 
cryopreservation tanks chained to the wall and wired with temperature monitoring devices. To 
the right of the entry way is the windowless lab area furnished with varying types of microscopes 
sitting atop lab benches, incubators stacked two high, and a couple of computers and phones. 
Each area of the lab is designated for certain activity, from sperm analyses to PGD to 
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cryopreservation. One small “hatch” door exists between the egg retrieval room and lab where 
freshly retrieved eggs are passed to embryologists for processing.  
 Harrington supports a large patient load by keeping a full schedule of back-to-back 
procedures most mornings. The Paloma clinic schedules egg retrievals (ER), embryo transfers 
(ET), and egg freezings (EF) 15 to 30 minutes apart. Ken and Zhao arrive at 5 a.m. to prepare for 
the morning’s procedures that begin at 7:30 a.m. and, on busy days, run through 11 a.m. 
Harrington also maintains a robust staff of eleven reproductive endocrinologists, seven 
embryologists, a dozen accounting specialists, and over thirty nurses and medical assistants; the 
Paloma clinic supports four reproductive endocrinologists, two embryologists, a few accounting 
specialists, and a dozen nurses and medical assistants as staff.  
Zhao and Ken manage the daily goings on within Paloma’s lab. Both have decades of 
experience building IVF labs from the ground up as well as establishing various systems, 
routines, and protocols for maintaining Paloma’s clinic flow. Lab management involves various 
tasks, such as topping up cryopreservation tanks with liquid nitrogen, managing supplies of 
media and tools, and working at the microscope readying materials for grading, transfer, or 
cryopreservation. Ken and Zhao form a collaborative team that has worked together for over 
twenty years. They trade lead responsibilities in the lab so that neither takes the heaviest load and 
both have alternating weekends off to spend time with their kids. For instance, on days that Zhao 
does embryo fertility checks and ICSI procedures, Ken takes care of the nitrogen tanks, freezing, 
embryo pictures on transfer days, and paperwork. They alternate attending professional 
conferences each year, the largest being the American Society for Reproductive Medicine, where 
they receive continuing education credit and gather information about current trends in embryo 
selection and other lab technologies. The next section focuses on one kind of document made 
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within IVF labs—embryology reports—to understand how grading practices are key to the 
production of embryo potential.    
 
Making the Grade: Culturing Potential through Grading Practices  
“Right now, we don’t fully know what a healthy embryo in a Petri dish looks like. 
Because of this, IVF clinics often insert multiple embryos into women to try to 
increase the odds of a successful implantation. Patients frequently have multiple 
births or devastating miscarriages. Half the time, the embryos don’t make it. If we 
could figure out what a healthy embryo looked like and what the best media was 
to grow it in, we’d cut down on that.”  
- Christine Moto, Sutter University Stem Cell Institute Principal Investigator and 
REDEEM Biobank Director  
 
Ethnographers over the past decade have described the “pull of documents” (Riles 2006) 
while in the field, a feeling that I too experienced. Fertility patients and clinicians, embryo 
adoption staff and clients, tissue bank professionals, and research scientists all expressed interest 
in one kind of document—the embryology report—in ways that attracted my curiosity too. As I 
approached them as ethnographic objects, I wondered how these documents were produced, 
noticed where they traveled, asked how they were interpreted, investigated what they were made 
to do in disparate settings, and took note with what effects. Embryology reports, I learned, are 
artifacts of the processes that produce embryo potentiality.  
I began to understand embryology reports by exploring how others made sense of them. 
A perusal of IVF patient blogs and fertility discussion boards elicits reference to what some 
curiously call “baby’s first report card.” Consider these gleanings: 
“Sometime during your embryo’s time in the lab, your embryos will get their first 
report card. Seems like too much performance pressure already, doesn’t it? Pretty 
soon, elite schools will probably be asking applicants for embryo reports.”  




“We aren't even fully pregnant yet, and already we are getting report cards, yikes. 
At least there is no major homework, yet.”  




“We have seven embryos total frozen, four of which are graded AA, one is AB, 
and 2 are BB… It’s the valedictorian in me being hopeful that they would be all 
straight As, A+s, top quality, but I think it’s perfect… We might have to frame 
this [holds up a Post-it note with grading handwritten on it]. I feel like this is a 
mini report card on my babies.”  
– Jena, in a video blog at Someday Mama, 
https://somedaymama.wordpress.com/2014/03/12/embies-report-card/ 
 
“It's their first report card of hopefully many in the future.”  
– Fertility patient, http://malamako.blogspot.com/ 
 
Rarely are writers talking about the grades doled out to their school-aged children born through 
IVF. Rather, “baby’s first report card” is a metaphor for an embryology report, a document that 
tracks clinical evaluations ranking egg, sperm, and embryos within an IVF lab. What do these 
two kinds of report cards—grades given to children by teachers in a school and clinical 
assessments from an IVF embryologist—have in common? Exploring below the surface of the 
analogy provides useful insights into the role grading practices and corresponding documents 
play in the culturing of embryo potential. The following analysis illuminates the quiet grammars, 
or how Bowker and Star describe classificatory systems (Bowker and Star 1999), which underlie 
grading schemes in schools, factories, and IVF labs. Embryology reports themselves are artifacts 
of processes that reveal how IVF embryos come to contain potential.  
 
In Class or In Glass? Understanding Baby’s First Report Card 
At first glance, “baby’s first report card” evokes new associations between normally 
unaffiliated professionals, persons, and places, or what Max Black describes as an interactional 
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process of similarity-making (cf. Stepan 1993). Fertility patients, for instance, are cast as 
already-parents to IVF embryos that are perceived as children at the earliest stages of 
development. Taking the metaphor further, embryologists—the report card authors—become 
observant teachers who nurture and guide early pupils along their pathways of cellular 
development. Further still within the analogy, embryology labs become akin to high-tech 
classrooms where skilled evaluators assess the quality of an embryo’s performance according to 
scales measuring quality.  
When related through analogy, school and embryology reports reveal similar worries that 
fertility patients and parents have about their offspring’s promise for future success. Just as 
scholarship on the historical and cross-cultural making of embryos reveals them to be products of 
myriad factors, potentiality too is not a naturally occurring quality awaiting discovery. Rather, 
potential is something compelled into existence and stabilized as a seemingly natural fact that 
children or embryos contain. These culturing processes invite further inquiry into how 
classificatory schemes, grading systems, and documentary practices collaborate in the making of 
potential. 
Going deeper into the metaphor, I examine three key qualities the grading systems of 
classrooms and embryology labs share: 1) grading systems are universally present, 2) 
standardization is the goal of modern grading institutions, and 3) grades are used as tools for 
predicting future potential.  
 
Universal Presence of Grades in Classrooms and IVF Labs 
In both classrooms and embryology labs, assessment scales are universally present. The 
familiar A-F letter grades, 4.0 grade point average, and 100-point percentiles are institutionalized 
 69 
measures across the United States for ranking the performance of school children. Grading 
systems are also ubiquitous within IVF labs. Every embryo produced by IVF in the U.S. 
undergoes evaluation by embryologists. Even though all IVF embryos are made in the controlled 
environment of an embryology lab, they vary widely in terms of how they develop, an insight 
made possible by the advent of in vitro fertilization technology. Through IVF, scientists of 
human embryology—a field dating back for millennia, to Aristotle—had the first opportunity to 
observe and investigate variations within human development at its earliest moments. 
Scholarship in the early years of IVF that brought to light the developmental variations among in 
vitro embryos also made the first proposals of systems for sorting embryos out (e.g., Cummins, 
et al. 1986). These proposals were among the first classification schemes for grading IVF 
embryos.     
Grading embryos through visual assessment of morphological characteristics has been in 
practice since the inception of human IVF and remains the “gold standard” method across 
contemporary IVF labs. In biology, morphology is the study of the form and structure of a plant 
or animal without regard to function; it is the study of how organisms look. Embryo morphology 
takes into account the structural aspects of human embryo development, such as cell symmetry, 
cell clarity, and cell fragmentation. “Grading embryos is a beauty contest,” Ken explained, 
echoing a sentiment shared by many colleagues. I became accustomed to hearing Ken describe 
the embryos he observed through the microscope in ranking terms; some were regarded as 
“beautiful” or “nice” and others as “cruddy” or “ugly.” Clear, symmetrical, un-fragmented 
embryos received “slam dunk” grades while clumpy, dark, misshapen embryos got the lowest 
marks. Whether in class or in glass, embryos and school children are similarly subject to 
assessments that measure and rank their performance.  
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Standardization as the Goal of Grading Institutions 
Standardization marks a second point of overlap between school and embryo grading 
systems. That a B+ in an American classroom means the same in another is the result of massive 
historical efforts to standardize school grades. These efforts arose during the late nineteenth 
century era of industrialization, a period driven by modernist principles of efficiency, 
predictability, and control. Paralleling similar trends in commodity markets, the standardization 
of school grades served as a key tool in scaling up and nationalizing the decentralized American 
education system (Schneider and Hutt 2014), a process that allowed for bringing to market 
uniformly assessed graduates ranked and ready for the labor force. The history of standardization 
within American education provides fodder for critiques of assembly line classrooms and 
conveyor belt criteria that sort children onto different educational tracks. “Special education” is 
one such track that is often made possible by another set of standards emerging from the arena of 
medicine, namely medical diagnostic categories of “learning disabled” (Ginsburg and Rapp 
2013b). 
Industrial era trends in standardization reveal how school children and crops were 
similarly regarded as commodity stock of significant national worth in part because of their 
perceived potential. School children and cereal crops were subject to standardized systems of 
assessment at the turn of the twentieth-century, systems that helped leverage idiosyncratic, local 
structures onto the national scale. For example, farmers and school administrators refashioned 
their work in industrial terms. While farmers established quality control mechanisms to define 
and rank good quality grain through standard measures of “plumpness,” school administrators 
likened report cards to merchant ledgers in the ways both “emphasized the accumulation of 
success over time and provided a running account of a student’s academic success” (‘The Credit 
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System’ 1862). The factory effect on classrooms and farms at the turn of the 20th century parallel 
what occurred with IVF embryos—a hybrid figure of potential child and commodity—at the turn 
of the twenty-first century. 
Contemporary IVF clinics have a different relationship with processes of standardization 
than do American schools. Despite the fact that standards originated from the domains of science 
and industry (Timmermans and Epstein 2010; Williams 1985), no uniform embryo grading 
system exists within the U.S. fertility industry. Instead, contemporary IVF labs are more akin to 
Civil War era schools where grades were universally present but scoring systems varied 
significantly across locales. According to Dr. Dunn, Director of Sutter University’s IVF clinic, 
there is growing agreement across fertility clinics around the goal of establishing a standardized 
grading system. Dr. Dunn’s perspective on the current state of embryo grading echoes the desires 
of late nineteenth century education reformers who saw standardization as a way to create a 
modern system for a modern world. She argues: “The development of a universally accepted, 
accurate, noninvasive, easy, simple, and quick grading system to select the best possible embryo 
with maximum implantation potential is one of the greatest challenges in in vitro today.” As 
discussed in Chapter 5, the current non-standardization of embryo grading leaves embryology 
reports open for interpretation within REDEEM Biobank and the Blossom program.25  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
25 How might such a universally accepted standard arise within IVF? In order to preempt 
regulation by federal or state policy, the U.S. fertility industry may institute standards, like 
embryo grading protocol across clinics, to function as soft forms of regulation (cf. Brunsson and 
Jacobsson 2000). Alternatively, if IVF shifts from a private, boutique-like clinical service to 
become accessible to broader populations (e.g. through classification as a disease or covered by 
health insurance), labs may feel pressure to scale up and standardize grading much like late 
nineteenth century schools did. Another possible pressure point toward standardization may 
occur if leftover embryos become ever more mobile in their afterlives—like nineteenth century 




Grades as Predictive Tools of Potential 
A third similarity between the grading systems within schools and embryology labs is the 
predictive purpose each system serves. Both school grades and embryo ranking systems 
document developmental achievements and failures, which are used as tools for predicting future 
potential. Since the era of frontier schoolhouses through America’s test-driven classroom today, 
scholastic rankings play a role in student transitions from the schoolyard into the workplace. 
According to one observer of the early twentieth century American educational system, records 
of academic activities have bearing on a pupil’s future, a point that remains salient within today’s 
educational system:  
They are accepted as real and fairly exact measurements of ability or of performance. 
Moreover, they not infrequently are determiners of the student’s career. They constitute 
the primary basis for election to honorary societies, for the award of various academic 
honors, for advancement from class to class, for graduation, and may even determine in 
some measure the student’s career after leaving the institution in which they have been 
assigned (Finkelstein 1913: 6). 
 
In some ways, universities and employers look to grades and other standardized markers of 
achievement as indices of future success. 
Similarly, embryology reports are also interpreted for insight about the future potential of 
offspring. Ken explained that “the goal” of embryo grading “is the same across fertility clinics: 
to identify the best embryo for achieving pregnancy.” Embryos are evaluated multiple times over 
the in vitro period of 1-6 days. Embryo assessments are read as forecasts to inform clinical 
decisions about which (and how many) embryos to transfer for pregnancy, save for future use, or 
discard as nonviable medical waste. For instance, Harrington’s informed consent for IVF 
explains how assessments of embryo development in the lab “help distinguish embryos with 
more potential from those with less or none.” Even though morphology remains the standard 
method for selecting embryos, many regard its predictive capacity as rough and imperfect. 
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Morphological assessment is the best method IVF clinics have currently, though it has 
many shortcomings. For starters, morphology tells you visual information only. With the advent 
of preimplantation genetic screening and diagnostic technologies, embryologists discovered that 
morphologically “beautiful” embryos are sometimes genetically abnormal, meaning they are 
chromosomally incompatible with development or indicative of disabilities. Almost every 
embryologist has a story about transferring “perfect” embryos that did not establish pregnancy 
while “ugly” ones “with no business being put back” do. Such stories suggest that there are 
factors beyond embryo morphology that are not being measured and impact pregnancy chances, 
like genetics, uterine health, or environmental factors.  
Patients in the process of signing Harrington’s informed consent for assisted reproduction 
are notified about the challenge of predicting embryo outcomes through morphological 
assessment. Harrington’s thirty-page consent form states: 
It is important to note that since many eggs and embryos are abnormal, it is expected that 
not all eggs will fertilize and not all embryos will divide at a normal rate. The chance that 
a developing embryo will produce a pregnancy is related to whether its development in 
the lab is normal, but this correlation is not perfect. This means that not all embryos 
developing at the normal rate are in fact also genetically normal, and not all poorly 
developing embryos are genetically abnormal. Nonetheless, their visual appearance is the 
most common and useful guide in the selection of the best embryo(s) for transfer. 
 
Also, embryologists are the first to admit that embryo grading is a subjective process. Neither 
Ken nor Zhao was ever formally trained in embryo grading, and Ken acknowledged that they 
each score embryos differently but consistently, e.g., what is a 4 for Ken is often a 3 for Zhao. 
Studies examining intra- and inter-observer variability among embryologists confirm the 
subjective dimension of grading by finding both to be factors within embryo assessments (Baxter 
Bendus, et al. 2006). 
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Although the scientific search for better embryo selection methods continues, selecting 
embryos for transfer is considered “a large part of the art of assisted reproductive technologies” 
(Behr and Hedge 2012: 398). Fertility professionals hoped to identify more effective ways to 
predict which embryos will likely establish pregnancy in order to reach the industry goal of 
reducing multiples pregnancies toward a safer gestation rate of one baby at a time (American 
Society for Reproductive Medicine 2012). Report cards and embryology reports both 
communicate to (would be) parents how their (hoped for) children are measuring up and any 
developmental struggles they face, which provide forecasts about the future (e.g., for establishing 
pregnancy, scholastic performance, or as laborers in the workplace). Grade reports show 
materially how potential is cultivated through recordings of past performance that are interpreted 
to predict future outcomes. 
 
How Grading Systems Culture Potential 
“Baby’s first report card” is a quaint metaphor shared casually among fertility patients 
and staff, in part to clarify the unfamiliar grading embryos undergo through a common analogy 
to school. When analyzed more closely, the metaphor evokes associations between classrooms 
and IVF labs that clarify what grading systems do. In schools and IVF labs, grading is a process 
of defining, classifying, and evaluating something’s “quality.” Grading establishes comparative 
categories for ranking on scales that range from higher to lower quality, which are processes 
integral to the production of potential. Also, grade reports and associated documents track 
evaluations systematically over time; through certain interpretive lenses, past rankings structure 
how future outcomes are forecasted. Within IVF clinics, grading is a key practice through which 
an embryo’s potential is compelled into existence through “culturing” apparatuses within the lab. 
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Although embryo rankings are not standardized across U.S. clinics as grades are in 
classrooms, grading practices serve as structuring logics or grammars (Tyack and Cuban 1995) 
within classrooms and IVF labs. Bowker and Star’s (1999) study of classificatory systems 
suggests that such logics and grammars often sink quietly into the taken for granted space of 
infrastructure that props up everyday life. The exploration into the metaphor of “baby’s first 
report card” highlights the grammar of potentiality within IVF labs as a quality that embryos are 
assumed or hoped to contain. Though often in the background, culturing mechanisms of 
classification, grading, and documentation are not without political or ethical import, a point 
salient to the overall goal of this dissertation.  
 
Document in the Making: Materializing Potential in Embryology Reports 
Sociologist Carol Heimer argues that the bureaucratic existence of contemporary 
American embryos and fetuses begins well before birth. She attributes this to documentary 
practices during prenatal visits that bring fetuses to life via records, such as ultrasounds, skeletal 
measurements, birth date prognoses, and genetic screenings (Heimer 2006: 100). The 
bureaucratic existence of some contemporary American embryos begins even earlier. 
Embryology reports give birth, so to speak, to IVF embryos as objects of bureaucratic knowledge 
from the first moments of fertilization. Also, embryology reports materialize in documentary 
form the process by which embryos are graded—a culturing process through which their 
potentiality is generated and naturalized.  
Most fertility practices in the U.S. maintain a medical file for each patient that documents 
her journey to and through IVF, a file that typically includes an embryology report. Embryology 
reports are forms unique to each fertility clinic on which IVF laboratory activities are recorded, 
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from oocyte retrieval to embryo evaluations to uterine transfer decisions. An explicit function of 
an embryology report is to track clinical evaluations that are used to inform which embryos to 
transfer into a uterus, which to save for future use, and which to discard. Another role of 
embryology reports is to travel beyond the bounds of the fertility clinic of origin when 
accompanying frozen embryos into their afterlives within tissue banks, embryo adoption 
programs, stem cell labs, and long-term storage facilities.  
Despite the fact that many ethnographers have taken Bruno Latour to task for his once 
dismissing documents as “the most despised of all ethnographic subjects” (Latour 1988: 54), the 
ethnographic record shows little interest in embryology reports. This comes as a surprise given 
the sustained ethnographic attention to reproductive technologies over the past four decades 
(Franklin 1997; Inhorn 2003; Ivry 2010; Kahn 2000; Strathern 1992; Thompson 2014) in 
conjunction with the ubiquity of embryology reports within IVF clinics. The following analysis 
provides a close reading of Susan and Chris Heller’s embryology report from Paloma’s 
embryology lab. Detailing one couple’s IVF cycle over one week reveals the way incremental 
grading practices recorded over time materialize as an embryology report. Ken’s jottings formed 
a report that I argue contributes to and illuminates the process of making things come into being 
(Frohmann 2008), and specifically embryos with potential. I approach the Heller embryology 
report as a clinical artifact of how potential is cultured in IVF labs.  
In the following discussion, I show how IVF embryos become objects of and through 
documentary practices, suggesting they and their potential are cultured in Petri dishes as much as 
in the classificatory and grading records kept by embryologists. I also discuss the multiple ways 
embryology reports are “documents in the making” (Miyazaki 2006: 220), or in the process of 
becoming. Finally, I suggest that embryology reports imbricate the present and future by 
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“stretching the present,” as Miyakazi puts it, into an open-ended, unresolved tomorrow. 
Embryology reports—the artifacts of grading practices and documentary efforts—show how 
potentiality is produced in IVF labs. Or as Derrida once said, “Archivization produces as much 
as it records the event” (Derrida 1996: 17). Embryology reports are undeniably potent documents 
that, like frozen embryos, are good to think about and good to think.  
 
Heller Embryology Report: Harrington Fertility - Paloma, October 2011, IVF Cycle #2 
“Embryo development in the lab helps distinguish embryos with more potential 
from those with less or none.”  
- Harrington Fertility Informed Consent for Assisted Reproduction, page 7 
 
Harrington’s embryology report is a two-page form that is filled in progressively by lab 
embryologists over the course of an IVF cycle. Susan Heller, a 42-year-old patient at the Paloma 
clinic, began her second IVF cycle on the first day of October in 2011. At the top of the 
embryology report, Ken handwrote Susan’s full name, her partner Chris’s name, and her date of 
birth, social security number, and age. Susan’s fertility history was summarized by her “GPAE,” 
an acronym that stands for Gravida (number of pregnancies), Para (number of live births), 
Abortus (spontaneous abortion/miscarriage), and Elective abortions. She had four pregnancies, 
three miscarriages, and one live birth. The cause of her infertility was also noted: secondary 
infertility, recurrent HAB (habitual abortion, or miscarriage). Additionally, some details from the 
ovarian stimulation regimens began weeks prior to egg retrieval were transferred to the 
embryology report by Susan’s IVF nurse, including: the thirteen maturing follicles observed by 
Susan’s physician via ultrasound before her scheduled retrieval, the note that she was prescribed 
a follicle stimulating HMG drug (e.g., Follistim), and the date and time she took the “trigger” 
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shot of hCG hormone thirty-five hours before the retrieval to help her eggs reach maturity (See 
Figure 3). 
Evaluations about Susan’s oocytes began halfway down the page. The retrieval procedure 
began at 8:50 a.m. the morning of October 11, 2011, ten days after beginning the cycle, and was 
completed ten minutes later. She received conscious sedation (SED) versus general anesthesia 
(GA) and the names of the anesthetist, physician, and nurse who were in the room with her when 
she went under are recorded. She showed no signs of premature ovarian failure (POF) during the 
transvaginal oocyte aspiration procedure—a technique involving a long needle inserted through 
the vaginal wall into the ovaries guided by ultrasound. Eleven eggs were collected from Susan’s 
ovaries.  
After follicle fluid was suctioned by needle from Susan’s ovaries, vials containing the 
cloudy pink fluid were passed through a “hatch” in the wall from the procedure room to the 
embryology lab. Ken was ready on the other side to locate and count the retrieved oocytes. He 
poured the contents of each vial into a Petri dish, swirled it around with his hand, and peered into 
the microscope. When he found an oocyte, he used a glass pipette to move it to a dish with an  
enzyme that would help “clean” the oocyte in preparation for IVF. On the embryology report, he 
noted that eleven eggs were collected and the type of culture media used for the collection (HTF 
Hepes and HSA).26 Ken numbered and evaluated each of Susan’s eleven oocytes based on  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
26 Culture media for embryo growth has a long history that began in 1912 with observations 
about the in vitro media to culture a rabbit embryo. By the mid-1980s, specialized media were 
developed for human IVF. In 1985, Quinn et al. published a media formula that mimics human 
tubal fluid (HTP), or the in vivo environment a mature egg or fertilized embryo is exposed to. In 
conjunction with the proposal by Menezo et al. in 1984 to add protein (HSA, human serum 
albumin) to culture media to help prevent sticking of eggs and gametes to pipettes and dishes, 
most IVF handling media today are based on Quinn’s formula and contain some percentage of 
protein.  
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27 Photo by author. 
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maturity, which is an indication of their preparation for fertilization: ten eggs were graded fully 
mature (MII), one as partially mature (MI), and none as immature (GV).28 
Next to the egg retrieval section on the embryology report was an area for sperm analysis 
results. Susan’s partner, Chris (indicated by the circled “H” on the form for husband), donated 
fresh sperm for this IVF cycle. Ken documented two evaluations of Chris’s sperm before and 
after the sample was “washed.” Similar to cleaning the oocytes of extraneous follicular tissue, 
washing sperm was the process of preparation to enhance fertilizing capacity by separating 
sperm from seminal fluid. Ken records Chris’s sperm sample volume (MLs), concentration 
(#x10^6/MLs), motility (%), and progression (1-4). In both sections, Ken noted the specific 
media used to nourish the egg and sperm while in vitro, including the protein content of each 
media and their lot numbers. 
The bottom half of the report summarized the series of embryo assessments over an IVF 
cycle. The corresponding grid on the backside of the report tracked Ken’s evaluations over the 
six-day fertilization period. These portions of the embryology report accounted for how twelve 
eggs removed from Susan’s ovaries became four viable embryos: two transferred into her uterus 
and two frozen for future use. They also translated a sequence of laboratory moments, each an 
instance of hopeful anticipation, that together crafted a “narrative” (Davis 1987) justifying each 
egg’s potentiality toward womb, waste bin, or freezer. These records show how grading systems 
make visible the work of classifying systems around embryos, which I suggest are central to the 
culturing of potentiality.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
28 GV means “germinal vesicle,” or an egg that has not undergone the process of meiosis and is 
considered immature. MI, or metaphase I, describes the first phase of meiosis. MI oocytes are 
not yet completely mature but may mature while in vitro. MII, or metaphase II, oocytes are in the 
second phase of meiosis and considered fully mature and ready for fertilization.  
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Paloma offers patients two methods for fertilization: conventional IVF (CONV) or intra-
cytoplasmic sperm injection (ICSI). Sandra’s eleven eggs were fertilized using ICSI, which 
involved the microinjection of a single sperm into each egg. Some clinics use ICSI only in cases 
of severe male factor infertility, some use it routinely on every case, and most fall somewhere in 
the middle. Ken performed the ICSI procedure on all eleven eggs at 11:30 a.m. and noted the 
type of media used to support insemination.  
At 8:20 a.m. the next morning, Ken did a “fert check” to determine which eggs fertilized 
overnight. On Day 1, embryologists look for certain characteristics to signify successful 
fertilization, which are the presence of two pronuclei (pn) and two polar bodies (pb). “Normal 
development is evident by the still single cell having two nuclei,” stated Harrington’s informed 
consent document. “This stage is called a zygote.” Ken noted in the First Evaluation column that 
nine of Susan’s ten mature eggs fertilized successfully; all of the MIIs had two polar bodies, all 
showed two pronuclei, and one showed only one pronucleus.29 Ken called these results a “good 
fert.” 
The embryos remained in a gas and temperature controlled incubator for the next two 
days before Ken reviewed them again under a microscope. For the Day 3 assessment, Ken’s 
observations shifted to embryo “stage,” “type,” and “decision.” Stage described how many cells 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
29 The presence of only one pronucleus on Day 1 generally indicates genetic abnormality, often 
meaning the egg has been activated but that there is no genetic contribution from the sperm. 
Susan and Chris’s embryo with one pronucleus developed typically until the third day, which is 
how long the egg genome drives development, after which it arrested and was discarded. The 
observation on Day 1 of there only being one pronucleus negated the high score it received on 
Day 3 with 8 cells and a highest ranking morphological score of 3.  Also, the MI egg that did not 
fertilize did not receive marks in the first evaluation column, indicating the end of its IVF 
trajectory. This outcome was expected. MI eggs fertilized through conventional IVF processes of 
coincubation have the chance to mature in the Petri dish, with ICSI, unless eggs are fully mature 
MIIs at the time of the procedure, they will not fertilize. Like all other materials over the IVF 
cycle, the unfertilized egg was left in the dish where it would perish on its own.   
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each embryo contained (e.g., 5C means five cells). Type is the morphological quality of an 
embryo. Paloma ranked embryo Type on a scale of 0-3 with 3 denoting the most “beautiful” 
morphology of symmetrical, clear, and unfragmented cells; scores dropped incrementally as cells 
showed increasing signs of unevenness, darkening, and fragmentation. By Day 3, Sandra and 
Chris’s ten embryos ranged from 4-8 cells, and all but one embryo received the highest score of 
3.  
Today within many IVF clinics, it is customary to “grow out,” or incubate, embryos for 
another 48-72 hours after the Day 3 observation. When Ken first started his career in embryology 
in 1985, each lab mixed their own culture media and embryo transfers happened on Day 1 to 
limit the embryo exposure to media: “Back then, media was harsh on them.” Media became 
commercially available in the mid-1980s and increasingly less harsh, which allowed embryos to 
grow in vitro longer. These developments extended the time between retrieval and transfer: by 
1990, Day 3 transfers were standard in fertility clinics, and by 1998, Day 5 was the norm. 
Embryologists have come to expect a fifty percent attrition rate of embryos during the in vitro 
period between Day 3 and 5. Even though half of embryos fail to make it to Day 5, the benefit of 
growing embryos in vitro for another 48 hours, according to Ken, was to “let embryos select 
themselves.” Depending on the case and physician, Ken often suggested letting embryos 
incubate longer: “You don’t know their potential until you get to Day 5.” Once he decided that 
Susan and Chris’s embryos looked good enough to grow to Day 5, Ken “flipped” the media to 
prepare their nine embryos for another two days of incubation toward blastocyst stage. 
Blastocysts at Paloma are graded according to the Gardner scale (Gardner, et al. 2000), 
the most commonly used rubric for evaluating embryos that have reached this developmental 
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stage.30 The Gardner scale is based on an alphanumeric scoring of three elements: degree of 
expansion of the embryo’s cavity (1-6), inner cell mass development (A-C), and trophectoderm 
development (A-C) (see Fig. 3). The best score a blastocyst can receive on the Gardner scale is 
4AA. “Like in school,” Harrington’s other embryologist Zhao reminded me, “As are better than 
Bs and Cs.” (See Figure 4)  
Five days after Susan’s egg retrieval on the morning of October 16th, Ken peered into the 
microscope to find four promising blastocysts, which he graded as 4AA, 4AB, 3AA, and 3BB. 
He also noted in the Decision column that four other embryos slowed deleteriously in their 
development. Their “no progress” designation sealed their fate for discard as medical waste. The 
remaining embryo fell somewhere in between; it had reached the very earliest stage of blastocyst 
development (Grade 1), so Ken held it in vitro one extra day to see if it would catch up 
developmentally to meet the lab’s criteria for freezing (minimum Grade 3BB). When it showed 
to be only Grade 2 on Day 6, Ken marked the report as “no progress” and it was slated for 
discard.  
The range of differences among Susan and Chris’s embryos five days after fertilization 
was expected, which Harrington’s informed consent for IVF explained: “Since many eggs and 
embryos are abnormal, it is expected that not all eggs will fertilize and not all embryos will 
divide at a normal rate.” Ken explained the reason for the variation as an outcome of embryo 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
30	  David K. Gardner, lead author of the journal article that published the Gardner scale, is a 
world-renowned Australian embryologist who trained in the UK and served as Director of the 
Colorado Center for Reproductive Medicine for ten years. Gardner is best known for his 
innovations in optimizing cell culture media; one of his most famous contributions to embryo 
research and IVF was providing cell culture media to James Thomson’s team at the University of 
Wisconsin for use in isolating the first human embryonic stem cell line in 1998. Gardner’s 
professional impacts within IVF and human embryonic stem cell research highlights the strong 
interface between the two fields (Franklin 2006b).  	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self-selection: “The embryos are telling me which ones are good.” Claims like this separating the 
observer from the observed are common among producers of scientific documents like Ken. 
Similar to other scientists adhering to ideas of objectivity, Ken described his work with embryos 
as engaging with autonomous entities that he considered independent from his labors and the 
“culturing” work through which they are produced (Hoag 2011). While IVF embryologists 
readily agree to be makers of embryos, protocols, documents, and babies, they do not consider 
themselves as participants in the production of embryo potential. By contrast, I do. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
31 Original scale published in Fertility and Sterility (See Gardner, et al. 2000).  
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At the end of the six-day in vitro period, Ken reviewed the embryology report to form a 
recommendation based on which embryos, made and graded in his lab, contained the most 
promise for pregnancy, which contained enough potential to freeze for the future, and which 
contained too little for destiny other than discard. Patients are prepared for the IVF lab results 
based on description in the informed consent paperwork where two classes for developing 
embryos are described: the “best-looking” and the “second-best.” The document explains that 
“after a few days of development, the best appearing embryos are selected for transfer to the 
uterine cavity” while “excess embryos of sufficient quality that are not transferred can be 
frozen.”  
Ken met with Susan, Chris, and their physician that morning to share his interpretation, 
from which they developed a plan that he charted on the grid: transfer two Grade 4 blastocysts 
into Susan’s uterus and freeze two Grade 3 embryos for future use. Although Ken describes his 
job as listening passively to what each embryo says about how good it is based on its past 
progression from fertilization to blastocyst, his interpretation of an embryo’s future potential for 
implantation—like all of the lab activities under his management—is active, productive, and 
generative. Ken, like all IVF embryologists culturing life in vitro, is unavoidably in the business 
of cultivating knowledge about their potential.   
The bottom section of the embryology report summarized the processes of embryo 
transfer and cryopreservation. At 10 a.m., the phone rang in the lab alerting Ken that Susan was 
ready for the embryo transfer procedure. He quickly and carefully suctioned the two chosen 
(ICSI) blastocysts into a catheter (Wallace type) and walked it down the hallway from the lab to 
the transfer room. There, Susan was waiting on the exam table in stirrups with Chris holding her 
hand. Ken handed the catheter to the physician, who inserted the instrument into her uterus on 
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the first try and, while all watched the ultrasound screen, released fluid high into her uterine 
cavity. Ken quietly left the room to check the contents of the catheter to make sure no embryos 
were stuck inside, and called moments later with news that all was clear. Susan’s physician 
visited the lab after the procedure to relay that that she showed no signs of bleeding or cramping 
during the transfer, details that Ken noted on the report. 
An hour after Susan’s transfer, Ken prepared the two remaining blastocysts for 
cryopreservation (See Figure 5). Since 2008, all embryos at Paloma have been frozen using 
vitrification, a quick freezing method with higher survival rates after thaw. Over the course of 
the ten-minute procedure, Ken transferred the two blastocysts between drops of increasingly 
potent cryoprotectant media to acclimatize them. Once the embryos were equilibrated in the full 
strength media, Ken had ninety seconds to transfer them into straws, seal both ends, and 
submerge the straw in liquid nitrogen. As he dropped the straw in to a Styrofoam cup sitting on 
his desk, he turned to me and said: “Instantly frozen.”  
The embryos were vitrified in one straw identifiable by a green plug assigned an 
accession number 30-02 and a sticker with Susan’s social security number and date of birth was 
attached to it. The frozen straw was inserted into a numbered cane that Ken stored in Canister 2 
of Tank 5, a randomly selected location in one of Harrington’s cryopreservation tanks. That mid-
October morning, while Susan and Chris’s hopes were suspended in expectation of news about 
their second IVF attempt, two embryos were suspended in liquid nitrogen, along with hundreds 





Figure 5. Sample embryology report (back)32 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
32 Photo by author. 
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Conclusion 
This chapter focused on the IVF clinic as a place where the work of embryologists 
reveals what else is made in the process of making babies through IVF. I argued that the IVF lab 
is a setting where embryos as well as documents, protocols, chances, and potentials are produced 
through the bench top and desktop activities of embryologists.  
Also, I explored the metaphor of baby’s first report card to distill how grading practices 
culture potentiality by tracking the past as a means to predict the future. Whether the graded 
entity is a child, a load of wheat, or an IVF embryo, grading mobilizes classificatory systems that 
define quality based on past evaluation and produce possibility in the present that manifests itself 
differently according to potential future outcomes. I showed the similar way that classroom and 
laboratory grading systems emerged from historically rooted but arbitrary classifications that 
were aligned for modern system-building. Grading embryos is compulsory practice in IVF labs 
today; while non-standard and far from perfectly predictive, grading produces embryology 
reports laden with authority about the “goodness” of IVF embryos that informs their clinical 
value.  
Lastly, I analyzed Susan and Chris’s embryology report to illustrate how embryos, 
embryology reports, and potential are generated in IVF labs. First, I showed the ways Ken’s 
record-keeping practices bring to documentary life embryos as objects of bureaucratic 
knowledge from the first moments of fertilization. Second, I traced how embryology reports 
function as “documents in the making” (Miyazaki 2006) that emerge over time through multiple 
grading processes. These two-dimensional reports capture dynamic processes at the intersection 
of systems of meaning and material practices that I argue produce the notion of embryo potential. 
Third, I showed that potentiality is presumed by IVF embryologists to be something embryos 
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contain intrinsically. By contrast, I argued that potentiality is made, not found, through culturing 
techniques of tracking, compiling into a report, and interpreting by expert eyes. In sum, I came to 
understand embryology reports as documentary artifacts that make visible how potentiality is 
brought into existence within the IVF lab.  
In the ways that many documents are “about or oriented toward some other entity, 
structure, or patch of the world” (Smith 1996: 13), embryology reports prove to be distinctly 
oriented to the idea of the future. Temporality is a critical variable for understanding how IVF 
labs make embryos and produce their potential. Although all of the areas of Susan and Chris’s 
embryology report were filled in, the perceived completeness of an embryology report is also a 
product of IVF laboratory labor. Signatures and dates index its authority and solidity. Instead, 
embryology reports remain open-ended and partial. They stretch time from the past to an 
indefinite future, which sustains an anticipatory quality to the report. Answers to curiosities 
about what comes next remain off the page, prefigured in the grid, and something only time may 
tell.  
To examine further the idea about the future orientation of embryology reports, let us 
revisit Susan and Chris’s story by reading off the page about what happened after their IVF 
cycle. Within IVF clinics, potentiality pools into three categories based on the goal of the clinic 
to “make babies”; embryos are classified as transferable, savable, or discardable. Transferable 
embryos are judged to be the most promising for producing a pregnancy, and thus are transferred 
fresh into a uterus for their chance to do what they were made to do: make babies. Of Susan and 
Chris’s five blastocysts on Day 5, the highest graded two were transferred into her uterus. 
Twelve days later when they returned to Paloma for a pregnancy test, they learned it was 
positive.  
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Discardable embryos are thought to contain the least promise because they fail to meet 
the minimum laboratory standards for transfer. The one blastocyst left to grow another day was 
given a chance to meet the minimum laboratory criteria for saving, but was fated for discard in 
the medical waste bin when it failed to develop further. As a result of Paloma’s specific 
cryopreservation protocol, the potential perceived within the discarded embryo on Day 5 
disappeared by new observations that Ken made on Day 6. Throwaway embryos reveal the 
precariousness of potential in an IVF lab and how quickly it can dissolve.  
The middle category is the one of interest in this dissertation: the savable embryos that 
are passed over today but banked for tomorrow. Susan and Chris had two savable embryos slated 
for cryopreservation. These embryos were good enough to preserve for potential future use but 
not good enough for being “put back” yet. The promise of embryos like these is frozen in time, 
suspended between desirability for transfer and undesirability of discard. Their potential hangs in 
anticipation of what purpose they may be thawed for and what outcome they may produce. The 
unsettled zone within which frozen embryos categorically exist mirrors their cellular suspension 
in liquid nitrogen where they are paused developmentally and await future use.  
My approach to “culturing” in this chapter focused closely on the techniques and 
documents within the IVF lab in producing embryo potentiality, though, as I mentioned above, 
forces beyond the lab also undergird and constitute the potentials cultivated within it. 
Acknowledging factors beyond the apparent laboratory productions of potential is important 
because, as Lynn Morgan argues, “potentiality as an analytic object cannot be isolated from the 
political and economic contexts in which it is catalyzed” (Morgan 2013: S22). For example, my 
discussion of the standardization of grading school children and wheat in American history 
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highlights parallel standards and techniques that inform how Ken and Zhao approach their task 
of “making babies” via IVF.  
To conclude, I examine facets of Susan and Chris’s story that also conditioned the 
circumstances of their experience with IVF and the potentials of their resulting embryos. As IVF 
patients in the United States, the Hellers represent an elite group with ample resources to afford 
the financial, emotional, and physical costs of fertility treatment. Unequal access to fertility 
treatment and disparate exposure to risk factors directly inform which babies are likely to be 
“made” through IVF, and which people’s reproductive potentialities remain underserved by 
assistive technologies or neglected entirely. In the U.S., ethno-racial categories, class statuses, 
and sexual and gender identities function as societal “grading” mechanisms that stratify 
reproductive potential such that couples like the Hellers have access to IVF while many others 
do not.  
In the 1980s, the United States witnessed a heightened pro-natalism in response to an 
increased presence of white women in career-track jobs and a falling birth rate among the same 
population. “Practically overnight,” legal scholar Dorothy Roberts observed, “the media created 
an infertility epidemic plaguing middle-class America” (1997: 269). Within the United States, 
assisted reproductive technologies are consumed by a limited population, which is typically 
white, heterosexual, and of higher socioeconomic status. This group is not the only one affected 
by infertility, nor the group most often affected. Roberts argues that “the profile of people most 
likely to use IVF is precisely the opposite of those most likely to be infertile… poor, Black, and 
poorly educated” (Roberts 2007a: 252-253). She cites a range of causes, including untreated 
sexually transmitted diseases, nutritional deficiencies, previous complications with birth or 
abortion, and exposures to environmental and workplace toxins. Roberts also highlights the 
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economic barriers and professional manipulations that “steer” black women away from 
reproductive technologies, which are reinforced by media hyped anxieties about the under-
production of white babies (1997: 253-256).  
Insurance coverage is another factor limiting access to infertility therapies for wider 
populations. Most states and insurance programs do not cover infertility costs in private or public 
plans, and when they do, coverage is often restricted through requirements of marriage or 
fertilization with the “husband’s” sperm. Hetero-centric definitions of infertility as being unable 
to conceive after a set period of unprotected sexual intercourse excludes single, lesbian, gay, and 
transgender people from coverage (Arons 2007). These examples illustrate anthropologist Gay 
Becker’s observation that “who uses these [reproductive] technologies is not simply a function of 
who wants to use them but also of whom society permits to use them” (2000: 20). Disparities 
between infertility users and those excluded shed light on yet another circumstance of stratified 
reproduction, or “the hierarchical organization of reproductive health, fecundity, birth 
experiences and child rearing that supports and rewards the maternity of some women, while 
despising or outlawing the mother-work of others” (Rapp 2001: 469). 
Culturing forces beyond the Paloma clinic raise questions about how the business of 
making babies might look if clinical priorities shifted from improving techniques for identifying 
“good” embryos to identifying and mitigating the causes of infertility; improving methods to 
limit exhausting trial-and-error cycles that IVF patients commonly endure; or increasing access 
to and affordability of fertility treatments. If “making babies thrive” became our collective task, 
how might our educational systems, farming practices, health care system, and housing policies 
change? Such topics may seem tangential to the making of potential in an IVF lab, but in my 
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view, are fibers of the sticky threads that weave the conditions making it possible for Ken, 
Susan, and Chris to team up in turning the Hellers into a family.   
--- 
The three categorical options for Susan and Chris’s embryos—transferable, savable, 
discardable—represent a scale of value created by IVF clinics and archived in embryology 
reports to achieve what embryologists set out to do: make babies. The next two chapters explore 
how the goals of the REDEEM Biobank and Blossom Embryo Adoption program participate in 
transforming the potential of leftover IVF embryos for new possibilities. These programs convert 
the unwanted but un-wastable remainders using different saving techniques, for each strives in 

















Wasting: Making Trash and Treasure in a Stem Cell Institute 
  
Paulo, the friendly manager of the research lab neighboring Dr. Christine Moto’s in the 
Sutter University Stem Cell Institute, and I took a shortcut one morning to walk along a verdant 
path from the train station en route to campus. On the outskirts of Sutter University where plants 
grow in a tangle, Paulo directed my attention to a man in the bushes with a shopping cart of 
items. Paulo took interest in this man after noticing one of his daily tasks: he collects cigarette 
butts strewn on the ground, removes the unsmoked tobacco remains, and rolls new cigarettes for 
trade or sale. As Paulo and I wended our way toward the paved university pathways flanked by 
manicured flowerbeds and grassy lawns, we discussed the man’s resourcefulness in connection 
to the documentary Redemption we both heard reviewed on the radio the day before. Neither of 
us had seen the film about the bottle and can collectors of New York, but we reflected on the 
lives of people like this cigarette collector whose “treasures,” according to the filmmaker, “are in 
the trash.” We parted ways upon arriving at the prominent steel and glass Stem Cell Institute, 
each to work alongside scientists who, I came to learn, also consider themselves recyclers of 
societal refuse; whose daily efforts repurposing cellular remnants may generate life-saving 
medicines, therapies, and knowledge. Over the course of the 2012-2013 school year that I joined 
Dr. Moto’s lab and shadowed researchers and staff affiliated with the REDEEM Biobank based 
within it, I thought often about the cigarette collector toiling just beyond the front door, living in 
the literal and figurative fringes. I wondered which of the lives talked about in Sutter University 
research labs are considered worth saving and which, like many refuse pickers of the world, 
become synonymous with the wastes they gather (Gidwani 2008). 
--- 
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 Dr. Christine Moto leads a research laboratory in the largest stem cell building in the 
world. As a principal investigator in Sutter University’s Stem Cell Institute, Dr. Moto’s lab is 
comprised of thirty graduate and postgraduate scientists from across the world. She has received 
over $28 million dollars in grants and an endowed professorship at Sutter University to support 
her lab’s investigations in human fertility and degenerative diseases. She was recognized 
nationally as one of the nation’s twenty most influential women in 2006 and acknowledged by 
Time magazine for developing one of the top ten biomedical breakthroughs of 2010.  
 Dr. Moto’s research makes headlines around the globe, in response to which she has 
become accustomed to answering questions about the ethical nature of her work with human 
embryos. In an interview with the New York Times in 2008, Dr. Moto explained her experience 
experimenting with human embryos: 
There are people who believe that when we use embryos for research at all, our 
society becomes hardened. I’ve searched myself on that and I don’t think I’m 
hardened. I can honestly say I still get goose bumps when I see embryos develop. 
You hope you are humble enough to take in the information and not change your 
course. If there was truly a substitute that was better for understanding human 
development than embryo research, that is what I’d do. But there isn’t. That’s 
where the data is.  
 
 In our first conversation, Dr. Moto explained that she was raised a Christian and described 
herself as “deeply religious.” She believes that “life begins at fertilization,” and experiences the 
feeling of awe when watching an embryo develop: “It’s incredibly difficult to become an atheist 
when you watch it.” She carries along with her reverence for human life “an ironic sense that it 
was pretty special to be born” because she understands that life itself is precarious. Sometimes as 
she rides her bike or cares for her aging mother-in-law, she is struck by the feeling that “the odds 
are against the fact that we’re here at all.” As a result, she has come to believe that “life is more 
special and precious than you would imagine.”  
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 As a public figure in a controversial profession, she had been challenged on the ethics of 
her work as an embryologist. Dr. Moto explained that she has “checked in” with herself 
numerous times to clarify if her work in human embryonic research feels right. She believes that 
walking with humility and the desire to do the right thing is important, as is her faith in God’s 
forgiveness should she be wrong. But each time she reflects on it, she comes to the same 
conclusion: “I’m sure there have been moments in my life when I haven’t been a model 
Christian, but my work on embryonic stem cells isn’t one of them.”  
 Connected to her feeling of reverence for human life, Dr. Moto takes issue with the idea 
that embryonic stem cell research is destructive. She engages the rhetoric of destroying in 
response to what has become a common argument against the destruction of embryos among 
opponents of embryonic stem cell research in the United States (Berg and Furton 2006; George 
and Tollefsen 2008). For example, President George W. Bush dramatized his opposition to a 
stem cell funding bill that passed in Congress by staging a press conference with twenty-one 
children born through embryo adoption. The press conference and photo lends a striking image 
of unused embryos becoming “blossom babies” rather than research material (See Figure 6). 
Notably, he praised the practice of embryo adoption for its effort “to ensure that our society’s 
most vulnerable members are protected and defended at every stage of life.” The reason 
President George W. Bush gave for vetoing the bill that passed in the Senate was that he morally 
opposed the destruction of human life. Similarly, the treatise Embryo: A Defense of Human Life 
argued against the moral permissibility of “treat[ing] human embryos as disposable research 
material that may be used and destroyed to benefit others” (George and Tollefsen 2008: 3), and 
likened the use of embryos in research to the killing of a human being.  
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Figure 6. President Bush Press Conference with Blossom Families33 
 
 
 Dr. Moto understands destruction differently: 
People say embryonic stem cell research destroys embryos. I guess you can say that 
but stem cell research is not the main driver of embryo destructions. When five to 
ten cell lines are made, five to ten embryos are used, in contrast to the 350,000+ 
embryos thrown away in IVF each year.  
 
This ethical issue, from her vantage point, is not the destruction of embryos as human life, but 
the waste of their potential. “I believe that it is not good to throw human embryos away,” she 
stated, “—without studying them.” Dr. Moto and many opponents of human embryonic stem cell 
research find common ground critiquing the fertility industry on the overproduction and wastage 
of embryos, but differ in a distinct way on the issue of what constitutes waste. For former 
President George W. Bush, the noble end of stem cell therapies did not justify the immoral 
means of destroying potential lives. By contrast, the disposal of embryos into medical waste bins 
without making good use of them is, in Dr. Moto’s view, wasteful.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
33	  Photo credit to Alex Wong and Getty Images, published in New York Times (See Stolberg 
2006).	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 In this light, Dr. Moto’s career in stem cell biology may be described as dedicated to 
preventing various kinds of waste. In interviews and speeches over the past decades, she has 
described stem cell research as a women’s health issue. Her research projects range from efforts 
to improve infertility treatments to addressing female incontinence. She is particularly critical of 
the IVF industry for the exploitative way fertility patients are subjected to imprecise technologies 
that waste time and money, invade women’s bodies, and produce paltry results.  
In my lab, we’re using stem cell research to look for ways to make fertility 
treatments safer and more rational. Considering all the heartbreak and expense of 
infertility treatments, this sort of research is something I believe women have a big 
stake in defending.  
 
In order to continue pursuing her research commitment to women’s health, she secured grant 
funding to establish the REDEEM Biobank as a resource. By seeking to remedy the waste of 
time, money, and remnants from IVF, Dr. Moto hopes her efforts might help women and men in 
their search for technological solutions for their reproductive health challenges.  
 Waste in Dr. Moto’s lab, from the first moments of my time at Sutter University, was never 
a simple matter. In this chapter, I explore the role of waste with respect to leftover IVF embryos 
donated to REDEEM Biobank in Dr. Moto’s lab. I examine the processes of making, managing, 
and preventing waste through classificatory schemes and laboratory practices within Sutter’s 
Stem Cell Institute. I argue that Biobank donors and recipient researchers similarly regard frozen 
embryos as un-wastable and make great efforts to prevent their misuse. Despite the generally 
universal regard for embryos as un-wastable, I explore how and why the Biobank’s procurement 
practices common to contemporary tissue economies do the necessary work of “trashing” valued 
materials in order to ready them as treasured lab resources. This chapter expands on a hunch by 
Helena, Dr. Moto’s assistant lab manager, that frozen embryos donated to the REDEEM Biobank 
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go through “one of those trash-to-treasure scenarios.” I argue that the trashing of treasured 
embryos reveals how the systemic production of surpluses—a signature of capitalist systems—
collaborates with propertization within the contemporary life sciences to convert wastes into 
extractable forms of value seemingly ad infinitum. Making and preventing waste within a stem 
cell lab act as saving practices that convert embryo potential for other intended purposes.  
  
Of Mice, Embryos, and the Paradoxes of Waste 
My introduction to waste at Sutter University’s Stem Cell Institute occurred during my 
first week of field research within Dr. Moto’s lab. Wendy, the lab manager, handed me a list of 
online orientation tutorials about lab safety that all researchers and personnel are required to 
complete. Since I would be based in Dr. Moto’s lab for the next school year, I needed to learn the 
basics of laboratory life. Wendy set me up at a desk in her office that became my home base for 
several months. The desk was situated next to a bright southern window with Biobank inventory 
all around: hundreds of informed consent files were stored behind me in a large filing cabinet 
and the large stainless steel tank housing the frozen IVF leftovers caught my eye when I looked 
up from the computer screen. (See Figure 7) 
As I clicked through online lessons about general safety, I was prompted to respond to 
quiz questions concerning waste management, collection and disposal practices, and associated 
hazards and risks. Wastes, according to the tutorial, are “materials that are no longer needed for 
their intended purpose.” The tutorial also prompted me to wonder about the leftover IVF 
embryos no longer needed by fertility patients. Could the tank just beyond my desk storing 
thousands of donated embryos be a freezer full of wastes? 
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Figure 7. REDEEM Biobank34 
 
 
Despite the fairly general definition of wastes in the tutorial, I encountered circumstances 
almost every day in Dr. Moto’s lab that revealed greater subtleties about the category waste. One 
mouse experiment in particular captures some of the nuances. Luke, a postdoc from Germany 
and the resident mouse expert, fell ill one week in the middle of an ongoing experiment. His 
research involves euthanizing—more commonly described by lab scientists as “sacrificing”—
male and female mice to extract their gametes in order to study the gene expression of mouse 
embryos. “That is a downside of research,” he explained to me through a stuffy nose. “I could 
not do the experiment but then the mouse is just wasted and I would feel badly.”  
The laboratory mouse is a paradigmatic figure and everyday tool within the biological 
and human sciences (Haraway 1997; Lemov 2005). Researchers like Luke order mice through a 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
34 Photo by author. 
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company that breeds research animals commonly used in biological research. Such catalog 
creatures are slated for one purpose: experimentation. He ordered the female mouse a few weeks 
in advance and prepared it daily with hormone shots to maximize the number of eggs she 
ovulated. If he missed the narrow window of opportunity to extract the mouse’s eggs, his 
experimental subject would be rendered useless. Even though the mouse would be euthanized 
whether he stayed home sick or came in, allowing it to become useless without fulfilling the role 
it was designed to play in his experiment would expose it a different kind of sacrifice—to being 
wasted. Wastefulness is the opposite of what good science and good scientists strive for. 
Luke chose not to stay home when he felt ill because he believed that sacrificing the 
mouse without studying it would be wasteful. The research mouse is made for sacrifice, a point 
Donna Haraway develops in her analysis of OncoMouse; allowing the mouse to perish without 
experimentation denies it, and perhaps the rest of us, the chance for redemption: 
The laboratory animal is sacrificed, her suffering promises to relieve our own; she is a 
scapegoat and a surrogate. She is the object of transnational technoscientific surveillance 
and scrutiny, the center of a multicolored optical drama. This mouse is a figure in 
secularized Christian salvation history and in the linked narratives of the scientific 
revolution and the New World Order—with their promises of progress; cures; profit; and, 
if not of eternal life, then at least of life itself (Haraway 1997: 47). 
 
Dr. Moto expressed a similar opinion about the use of human embryos for scientific research. 
Her belief that it is “not good to throw human embryos away—without studying them” suggests 
that waste does not result from the destruction of embryos through experimentation; rather, waste 
results from discarding embryos without mobilizing them to contribute to the redemptive 
promises of progress, cures, and profit. Together, Luke’s and Dr. Moto’s perspectives on their 
research subjects reveal more subtleties about laboratory waste than the online tutorial definition 
lets on. Each researcher perceives their role in science as extracting valuable data, knowledge, 
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and information from their research subjects. While the process of extracting value from 
experimental creatures may result in a certain kind of destruction, they believe that the more 
grave ethical concern is allowing the potential perceived within embryos, mice, and etcetera to 
go uncollected and unused.  
Dr. Moto’s and Luke’s perspectives distill a few seeming paradoxes of stem cell 
biological research: that scientists participate in destruction without destroying and sacrifice 
without sacrificing. The question explored in this chapter is if there can be waste without wasting 
within embryo research labs too. During the school year that I spent at Sutter University, I made 
a number of observations about waste in the Dr. Moto’s lab. First, embryo donors as well as 
recipient researchers consistently regard frozen embryos as precious, invaluable, and supremely 
un-wastable. At the same time, REDEEM Biobank categorically “trashes” embryos in order to 
facilitate their donation and use by researchers. The seeming contradiction of frozen embryos 
being both waste and non-waste makes sense, according to sociologist Martin O’Brien, within 
“rubbish societies” (1999).  
How stem cell scientists waste without wasting hinges on clarifying a key distinction 
between the types of research subjects common to Dr. Moto’s lab. Laboratory mice, for instance, 
are made for experimentation while human embryos are the by-products of IVF, the technology 
that makes embryos for the purpose of establishing pregnancy. To redirect their potential from 
fertility clinic to research lab, frozen embryos are “trashed” via informed consent processes and 
classificatory framings that shift ownership from patient to tissue bank. I argue that waste is the 
transformative category embryos pass through that changes IVF by-products into laboratory 
treasures. The next section reviews general and theoretical approaches to waste, after which I 
detail how donors and recipient researchers cherished embryos as un-wastable entities.  
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Keyword: Waste  
Waste is a contemporary keyword that shares conceptual kinship with various other 
terms, such as detritus, excreta, discards, filth, garbage, refuse, rubbish, surplus, excess, and 
trash. Waste entered the English lexicon in the thirteenth century from an Old French term rooted 
in the Latin, vastum. Waste (n.) is generally regarded as unproductive matter pushed beyond the 
bounds of society. From deserted lands to material garbage to social rejects, waste is assumed to 
be the extraneous, useless byproducts of life (OED). Waste is also defined as the opposite of 
value. Acts of wasting (v.) are described as destroying, deteriorating, and diminishing things 
considered precious, like time, land, money, and health. Wastrels are those who throw away 
opportunity and squander chances for profit. Wasteful practices are characterized by lavish 
consumption without regard for consequences or return.    
Among scholars who theorize waste, some recapitulate commonplace notions of it as 
negative excess and absence of value. John Locke’s (1964 [1689]) treatise on property, for 
instance, established within the Western liberal tradition a regard for uncultivated land as res 
nullius, or lying in waste, which reified it as unclaimed, un-owned, and abandoned matter. Mary 
Douglas’s (1966) symbolic study of dirt and pollution helped put waste on the theoretical map, 
but located it outside the material realms of production and consumption and beyond the 
symbolic order of society. Waste, in Douglas’s terms, is matter that is categorically “out of 
place.” Similar to Julia Kristeva’s (1982) psychoanalytic theory of abjection—or the horrific, 
rejected, and liminal other—Douglas emphasizes the role space plays in sequestering 
unacceptable objects, populations, and practices from normative society.35        
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
35 Naomi Pfeffer (2007) and Julie Kent (2008) analyze one form of reproductive waste—aborted 
fetuses—through Kristeva’s lens of “abjection” to understand the contours of fetal tissue 
economies. 
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In response to the relative sidelining of waste in social nomenclature and theory, scholars 
started dragging discards to the center of analyses to challenge the common refusal of the role 
that leftovers play materially and symbolically within everyday life. Scholarship that refuses to 
let waste remain in the intellectual dustbin articulates the many ways in which it matters socially, 
politically, economically, and morally. For this chapter’s purposes, I identify approaches to 
waste that illuminate its multi-dimensional role within frozen embryo disposition through themes 
of economies, value, and time.  
 
Waste & Economies 
Discard scholars argue that waste is essential for understanding all forms of economy 
(Waldby and Mitchell 2006). Rather than merely the byproducts of symbolic and material 
systems of production and consumption, waste and wasting practices are integral for 
understanding how economic systems work (O'Brien 1999). For capitalist systems in particular, 
waste is considered to be a signature feature. Some examine the systemic production and 
luxurious expenditure of excesses inherent to the function of capitalism (Bataille 1988). Others 
emphasize capitalism’s generation of surplus populations in the form of workers whose life, 
health, and labor are, as Marx describes, “squandered” (Gidwani and Reddy 2011; Marx 1981 
[1885]; Marx 1993 [1894]). Feminist scholarship on reproduction illuminates a different facet of 
the role waste plays within capitalist systems. For example, within medical textbooks that liken 
women’s reproduction to industrial forms of production, anthropologist Emily Martin noticed 
that menstruation is depicted as “the waste product of a failed conception, composed of debris, 
dead tissue, and useless scrap” (Martin 1987: xvi). For critics of neoliberal capitalism, like 
Melinda Cooper (2008), waste represents the sphere of activity where ideals of “continual, 
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euphoric growth” play out through seemingly endless projects of value extraction.  In this 
chapter, I draw from Cooper’s approach to “life as surplus” to elucidate how IVF leftovers 
become promising research materials within contemporary bioeconomies.  
 
Waste & Value 
Material analyses of waste, wasting practices, and waste management systems provide 
novel approaches for understanding the relationship between waste and value (O'Brien 1999). 
Rather than the simple characterization as being absent of or opposite to value, some argue waste 
to be “a source of latent value” (Cooper 2006; Waldby and Mitchell 2006) that can be extracted 
endlessly. In a challenge to Douglas’s premise that wastes are “out of place” socially and 
materially, scholars highlight the ways societies actively manage these potent leftovers by 
creating and mobilizing intricate systems that convert and extract value from materials 
designated as waste. My interpretation of frozen embryo donation utilizes sociologist Michael 
Thompson’s (1979) notion of waste as a liminal space for transforming—rather than losing—
value, which he calls a realm of “pure potential.” I take particular interest in the ways waste and 
frozen embryos become “potent” entities within circuits of recycled tissues. 
 
Waste & Time 
William Viney (2014), in dialogue with Douglas, suggests that waste should also be 
considered “matter out of time,” which helps draw attention to the ways temporality conditions 
waste and vice versa. Certain forms of waste, like nuclear radiation and environmental pollution, 
introduce extreme temporalities that refigure how humans, things, and places relate (Masco 
2006). Time also amplifies relationships between pasts, presents, and futures. For instance, waste 
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is always a waste of something, which implies the lingering of past residues even as wastes are 
transformed toward new futures. My analysis of REDEEM Biobank’s informed consent 
processes highlights how “trashing” embryos seeks to catapult them “out of time” by cutting 
historical ties and hitching them to speculative futures.  
 
Unwanted and Un-wastable: Embryo Donors Give to Research for Greater Good 
 
dispose (v) 
a. to put in place 
b. to settle a matter finally 
 
Since the late 1990s, frozen embryo disposition—or what people decide to do with their 
remaining embryos after IVF—has attracted the attention of researchers around the world in 
places where IVF and cryopreservation are practiced. Reports indicate that the desire among IVF 
patients to donate to science is becoming an increasingly popular disposition option (Lyerly and 
Faden 2007; McMahon, et al. 2003; Parry 2006). I spoke to one New York mother in the midst 
of her second IVF cycle as a result of secondary infertility who recalled the factors that informed 
her embryo disposition interests. On the day of her egg retrieval while sitting in the clinic, she 
and her husband contemplated what to do with their unused embryos.  
I had the pen in my hand and thought that my sister is a doctor and I have two siblings 
with multiple sclerosis, so I know that stem cell research has been significant, or could 
be. So I was like, ‘Science, that’s good.’ The idea of discarding our three embryos 
doesn’t work. If it could be used, make it useful.  
 
An Oregon mother of two described different circumstances for her openness to donating 
remaining embryos to research. After a devastating car accident that resulted in the loss of her 
eight-month pregnancy as well as her uterus, Suzie endeavored to continue her family through 
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IVF and surrogacy but faced severe financial obstacles. Short of being able to afford a surrogate 
to receive any of her four frozen embryos, she described “this immense connection to the idea 
that these [embryos] are my babies” that informed the feeling that she “probably wouldn’t donate 
embryos to another couple, but would donate to research in helping to better their testing.”  
Staff at REDEEM Biobank noticed the upward trend in donor activity since opening in 
2008, though as Donna the coordinator explained, “we have no idea what they think about the 
donation.” The Biobank’s informed consent process does not ask donors to report their reason 
for donating nor does the Biobank have a mechanism for tracking donor motivations. This left 
some staff wondering why people go through the sometimes arduous process of donating. “They 
could be giving away their potential children for all we know,” Donna stated, which echoed one 
donor’s joke about their motivations: “This is the only way our kids will ever get into Sutter 
University!” Yet the range of impressions staff shared with me about why people donate suggest 
that they have some ideas. I did not have the opportunity to speak directly to more than one 
REDEEM Biobank donor, though found that being in the Biobank office allowed me to glean 
staff impressions and experiences that illuminated how donors regard their embryos. Even 
though Biobank staff do not ask patients directly about factors around donation, Sophia 
explained that she often finds out anyway: “People dump a lot of their stuff in the call saying, 
‘I’m donating and here’s why.’”  
Many professionals across my varying field sites identified the embryo cryostorage bill as 
the precipitating factor for patients to make a disposition decision. Sophia initially believed that 
relief from the financial expense of storage was a chief motivator for Biobank donors, but came 
to see it differently once she began assisting in the Biobank office. “Patients could stop the 
billing tomorrow by saying, ‘Discard them,’” she noted. “Many do, but these people choose to 
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give to the Biobank.” Why? Fertility patients report that cryopreservation storage fees, which 
range annually between $300-$1000, do impact their embryo disposition decisions (Brzyski, et 
al. 2000), though numerous other factors and motivations inform whether fertility patients from 
clinics around the world donate to scientific research or not. Variables range across reproductive 
history, clinic information, life circumstances, embryo quality and quantity, personal values, and 
conceptualizations about embryos (Samorinha, et al. 2014). Storage bills reminded patients about 
their frozen remainders, but financial considerations are just one part of the decision-making 
process for potential embryo donors. Also, since donation to REDEEM is rarely a seamless 
process, donors that follow through to completion are likely driven by more than the desire for 
relief from financial expenses, which, as Sophia pointed out, can be easily achieved by choosing 
to discard. The next sections examine donor motivations and the obstacles they confront through 
the donation process. Together, they suggest that even though fertility patients who donate to 
REDEEM Biobank regard their embryos as unwanted, donors consider them equally un-
wastable. 
 
Donating Embryos to Help Others 
Biobank staff believes that, for many donors, the decision to donate can be difficult. “It’s 
kind of a big decision,” stated Tori, the former Biobank coordinator, about the process fertility 
patients experience when donating their remaining embryos. “It is an embryo and they did pay 
$25,000 to get it made and paid storage for however long.” From Dr. Dunn’s perspective, 
donating embryos is a process of “honorable discard” and a “savior option” for those she 
perceives to be making challenging decisions. Their hunches echo findings from studies with 
fertility patients in the United States who describe their decisions as “agonizing” and 
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“anguishing” (de Lacey 2005), consider the typical four disposition options as unsatisfactory 
(Lyerly, et al. 2006; Lyerly, et al. 2010), and delay their decisions for multiple years 
(Lanzendorf, et al. 2010).   
One of the primary reasons Biobank staff believes that donors give up their remaining 
embryos is to help others. Adam and Julie Golds’ donation of their ML4 embryo was motivated 
by the desire to do something to prevent another family’s pain, and they believe their embryo 
with a rare genetic disease could be instrumental in such a mission. “I’d be devastated if 
someone else had to suffer daily the tragedy that we suffer,” explained Adam. The Golds are 
guided by a strong sense of responsibility, which Adam described in this way: “It’s when you 
feel in your gut and it tells you in a real tangible sense [that] this is something you have to do. 
It’s the difference between right and wrong. There’s a line.” Through the embryo donation 
process, Adam came to understand it is a way to address unmet need and provide opportunity.   
Why would you take that incredibly meaningful good deed away from yourself 
and your child, and take that potential benefit away from another family and 
another child?… I hope that [fertility patients] would donate the embryo to a 
family that needed it or donate it to science. Discarding it would just be travesty 
to me. Because of the scientific opportunity to help other folks or because of the 
ability to help somebody else have the family that they want. It would be sad to 
lose those two opportunities. 
 
Similarly, Jessica expressed hope that the donation of her embryos to the Biobank could help to 
improve IVF techniques for other patients. After detailing her infertility journey over the phone 
with Donna, she described wanting “to give someone the chance in the future to have a child as 
great as ours.” Rather than donate her embryos to someone for the chance at pregnancy, Jessica 
hopes her embryos can be used to improve clinical techniques so that a more general “someone” 
may benefit from improved IVF rates of success. Like Adam and Jessica, patients from fertility 
clinics around the world choosing to donate their embryos to research express similar beliefs in 
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the social benefits of scientific research and desires to contribute to individuals in need as well as 
to a healthier world more generally (Samorinha, et al. 2014).  
REDEEM Biobank donors also emphasize the hope that their specific donation will 
generate direct results. After hanging up the phone with a donor one afternoon, Donna shared 
with me a sentiment she heard often during such calls: “She really wanted hers chosen for 
research and to be the one that will cure something.” Few donors inquire, as the Golds did, about 
contributing to specific research and ongoing projects but some discuss their passion for stem 
cell research, citing the hostile political climate as a motivating factor for their donation. In fact, 
a few Biobank donors are impassioned to the point of becoming frustrated when learning that 
they are not able to donate to Class 2 stem cell research because their embryos were made with 
donor gametes (which, because of consenting protocol, are not allowed to be used for 
establishing cell lines). Staff sense that donors are “really hoping that something turns out with 
their donation,” which highlights donor expectations that their donated gifts will be purposefully 
utilized. Tori believed that Biobank donors are specifically hopeful “that someone can learn 
something and get useful information instead of us putting it in the trash.” Impressions from 
Biobank staff about donor motivations reveal donors to be consistent with other fertility patients 
who are driven by the belief that donation to research is a better alternative to “wasting” 
resources through discard considered to be “precious” (Nachtigall, et al. 2010). 
 
Overcoming Challenges to Donating 
The process of donating embryos to REDEEM is, on paper, straightforward, though daily 
life in the Biobank office revealed aspects of the process that slow, interrupt, and sometimes 
preclude donations altogether. Donors that follow through with donating to REDEEM despite the 
 111 
logistical headaches they sometimes experience reflect a commitment to their embryos being 
utilized for a greater scientific good.  
Sophia is an embryologist from Venezuela who has worked in Sutter University’s IVF 
clinic for nearly two decades. She and her lab colleague Pamela were asked to assist the Biobank 
during a period of transition between coordinators that coincided with my arrival. Their 
perceptions as IVF embryologists of the embryo donation process changed once they witnessed 
the difficulties entailed in donating to research; patients donate not just to avoid paying their 
cryopreservation bill, but to follow through with an underlying desire to contribute their un-
wastable remainders for scientific use. This section looks closely at the Biobank’s donation 
protocol, which was designed intentionally to give people autonomy and time for thoughtful 
decision-making, although the design also contributes to mistakes, delays, and confusion.  
REDEEM’s donation process follows these steps: Fertility patients interested in donating 
to REDEEM contact the coordinator, who follows up inquiries with an introductory letter, six-
page informed consent form, and voluntary health questionnaire. Patients are instructed to review 
the materials at home; if they decide to donate, they mark their preferences for how researchers 
may use their embryos,36 sign the donation forms in the presence of a witness, and return the 
paperwork to REDEEM for review and final consenting over the phone. REDEEM considers 
embryo donations “complete” when patients submit their consent forms free of error to the 
Biobank office at Sutter University. REDEEM established this multi-stage, interactive, and 
donor-driven consenting process in response to heightened ethical and political concerns in the 
United States about using embryos for stem cell research (Scott 2006; Thompson 2014). The 
consent process is designed to promote donor choice through the core principles of informed 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
36	  Class 1 human development research, Class 2 stem cell research, or approval for both.	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consent and build in extra time for donors to consider their preferences, make a decision, and 
review it before finalizing their embryo donation.  
Every word of REDEEM’s paperwork and protocols was approved under the scrutiny of 
Sutter University’s Institutional Review Board and the Embryonic Stem Cell Research Oversight 
committee to ensure that Biobank’s donation process is in compliance with U.S., state, and 
California Institute of Regenerative Medicine guidelines concerning the protection of embryo 
donors. It took nearly two years for the protocols to be developed and approved by the various 
oversight committees. All of these efforts reflect “ethical accounting procedures” (Thompson 
2014), or the principled actions taken by groups like the REDEEM Biobank to adhere to 
standards for utilizing donated embryos in research. Within the bureaucratic procedures of 
consent protocols and committee approvals, it is possible to see how the “pro-cure” rhetoric of 
stem cell science translates into “procuratorial” practices—like embryo donation—that shape the 
way human embryonic stem cell research is conducted in labs at universities like Sutter.  
Efforts that went into designing REDEEM’s embryo donation process contribute to the 
myriad “problem” files that Biobank staff confront and try to resolve each day. In addition to 
dozens of calls and emails Biobank staff juggle from prospective donors, Pamela described the 
reality of the consenting process in this way: “Eighty percent of the consents are incorrectly 
filled out and fifty percent of patients don’t respond to requests to correct their forms. The other 
fifty percent don’t have return phone numbers or clinic contact information written on the form 
to reach them, so that list grows.”  
While Biobank staff reports “drowning in work,” potential donors sometimes feel 
overwhelmed too. For example, Nathan, a divorced Veteran wanting to donate his leftover 
embryos sent in his consent forms to REDEEM twice, both times containing mistakes. “When I 
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got him on the phone,” Sophia said, “he was exasperated, saying that he has mental and physical 
trauma that makes filling out the form impossible and that he wants me to just fill it out for him. 
I told him, ‘I am so sorry but we just cannot do that.’” REDEEM staff makes every effort to 
provide a smooth donation process for donors, but staff and patients still experience a variety of 
bumps along the way that make donation to research not as simple as signing a form. Strict 
institutional protocols that strive for high ethical standards and legal safeguards within the highly 
political climate of human embryo research make it sometimes challenging to donate precious 
leftovers to Sutter University at all. Donors who see the donation process through to completion 
are committed to making their reproductive remainders available for use by scientists because 
they hope to contribute to a greater scientific good.   
Potential Biobank donors are not the only groups that consider embryos un-wastable 
entities. Dr. Moto’s lab members also regard the embryos they utilize in their human 
development and stem cell experiments as invaluable resources for which they feel privileged to 
have access. Embryo donors and recipient researchers similarly treasure frozen embryos by 
considering them too precious to waste.  
 
Wanted and Un-Wastable: Scientists Prevent Waste in the Name of Good Science  
“As a scientist, you try to ask key questions, do good science, do good work, and 
not be wasteful.”  
- Simone, Postdoctoral researcher in Dr. Moto’s lab 
 
 Dr. Moto’s lab is the largest in Sutter’s Stem Cell Institute and one receiving the strongest 
financial support. At the surface, Dr. Moto’s well-funded lab with full benches, stocked supply 
cabinets, and state of the art instruments appears to be a space where few would learn the merits 
of thrift. At worst, lab members may fall into a habit of expending resources mindlessly. A non-
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biologist, I did not have a baseline for understanding how “lucky” lab members feel by 
comparison to colleagues in other labs and institutions. 
 Wendy, the Moto lab manager who approves all supply requests from researchers in the 
lab, finds it “difficult to make researchers aware of how much money they are spending.” As an 
example, she notices that researchers use chemical wipes to clean up a lab space instead of paper 
towels—the cheaper option—that she chides them to use instead. Caitlin, a senior-level postdoc, 
similarly perceives “quite a bit of wastefulness” within the lab. She completed her doctoral 
studies at a private university that “had money, but we were very mindful of it.” Everyone in her 
home lab, for instance, made his or her own phosphate buffered saline (PBS), a common solution 
for working with cells in vitro. “The first thing that shocked me coming to Dr. Moto’s lab is they 
buy PBS. Dr. Moto is more than willing to pay the money,” which Caitlin believes leads to a 
lack of awareness among some lab members about the material expense of running a lab, and 
results in buying duplicate supplies or too much media that expires before being used. 
Researchers, like Aanya, a Masters-level lab assistant, came to Sutter from a nearby state 
university where she became accustomed to reusing gloves to save costs. “People who work here 
don’t realize how fortunate they are. The resources are amazing.” If a principal investigator like 
Dr. Moto has a seemingly endless supply of financial resources, lab members might not learn the 
practices of waste prevention that are considered a cornerstone of how scientists “do good 
science,” according to Simone.  
 Despite the abundance of resources within Dr. Moto’s lab, efforts to prevent waste are also 
in vast supply. Lab members feel privileged to have access to “scarce” and “precious” research 
materials like human embryos. These sentiments inform the ways researchers strive to “do good 
science” through everyday practices with the lab. In this section, I explore the sentiments and 
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practices of scientific researchers within Dr. Moto’s stem cell lab. Just as embryo potential is 
produced through fertility clinic IVF lab practices of ranking and grading, I argue that laboratory 
efforts to prevent waste make visible how the frozen discards of IVF become the treasures of a 
stem cell lab.   
 
Between Abundance and Scarcity: Privilege, Stress, and Respect in the Lab 
 Researchers in Dr. Moto’s lab work daily with a range of cells—gametes, embryos, fetal 
cells, stem cells, and adult cells—from a wide range of species. Regardless of cell type or species 
origin, researchers express reverence for cells that are difficult to obtain, scarce in supply, or 
impossible to replace. For those who work with renewable cell types, such as induced pluripotent 
stem cells (iPSCS) or established human embryonic stem cell (hESCs) lines, like the standard H1 
or H9 lines, being cavalier with cells, as some learned the hard way, puts the researcher at risk of 
losing time and energy invested into their experiments.  
 For those who work with human embryos, the challenges are different. “Embryos are a 
difficult reagent to work with because you can’t ask someone really nicely for more,” explained 
Madison, a late twenties doctoral student in genetics. She works primarily with iPSCs, cells that 
allow her to start a new cell line relatively easily if needed. But with human embryos, she 
explained, “you can’t get more just willy-nilly.” Diya, one of the lab assistants, suggested that 
the origin of the tissue impacts its supply. Her sense is that human tissues samples will always be 
limited:  
When it comes to any kind of human sample, whether from skin or embryos, I 
think it’s always valuable because of access to it. It’s not easy to get any kind of 
sample any time. That’s the reason. Any kind of human tissue—embryos, skin, 
muscles—it’s of value. 
  
 116 
 Caitlin was reminded of the rare opportunity she has at Sutter to utilize the REDEEM 
Biobank as she sought faculty positions at the end of her postdoc in Dr. Moto’s lab. She traveled 
a lot during the spring quarter to other academic labs where she presented her data from 
experiments with human embryos. When we caught up between trips, she conveyed impressions 
such as: 
I feel very, very privileged and lucky to have this source of embryos and it's very 
clear as I go out on the job market, that people are like, ‘You are so lucky that you 
get to work with human [materials]. I work with mouse and bovine and it would be 
great to work with human [materials]’. Everyday I think to myself, I'm very 
privileged. 
 
Access to the Biobank for Caitlin’s research informs her waste prevention efforts in the lab. 
Helena sees the privilege Caitlin described as not limited to the Biobank but extending to the 
opportunity to study at a top ranked research university like Sutter: “I think it’s one of those 
things where you’re privileged to work here, go to school here. It’s what keeps Sutter ahead of 
other schools, because we do have access to these things. It takes a lot of funding, politics, 
meetings, paperwork, and red tape.”  
 Because of this feeling of privilege, some researchers experience increased stress and awe 
when working with human materials. Simone, a postdoc and mother of three from the Northern 
California coast, is prone to saying “mousey prayers” and giving gratitude to frogs that she 
sacrifices for experiments. She feels that, 
With the human system, it’s even more nerve wracking… You do get a little frantic 
and nervous. It’s an important sample. It’s such an important, precious thing, in 
your hands. It’s very hard to not be shaky. Maybe it’s just me but I worry that I will 
drop them or mess this up or suck them up too far and lose them [in the pipette] 
because these kinds of these happen, right? Little technical things that you can’t 
control.  
 
Others, like Lucia, a visiting doctoral student from Spain who works primarily with two 
pronuclear stage (2PN) human embryos, feels lucky to have easy access to human materials. She 
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clarified that she structures her lab practices around the respect she feels for having privileged 
access rather than from a feeling of awe for the human material she works with. It is conceivable 
that researchers accustomed to Dr. Moto’s well-resourced lab could take for granted the supply 
of precious materials in the REDEEM Biobank, but, instead, all of the lab members I 
encountered express awareness, privilege, and respect for the range of cells in their respective 
dishes.  
 The stress such privileges entail leads researchers to act respectfully within the lab with the 
ultimate goal of preventing waste. “You feel privileged and nervous all at the same time. You 
don’t want to mess anything up,” explained Simone about the way stress informs her behavior at 
the bench. “You have a precious commodity and you don’t want to ruin it.” For Caitlin, the 
awareness of privilege conjures feelings of respect: “I feel, because it’s such a privilege that I 
need to be respectful of it, respectful of what I get to use, respectful of how I treat them.” 
Vivian’s sense of awe and privilege generates for her feelings of respect for the suppliers of her 
coveted research materials, the Biobank donors:  
We just need to be respectful, whoever these people are. They are helping us in 
their ways, so we just need to do the right thing… I guess we are really grateful to 
the patients who agree to donate their embryos. It’s just—what’s the right word?—
they are really supporting us. 
 
 
Preventing wastefulness is a motivating force among researchers in Dr. Moto’s lab, and 
arguably much of contemporary biological sciences. Sentiments of privilege, stress, and respect 
arise among Dr. Moto’s lab members due to access to human embryos for their experiments. 
After reviewing various saving techniques operating within Sutter University, I explore how 
making precious embryos conspires with the ways scientists try to “do good science.”  
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Avoiding Waste in a Stem Cell Lab 
 Waste prevention practices are part of everyday life around Dr. Moto’s lab and take 
various form: 1) rigorous planning of experiments, 2) committing to timelines necessitated by 
experiments with living cells, 3) making mindful requests for and maximal use of scarce 
resources, and 4) behaving with vigilance, persistence, and care. These practices bring to life 
saving ethics that inform how Dr. Moto’s lab members do good science.  
 
A Developed Plan with Good Questions 
 Waste prevention begins well before launching an experiment as researchers make a plan 
to determine what they need materially to achieve their goal, no more and no less. Simone 
believes scientists “have a certain obligation to do your best, to be rigorous, and to have a good 
question.” Diya emphasized the importance of having “good intent to evaluate the sample that 
you have, trying to use it to the maximum and to get the maximum data from it that you want to 
get.” In order to obtain maximal data by using minimal resources, researchers are clear that 
preparations are essential. Learning how to strike such a balance involves being considerate 
about waste.  
My field research started at Sutter University at the beginning of the 2012-2013 school 
year, which coincided with the matriculation of the Institute’s first PhD program students in 
Stem Cell Biology and Regenerative Medicine. The program is one of the first in the nation and 
world to support doctoral studies in translational science, which is an approach that provides a 
critical link between basic science, clinical therapies, and biomedical entrepreneurship. The goal 
of the program, according to the website, is to offer “specialized training in the development and 
clinical application of discoveries in the basic sciences to achieve regenerative therapies” with 
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hopes to “produce future leaders in translational science” who are passionate about “improving 
the human condition.” Sutter distinguishes its program from others by emphasizing its “applied 
culture,” as a first year student described, by regularly featuring clinical researchers working 
with disease as guest speakers as well as “literally passing samples back and forth” between the 
medical school and Stem Cell Institute. Being in close proximity to California’s vibrant startup 
community also attracts doctoral students planning careers in the biotech industry; students 
pursuing entrepreneurial careers in stem cell biology are encouraged to submit business plans 
rather than funding grants for final course projects, and conduct internships in venture capitals 
firms rather than clinical departments. My participation in the inaugural program’s core courses 
and journal clubs as well as conversations with faculty and students introduced me to key 
ingredients in the making of a stem cell scientist. Good questions within scientific inquiry are 
fundamental to their training.     
One way that researchers across the Stem Cell Institute develop rigorous research 
questions is through regular presentation of ongoing data, collaboration, and mentorship. At any 
give hour during an average weekday, lab scientists can be found sitting around a large table in 
one of the Institute’s glass-walled seminar rooms snacking on pastries or pizza while a journal 
club, lecture series, or open seminar is underway. At the front of the room, stem cell researchers 
move through their obligatory Power Point presentations that follow a conventional formula of 
“telling a story” about their project. Describing experiments as stories, one research assistant 
suggested, is because “when we start something we want to finish it, with a good ending.” 
Presentations follow a similar structure: introduce a health problem, articulate hypotheses, 
describe methods, review experimental evidence, and offer discussion points about findings. 
Lectures attract questions from colleagues, provoke the sharing of ideas, and contribute to 
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participants’ skills around refining their methods of inquiry. For presenters and attendees, such 
presentations reinforce the way good scientists plan and execute experiments.  
During the fall quarter, I attended one of the program’s core courses twice a week. 
Faculty investigators from around the Institute delivered lectures on topics deemed fundamental 
for preparing the next generation of leaders in the field of stem cell biology, including: human 
embryological development, epigenetics, cellular reprogramming, pluripotency, and 
bioinformatics. In both the graduate course classroom and open campus seminars, engagement 
with scientific studies in progress in the Institute contribute to the cultivating of habits among 
students, postdocs, and professors alike that kept mindfulness about waste at the forefront of 
their bench activities.  
In Dr. Moto’s lab, an “embryo interest group” formed among the scientists working with 
human embryos, which is accompanied by a few clinical staff from the IVF clinic interested in 
research. This small, informal group meets monthly to present issues around ongoing 
experiments, solicit feedback, identify opportunities to collaborate together, and discuss topical 
issues relevant to participants’ shared fields of interest. Dr. Moto provides project guidance and 
financial support by meeting weekly with each of her graduate and postdoc mentees. Caitlin, the 
lab’s senior-level postdoc, offers mentorship to junior researchers from the group, including 
Lucia, the visiting Spanish doctoral student, Vivian, the Chinese postdoc, and Rachel, the 
American third year reproductive endocrinology fellow doing a lab experiment for her capstone 
project. As the self-described “embryo firewall,” Caitlin also serves a key role in the lab as the 
liaison between Donna, the Biobank coordinator, and researchers requesting embryos for 
experiments.  
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Various systems—from research presentations to individualized mentorship to an embryo 
firewall—are in place in the Stem Cell Institute to reinforce methods of scientific inquiry that 
plan with care around resources. Thus, prior to requesting embryos from the Biobank for use 
within an experiment, scientists are trained to plan thoughtfully and economically with respect to 
the invaluable frozen assets.  
 
Committing to a Timeline 
Another form of waste prevention among stem cell researchers is time management. A 
key facet of running an experiment with cells is scheduling a timeline for activities and adhering 
to it rigorously. Aanya, a research assistant who migrated from India, worked straight through 
one weekend with a migraine because she had an experiment in progress: “Experiments with 
mice are huge for me if I have to sacrifice. These cells that I extracted from them, [if I didn’t 
come in] I would just think the whole effort is being wasted. So because of that I wouldn’t take a 
day off.” One reason that rigid time schedules sometimes feel “like a lot” is because, as many lab 
members acknowledged, it is uncommon to ask each other to do the labor of running another’s 
experiment. Fellow lab members actively collaborate to offer planning advice, share culture 
media, and occasionally help change media for another, but as Aanya explained, “unless it’s 
something really simple, we don’t normally ask for help.”  
The idea of odd hours does not exist for researchers because cells might require changes 
of media or monitoring at all times of the day. Researchers often block off weeks at a time for 
running experiments around which their personal lives have to fit. Madison described the time 
management involved in her stem cell work:  
For the first two years here I never went on vacation except for holidays and when I 
didn’t feel too guilty asking people to take care of my cells… I’m organized and like 
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following a schedule but sometimes it’s a huge pain, like being up at 4 a.m. so that I can 
go out with friends when they go to the city at 9 a.m. Or when I’m here at midnight to 
make sure I can start something the next morning.  
 
Lucia picked an apartment near campus so that she can bike over easily to accommodate late 
nights and early mornings dictated by the in vitro embryos she studies. My efforts to 
accommodate the rigorous scheduling of biological research failed a few times. Since I, like 
many at Sutter University and the Stem Cell Institute, commuted an hour each way by train, I 
missed some early morning and late night opportunities to shadow during certain experiments.  
 Many researchers liken the time management required for stem cell research to the tasks 
of parents. “I say that I’m going to feed my cells,” Madison tells friends. Like babies, cells need 
regular feeding, monitoring, and cleaning in order to thrive. Some lab members with children 
understand intimately the dueling challenge of commitments around care that are shaped by 
schedules. Nena, a postdoc from India and mother of a one year old, believes she is still “trying 
to manage how I structure my time.” Key to her ability to manage the duties of a parent, wife, 
and caretaker of her in vitro “babies,” as she called the iPSC cell colonies she creates, is having a 
“very supportive partner”: “Whenever I have to come to the lab, he is fine taking care of the 
baby, or if I can’t manage to do things at home, he is fine with that.” Similarly, Aanya opted to 
postpone her research timeline by one year when her daughter’s spring break fell in the middle of 
an experiment cycle. In order to prevent the waste of time and materials, researchers like Aanya 
rely on family and childcare providers to support them in the care for their cells.  
 
Maximal Use of Resources: Anticipating Need and Freezing Down for the Future 
Researchers also prevent waste by requesting only the amount of material they need. 
“You don’t thaw an embryo and realize that you don’t actually need it,” explained Vivian. 
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“That’s not acceptable.” For example, Luke requested six 2PN stage embryos from Donna, and 
Caitlin worked with him to thaw the embryos for his experiment. He initially asked her to thaw 
only two of them because “each embryo counts,” as he said to me. Researchers are aware that 
embryos, especially 2PNs, are highly valued, so they plan their use of them carefully in order to 
avoid unnecessary waste. “I think the majority of us in the embryo group have that attitude that 
you only thaw what you need,” Caitlin reflected. “You need to obviously consider that probably 
not everything is going to survive when you thaw, so we try to ask for a little bit more… You 
just don’t overuse and don’t thaw more than you need.”  
Once materials were thoughtfully and thriftily requested, researchers strive to use their 
materials to the fullest capacity. “You try to make the most out of it,” Diya shared, “because you 
never know if you’re going to have the same sample back again.” Researchers describe this 
approach as “maximizing” the biological materials they worked with. Eric, an Austrian doctoral 
student of genetics who graduated the same month I left Sutter, worked primarily with adult cells 
and iPSCs. “Waste is something I am always concerned about,” he began. “When I’m done with 
an experiment and I don’t need the cells anymore, I could either just toss them because, for now, 
I don’t need them. But even though the experiment is done, I always like to freeze them down.” 
“Freezing down” involves saving the remainders from an experiment for potential future use. 
Eric, for example, froze down extra cells to use as a control line for testing new media that 
companies rolled out regularly. Freezing down, or banking, the remainder cells from experiments 
captures what Helena meant when she described stem cell science as “kind of like a recycling.” 
The potential value of an embryo is so great that the left overs from an experiment with surplus 
embryos merit saving too.   
Since researchers regard human embryos as “very precious,” most have contingency 
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plans in case of unforeseen circumstances, errors, and accidents. Caitlin described times where 
she thawed embryos that turned out to not be what she requested or expected. When she thawed 
the embryos and looked into her microscope, she was shocked: 
My goodness, it was the wrong stage. Even though [the embryology report] said it 
was 2PN, the embryo was cleavage stage. What are we going to do now? I make 
the point, even if we don't have a use for it now, I'm not going to throw it in the 
trash. I'm going to disassemble it, have single cells, and I just know two months 
from now somebody is going to come along and say, ‘Hey, I need some single 
blastomeres.’ I feel really strongly about doing that. 
 
Caitlin’s practice of freezing down and banking the extra cells—the remainders of remainders—
reveals preparedness against the risk of squandering potential, which many of her lab mates 
agree is a primary ethical concern within stem cell science. It also suggests the way an embryo’s 
preciousness does not cease, even when the embryo itself is destroyed through the experimental 
processes of disaggregation. Even when thawed by mistake, its value is worth preserving and 
preventing from going to waste. Diya, Eric, and Caitlin’s efforts to maximize the use of valuable 
biological materials by managing risk and saving for the future help prevent the wastage of 
valuable cells.  
 
Care in the Lab 
Feelings of privilege, anxiety, and preparedness breed careful lab practices that help 
researchers prevent waste. When Vivian, a postdoc from China, works with human embryos, she 
notices that she becomes “super, super careful.” She meticulously cleans the embryo room in 
preparation for an experiment without using ethanol, a chemical thought to have negative effects 
on incubating embryos. She also monitors the temperature of the room and gas percentages more 
frequently than usual to ensure the best environment for culturing embryonic cells. “I make sure 
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everything is perfect for the embryos. [These are] good procedures for cell culture in general,” 
she explained, “but I don’t know if people do it” as regularly or religiously with all cell types.  
Caitlin is similarly vigilant when working with human cells at the bench. “Things are 
going to happen, whether it’s due to human error, mechanical problems with the pipette, or 
inherent to the embryo itself,” and when an accident inevitably happens, Caitlin chooses to not 
give up. When an embryo goes missing in the dish, for example, Caitlin described how she 
responds: “I sit there for twenty minutes looking for it… I just feel the need, rather than have the 
attitude of letting it go, that I’m going to do everything I can to find it.” An embryo can go 
missing, she teased, because:  
It's not like it’s the size of a cat or something; it’s small and there’s a lot of hand-
eye coordination. I think the first time you lose [an embryo] you get really upset 
and then you try to get over it. The same goes for even single cells. Even with 
single blastomeres, I’m so upset if I lose a blastomere. That’s my attitude but I 
can’t say that I necessarily expect everybody to share that. I mean you are going 
to lose some. It’s kind of natural. I still make an effort even now to do what I can. 
 
Caitlin’s concerted efforts are tempered by awareness that the unexpected can be expected in the 
lab, despite her best-laid plans and mindfulness. Moreover, her efforts suggest that it is not the 
outcome of experiments that define “good science” so much as scientists being careful in 
anticipation of surprises and uncertainties. 
For Nena, a postdoc who works primarily with adult stem cells, vigilance and diligence do 
not adequately capture her approach to care at the bench. How she behaves in the lab reflects her 
broader philosophy for practicing in the life sciences, which is premised on respect for cells as 
living entities rather than tools for her to manipulate.  
My philosophy is to treat cells as if they are my own babies, to take care of them, 
to not just use them as a tool to get higher in our career. That’s how I like to treat 
them. They have a life of their own. Just as we treat our pets and our kids at 
home, I feel we need to treat [our cells] with respect and study them, not just to 
 126 
use them.  
 
Nena came to Dr. Moto’s lab as a postdoc three years earlier after completing her doctoral 
studies in India. She describes herself as a religious person who is “practical.” She believes in 
God and draws from religious texts, like the Baghadavita and writings from J.K. Krisnamurti, to 
inform how she leads a life of intention with the people and things receiving her care, including 
her daughter, her vegetarian grandmother, and the cells she works with at Sutter University.  
Even if people give biopsy samples, it is so important and crucial for scientists 
like us to treat it well and not use them just as some tools for studying something 
that we are interested in. We need to value them. Sometimes when we have a 
busy schedule, we think, ‘Oh, I can do that tomorrow. It’s okay to skip a feeding 
today.’ We can’t keep them hungry. Though they can’t say anything, we should 
change the media and know that the cells are going to be in a good state, and then 
your experiments will reflect the same state. 
 
Nena’s remarks challenge her lab mates to consider how the end goals of their experiments 
inform their means. For her, respect and sincerity are core values that shape her participation in 
stem cell science and belief that such endeavors ought to hold sacred the value of cellular life.  
--- 
Waste prevention values are in abundant supply in Sutter’s Stem Cell Institute and evident 
through various practices in which Dr. Moto’s lab members “care for the data” (Fortun and 
Fortun 2005). Planning experiments, adhering to strict time schedules, requesting and using cells 
efficiently, and caring illustrate how researchers do the best scientific work they can.  
 
Understanding Good Science 
“For me, doing good means helping people suffering from neurodegenerative diseases… 
I believe that is the ultimate goal, to treat each other as nicely, as kindly as possible and 
to do good.” 
- Christine Moto, Sutter University Stem Cell Institute Principal Investigator and 
REDEEM Biobank Director 
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What remains unclear is how preventing the waste and misuse of frozen human embryos 
relates to doing good science, as Simone and Dr. Moto describe it. According to anthropologists 
Kim and Mike Fortun, “articulations of ‘good science’ must be rooted in a tradition of thought 
and practice, even when intended to establish new agendas and open up new lines of work” 
(Fortun and Fortun 2005: 47). Sociologist Charis Thompson’s recent study about stem cell 
research in California clarifies the traditions and practices pertinent to the new agendas within 
stem cell biology (Thompson 2014). My approach to “good science,” like the Fortuns’ and 
Thompson’s, does not assert a value judgment about which scientists or scientific practices are 
good, bad, ethical or otherwise; instead, I take interest in the role that “good” plays within the 
daily efforts to save at Sutter University’s Stem Cell Institute. 
Thompson, a professor at UC Berkeley, was an active participant in the public 
engagement process following the passage of Proposition 71. In her book on the topic, she 
describes three senses of the concept “good science.” The first two meanings refer to common 
judgments of “good” circulating within scientific communities, specifically 1) science that is 
considered to make a definitive contribution to the field and 2) science that is practiced 
according to established procedures that adhere to values of transparency, accountability, 
integrity, and replicability. Both are essential to the modern scientific enterprise, and are in some 
sense “internal to the science itself” (Thompson 2014: 61). Dr. Moto’s lab members prove to be 
sincerely motivated by these descriptors of good science. Each for their respective reasons came 
to Sutter University to be among the finest thinkers and to work with cutting-edge materials on 
visionary projects; Sutter is a place where many feel lucky and well positioned to make impacts 
in their field. Whether driven by aspirations to be a leader in basic science discovery, translating 
“bench” discoveries to “bedside” therapies, or biotech entrepreneurship, researchers at the Stem 
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Cell Institute align their daily labors with norms and values about doing “good” science that are 
the “sine qua non of a flourishing research environment” (Thompson 2014: 61). My observations 
within Dr. Moto’s lab and conversations with researchers reveal that preventing waste is a core 
value within stem cell science that shapes how scientists achieve these two types of good in their 
work.  
Thompson offers another perspective on “good science” that broadens the framework 
beyond the normative values of science to include ethics and politics. Thompson’s third 
definition of good science addresses the ways science engages with evolving regulatory ethical 
considerations. Soon after the first human embryonic stem cell line was established in 1998, stem 
cell research became embroiled in high profile debates about ethical mandates to save lives—
saving people living with debilitating disease on the one hand, and saving the frozen unborn on 
the other. Thompson “followed the ethics” within California’s stem cell controversy and 
identified two ethical “landscapes” that dominate the terrain: a “pro-cure” framework focused on 
overcoming barriers to research with embryos and a “snowflake” framework dedicated to 
protecting frozen embryos from destruction.37   
The originators of the REDEEM Biobank navigated these ethical landscapes to establish 
and open the bank for embryo donations. Within the pro-cure logic, REDEEM exemplifies 
“good science” by managing an invaluable supply of human embryos that are ready for research 
in accordance with guidelines set out by the National Institutes of Health, CIRM, and Sutter 
University’s Stem Cell Oversight Committee.38 In other words, the Biobank helps overcome the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
37 In Chapter 4, I examine the other predominant framework articulated by the Blossom Embryo 
Adoption program not as a “snowflake” ethical landscape, but through a familial notion of good 
premised on Christian values of equality, dignity, and inclusion.  
38 For history about Stem Cell Research Oversight committees, see Thompson 2014, especially 
pages 35-36 and 106-107.	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common obstacle of embryo supply within stem cell research. Simone’s wish that more people 
understood how stem cell scientists regard and handle all types of cells, especially human 
embryos, reflects the pro-cure framework of valuing embryos as scarce resources:  
We all treat these things like gold. These are very precious samples. There’s no way we’d 
be throwing things away or wasting. We collaborate, we group up, and we try to maximize 
our resources. We take it very seriously. It’s an honor actually to work with human 
samples because there’s so little. 
 
The work of Biobank staff also conforms to the pro-cure landscape; like curators of art for 
museums, they select, care for, guard, safely transport, and analyze valuables whose value cannot 
be reduced to market prices (Thompson 2014: 37). As discussed previously, REDEEM embraces 
pro-cure “ethical accounting procedures” to keep resources flowing to the Biobank—both CIRM 
funding and embryo donations—and out of the bank to researchers’ Petri dishes.  
Consider, though, what the accounting practices for the REDEEM Biobank might be if 
the ethical landscape were framed by social justice, disability rights, health care access, or the 
fair compensation of tissue donors. Or, as Ruha Benjamin suggests, was a landscape shaped by a 
“people’s science” (Benjamin 2013). It is reasonable to wonder if REDEEM would even exist 
within these other frameworks. Understanding the REDEEM Biobank as a product of a broader 
ethical landscape, which has been forged through social, political, financial, and moral forces 
beyond the researcher’s bench, clarifies the fundamental role of waste prevention within the pro-
cure ethical terrain. Preventing waste is evident through laboratory practices, but is exemplified 
by the fact that excess embryos are saved at all, in this case for possible use by grateful 
researchers in a contentious political environment. “Good science,” when seen through the lens 
of ethical landscapes, proves to be a dynamic terrain comprised of neither fixed rules nor 
practices; rather, “good science” is better understood as being contingent upon social tectonics 
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and political winds, which are powerful forces that shape saving priorities. 
--- 
This section and the previous one showed that fertility patients and Sutter researchers 
similarly regard frozen embryos as un-wastable and make efforts to prevent their waste. These 
examples set up the beginning of a paradox that I explore below, which is how such treasured 
leftovers become trash through the Biobank’s procurement practices. I argue that informed 
consent procedures common to contemporary tissue economies do the work of “trashing” valued 
biological materials in order to disentangle treasured tissues from their progenitors and ready 
them for their promising futures as research materials. Specifically, REDEEM’s informed 
consent process illuminates how embryos become “waste” by being severed from donor ties of 
kinship and ownership, thus rendered available for new property claims by the biobank and 
researchers.  
 
On the Way to the Waste Bin: Trashing Treasured Embryos  
“By conferring the category of waste upon an object, we must narrate its past and 
speculate as to its future, an act of narration that attempts to chart the comings and 
goings of utility, and necessarily, the passing of different orders and disorders.”  
 - William Viney, Waste: A Philosophy of Things 
 
 
Dr. Moto established the REDEEM Biobank to serve as a repository for procured 
embryonic materials awaiting scientific research. In REDEEM’s brochure for advertising 
donation services, they express hope that embryo donations will facilitate “necessary” and 
“important” research that could “produce valuable information” and “may some day lead to new 
treatments” for adult diseases and infertility. In order to fulfill this mission, REDEEM facilitates 
the categorical trashing of embryos in order to foster their donation and reclaim by researchers. 
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How and why donated embryos become waste runs counter to common intuition in the United 
States where the moral, ethical, and ontological status of embryos is actively debated (Berg and 
Furton 2006; Brakman and Weaver 2007; George and Tollefsen 2008; Maienschein 2003; 
Maienschein 2014). The previous section detailed many ways frozen embryos are regarded as 
neither waste nor wastable in the eyes of fertility patients and stem cell researchers. Others 
scholars have made similar observations. Catherine Waldby and Robert Mitchell discuss 
donating “spare” embryos in the U.K., which they argue are “emphatically not waste” due to 
their “ontological significance” as the beginnings of human life (Waldby and Mitchell 2006: 84). 
I suggest as emphatically that donated frozen embryos are paradigmatic forms of waste. A close 
examination of the REDEEM Biobank’s informed consenting process makes visible the ways 
donated frozen embryos become trash as a mechanism for becoming new forms of treasure.  
Rubbish theorist Michael Thompson (1979) helps clarify how frozen IVF embryo are 
exemplary forms of waste. Thompson, a student of Mary Douglas’s, makes the astonishing claim 
that waste is a “realm of pure potential” (quoted in Squier 2004: 207) as opposed to the 
commonly held understanding of waste as absent of value and vacant of purpose. He comes to 
this conclusion by examining how value operates with respect to transient objects (whose value 
declines over time) and durable objects (whose value endures over time), like antiques and 
junkyard cars. For objects to shift categories, he argues that they enter the third realm of rubbish, 
a “transformative category” that functions like a “machine through which objects acquire new 
values and properties” (Ibid.). In other words, waste is a category that facilitates the production, 
conversion, and redemption of value.39  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
39 I dispense with some aspects of Michael Thompson’s fruitful argument in the making of my 
own. Thompson argued that value converted from transient to durable forms by passing through 
rubbish in one linear direction. I maintain a more open-ended, multi-directional, and messy 
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Frozen embryos, figures of pure potential in the realm of IVF clinics, find a classificatory 
companion in waste. Once IVF remainders are donated to REDEEM, they are transformed into 
research materials banked for their potential to generate promising futures. IVF embryos are 
wasted through processes of informed consent that are designed to sever the social relations and 
property ties between donors and embryos. By conferring donated embryos to the category 
waste, they become available for reclamation and reuse. 
 
Informed Consent: How Embryos Become Waste  
“The moment when magic is required is when scientists try to cut one network 
and make possible another network, a scientific network.”  
- Warwick Anderson, “The Frozen Archive, or Defrosting Derrida” 
 
Simone is concerned that many non-scientists misunderstand how IVF embryos that were 
made for pregnancy become research materials intended for experimentation. She worries that 
people believe IVF embryos and experimental embryos are the same while she recognizes them 
as categorically distinct. “They think that there is just this pool of embryos and they could 
potentially be implanted [into uteruses], but here we [scientists] are using them to generate lines 
because we think it’s so important.” Simone wants people to know that the leftover frozen 
embryos stored in the Biobank and used in experiments “were never going to be put back into a 
female or destined to become a baby.” Instead, she understands that the original intended 
purpose of IVF embryos expires at the time of donation to the Biobank, which renders the 
embryos available for repurposing by scientists. Most of the researchers, students, and staff I met 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
awareness about the transient forms value takes for any entity with respect to matters of place 
and time. Also, Thompson argued that rubbish is a category of zero-value, yet a realm of pure 
potential. This dissertation utilizes a more capacious notion of value that sees the contentious 
multiplicity, rather than a zeroing, of value, especially values associated with markets and 
moralities.   
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at Sutter University regard frozen leftover embryos in the same way Simone does: as being on 
the way to the waste bin.  
REDEEM’s informed consent procedure reflects the common refrain expressed to me 
around the lab that Helena captured well: “Leftover embryos would just be discarded or 
incinerated anyways, so why not use them for good?” A brief history of what informed consent 
procedures are designed to do clarifies how the category waste is conferred upon frozen embryos 
when donated and the role waste classifications play within two related outcomes—the 
dispossession of donors and disentanglement of embryos. 
Informed consent became a standard process in the twentieth century within U.S. 
scientific research involving human subjects. The principles of informed consent were enshrined 
in international human rights conventions as early as the Nuremberg Code of 1947, as well as 
national commissions, such as the Belmont Report of 1978. It is one of the core bioethical 
principles that strives to protect patient autonomy and prevent risk to research participants. 
Moreover, informed consent procedures are commonly described as providing subjects 
information about risks, rights, and benefits as well as the opportunity for them to give or deny 
consent for participation.  
Critics of bioethics describe various functions other than protecting patient rights that 
informed consent procedures perform. For instance, legal scholars argue that informed consent 
forms were first developed to mitigate risk for medical professionals rather than being an 
instrument for protecting the rights of patients. The first informed consent forms were used in 
U.S. clinical trials in the 1940s and 1950s in response to worries of litigation from research trial 
participants. As a result, some conclude that informed consent procedures provide medical 
professionals a “state of exception” wherein patient rights are reduced rather than expanded (e.g., 
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Menikoff and Richards 2006 quoted in Cooper and Waldby 2014: 143).  
Once fertility patients decide that they want to donate leftover embryo for research, they 
are required to sign two forms indicating their consent: one for the IVF clinic and one for the 
Biobank. At Harrington Fertility’s Paloma clinic, patients make their first disposition decisions 
prior to beginning IVF by marking in the thirty-page informed consent form their wishes for 
their embryos should the patient experience death or divorce. To notify the clinic about 
disposition desires after IVF, Harrington patients are asked to submit the two-page Disposition of 
Frozen Embryos form along with their final cryopreservation bill. Patients who decide to donate 
their remaining IVF embryos to REDEEM need to fill out a six-page informed consent form 
available for download from REDEEM’s website. Once submitted, the Biobank confers with the 
fertility clinic to coordinate shipping of the frozen remains to the lab.  
Each document captures a different angle on the same process of donating IVF embryos 
for laboratory research. In places, they echo similar language and serve as legal contracts to 
protect all parties. What intrigues me is their difference. A comparative reading of the clinic and 
tissue bank embryo disposition forms shows how waste serves as a useful category for donating 
embryos to scientific research. My attention to seemingly innocuous, even dull, paperwork 
extends the argument from Chapter 2 that documents produce things (Frohmann 2008). 
Specifically, I am interested in the production of leftover embryos as clinical waste within the 
Biobank’s consent literature, and specifically the classificatory language that frames frozen 
leftovers as already en route to becoming waste. To use Warwick Anderson’s turn of phrase, this 
analysis lays bare the processes behind the “magic” of transforming embryos into trash because 
they are so treasured.  
At first look, Harrington and REDEEM’s consent forms for donation share many 
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qualities. Each are lengthy legal documents organized by boldface titles and lettered categories 
about “Embryo Disposition” directing signers to “Initial Here” and “Choose One.” Each opens 
with a statement that narrates the original intention for IVF embryos, which they agree is to help 
patients become pregnant. And each describes IVF as a process through which “materials” are 
made to assist with pregnancy. After IVF, they acknowledge that some patients face decisions 
about “discarding” what are described by each as “excess” embryos.   
Here is where they began to differ. Harrington’s forms approach the “additional” 
embryos that “may remain in the lab after the transfer is complete,” noting that the 
cryopreservation of leftovers is common. The forms communicate that Harrington follows 
national guidelines to help “curtail the problem of multiple pregnancies” by limiting the number 
of embryos they transfer at one time. How many embryos are transferred at once, which impacts 
how many remain after the IVF cycle, is determined by “the developmental stage of the 
embryos,” their “quality,” as well as the patient’s personal history. Depending on the 
“developmental normalcy” of the untransferred embryos, “it may be possible to freeze them for 
later use.” The embryos to be frozen are described as “second-best,” and their “viability to 
provide additional chances for future pregnancy” is determined by clinical probabilities as well 
as by patients’ “choices” and “future wishes” for future thaw and transfer.  
REDEEM’s form also evokes the notion of clinical viability, yet reframes embryos 
through waste and need. REDEEM describes IVF as a technique that produces some “nonviable” 
cells “in excess of clinical need… which may not be further required for your treatment.” Prior 
to detailing the options patients have for donating the IVF materials they “no longer require,” the 
consent form echoes the sentiment common among stem cell scientists that embryos are en route 
to becoming trash. REDEEM donors are made aware that: “All cellular materials to be used in 
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this research would normally be discarded because you, the patient, have chosen to discard the 
material.” This language articulates a kind of embryo that was already a form of waste, even 
prior to donation. 
In a fertility clinic, leftover embryos are perched in a place where their potential to 
become many things is vibrantly alive whereas a tissue bank for research identifies embryos as 
already en route to the medical waste bin. On Harrington’s disposition form, patients and their 
partners initial boxes next to an open-ended list of options that depend on their “desires for future 
use” of their frozen remains. These potential trajectories contrast with REDEEM’s specific 
vision of the future predicated on the needs and desires of science. The Biobank’s form invites 
patients to consider the “opportunity” of donating “unusable biological materials” that they “no 
longer require” to researchers at Sutter University. Rather than let embryos “go to waste,” as 
they say on their website, the REDEEM Biobank frames embryos as clinical waste to justify 
their procurement as IVF byproducts. Making use of invaluable materials that are as good as 
trash provides the opportunity for the Biobank to transform them into treasures. 
 
 
Severing Ties: Disentangled Embryos and Dispossessed Donors  
Frozen IVF embryos are profoundly “entangled” entities (Callon 1998) within multiple 
webs of relations and intersecting ties of kinship, ownership, and stewardship (Haraway 1997; 
Hayden 2007; Strathern 2005). Entangled entities may circulate within networks, though some 
are more strongly grasped and bound by connections that are sustained even when seemingly 
given away (Weiner 1992). Frozen embryos offer a striking example of a kind of entity whose 
alienability—or ability to be disentangled—is essential to scientific research and hard won, if 
ever fully (Svendsen and Koch 2008).  
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The Biobank’s donation protocol allows donors to have continued connections with 
donated embryos in some notable ways. Upon donation, donor information is made anonymous 
to protect identifying information and donors are made aware that they will not receive 
information about study results from the use of their embryos. But on the consent form, 
REDEEM donors have the opportunity to be re-contacted by researchers at an unknown future 
date for two reasons: to be asked for additional health information or to receive genetic 
information that investigators learned from testing on their cellular materials. Based on 
unpublished research Donna and I conducted on consenting trends at REDEEM between October 
2010 and March 2013, more than half of the 841 consented donors during that period wished to 
be re-contacted to give health information (57.2%) or to receive genetic information (62%). It is 
difficult to qualify these numbers without having the opportunity to ask donors themselves why 
most opted to keep contact open with Sutter around health and genetic information. If one looks 
to other kinds of donations, such as of eggs, sperm, and embryos for procreation (Almeling 
2007), or organs (Sharp 2001), the reason may be simple: some people wish for any information 
about their biological matters when anonymity remains the status quo within tissue economies 
(Everett 2007).   
Another pathway REDEEM provides donors for remaining bound through kinship and 
ownership with their embryos involves the standard human subjects protection of being able to 
withdraw from the research at any time. When signing the consent form, donors agree to let their 
embryos be manipulated and destroyed at some point in the future by researchers at Sutter or 
elsewhere. Yet even once embryos are shipped and stored within the Biobank, donors can 
withdraw consent and pull their embryos from the bank at any time prior to the release of their 
embryos to researchers. Written into REDEEM’s consent is a narrow window of opportunity 
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available to donors should they wish to reclaim responsibility for their embryos.  
Over the five years since the Biobank opened, only once has a panicked donor called 
requesting her embryos back. Six months passed when she realized that she made a “terrible 
mistake” and wished to use them for another try at pregnancy. The Biobank agreed to return 
them and even agreed to pay the $300 shipping, but the donor’s fertility clinic was not 
comfortable taking back the embryos because of risks like cross contamination by other stored 
samples. As a solution, Dr. Dunn invited the donor to become a patient at Sutter’s IVF clinic 
where they offered to perform the frozen embryo transfers she wished to have. I first heard this 
story while on a walk with Wendy one afternoon as we brought an empty cryotank to the FedEx 
drop site near the campus medical center, though the story would be repeated to me a few more 
times by Dr. Dunn, Dr. Moto, and other researchers. The Biobank’s generosity in this account 
presents them as helpmates for fertility patients, aware of the tender ties that may linger with 
their donated matters, and not an indifferent bioprospector of IVF patients’ embryonic gold.  
 Despite these examples, informed consenting processes disentangle embryos from donor 
ties. At REDEEM, the consent process serves as a “magical” mediating force that severs the 
relational network between donor and recipient (Strathern 1996) in order to make possible, as 
Anderson described above, a new scientific network. Once consents are finalized and embryos 
are considered officially donated, a series of shifts occurs: embryos are declared forms of 
“unimproved waste,” severed from historically relative ties of belonging (Rabinow 1996b), 
rendered a microscopic terra nullius awaiting productive cultivation in vitro, and hitched to new 
speculative futures through mechanisms that transform their potential. Informed consent protocol 
helps catapult embryos “out of time” (Viney 2014) by loosening the strong grips of kinship and 
ownership through which they originate. Disentanglement allows clinical embryos to become 
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anonymous research materials that are freer to circulate to researcher Petri dishes without the 
burdens and liabilities of their histories in tow. In these ways, the trashing of embryos dovetails 
with dispossessing donors. 
One tie most surely severed through embryo donation is the possibility of donors to claim 
profits from the promising potential embryos might manifest. In the language of the REDEEM 
Biobank consent form, donors read on page two that researchers—not donors—can own and 
profit from experiments utilizing donated embryos: 
Any materials you have donated to research, or results of research including new 
products, tests or discoveries, may be patentable or have commercial value. In 
some instances, research results may be developed and owned by the 
Investigators, Sutter University, and/or others. Under California law and rules, if 
you consent to donate materials to the biobank, you will have no legal or financial 
interest in any commercial development resulting from the research. 
 
This kind of language is typical of tissue procurement around the United States and characterizes 
the “implosion” (Sunder Rajan 2006) between the life sciences and capital starting in the 1970s. 
 
Embryo Cryocapital 
The postwar engine for the U.S. economy began to sputter in the late 1960s and early 
1970s, followed by mounting economic crises and forecasting literatures about possibilities for 
postindustrial economic growth. The emergent neoliberal project played a decisive role in 
fostering the biotech revolution and growth of life sciences. The advent of recombinant DNA in 
the 1970s, more commonly known as tissue engineering (Rabinow 1996a), and the opening of 
the first genetic engineering company, Genetech, shifted scientific attention to the molecular and 
reprogrammable body. This redirection incited both anxiety and exhilaration as the “gold 
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standard” (Brodwin 2000) in biology of the integrated, whole body was superseded by newer 
forms of value extracted from fragments of biological tissue.  
By the 1980s, the Reagan administration dramatically increased federal funding for 
research and development in the life sciences, which directed funds away from social services 
toward private industry. The Reagan administration also reformed intellectual property law in 
support of patenting new biological products. The Patent and Trademark Act of 1980, or the 
“Bayh-Dole Act,” responded to waning industry innovation and patent production by 
encouraging new public-private alliances that allow publicly funded researchers to patent their 
inventions, which they could license or sell to private industry. The hope was that capital 
investment in the life sciences would rejuvenate America’s “inventive spirit” and ensure that 
“innovations, whatever they might be, were constantly channeled into economic growth” 
(Waldby and Mitchell 2006: 104). Narratives of profit-driven salvation imbued biotechnologies 
with messianic promise to resurrect the American economy. The “spirit of biocapitalism” in the 
late twentieth century was enlivened by a “born-again ethic” of gambling, chance, and excess 
(Sunder Rajan 2006: 199). 
The 5-4 Supreme Court ruling in Diamond v. Chakrabarty40 gave the increasingly 
“intense traffic” (Rabinow 1996a) between capital and the life sciences enhanced significance. 
The case arose when General Electric microbiologist Ananda Chakrabarty appealed the denial of 
his patent claim for a genetically engineered bacterium able to consume and digest oil slicks. In 
review of the criteria for patentable inventions, which required them to be novel, useful, and non-
obvious, the U.S. Supreme Court determined that the critical line of demarcation for a patentable 
invention was not between living and non-living matter, but between naturally occurring and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
40 Diamond v. Chakrabarty, 447 U.S. 303 (United States Supreme Court, June 16, 1980) 
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fabricated entities. In their words, “Congress intended statutory subject matter to include 
anything under the sun that is made by man” (Rabinow 1996b: 132). Their ruling in favor of 
Chakrabarty paved the way for the patenting of and profiting from genetically engineered plants, 
oysters, OncoMouseTM, and ultimately, human cell lines.41  
Such administrative, legal, and economic events of the 1970s-80s fostered conditions for 
new tissue economies characterized by capital investments in life technologies and their 
promising forms of profit. Moreover, leading scholars of biocapital—or the novel life-forms and 
forms of value generated by the impolsions between capital and the life sciences—agree that 
“life itself” has become increasingly “isolated, delimited, stored, accumulated, mobilized and 
exchanged, accorded a discrete value, traded across time, spaces, species, contexts, enterprises” 
(Rose 2006: 7). 
Yet most theorists of biocapital limit their understanding about the intense traffic between 
capital and the life sciences by emphasizing capital in production, or industrial biocapital. As a 
result, little attention has been paid to the impact of finance and speculative logics at 
bioeconomic junctures. Frozen embryos and other reproductive remainders serve as a useful 
vehicle for understanding forms of biofinancial practices that increasingly characterize global 
reproductive technologies. For instance, frozen embryos banked by REDEEM are, in the 
language of venture capitalists, “upstream” materials that may one day lead to “downstream” 
therapies and profits (Sunder Rajan 2006). The promise of human embryonic stem cells hinges 
on the perception of their “biovalue,” or the presumed latent “capacity of tissues to lead to new 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
41	  In 1987, the Assistant Secretary of Commerce and Commissioner of Patents and Trademarks 
issued this memo about the patenting of human biological parts: “A claim directed to or 
including within its scope a human being will not be considered to be patentable subject matter” 
(Cooper 2008: 146). John Moore’s “waste” spleen tissue was already patented in 1981 (patent 
number 4,438,032) and pluripotent human embryonic cells were first patented in 2001 (patent 
number 6,200,806). 
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and unexpected forms of value” (Waldby and Mitchell 2006: 108). The “aura of potential value” 
assigned to frozen embryos increasingly renders them “negotiable assets” for public and private 
enterprises (Waldby and Mitchell 2006), and therefore a novel species of speculative biocapital.  
Activities within Sutter University’s Stem Cell Institute exemplify the financialization of 
the life sciences begun decades ago and the increasing difficulty of distinguishing basic research 
from speculative profit. Dr. Moto, for instance, is an exemplar; an amply funded academic 
scientist, she is also the innovator behind four startup companies. One company has raised over 
$45 million in venture capital, employs more than 100 people, and is currently licensing a 
technology for use in IVF embryology labs. Similarly, though the REDEEM Biobank is funded 
by public grants, the bank receives embryo “wastes” to be used in experiments that Dr. Moto and 
her lab members have already utilized to develop patent applications. Also, the Institute’s stem 
cell biology Ph.D. program offers a distinctive mixture of basic science training with 
translational medicine and entrepreneurial opportunities for students. How the program links 
science and the biotech industry within academic training may model how the nascent field of 
stem cell biology will shift in training future leaders.  
--- 
Informed consent plays a key role in serving commercial interests in the life sciences by 
severing donors’ ties to their invaluable materials and making them available for scientific patent 
and profit. Consider the Moore v. Regents of the University of California case, which was among 
the first legal considerations in the United States of whether a living person has property rights in 
his or her extracorporeal body parts. In 1984, John Moore filed suit against Dr. Golde and his 
associates of the University of California who developed and patented the multi-billion dollar 
“Mo” cell line from Moore’s rare excised spleen cells. He consented to the surgery that removed 
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his tissue, but not to the use of the “waste” tissue in research. The case made its way to the 
California Supreme Court where two things happened: Moore’s ownership claim to the cells 
removed from spleen in a clinical procedure was denied while the University’s patent hold on the 
“Mo” cell line was upheld. The Supreme Court majority opinion argued that it was better not “to 
force the round pegs of ‘privacy’ and ‘dignity’ into the square hole of property in order to protect 
the patient” (Rabinow 1996b: 141), though many have questioned how such a ruling protects 
patient rights against such exploitations. While John Moore could not lay claim to owning his 
bodily tissues, the University of California could. Since the Moore case, informed consent forms 
like REDEEM’s now include language about tissue donors having “no legal or financial interest 
in any commercial development resulting from the research.” While informed consent adheres to 
many ethical principles, it also collaborates with the profiteering of science and industry by 
providing the “enabling regulatory conditions for the market” (Cooper and Waldby 2014: 14). 
Highly treasured leftover IVF embryos are put into the trash—categorically speaking—at the 
same time donors are dispossessed so that clinical wastes become available for property claims 
allegedly foundational to scientific research and development. 
 
Trashing for Good 
“Making an embryo into waste is an outcome not a by-product.” 
- Charis Thompson, Making Parents: The Ontological Choreography of 
Reproductive Technologies 
 
What is the strategic utility of “wasting” frozen embryos otherwise regarded as 
precious and invaluable? The classification of remaining IVF embryos as waste at the 
time of donation renders them available to the “procure/pro-cure” practices of stem cell 
research in the name of good science. In this light, classifying donated embryos as 
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clinical waste situates REDEEM Biobank within a salvational hue as an institution that 
makes respectful use of something no longer needed for its original purpose. Simone 
shared what was a common sentiment among her lab mates: 
Instead of being thrown away, that’s where the scientists will say, ‘No, don’t 
throw them away. Give them to us.’ Instead of throwing them away or discarding 
them, they are being used for these critical, insightful scientific studies… They 
were destined for the garbage and then scientists are using them… They are very 
precious things because we can address really critical things about human 
development that we couldn’t otherwise address if we didn’t have access to these 
discarded samples. 
 
By framing embryo procurement efforts as recycling society’s nearly wasted treasures on 
behalf of the greater scientific good, the REDEEM Biobank positions itself as an ethically 
oriented organization at a critical juncture between a good and a wasteful society. Recall the 
mission-driven language of REDEEM’s brochure advertising donation services, such as the hope 
that embryo donations will facilitate “necessary” and “important” research that can “produce 
valuable information” and “may some day lead to new treatments” for adult diseases and 
infertility. When IVF embryos are at risk of being destroyed without study, the Biobank and its 
affiliated researchers emerge as redeemers who respond ethically through making good use of 
valuable resources. 
In another light, REDEEM Biobank operates as a kind of “waste-exploiting club,” to 
borrow O’Brien’s phrase about life within rubbish societies. The Biobank leverages the category 
of waste to bestow potential value on embryos conceived by researchers as untapped resources 
and timely assets (Ferry and Limbert 2008). Like other forms of waste within rubbish societies 
and tissue economies, embryos donated to the Biobank become “simply another raw material” 
that can be turned into profit with the help of “modern day alchemists” (O'Brien 1999: 281). 
Biobank staff contribute to the alchemy by allying with Dr. Moto’s lab members who are in a 
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“search to renew, revitalize, refurbish and reaffirm the value of something that appears, 
superficially, to possess no value” (O'Brien 1999: 282). As detailed above, the informed consent 
process, including dispossession and disentanglement, facilitates such endeavors to spin straw 
into gold.  
As one of the only active tissue repositories for all types of leftover IVF embryos in the 
United States, REDEEM Biobank’s recycling work plays a key role within what I describe as the 
reproductive waste sector: the political economy of regenerative tissue that organizes labor, 
adjudicates different systems of value, structures the articulation of values within and between 
institutions, and manages complex controls, consents, and conditions for accessing biological 
resources defined as waste. Within this sector, waste serves as a strategic and necessary passage 
point in the process of tissue donation, a role that Lynn Morgan (2009) reveals to have been in 
place for over a century.  
Morgan’s study of early twentieth century embryo-collecting projects provides a 
comparative example and historical context for understanding the role of waste within 
reproductive tissue economies. Before prominent embryologists spearheaded a national embryo-
collection network, women typically discarded miscarried and aborted fetuses in unceremonious 
ways through burial in the backyard or by tossing down a privy. In order to secure the flow of 
precious reproductive remains to his Baltimore lab, Franklin P. Mall and other embryologists 
collaborated with state officials to ensure the classification of embryo and fetal remains as 
“medical waste” rather than corpses based on their assurance that the remains would be “put to 
good use” by researchers (Morgan 2002; Morgan 2006). In both examples of being “wasted,” 
dead fetal tissue of the early twentieth century and frozen IVF embryos in the early twenty-first 
century became “constitutive tissues” as a result of moving within the reproductive waste sector. 
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Constitutive waste tissue contains the promise of value as well as a “precondition for producing 
‘the new’” (Waldby and Mitchell 2006: 109), which returns us to the idea of waste as a space of 
pure potential. 
Conclusion 
This chapter examined what appears initially to be a series of paradoxes: that Sutter 
University’s Stem Cell Institute is a place where there exists destruction without destroying, 
sacrifice without sacrificing, and waste without wasting. The strikingly simple definition of 
waste I encountered in the online tutorial during my first week in Dr. Moto’s lab—as materials 
that are no longer needed for their intended purpose—betrayed what I came to realize about 
waste, which is that it is no simple matter.  
I began the chapter with descriptions of sentiments and practices that revealed how fertility 
patient donors and researcher recipients similarly regarded embryos as emphatically un-wastable. 
In doing so, waste came to seem like a classificatory companion for frozen embryos rather than 
their opposite. Like frozen embryos, wastes are neither stable nor neutral categories nor 
singularly identifiable as object, person, or place. Both function as liminal forms where values 
intersect and differently operate as matters out of place as well as time. Moreover, each is 
suspended within realms of pure potentiality. The qualities shared in common between waste and 
frozen embryos inspired my claim that frozen IVF embryos—those supremely un-wastable 
entities—are paradigmatic forms of waste. Within California’s pro-curatorial ethical landscape, 
preventing the misuse of waste is a core value that shapes how stem cell researchers “do good 
science.” The processes through which REDEEM Biobank “wastes” treasured embryos without 
wasting them illustrate how fundamental saving is to the daily rigors of stem cell research.    
To conclude, I consider what the cigarette collector on the edges of Sutter’s campus offers 
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to my considerations about saving, value, and potential in this dissertation. Though I never spoke 
with him directly, my encounter with this man on the fringes of the Stem Cell Institute provoked 
my curiosity about alternative stories to the familiar one about Sutter University as a center of 
power fueled by a moral and political mandate to save lives. For whose bodies and which lives 
are novel therapies being developed? How may communities benefit—economically, medically, 
socially—from the trickle-down logic of investing in the promise of stem cell science? What 
would it take for historically marginalized populations, as racial justice health activist Joseph 
Tayag asked, to “be taken off the table and brought to the table” (Benjamin 2013: 41)?  
These questions assume greater poignancy when considering the wider context for 
Proposition 71’s passage, the $3 billion investment by the voters of California in the promise of 
stem cell science to generate curative therapies and regenerate the flailing state economy. 
According to supporters, part of the proposition’s appeal was that it claimed to be able to close 
the gap on disease, minimize long-term health expenses, and serve as an “economic engine for 
California’s future.”42 At the outset, Proposition 71 seemed like a real contender for delivering 
on its promises and democratizing stem cell research as a publicly informed “people’s science,” 
which is a noteworthy achievement in an era of commercialized science (Benjamin 2013). The 
voter initiative passed by a landslide margin of 59 to 41%, signaling the beginning of a new 
social contract between scientists, entrepreneurs, and the people of California.  
This massive state investment in stem cell research came at a precarious time in 
California’s financial and social stability: the state budget deficit had surpassed $16 billion; 
housing foreclosure rates ranked among the highest in the nation; more than 1 in 5 Californians 
were living without health insurance; and the income gap continued to widen (Benjamin 2013: 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
42 See the text of Proposition 71, the “California Stem Cell Research and Cures Initiative of 
2004”: https://www.cirm.ca.gov/sites/default/files/files/about_cirm/prop71.pdf  
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12). Poor and other historically marginalized communities disproportionately carry the weight of 
California’s economic burdens, adding urgency to concerns about how the benefits of stem cell 
research would reach communities in need. Additionally, Proposition 71’s success at the ballot 
box obscured the failure of Proposition 72, a law that would have extended health insurance to 
working classes of under- and un-insured people. Investing in the potential of medical 
breakthroughs in a state where access to basic health care remains insecure reveals a tension 
between banking on the promises of tomorrow and redistributive justice for the public goods of 
today. The procuratorial ethical landscape that focuses attention on the rigors of doing good 
science diverts attention from other “goods” within which $3 billion state dollars could be 
invested. For instance, the underlying causes of health disparities, if systemically acknowledged 
and redressed, could also save myriad lives.  
This line of inquiry provokes questions about which lives matter, and which are wastable. 
At the time of writing this dissertation, the Black Lives Matter movement catapulted such 
questions onto the national stage where demands for an end to the systemic violence against 
African American communities are building unprecedented momentum. As this topic assumes 
increasing significance extending well beyond fixations in California with saving life, procuring 
valuables, and preventing waste, many people’s lives—including the cigarette collector’s whose 
name I never learned—are implicated in the activities within the laboratories of Sutter 
University’s Stem Cell Institute. The next chapter shifts from waste to consider the logic of 
rescue that informs the saving efforts within the Blossom Embryo Adoption program. It begins 




CHAPTER 4:  





a. to prevent someone or something from being lost, abandoned, or damaged 
b. to deliver from evil, trouble, or harm; e.g., salvation  
c. to set free or liberate those enchained or at risk  
 
 
By the time Hurricane Katrina made landfall on the morning of August 29, 2005, staff of 
the Fertility Institute of New Orleans topped off their cryopreservation tanks with liquid nitrogen 
and relocated fourteen hundred frozen embryos from the first to third floor of their Lakeland 
Hospital clinic. Within hours, power lines were down. Days later, floodwaters from broken 
levees swelled eight feet into the hospital’s ground floor. The embryos in storage would have 
been safe from the sweltering August heat for twenty-seven days, though danger mounted 
quickly for the survivors of the storm left behind. Adding insult to the injured city, forecasts of 
tropical storm Rita loomed on the horizon.  
On September 11th, the Fertility Institute’s lab director Roman Pyrzak led a team of state 
troopers into the flooded hospital with one mission in mind: rescue. One meaning of the word 
involves the prevention of things from being lost, abandoned, or damaged (OED). This is what 
Pyrzak meant when he proclaimed to reporters, after leading the successful relocation of fourteen 
hundred embryos by boat to another hospital on higher ground: “I’m the guy who rescued those 
embryos” (Reid 2007). In anticipation of the monster storm, the Fertility Institute implemented 
their emergency preparedness protocol to mitigate the loss of their clients’ frozen assets (Dickey, 
et al. 2006). Once the levees broke, Dr. Brenda Sartor contacted her state legislator seeking help: 
“We were troubled about the embryos and how we could easily access the hospital. The city was 
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still in lockdown mode, and we knew it would have to be coordinated through a civil authority” 
(Goldenberg 2007). Her request made it to the desk of Louisiana Governor Kathleen Blanco, 
who dispatched troops and trucks to rescue the clinic’s frozen embryos. (See Figure 8) 
 
Figure 8. Louisiana State police officers rescuing frozen embryos from Hurricane Katrina 
floodwaters43  
 
                                  
 
Such rescue stories from post-Katrina New Orleans operate, as historian Karen Dubinsky 
notes, to “smooth out or even submerge complicated political issues under the veneer of 
sentiment” (Dubinsky 2010: 44). The rescue of frozen embryos from Pyrzack’s clinic stands in 
stark relief to the social abandonments that informed who survived and who died in the wake of 
the storm, or what social critic Henry Giroux calls a “biopolitics of disposability” (Giroux 2006). 
The abandonments in New Orleans glossed by stories of rescue are well known. Media reports 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
43 Photo originally published in Fertility and Sterility (See Dickey, et al. 2006).  
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about the devastation befalling New Orleans circulated unforgettable images that exposed the 
“ruts of social difference” (Smith 2005) eroded by the hurricane and floods. These ruts rendered 
certain populations of New Orleans—namely poor, African American, elderly, and ill people—
extremely vulnerable to abandonment after the storm. Images emerging from the devastated delta 
depicted people stranded on rooftops and barren highways, crowded with low food and water 
supplies in the Superdome, delivered so-called relief by rifle-wielding military, and floating dead 
in the toxic floodwaters. According to then-Senator Barack Obama, the residents of New Orleans 
were abandoned not just during the disaster but long before through the ravages of extreme 
poverty, racial segregation, and governmental neglect that characterized the city well before 
Katrina. While rescue was at work in the delta cultivating notions of worth and value, 
abandonment operated too. 
I endeavor to “go deeper than ‘rescue’” in this chapter, as historian Karen Dubinsky 
encourages, in order to explore how embryo potentiality is valued within submerged and 
complicated Christian life-saving politics. I begin with the flooded Louisiana delta because it 
highlights the coincidence between rescue and abandonment that is also evident within the 
practice of embryo adoption. Through the lens of saving, I examine the prominent role of rescue 
in efforts to place IVF embryos for adoption through the Blossom Embryo Adoption program of 
Pacific Christian Adoptions agency. I describe the beginnings of the Blossom program and 
situate them within traditions of humanitarianism and responsibility. Rescue facilitates the 
making of an orphaned embryo crisis for which embryo adoption is presented by pro-life 
Christians as the moral solution to the problem of IVF’s cheapening of life. Despite the appeal of 
embryo adoption being a responsible act for Blossom donors and adopters, I discuss their 
criticisms of the abandonments entailed in the embryo orphaning process. Lastly, I argue that 
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race and gender politics are integral to cultivating frozen embryos as cultural innocents worthy of 
rescue.  
This chapter also illuminates the parallel functions that rescue and waste serve within 
American saving politics. Blossom emerges, like the REDEEM Biobank, as a program in the 
business of salvaging reproductive leftovers and repurposing frozen treasures for future use. 
Christian strategists and stem cell biologists mobilize IVF surpluses to forward life-saving 
missions that sustain visions for redeeming life in America. The lens of saving shows how rescue 
and waste management are similarly dedicated to “doing good” by stripping embryos from their 
IVF origins so that their potentiality can be realized anew.  
 
Embryo Salvation 
“We are dealing with the seeds of the next generation.” 
- President George W. Bush, Speech delivered on August 9, 2001 about federal funding for 
human embryonic stem cell research 
 
Another kind of rescue mission brewed in the aftermaths of Hurricane Katrina that 
expresses an alternative meaning of rescue—as salvation through deliverance from evil or harm. 
Robert George and Christopher Tollefsen begin their philosophical case for “embryo 
personhood” with a story about Noah’s rescue from the flood: 
Noah Benton Markham's life had been jeopardized by the winds and rain of 
Hurricane Katrina. Trapped in a flooded hospital in New Orleans, Noah depended 
upon the timely work of seven Illinois Conservation Police officers, and three 
Louisiana State officers who used flat–bottomed boats to rescue Noah and take him 
to safety. Although many New Orleans residents tragically lost their lives in 
Katrina and its aftermath, Noah's story of rescue is, nevertheless, one of many 
inspirational tales of heroism from that national disaster. What, then, makes it 
unique?... The answer is that Noah has the distinction of being one of the youngest 
residents of New Orleans to be saved from Katrina: when the Illinois and Louisiana 
police officers entered the hospital where Noah was trapped, he was an embryo, a 
human being in the very earliest stages of development, frozen with fourteen 
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hundred embryos in canisters of liquid nitrogen. Noah's story had a happy ending: 
Noah's parents were overjoyed those sixteen months later [on January 16, 2007] 
when Noah emerged, via cesarean section, into the light of the wide world. His 
parents named him in acknowledgment of a resourceful survivor of an earlier 
flood… In later years, if Noah were to look back to that troubled time in New 
Orleans and ask himself whether he was rescued that day, whether it was his life 
that was saved, we believe that there is only one answer he could reasonably give 
himself: "Of course!" (George and Tollefsen 2008: 1-2) 
 
As the only state in the nation to legally accord embryos the status of “persons,” Louisiana is a 
fitting birthplace for Noah’s rescue story.44    
Since Katrina, right-to-life proponents have mobilized Noah’s birth to argue for extending 
the legal rights of persons to the moment of fertilization. They argue that the half million frozen 
IVF embryos stored across the United States are at risk of drowning in the metaphorical 
tidewaters of indifference, or, more nefariously, at the hands of stem cell scientists who consider 
their use in research justifiable for the greater good. Embryonic stem cell research, according to 
George and Tollefsen, is “one of the most morally and politically troubled issues of our day” 
(2008: 3). They use Noah’s story to leverage one national disaster in order to make a moral case 
for delivering embryos from the grips of what they perceive to be another: the destruction of 
human embryos regarded as persons. 
George and Tollefsen consider the threat brought upon frozen embryos in a devastated 
New Orleans hospital to represent the danger that all frozen embryos in cryostorage currently 
face: “It cannot be denied that there are many more persons in precisely the same predicament as 
was Noah, and whose need for rescue is independent of the contingencies of the weather” 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
44 Louisiana passed revised statutes in 1986 defining IVF embryos as “juridical” persons, a 
category more commonly utilized for corporations. Louisiana is the only state in the U.S. to 
accord special legal status to embryos. The law stipulates that once frozen, embryos cannot be 
discarded or donated to scientific research but thawed only with the intention of being transferred 
into a uterus (LA Rev Stat § 9:133, 1986). 
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(George and Tollefsen 2008: 217). In the final pages of their book, George and Tollefsen 
champion embryo adoption in their “Cultural Proposal” for “address[ing] the fate of the millions 
of embryos currently trapped in cryopreservation” (George and Tollefsen 2008: 216).  
Tim Shoener, the Executive Director of Pacific Christian Adoptions45 and originator of the 
Blossom Embryo Adoption program, could not agree more. He helped initiate the world’s first 
embryo adoption program as a solution to a perceived social need. “I think there is a problem,” 
Tim explained.  
Part of the problem is as a society we are valuing life less and I think one of the symptoms 
of that is 500,000 embryos frozen that we, as a society, have commodified because it’s 
more economical. There’s an attitude in IVF that as long as you are doing it, you might as 
well make it by the dozen. But life isn’t cheaper by the dozen. Embryo adoption is a 
movement to remind people that life begins at conception. 
 
The Blossom Embryo Adoption program was established in 1998 from the desire to rescue those 
left, literally and figuratively, in the cold. Rescuing embryos is one way pro-life Christians may 
redress the moral problem in American society of devaluing life.  
 
From Seed to Bloom: The Origin of the Blossom Embryo Adoption Program 
“I was adopted as a seed and put in my mommy’s tummy to grow.”  
- Rachel Dryler, First child born through the Blossom program 
 
The following narrative is a composite story that describes how the Blossom program 
originated, based on perspectives shared with me by various embryo adoption professionals and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
45	  Tim served Pacific as Executive Director for nineteen years (1994-2013). After finishing law 
school in in 1973, Tim worked in the private medical device sector before opening a private 
adoption practice after being asked by his pastor to assist some friends with legal aspects of an 
adoption. In 1994, he established Pacific Foundation and joined Christian Adoption and Family 
Services as the Executive Director in 1995. Under Tim’s leadership, the foundation and agency 
merged in 2000 as Pacific Christian Adoptions where Tim would stay until retirement in 2013. 
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program participants during field research between June 2008 and April 2013. 
 
A Program takes Root to Revalue Life 
As an example of the cheapening of life Tim hoped to counterbalance by starting the 
Blossom program, he cited the planned destruction of 3300 unclaimed frozen embryos in the 
U.K., a controversy that circulated on international airwaves in 1996 (Forster 1998). The 
deadline for the mass discarding of the British embryos was a stipulation of the Human 
Fertilization and Embryology Act, which limited embryo cryopreservation to five years 
(Kennedy and Kallenbach 1996). Thirty-three hundred frozen embryos remaining unclaimed 
signified to Tim a pervasive ambivalence among fertility patients who were faced with, as he 
believed, unsatisfactory disposition options: “People are just not happy with the choices that they 
have.”  
Individuals unwilling to discard or donate to science already had the option of anonymous 
donations within fertility clinics, a practice that seems to Tim an invitation to “drop your kids in 
a black hole.” Anonymous embryo donation mirrors many of the facets of mid-century domestic 
adoption premised on secrecy, shame, and closed records. By contrast, Tim believes the Blossom 
program provides fertility patients with a “very viable alternative” rooted in contemporary 
adoption values around openness. 
My theory was that if a family with embryos had the ability to know whether any children 
were born, to know where they were, and possibly to be able to have a relationship with the 
new family if they chose to, that it would be easier for them—not harder—to make this 
decision [to donate]. 
 
From a southern California suburb, Tim and two infertile couples forged the first legal 
transfer of twenty frozen embryos through the protocols and practices of an adoption agency. A 
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practical goal of the new embryo adoption program was to allow people to give birth to their 
adopted child. “Blossom sort of bridged the gap between infertility work and adoption,” Tim 
explained. “It is kind of the middle road.”  
From Blossom’s inception, the most common question Tim fields about the program 
concerns language: why call it embryo adoption? On a practical level, he feels “from a 
counseling and social service perspective [that] it recognizes the needs of the donor family, the 
adoptive family, and of the child in the future, so we called it embryo adoption.” On a societal 
level, Tim acknowledges that conjoining embryo with adoption is powerful:   
What we call things matters. Of course using the word adoption means something. Does it 
mean I’m trying to outlaw abortion? No. It means we’re trying to give the status of what is 
happening between these families and the baby that is involved some meaning and some 
dignity. It’s instead of answering the question ‘How did I come to be in your family?’ with 
‘Hey Junior, you were donated!’ I think that by elevating the conversation and the 
terminology that applies to embryos may have some aftereffect. Just like the abortion 
language has had a tendency to devalue life, I hope the embryo adoption debate helps to 
revalue life.46 (Crockin 2005) 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
46	  The study of embryo adoption involved entering an ongoing debate around language. The first 
embryo adoption/donation conference held in May 2008 in Washington D.C. was my first entrée 
into key arguments in the debate. The clunky conference name itself—“Emerging Issues in 
Embryo Donation and/or Adoption”—underscores the ongoing challenge of language to describe 
the practice of giving and receiving embryos for procreation. The conference was hosted by the 
National Embryo Donation Center and funded by one of the “awareness” grants funded by the 
Department of Health and Human Services. It attracted 80-100 attendees across legal, adoption, 
activist, clinical, religious, social work, and governmental professions. Varying speakers and 
participants addressed the political and social implications of terms like donation or adoption; 
others forwarded alternative descriptors, such as transfer, placement for parenthood, donation 
for procreation, embryo rescue, etc. One bioethicist argued that a new language is needed for the 
words commonly used concerning embryos (e.g. fresh, frozen, thawed, storage, cost, amount, 
services, used) objectify them as things and undermine their intrinsic personhood. Adoption 
surfaced as the most passionately defended or contested term. Thomas Attwood, President of the 
U.S. Council for Adoption, advised choosing a “name that is accurate and doesn’t dip into 
controversy and inhibit consensus”; he preferred the term placement over adoption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 The debates at the conference occurred within a community of professionals involved in 
the movement of embryos from freezers to families. Beyond the supportive circle, embryo 
adoption has inspired numerous critics to weigh in on Blossom’s language choices. The 
American Society for Reproductive Medicine and RESOLVE, an infertility patient advocacy 
group, oppose the language of adoption because, as one ASRM spokesperson wrote, of the 
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The Blossom program is based in Pacific Christian Adoption agency, a non-profit that first 
opened its doors in 1959. Pacific is headquartered in southern California though had offices in 
three other states during my research period, and has since expanded their presence to seven 
states. My field research (2008-2013) coincided with a period of severe economic devastation in 
the United States that saw the bankrupting of many businesses, including adoption agencies. As 
agencies around the country reduced program offerings or were shuttered completely, Pacific, by 
contrast, absorbed struggling agencies and expanded its programming and payroll. In the midst 
of the economic turmoil of the recession, Pacific staff noted that the Blossom program was the 
agency’s financial saving grace. Thomas, the agency’s new Executive Director (2013-present) 
who followed Tim’s retirement from eighteen years of service (1994-2013), confirmed in 
hindsight that “Blossom kept us in a good position” through the recession.   
A team of college-educated, white, Christian women ranging in age from 22 to 50 manages 
the Blossom program, which is a demographic that characterized many other Pacific staff. 
During my period of field research, the Blossom staff shifted over time as individuals came and 
went and program emphases evolved. The core Blossom team is comprised of a program 
manager, social worker, program assistants, and a web developer. Aside from the web developer, 
who works remotely, Blossom staff work alongside each other at computer terminals in a large 
room tucked away on the second floor of Pacific’s suburban office park building.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
“insurmountable legal, moral and political difficulties for patients and membership.” Legal 
scholar Susan Crockin, calls out the misleading nature of the term. “There is no such thing as 
‘embryo adoption,’” she argued. “It isn’t adoption, and it isn’t legal.” Crockin addresses Tim’s 
dismissal of the Blossom program as a tactic to undermine abortion rights by suggesting that, in 
fact, it is: “Maybe, just maybe, the real goal behind this ‘language creep’ is to change the 
public’s perception of embryos. Rather than a collection of undifferentiated cells, they become 
‘preborn’ children and part of a thinly disguised anti-choice agenda and an all-out cultural war 
on modern reproductive medicine, stem cell research, and personal choice” (Crockin 2005).  
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The reception area of the agency is decorated with a wooden cutout of the word “family” 
that hangs next to a large painting of Jesus walking hand in hand with a child. Large metal filing 
cabinets lining the walls contain hundreds of Blossom client files, each brimming with personal 
letters, family photos, health histories, and matching preferences. The Blossom office is speckled 
with Anne Geddes images of newborns, angel figurines, and flower iconography. A placard 
stating, “Life is fragile, handle with prayer,” rests on a bookshelf beneath the Dr. Seuss Horton 
Hears a Who movie poster with the tagline: “A person’s a person no matter how small.” A faux 
cryotank—used as a prop for Blossom outreach events—is stored in the conference room with an 
accompanying sign that reads: “Frozen Embryo Nursery: where children wait for their dreams to 
come true.” (See Figure 9) 
Pacific is one of numerous Christian evangelical adoption agencies in the country.47 
Although the agency operated under different names, starting as the Evangelical Welfare 
Agency, shifting to Christian Adoption and Family Services, and settling in 2000 on Pacific 
Christian Adoptions, their Christian mission remained constant. Pacific strives “to share God’s 
love” by realizing four main goals: 1) help children find loving homes, 2) assist birth parents and 
embryo donors in making a plan for their children’s future, 3) prepare adoptive families, and 4) 
recognize and advocate for the personhood of pre-born children. 
As a “biblically driven Christian ministry,” Pacific leadership regards the agency as 
“uniquely pro-life.” According to Thomas, Pacific puts its pro-life Christian values into practice, 
and cited the Blossom program as the chief example: “The embryo adoption program is beyond a 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
47	  Some adoption watchdogs estimate that roughly half of the U.S. adoption industry is 
composed of evangelical agencies, though David Smolin found the tally to be lower in a survey 
of 200 accredited adoption service providers. Even if evangelical adoption agencies do not 
constitute the majority, Smolin suggests the biggest and most powerful agencies are Christian 
(Joyce 2013: 65). 
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Figure 9. Faux frozen embryo cryotank48 
 
mission statement; it’s pro-life work.” The Blossom program helps Pacific exercise its pro-life 
Christian values by serving as a “talking point” that “awakens evangelicals” to the biblical 
imperative around adoption. “There is undoubtedly an adoption mandate in the Bible,” explained 
Thomas. As a former Baptist pastor and Christian college professor, he is surprised when 
pastors, even from “Bible-believing churches… need some education on the [adoption] issue.”  
Upon my expressing interest in his remarks about rescue, Thomas printed for me a list of 
biblical passages from a keyword search of “fatherless”—a theological synonym for orphan—
through an online version of the New International Bible. “It’s clearly there, that we are to care 
for the widow, fatherless, stranger, oppressed,” Thomas explained. “This is not just a command, 
but is rooted in God’s concerns.” He then paraphrased a passage from Proverbs about the perils 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
48 Photo by author. 
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of not rescuing those in need to describe the core value that he sees driving the Blossom Embryo 
Adoption program. “God has a heart for orphans,” he said, “and therefore so should we.”49 
 
A Blossom Blooms 
In the summer of 2008, I visited the home of Jack and Susan Dryler—the Blossom 
program’s first adoptive family—where I learned about their daughter Rachel’s origin story. The 
Drylers are a wealthy white couple living in a northern suburb of San Diego in an impressive 
home surrounded by avocado trees. Susan met her husband, a journalist, while she was working 
as a hotel clerk in her mid-twenties. During their first years of marriage she took night classes 
toward a degree in occupational therapy, a career that she eventually left to focus on parenting 
her only child as a stay-at-home mother. The Drylers attend the nearby Lutheran congregation in 
their small town. 
Minutes after my invitation for interviewees posted to the Blossom program’s adoptive 
parent listserv in 2008, Susan phoned me, curious if she was “the first to call.” Susan seemed 
comfortable being recognized as the first Blossom family. Over the years, she seized numerous 
opportunities to share publicly how her family came to be. Susan and her daughter, Rachel, 
joined other Blossom families on three trips to the White House and twice met President George 
W. Bush personally. “We were standing behind him at the podium [in 2006] when he announced 
the veto of the stem cell bill. Who would have guessed? I just wanted to have a baby, but God 
had other plans for our family,” she explained.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
49	  Proverbs 24:11-12 (NIV): “Rescue those being led away to death; hold back those staggering 
toward slaughter. If you say, “But we knew nothing about this,” does not he who weighs the 
heart perceive it? Does not he who guards your life know it? Will he not repay everyone 
according to what they have done?”	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The Drylers struggled with infertility for two years in the early 1990s before Susan found 
out that she had premature ovarian failure. As a solution, her fertility doctor suggested egg 
donation and IVF, but they felt strongly that this was not an option because “using a donor egg 
would be creating life outside the marriage bond.” In a conversation with a co-worker, Susan 
shared another one of her concerns about IVF: what would they do if they created embryos, had 
triplets, and weren’t able to parent the ones unused? Her co-worker suggested that another 
Christian couple could parent them. The idea was novel, and sparked something in Susan: “I 
think it was the Holy Spirit planting the seed in me.”  
Susan sought counsel by contacting three Lutheran pastors and the evangelical pro-life 
organization Focus on the Family for religious advice. James Dobson, the organization’s 
conservative leader, called Susan directly, stating that he had never heard of such a practice and 
would look into it. Meanwhile, the Drylers met with their friend, Tim Shoener of Pacific 
Christian Adoptions, whom Susan first met when she participated in his youth group as a 
teenager. They discussed the domestic and international adoption options available through 
Pacific when Susan expressed interest to Tim in “adopting” an embryo. “Tim didn’t even flinch,” 
Susan recalled. “He took it and ran with it.” Tim also sought counsel by investigating the 
contractual legality of transferring embryos between parties and if there existed a fertility clinic 
that would be willing to do the procedure. Focus on the Family helped connect the Drylers with a 
couple in the Midwest who had twenty extra frozen embryos that they were willing to place for 
adoption. Like many Blossom donors and adopters, Susan described the alignment of 
circumstances that made the adoption possible, “a God thing.”  
Once the first embryo adoption agreement was drafted and signed, the Drylers received 
twenty frozen embryos via FedEx to their Los Angeles fertility clinic in March 1998. Early 
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clinical results were devastating: most of the embryos failed to survive the thaw process and the 
first frozen embryo transfer was unsuccessful. Susan’s final transfer with the last three embryos 
resulted in the pregnancy that delivered their “blossom” baby on December 31, 1998. The 
following year, Dobson announced his support for the new Blossom Embryo Adoption Program 
through a radio showcase of the Drylers (Focus on the Family 1999). This broadcast was the first 
public attention brought to embryo adoption, and according to many donating and adopting 
clients, how they first discovered Blossom.  
Supporters of embryo adoption accommodate the cutting-edge technologies required to 
create families through the exchange of IVF embryos by situating the practice in a tradition 
within which Christians are familiar: adoption. According to Susan: 
The techniques [involved in embryo adoption] are new but the family building is not 
new. It is just adoption nine months prior to traditional adoption… I carried her providing 
all those things that she needs now—oxygen, nutrients, and a warm place to grow. We 
just got to do it with my body and nine months earlier.  
 
Rachel, the oldest of the “blossom” children born through embryo adoption, describes her origin 
through a metaphorical reference to one of humanity’s oldest reproductive technologies: the 
planting of seeds. In an interview with a journalist when she was seven years old, Rachel 
explained: “My mom had bought this packet of seeds and she planted them and froze them. And 
she was like, ‘That was you, you were a frozen seed and we put that seed in my tummy to 
grow.’” Susan liked reminding her, “Only God could see you because you were so tiny.” The 
seed metaphor traveled to my mailbox across the country on Valentine’s Day of 2009 when I 
received a homemade card from Rachel. She made a red flowerpot with construction paper and 
glued a packet of flower seeds from the American Seed company inside. Her note to me read: 
“Hey Valentine… Life begins as a seed… just like you!” (See Figure 10) 
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Figure 10. Valentine from the first child born through embryo adoption50 
 
--- 
The Blossom Embryo Adoption program began in response to the perceived crisis of 
devaluing of life in America. Though embryo adoption raises suspicions from many corners of 
political and religious spectrums, the Blossom program has taken root—especially among pro-
life evangelicals—as paradigmatic pro-life work and a solution for its time. Since 1998, about 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
50 Photo by author. 
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4000 embryos have been adopted through the Blossom program and 460 “blossoms” born to 
hundreds of adoptive families.51  
 
Christian Rescue Scripts 
Blossom spokespersons propose resolving the problem of leftover IVF embryos by 
putting the discourse of rescue to work. This section introduces how rescue as a “script” 
operates, what Christian rescue scripts are, and the work they do through tropes of 
humanitarianism and responsibility.  
 
Christian Rescue Scripts 
Social science scholars who examine the theoretical and practical contours of rescue 
discover it within diverse arenas, from postcolonial gender politics to animal studies to adoption 
(Bracke 2012; Briggs 2003; Joyce 2013; Scoggin Mckee 2013). Across these various contexts 
are common “scripts” that illuminate how rescue operates in a given setting, and suggest that 
rescue does three main things: 1) constructs certain entities as morally and economically worthy 
of being spared; 2) frames specific contexts or conditions as risky; and 3) promotes courses of 
action in order to meet alleged needs.  
Within Christian theology, rescue scripts are discernible within Biblical stories that 
identify those considered worthy of redemption, describe circumstances that threaten salvation, 
and justify worldly actions based on godly behaviors. In the New Testament, the sacrifice of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
51 Four hundred sixty is the reported number of children born through the Blossom Embryo 
Adoption program as advertised on the agency’s website at the time of depositing this 
dissertation in March 2016. At the time of writing, current agency staff provided estimates of 
embryo adoption numbers, or 4000 embryos, which is roughly consistent with the 12 percent 
chance of successful thaw, implantation, gestation, and birth for each frozen embryo transferred 
into a uterus (Keenan et al. 2008).	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Jesus on the cross—“who gave himself for our sins to rescue us from the present evil age” 
(Galatians 1:3-4 NIV)—represents the ultimate act of rescue through which all sinners were 
made redeemable.  
Christian rescue is fundamentally a discourse about family expressed through kinship 
language of fathers, families, orphans, and adoption. Orphans in the Bible, or those who are 
“fatherless” and outside the family of God, are targeted for rescue through adoption into God’s 
family. Christian Scripture describes adoption as the central means by which God rescues souls 
by delivering the gospel to sinners and transforming them from the realm of fallen humanity into 
a familial relationship with him and his redeemed body, the Church (Smolin 2011). The kin 
language of “adoption into God’s family” is a metaphor for religious conversion, or the “great 
act of redemption in which sinners are forgiven, justified, sanctified, and made into a ‘new 
creation’” (Smolin 2011: 70). Scholarship also highlights how Christian notions of rescue both 
draw from and intersect with forms of race, caste, and class (Dirks 1996; Goetz 2012). These too 
are types of familial discourses that put into relief how Christian tropes of inclusion are 
intermixed with logics for exclusion.   
 
Humanitarianism and Responsibility 
Modern Christian projects (Keane 2007) like the Blossom program that translate divine 
forms of rescue—such as Jonah’s rescue from the belly of a whale and the Israelites’ delivery 
from bondage in Egypt—into worldly action are often expressed through discourses of 
humanitarianism and responsibility. Blossom taps into these traditions to legitimize embryo 
adoption as the moral solution for remaining IVF embryos and the broader problem it represents 
of cheapening life. Humanitarianism expressed by Blossom proponents makes legible the plight 
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of abandoned embryos while responsibility helps cultivate a sentiment of duty for providing 
embryos the chance to be born. Both discourses justify Blossom’s goal of finding “homes” for 
IVF leftovers, which for embryo adoption means finding receptive uteruses.  
Blossom turns to humanitarianism and responsibility traditions because they align with 
their core Christian values of equality, dignity, and duty. Humanitarianism represents the moral 
imperative to relieve human suffering based on the belief that “the lives and welfare of those 
now living fundamentally matter and cannot be consciously sacrificed in the pursuit of other 
goals” (Redfield and Bornstein 2011: 6). Humanitarianism first emerged in the early nineteenth 
century as a form of Christian charity (Calhoun 2008). Later secular forms of humanitarianism—
such as international aid organizations like the Red Cross and Doctors Without Borders—share 
with Christian humanitarianism an ethic of dignity and equality among all humans, though these 
ethics does not always translate into practice (Fassin 2012; Redfield 2013; Ticktin 2011).  
Responsibility is a moral concept premised on the societal imperative to manage risk 
(Jonas 1984). In law, responsibility concerns a person’s fair and just obligation for repayment in 
the case of past wrongdoing. Legal responsibility parallels the Christian notion of judgment 
before God and accountability for one’s sins. Over time, responsibility has become a manifest 
duty for everyone and everything, simultaneously at the level of individual and wide collective, 
and connected to times passed and anticipated futures (Ricoeur 2000).  
The Blossom program deploys Christian rescue scripts, including the familial discourse 
of assisting the “fatherless” orphans of the world, and draws from the traditions of 
humanitarianism and responsibility in order to make adoptable orphans from IVF remainders. In 
the following sections, I show how these frameworks operate in the making of orphaned 
embryos—an entity simultaneously without origins, with potential, and deserving of a chance. 
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The transformation of IVF leftovers into orphans illuminates how the practice of embryo 
adoption “salvages” frozen treasures (Anagnost 2000) through a conversion process that turns 
what one adoption scholar describes as “needy objects” into “treasured subjects” (Eng 2003). 
Rescue practices, like the trashing of embryo treasures in a stem cell lab, abandon embryos so 
that their potentiality as unborn children can be realized.  
 
Making Orphan Embryos 
“What is the ideal future for frozen embryos in storage? The question sounds like what to 
do with all the orphans in Africa.” 
- Jackie, Blossom embryo adoptive parent 
 
In 2001, Blossom staff and supporters testified before Congress during hearings about 
federal funding for stem cell research. In her remarks, the first manager of the Blossom program, 
Anna Douglas, likened remaining IVF embryos to orphaned children:   
These children are not a product of some wonderful medical research. They’re a 
product of the fact that a huge problem exists, that too many embryos have been 
created…This [embryo adoption] program is not here to provide a new way for 
families to get children. It’s here to eliminate a problem that currently exists, in 
that there are children waiting to be born. It’s no different than an orphanage, an 
orphanage that has never been really looked at as a really neat opportunity for 
somebody to add children to their families. It’s been seen as a travesty that these 
children are not being parented (U.S. Congress 2002: 91). 
 
During the same Congressional hearing, Susan delivered testimony as the parent of the “first 
adopted former frozen embryo.” She recounted her story in detail for the committee of fifteen, 
ending with another statement about orphanages: “Looking into Rachel's eyes, I weep for the 
roughly 188,000 frozen human embryos like her placed in frozen embryo orphanages, who could 
be adopted, rather than terminated with assistance from my federal tax dollars.” Frozen embryos, 
in both testimonies, were presented as orphaned children in need of rescue.  
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Rescue is at work in nuanced ways within the testimonies of Anna and Susan to 
configure IVF embryos as orphans. The lens of rescue reveals that orphanhood acts as a 
necessary precondition (Oh 2012), or an obligatory passage point (Callon 1999), through which 
leftover IVF embryos become adoptable children deserving a chance to be born. In order to 
describe the processes through which embryo orphans are transformed into “needy objects” then 
“treasured subjects” (Eng 2003), I draw connections to how other orphans have been made. 
Rescue, like the making and preventing of waste in a stem cell lab, is another kind of saving 
practice that converts embryo potential for alternative futures.  
Historian Arissa Oh analyzes how postwar Korean children became adoptable orphans in 
the 1950s and 1960s. She argues that the Korean child, at first a “war waif,” was “imagined as an 
orphan” through rescue scripts common to the Christian Americanist movement that fueled the 
international adoption industry in the mid-twentieth century. Rescue operated in making Korean 
orphans through processes that obscured children’s families and communities of origin, which 
wiped clean their pasts and readied them for potential futures as adoptee-immigrants (Oh 2012). 
“In order for the ‘rescue’ narrative to work” in the making of orphans, historian Karen Dubinsky 
echoed Oh’s argument that “you really have to erase the families of origin” (quoted in Joyce 
2013: 98). Once the Korean child was regarded as without history, orphaning processes 
fashioned her as a blank slate on which to draw a new future via immigration. Oh’s analysis of 
orphanhood shows how it served for Korean children as a precondition for transitioning them 
from needy war waifs into adoptable immigrants for American families.  
The Blossom program operates similarly to Korean adoption in the U.S. by transforming 
salvaged IVF remnants into abandoned embryos without origins, with potential, and deserving of 
a chance. In order to understand this transformation, I will discuss two facets of the orphaning 
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process—erasing origins and facilitating chances—as well as the mechanisms that make 
orphaning possible, which are classifying, quantifying, and facilitating potential. In the next 
section, I explore how classification and quantification collaborate in producing the orphan 
embryo crisis and justifying adoption as the solution, which result in the erasure of embryo 
origins. The definition and counting of orphans is similar to the trashing process discussed in the 
previous chapter through which embryos are disentangled from ties of kinship and ownership en 
route to becoming adoptable. Then I examine how embryo chances are facilitated through donor 
and adopter efforts to embrace responsibility with respect to embryos, God, and each other. 
Cryopreservation tanks, presented as frozen orphanages by embryo adoption proponents, operate 
as realms of “pure potential” where the future chances of treasured embryos are sustained and 
enlivened.  
How embryo orphans are made illuminates the ways rescue and waste are parallel 
techniques for transforming the perceived potential of these frozen remains. Waste prevention 
and rescue are core saving values that inform and characterize the respective embryo saving 
organizations. They are also practices that operate to preserve embryo potential through 
transformative processes that ready them for new futures. The trashing of IVF treasures by the 
REDEEM Biobank echoes the role the Blossom program plays in the orphaning of embryos in 
order to render them adoptable children deserving of a chance.  
 
Making Orphan Embryos: Erasing Chances 
Anna’s testimony conveyed Blossom’s belief that “a huge problem exists… too many 
embryos have been created.” Susan’s testimony quantified the “travesty” with a figure—
188,000—to indicate the number of frozen embryos “who could be adopted.” Rescue is at work 
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in such statements where they classify embryos as adoptable and quantify the supply. 
Classification and quantification are accounting processes that generate authoritative statistics 
(Bowker and Star 1999; Porter 1995), which are then used to forward embryo adoption as a 
solution to the perceived frozen remainder crisis. Such accounting processes are also evident 
within the contemporary Christian led movement concerning the “worldwide orphan crisis.” A 
comparative look between the testimonies of Anna and Susan and the evangelical orphan 
movement reveals the work rescue does in severing familial ties for IVF embryos and 
transforming IVF surpluses into parentless orphans in need of homes. 
 
Making an Embryo Crisis by Defining and Counting Orphans   
“With 143,000 orphans in the world and over 600,000 embryos in storage, we are facing 
a crisis that will require more help than our existing clients can provide. Please join me in 
continuing to support Pacific Christian Adoptions.” 
- Tim, Pacific Christian Adoptions Executive Director, End of 2012 donor solicitation 
letter  
 
For both embryo adoption and orphan care movements, statistical estimates serve as 
effective rallying cries for their respective causes. The worldwide orphan crisis became a 
passionate issue among evangelical Christians when, in the twenty-first century, the Church 
embraced adoption as its signature issue. These international “child–catchers” incorporate into 
promotional campaigns an oft-cited estimate of the number of orphans around the world—143 
million—a number that has ticked upward among orphan crisis proponents to 153 million, 163 
million, and in some instances to 210 million (Joyce 2013: 61-67).  
Similarly, embryo adoption advocates actively publicize the estimated number of frozen 
embryos in fertility clinics nationwide that, as discussed in detail below, are alleged to be 
available for adoption. Since Blossom testified before Congress in 2001, the reported number of 
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frozen embryos increased from 188,000 (Andrews 1999) to 400,000 (Hoffman, et al. 2003) to 
more than 600,000 when I left the field.52 By reporting increasing numbers of orphaned children 
and embryos, each movement makes a case about growing crises. Just as 143 million is now 
“shorthand for a belief system” that the orphan crisis exists and international adoption is the 
solution (Joyce 2013: 62), the Blossom program keeps the increasing estimate of frozen embryos 
at the forefront of their advocacy for adopting embryos that they believe are deserving of rescue.  
The frozen embryo crisis brings rescue to the workplace where Blossom staff struggle 
with how to face the monumental task of saving mounting numbers of embryos in need. Blossom 
staff wonders if they can possibly make a dent in the frozen embryo estimates that continue to 
climb. Pacific leadership expressed hope that, in an ideal world, the Blossom program would 
“work ourselves out of a job.” While such a sentiment may mean to simply communicate the 
Blossom program’s altruistic rather than financial incentives, it adds unspoken pressure to the 
daily tasks of the Blossom team. On top of the growing rates of frozen embryos on ice, agency 
leadership asked the Blossom team to double the embryo adoption births in the 2012-2013 
calendar year so that more babies would be born. At the time of the request, Tim and Thomas 
were aware that at least one newer embryo adoption program had outpaced Blossom in terms of 
births and they wanted to do what they could to catch up.  
When Monica assumed the role of Blossom program manager in 2005, the outgoing 
manager told her to be aware that she was entering a “spiritual battlefield.” Over the seven years 
Monica served as the Blossom Program Manager, she coped with the pressures of crisis and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
52	  In 2009, Blossom shifted to advertising that more than 600,000 embryos were frozen based on 
an unpublished “embryo census” conducted by the grant-funded arm of the Blossom program. 
The 600,000 number is currently featured in all of Blossom’s literature as well as on the Office 
of Population Affairs website of the U.S. Department of Health and Human Services website: 
http://www.hhs.gov/opa/about-opa-and-initiatives/embryo-adoption/	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spiritual battle by “not adhering to the pro-life mission” of the Blossom program “too much” 
because the task of saving every embryo felt daunting. Rather than a crusade to rescue every 
embryo from a frozen orphanage, Monica approaches the daily tasks of coordinating contracts, 
matching families, and scheduling embryo shipments as logistical efforts that help donors “find a 
home” for the embryos they want to give a chance at life. Simply, Monica stays focused on the 
embryos in front of her: 
As far as going out to the world to save every embryo, it’s not really on my heart, which I 
think is a good thing to save my own sanity. Thinking of 500,000 embryos in storage, 
thinking about that whole picture, is way too overwhelming for me. When I have six over 
there that we can’t find a home for, or two, I think, ‘Oh my gosh, these two little tiny’ 
and then I imagine them as little babies. It helps me. Sometimes I even name them, the 
ones that are really hard to place, because I have to personalize them so that I can keep 
working for them. 
 
Sarah, the driven and gregarious Blossom program assistant (2011-2013) who came to 
Pacific after graduating from a local evangelical university, also feels stressed by the program’s 
saving mission.  
I’m a task-oriented person. I like to cross things off my task list. If you look at this as 
saving every embryo, that would be very stressful. For a lifetime, I feel like that task 
would never be over. There are, right now, 600,000 embryos and not every one of them is 
going to be a human being. 
 
Sarah resolves this tension by delegating some of her tasks to God. She described her job as 
“giving the chance of life to as many embryos as can be, and trusting that God knows which 
embryos are going to be human beings.” Sarah’s work within the Blossom office made her aware 
that becoming pregnant is not guaranteed, or even probable, for adoptive clients. This awareness 
helps her keep in mind that “there are so many other circumstances involved when embryos 
don’t become human beings not having to do with frozen embryos. That is God’s will too.” 
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Sarah translates Blossom’s mission into work she can manage every day and gives up some of 
the labor of rescuing embryos to God.  
 
Justifying Adoption by Erasing Families of Origin  
“Children don’t grow in cabbage patches, just waiting for us to find and rescue them.”  
- Karen Dubinsky, Historian, quoted in Child-Catchers: Rescue, Trafficking, and the New 
Gospel of Adoption 
 
 “Embryos are orphans until they are born. They are not being cared for. Well, obviously 
they are not orphans in the sense that there are parents who are storing them…” 
- Thomas, Pacific Christian Adoptions Executive Director (2012-present) 
 
Despite the power of orphan counts to mobilize Christians into humanitarian action, the 
problem with child and embryo estimates is that they exaggerate how many are abandoned or 
parentless in order to justify adoption as the responsible solution. Such obfuscations reflect what 
journalist E.J. Graff describes as “the lie we love” to believe about the international adoption 
industry (Graff 2009). The making of the worldwide orphan crisis through the erasure of families 
of origin mirrors what happens in embryo adoption too. 
“There are over 143 million children who go to bed each night without parents,” Tim told 
the Christian Examiner for an article about National Adoption Month, a sentiment that is 
common within Christian international adoption programs endeavoring to rescue the world’s 
orphans via adoption. 143 million was originally derived from the 2004 UNICEF report 
“Children on the Brink,” though the report itself undermines the sense of crisis that Tim and 
others try to achieve when claiming that all 143 million are without family and home (UNICEF, 
et al. 2004). The report gathers data on an intentionally broad group of children—those orphaned 
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as well as vulnerable—in 93 low and middle-income counties.53 The report defines orphans as 
children who have lost one or both parents, a category that is broader than the common meaning 
of orphan in Western legal contexts as a child who has lost both parents. Due to the report’s wide 
analytical net, the vast majority of children counted in the 143 million total are not parentless but 
either living with a surviving parent or relative. Of the approximately 16.2 million “double 
orphans” without either surviving parent, many are reported as being cared for by older siblings 
or extended family. Efforts to define and count orphans are further complicated by the scores of 
children in orphanages placed by families temporarily, the numerous street children beyond the 
care of their living parents, and the hundreds of millions of children worldwide under the age of 
five without birth certificates. Furthermore, nowhere does the UNICEF report identify 
international adoption as a solution for the world’s vulnerable children, but argues instead for 
supporting parents and communities to raise their own children.  
Nevertheless, the orphan crisis movement mobilizes the UNICEF report’s count of 143 
million vulnerable children around the world to promote action among Christians in the face of a 
perceived orphan crisis. As a result, children’s origins are actively erased through suggestion that 
the alleged orphans are parentless and available for adoption. International adoption emerges as a 
humanitarian rallying cry for Christians, the significance of which, as legal scholar David Smolin 
argues, “is founded on the insignificance of the adoptee’s original family ties” (Smolin 2011: 
317). 
Within embryo adoption, a similar process occurs whereby proponents exaggerate 
numbers in order to quantify the frozen leftover crisis and justify the adoption of embryo 
“orphans” as the solution. For instance, Susan calculated in a footnote that was submitted with 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
53	  Vulnerable children in this report refer to “those children whose survival, well-being, or 
development is threatened by HIV/AIDS” (UNICEF 2004: 6) 
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her printed Congressional testimony how many frozen “children could be placed for adoption 
and born into the families of infertile married couples in America who seek to raise children.” 
She claimed that 12,600 to 35,000 children could be born if all 188,000 estimated frozen 
embryos were placed for adoption, thawed, and transferred into uteruses. Like the 143 million 
orphans around the world who allegedly go to sleep at night without parents, Susan’s testimony 
suggested that all of the nation’s frozen embryos are abandoned, in need, and adoptable—but 
they are not.  
Susan’s calculation runs counter to the few studies that have examined fertility patient 
disposition preferences in the United States, which are challenging to summarize with any 
accuracy. The disposition of embryos within the private U.S. fertility industry is not standardized 
in a systematic way and fertility patient attitudes about their frozen remainders change over time 
(Nachtigall, et al. 2005). Nevertheless, studies available about patient wishes for frozen embryos 
report that the majority of embryos banked for the future are not abandoned but claimed 
(Hoffman, et al. 2003; Lyerly, et al. 2010); most are stored by patients for future use, designated 
for donation to research, or en route to being discarded. Susan’s confidence that “the ‘excess 
supply’ of embryos will evaporate... as embryo adoption proliferates in the wake of this 
[embryonic stem cell funding] controversy” may be an expression of hope but belies 
circumstances like death, divorce, and financial hardship that have rendered many frozen 
embryos stuck in perpetual limbo.54 Susan’s testimony illustrates one way the frozen IVF 
embryos are abandoned through rhetoric that obscures the ties of kinship and ownership actively 
entangling embryo remainders banked for the future. Humanitarian tropes are visible within the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
54	  Chapter 5 examines how some donated frozen embryos come to “wait” without foreseeable 
redemption.	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exaggerated embryo estimates that are calculated to promote the notion of a frozen crisis and 
embryo adoption as the moral solution.  
In sum, this section detailed one facet of the embryo orphaning process: the abandonment 
of embryos by obscuring their progenitors. The Blossom program mobilizes orphanhood as a 
necessary precondition for IVF embryos to realize their potential via adoption and birth, yet the 
erasure of embryo origins is a troubling part of the process for some Blossom donors and 
adopters. While the erasure of embryo origins helps generate the notion of embryo crisis and 
promote the idea of widespread availability of embryos for adoption, Blossom staff is 
overwhelmed by the crises they helped to create and publicize.  
 
Blossom Donors and Adopters on Abandoned Embryos   
Blossom program participants are critical of the effects of orphanhood on donors, 
adopters, and children born. I was surprised, though, to hear the first critical remark about orphan 
embryos from Monica, the Blossom Embryo Adoption program manager. During our first 
conversation in 2008, she subtly rejected the idea that any embryo donated for adoption is 
abandoned: “I haven’t been around embryos that have been abandoned,” she stated, “because 
everyone I’ve talked to owns their embryos.” Over seven years of talking with Blossom donor 
and adopter clients, Monica became aware of the limitations and appeals of frozen embryo 
rescue. As a result, she stopped using humanitarian orphan language with clients because it does 
not acknowledge the efforts of donors to place their embryos for donation. “It implies that the 
parents aren’t paying storage fees, waiting to be matched with an adoptive family, etcetera,” 
Monica explained. “The embryos aren’t abandoned, but are the opposite: they are loved and 
cared for.” 
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How Monica came to manage the Blossom program was a journey that confirmed for her, 
as she explained it: “giving life to an embryo is not the same as bringing a kid home from an 
orphanage or adopting an infant.” She developed an interest in international orphan care from 
living abroad after college as an au pair with a Swedish family and caring for their daughter who 
was adopted from China. Upon returning from Sweden, she accepted a front desk job at Pacific 
in 2005 where she hoped to eventually work in the international adoption program. “I came to 
adoption wanting to help people and especially kids, not the frozen ones though!” When Monica 
was asked to assist with the growing Blossom program, she thought it would be a temporary 
position from which she would transition into international adoption. When the previous 
Blossom manager left in 2005, Monica was the obvious choice as her successor. Monica led the 
Blossom program for seven years though continued to feel strongly that embryo adoption 
differed markedly from finding homes for orphaned children. “They are totally different,” she 
explained. “They are parallel but separate problems.” 
 
‘You rescued our embryos? Really?’: A Donor Couple’s Critique of Orphanhood 
Monica’s perspective resonates with the Bakers, a donor couple who experienced deep 
pain and offense at the suggestion that their embryos were “abandoned” by them and “rescued” 
by an adoptive family. The feeling of erasure led to the dissolution of the relationship between 
the Bakers and the Channings, the family that adopted their twenty-four embryos. I interviewed 
Sharon Baker and Tara Channing in the summer of 2008, the week they first met in a café. The 
next time I spoke to Sharon was four years later when she and her husband Dennis were in the 
process of taking their embryos back from the Channings because they considered their 
differences irreconcilable.  
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The retrieval of embryos that have already been placed with adoptive clients is a rare 
situation in the Blossom program. Taking embryos back once they have been “adopted” is a 
feature of the Blossom contract, which is not a legal adoption but a transfer of property 
agreement. Blossom contracts are “permanent” unless or until either party breaks the agreement. 
Each contract includes a “relinquishment clause” to address the retrieval of already given 
embryos. To break the contract and relinquish embryos, donors are required to send a letter to 
Pacific stating their request to renege the contract with a $500 check and storage agreement form 
for shipping the embryos from the adoptive client’s clinic to a new cryostorage facility. For 
adopters to break the Blossom contract, they have to send a letter requesting to terminate. In that 
case, adoptive clients pay storage for the embryos to remain in their fertility clinic until the 
embryos are re-matched with another adoptive family and shipped to their clinic. It is far more 
common for adoptive clients to break the Blossom contract when embryos remain after they are 
done using them to build their family. The Bakers’ recall of their donated embryos is rare, but 
not unique; a few other Blossom donor families retrieved embryos after placement for various 
reasons. 
The Bakers are a white married couple in their early forties living in the Northeast where 
Sharon works as a schoolteacher and Dennis as a software technician. They are members of a 
Covenant church congregation in their suburb of a large city where Sharon first explored fertility 
services. She gave birth to three children through IVF before facing the decision of what to do 
with the frozen embryos that remained. “In the moment the embryologist called to say we had 
twenty-four embryos, I cried because I was happy and I cried because we couldn’t parent them 
all,” Sharon explained. “I wondered, what have we done? I had this overwhelming sense of 
responsibility.”  
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The Bakers embarked on what seemed to be an ideal embryo adoption journey with Tara 
and Albert Channing. The couples found each other through a Christian online infertility forum, 
Hannah’s Prayer, that Sharon and Tara participated in. Sharon had been intrigued to read Tara’s 
postings about wanting to adopt embryos and found herself attracted to Tara’s passionate 
commitment to pro-life issues informed by her deep Christian faith. The couples lived in 
neighboring states and made an effort to meet in person to discuss their idea of partnering 
together. Regular communication and reading of each other’s blogs facilitated their budding 
relationship. Rather than use an attorney to draft a private contract for the embryo transfer, they 
decided to use the services of the Blossom program to coordinate an adoption of the Baker’s 
embryos by the Channings. Soon after receiving the embryos at their clinic, the Channings began 
a tumultuous multi-year journey of three failed embryo transfers and two miscarriages before 
giving birth to their son, Gregory.  
The partnership between the Bakers and Channings started breaking down over their 
differing perspectives about rescuing orphan embryos. Sharon’s reason for placing her embryos 
for adoption with the Channings was because “we wanted to help another family who has been 
through what we’ve been through, which is infertility.” She explained that shortly after contracts 
were signed, 
I learned that she [Tara] was against IVF because she thought the creation of embryos in 
a laboratory was sinful… What ended up happening was that they would say things to us, 
like “We saved Gregory” and “We rescued him from his frozen orphanage,” referring to 
him as an “orphan” and his siblings that were frozen as orphans. They were taking the 
standpoint of wanting to spread awareness about embryo adoption from a fundamental 
Christian point of view and wanting other people, other fundamental Christians, to get on 
board to save embryos whereas Dennis and I went into this trying to help somebody. … It 
just made Dennis and I feel terrible. It’s like, ‘Wow, we’re giving you this gift and your 
point of view is that you rescued him? You rescued our embryos? Really?’ Their point of 
view and our point of view are on two different spectrums.  
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Sharon and Dennis were disturbed by the Channings’ approach to embryo adoption as a saving 
mission, in large part because it diminished their role as caring parents who made an adoption 
plan for their much loved embryos. Their recall of the donated embryos from the Channings was 
an uncommon but clear expression of embryo inalienability—the quality of being given without 
being given up (Weiner 1992). The Bakers’ experience puts into relief how the erasure of 
families of origin through embryo rescue may be injurious to donor families for whom donated 
embryos remain intimately connected and anything but abandoned.  
The Bakers also worried how being “abandoned” could affect Gregory. “We were 
concerned for their son,” Sharon explained. “We didn’t want any children born from the 
adoption to feel like they had been rescued by their [adoptive] parents. We never intended that 
for them.” How the orphaning of adopted embryos could affect Gregory, and all children born 
through the Blossom program, is still to be known.  
It matters to many of the Blossom donors who I spoke to that their embryos are 
acknowledged as once wanted and made with family-building intentions. Donors expressed their 
continued sense of belonging to the embryos and feeling of responsibility for their potential 
futures by investing time into choosing an adoptive family and wondering about the people who 
adopt their embryos. Many feel at peace with their decision to donate, though mixed feelings 
arise around shipping dates, frozen embryo transfer procedures, pregnancy results, and birthdays 
of their biological children who are born into other families. While embryo humanitarianism 
casts embryos as at risk and in need, Blossom donors reject the notion that their frozen 
remainders are ever without parents.  
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 ‘I hate the language because it’s at the expense of somebody else’: An Adoptive Mother’s 
Critique of Orphanhood Imagery 
Jessica Stohl, an early Blossom adopter and public advocate for embryo adoption, 
expressed the most critical perspective I encountered about the negative impacts of embryo 
humanitarianism on donor parents as well as the children born. Over time, Jessica came to reject 
the orphaning of embryos: 
The terminology that adoptive families use that diminishes the role of the genetic and 
birth parents subsequently diminishes the child. They don’t see that at the time but 
eventually the child does. I have learned to hate the words rescued, orphaned, abandoned, 
but I had to be educated into it… I just absolutely hate the language because it’s at the 
expense of somebody else. Not to say that there aren’t times when a child, whether born 
or unborn, does indeed absolutely need to be rescued, but even if that is the case, I would 
hope the rescuing isn’t done from a self-righteous place. 
 
Jessica did not always hold a critical view of embryo orphanhood. Like many Blossom 
adoptive clients, Jessica experienced infertility that stretched over seven years of IVF cycles, 
four miscarriages, and devastating periods of grieving losses. At the age of thirty, she and her 
husband adopted eleven embryos through the Blossom program in 2000, followed by four frozen 
embryo transfers, three miscarriages, and one successful birth to her son, Logan. “We were 
committed to all eleven of those babies,” she told a Washington Post reporter in 2005 about her 
experience with embryo adoption. “We were going to see it through as long as it took.” 
Although her hands were full as a professional photographer and stay-at-home mom of 
three adopted children—two adopted domestically, and one embryo adoption—Jessica became 
active in embryo politics in the early 2000s as a vocal pro-life advocate who regularly used the 
language of rescue, frozen orphanages, sacrifice, and risk. She and her husband joined two other 
Blossom adoptive families as plaintiffs in a legal case filed against the National Institute of 
Health on March 8, 2001 challenging President Clinton’s approval of distributing federal funds 
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for embryonic stem cell research. In 2002, she testified as an embryo adoptive mother in a 
Wisconsin State Assembly Health Committee Hearing in favor of the Human Embryo Protection 
Act to “to help put a real face on a hard-to-visualize group within the human family: frozen 
embryos.” A few years later in 2006, she and Logan were one of twenty Blossom families that 
traveled to Washington D.C. to attend the press conference where President Bush vetoed the 
Stem Cell Research Enhancement Act of 2005 that would have allocated federal funds for 
embryonic stem cell research.55 “All of Logan’s uniqueness was in that embryo that was just 
waiting for parents,” Jessica asserted.  
He wasn’t a person that was yet to be. Who he is now was already there as a tiny being. It 
was important to me to help people understand that…. From my experience, when I have 
talked to people about embryonic stem cell research, people did not understand the cost 
to somebody else to do it until they heard my story. Then they would look at Logan and 
then see. There may be some great benefits [from embryonic stem cell research] here but 
there are great costs involved too. And you are looking in the face of the sacrifice. 
 
Jessica decided to scale back her advocacy efforts after years of making regular 
statements to the press, attending legislative hearings in and beyond her home state, and igniting 
debate through her personal blog and participation in the blogosphere. The primary reason for 
slowing down politically was that she wanted Logan to have a life outside the limelight. Also, 
her perspective on embryo rescue was shifting.56 As Logan and her other children aged, she 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
55 Jessica felt that she and her son were chosen to stand behind President Bush during the press 
conference because of Logan’s vibrant red hair, which she feels represents his, and every 
embryo’s, uniqueness. “He doesn't look a thing like me.  He’s incredibly beautiful. In many ways 
I’m grateful that he doesn’t because it testifies to the uniqueness he was before I got him, that the 
design for Logan, the blueprint of who he would be, that picture was already stamped before he 
was put into my womb. When you see him, it’s very obvious. It happened to be on Logan’s 4th 
birthday that we did that, and so they had birthday cake at the White House in Blue Room. After 
the President addressed the nation we went in and celebrated his fourth birthday with cake made 
by the White House staff and all. That was pretty fun.”	  
56	  Jessica elaborated: “When he was little, that was important to me because there weren’t many 
people who could stand up to such claims [in favor of embryonic stem cell research] except for 
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became sensitive to what humanitarian discourses did to placing families and adopted children. 
Part of her advocacy now involves calling out the negative effects of treating frozen embryos as 
abandoned orphans. For instance, Jessica expressed a sentiment that many embryo adoptive 
families share, which is feeling like a recipient of blessings rather than a provider of them. 
I don’t agree with myself now, but at the time [when I was first married], I saw 
adoption as a beautiful thing that I could do for this child, you know, a kind of a 
rescue. Now, eighteen years later, I would tell you that that is the last reason I 
would want to adopt… I started out wanting to rescue babies, but it turned out that 
the babies rescued me. 
 
Jessica was initially enthusiastic about contributing to Blossom’s mission of rescuing 
orphaned embryos from frozen orphanages, but her perspective changed over time as the effects 
of humanitarian rescue became clear to her: embryo donors are obscured, resulting children are 
objectified, and adopters are lionized as altruistic do-gooders. Jessica suggests that embryo 
orphanhood provides Blossom a language and platform to leverage politically for “pro-life” 
causes, but such opportunities come at the expense of embryo donors and Blossom children born. 
For Jessica, the costs of orphaning embryos are not worth it.  
The severing of IVF embryos from their origins in order to prepare them for adoption is 
key to revaluing the potential of IVF remains, yet, as the Bakers and Jessica suggested, is not 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
parents of children who have had babies formerly cryopreserved. I felt like we had something to 
say about justice and their personhood. However, as time went on, it’s not that don’t believe 
that—I still do believe that—and I still, like talking to you today, still do take opportunities to 
speak up for them as I can, but as your child grows, mothering kind of kicks in too… I now feel 
more protective of him as a mom until he is old enough to make a choice for himself. When he 
was little, it didn’t make difference. He didn’t know what we were talking about. By the time he 
got old enough, when he would realize that he was evidence for my soap box—you know what I 
mean?—I didn’t want it to give any appearance of that to him. I know there’s a better way to 
word that. Now I really don’t step out and say too much on the topic unless I can do in more 
private way. Right now Logan just needs to live his life with mom, dad, and siblings. The fact 
that he was adopted is really cool but it is not the central theme of his life or mine by any 
stretch.”	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without costs. Their experiences suggest that the erasure of embryo origins is an unnecessary 
precondition for embryo adoption. But they and other program participants are not entirely 
dismissive of embryo orphanhood. Blossom donors and adopters embrace the other facet of 
embryo orphaning that calls for accepting responsibility to facilitate embryo chances. 
 
Making Orphan Embryos: Facilitating Chance 
“We believe that every embryo is a baby that deserves a chance at life it was created for.” 
- Monica, Blossom Embryo Adoption program manager  
 
I have argued that classifying and counting practices transformed embryos into orphans 
without origins, family, or history, or what I refer to as needy objects. These mechanisms for 
rescuing embryos mirror REDEEM Biobank’s wasting practices that disentangle embryos, 
dispossess donors, and ready embryos for research. This section discusses the last part of the 
orphaning process where orphaned embryos become “treasured subjects” whose potentiality as 
unborn children can be realized through transfer into an adoptive woman’s uterus. First I revisit 
the case of the Korean orphan to illuminate how orphanages and cryopreservation tanks are, in 
Christian rescue narratives, spaces that cultivate an orphan’s potential. Then, I examine how 
embryo donors and adopters facilitate embryo potential by assuming bodily and Godly 
responsibilities to help manifest their chances for birth. Orphanhood, like waste, is a 
transformative category embryos pass through that changes them into adoptable preborn 
children; rather than lying in waste as abandoned, “needy subjects,” embryos are converted into 




Frozen Orphanage as Realm of Potential 
“I guess that’s true for any child sitting in an orphanage or embryo sitting in a freezer; 
unless you expose them or give them the opportunity, you never know what gifts will go 
undiscovered.”  
- Betsy and Joe Banyon, Blossom adoptive parents 
 
Once classified as orphans, quantified in undifferentiated batches, and severed from 
families of origin, orphans enter the orphanage—a material and symbolical space within 
Christian rescue tropes where children without origins await what are called “forever families” 
(Joyce 2013). International orphanages figure within the worldwide orphan crisis as sites that 
standardize children through dress, documentation, and regimen in ways that wipe clean prior 
habits and histories. Oh suggests that in the post-war Korean orphanage a child became a “tabula 
rasa,” or a blank slate on which to draw a new future. As a result, the Korean orphan “came to 
represent a particularly exemplary immigrant due to her youth and perceived malleability” (Oh 
2012: 36), allowing her potentiality as an “ideal immigrant” to shine. Anthropologist Ann 
Anagnost describes the potentiality of children in Chinese orphanages through the framework of 
uncertainty and possibility; she also argues that Chinese orphan potentiality is created by 
separating orphans from their origins. In Anagnost’s view, uncertainty and possibility “figure 
complexly in the structure of the salvage narrative” that pervades adoption (2003: 399). 
Susan and Anna’s Congressional testimonies about frozen orphanages similarly regarded 
cryopreservation tanks as realms of possibility and potential where, as they stated, “children are 
waiting to be born.” Their invocation of orphanage imagery through the sentimental discourse of 
rescue aided their plea to lawmakers about potential harms facing the frozen preborn. They 
argued in favor of IVF orphans being saved from the risk of “termination” by scientific research 
so that adoptive families may give them a chance to be born. Other Blossom adopters extend the 
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metaphor between cryotanks and foreign orphanages as spaces of potential filled with hope. 
Louise Hayworth, for example, likened the fertility appointments after her eight adopted 
embryos arrived to her fertility clinic and before their transfer into her uterus “like visiting an 
orphanage.” Spending time in their fertility clinic where the embryos were stored felt the same to 
the Hayworths as visiting orphanages in China, from where they adopted two of their five 
children. Louise explained that in clinics and orphanages, “you couldn’t go into the room where 
the children were, but your heart is just excited.” Just as they did in a Chinese orphanage, the 
Hayworths “prayed and thanked God for the little ones, for their protection, and for the doctors 
who’d be handling them” from their fertility clinic waiting room. For Blossom proponents like 
Louise, the “frozen orphanage” was not only a tragic space of abandonment but a container of 
possibility as well.  
 Responsibility, as discussed above, is a contemporary moral concept that connotes the 
management of risk with respect to oneself as well as higher authorities. Blossom donors and 
adopters helped facilitate embryo potential by embracing the call to act responsibly: toward 
leftover embryos, through women’s bodies, and in relationship with God.   
 
Blossom Donors and Adopters on Embracing Responsibility 
Embryo donors and adopters describe two kinds of responsibilities—through their bodies 





‘Our one objective was to get embryos into the uterus’: Donor Perspectives on Bodily 
Responsibilities  
Feelings of bodily responsibility emerge for many Blossom donors when women 
encounter obstacles to using their remaining IVF embryos themselves for parenthood. Ten years 
passed before Sally and Jonah Anderson, a white Catholic couple with two pre-teen children 
living in the Northeast, returned to their fertility clinic to resume using their five frozen embryos. 
At the appointment, they learned that Sally’s uterus was no longer compatible with carrying a 
pregnancy to term. The Andersons grudgingly started discussing other options for their 
remaining embryos. Physically and financially, Sally realized that she “could no longer provide 
for them… We weren’t able to be a vehicle to be used for them, and we felt it to be a burden. We 
couldn’t accept responsibility anymore to give birth ourselves but we had the responsibility of 
finding a solution.” They believed the Blossom program was a good option because it allowed 
their treasured remainders the opportunity to be born, even if to another family. Still, Sally felt 
“such a mothering feeling towards embryos” that she struggled for over a year to complete the 
Blossom donor application. “It felt like being the world’s worst mom even thinking about 
adopting them out. For the longest time I couldn’t think about it because I was imagining Jack or 
Zoe living with another family.” She crafted multiple drafts of the letter required by the Blossom 
program from embryo donors to the prospective adoptive family to complete the donor “profile.” 
She read the letter drafts to her husband at night for feedback until the letter, and Sally, felt 
ready.  
Eileen Tyler, a married Canada-based mother of two and one of the few Blossom donors 
who described herself as pro-choice, expressed a similar feeling of responsibility once becoming 
aware of her own bodily limitations for becoming pregnant. During her first IVF cycle, Eileen’s 
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endocrinologist realized that she had severe problems with her uterine lining that precluded her 
from ever carrying a pregnancy. They halted the IVF cycle by freezing six embryos and faced 
the problem of having embryos but “nowhere to put them.” The Tylers decided to hire a 
surrogate, who received four embryos and delivered twins. With two children to parent and 
depleted finances, Eileen felt a responsibility toward their remaining two frozen embryos to not 
waste chances. Knowing they would likely not establish a pregnancy in her body, Eileen 
approached the decision to donate embryos for adoption as a practical task of getting them into a 
uterus: 
I view embryos as potential babies and always felt that any embryo created should be put 
in and get chance at life or, you know, have a shot. Our one objective was to get embryos 
into the uterus. We could have put them in my uterus, which would have been cheapest 
way to go, but the medical advice we received was that the embryos wouldn’t survive in 
me, so that would be fairly akin to throwing them away. Transferring to me would not 
provide them a good chance, not a good enough chance anyway. 
 
Sally’s and Eileen’s experiences evoke different feelings around their inabilities to use the IVF 
embryos they made, but both believed—as do many donors I spoke to—that finding a way for 
embryos to have a chance in another’s body is their duty. 
 
‘I wanted them to be nurtured’: Adopter Perspectives on Bodily Responsibilities 
Adopters also assume responsibilities for embryos by readying their bodies to bring 
embryos “home.” Although rarely discussed explicitly by the Blossom program, the first “home” 
for adopted embryos is not a nursery but a woman’s uterus. Blossom adoption clients are 
required to complete a multi-part application process before being matched with donor families, 
which includes a detailed application with personal, financial, and medical histories; a 
descriptive family profile; and a traditional adoption home study. The application also requires 
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adopters to submit a doctor’s letter verifying the female applicant’s ability to carry a pregnancy 
to term. Maria translated Blossom’s desire to find “homes for embryos” into making sure that the 
ones she adopted and transferred were received into the safest conditions her body could provide.  
From the very beginning I wanted them to be nurtured. I was careful about my diet, and 
anything that I could read up on, I did. I started drinking green tea, for instance… I 
wanted them to be taken care of and in a good home and have every chance at life. 
 
The preparation of one’s body to receive adopted embryos is distinctly gendered labor 
conveyed through themes of nurturance and care. Most of Blossom’s adoptive clients have tried 
forms of assisted conception or have histories of reproductive failures. The opportunity to give 
birth to an adopted child answers the prayers of Blossom adopters who wish to experience 
pregnancy, in addition to control the uterine environment and bond with their adopted child from 
the earliest stages of development. At the same time, many of the women experience anxieties 
about their bodily performance and feel pressures to reproduce. Even though each donated frozen 
embryo averages a 12 percent chance of successful thaw, implantation, gestation, and birth 
(Keenan, et al. 2008), Blossom is dedicated to giving every embryo this opportunity. For these 
and other reasons, the stakes and hopes are often high for adoptive women on the eve of their 
embryo transfers.  
After Kate, a recently married white lawyer in her forties living on the East Coast, 
transferred four embryos that did not implant successfully, she reconciled herself by saying that 
her adopted embryos were at the mercy of chance despite her efforts to provide them a 
welcoming “home” in her body.  
I tried my best to have them become babies. When you’re going through it, you 
automatically think ‘Four little babies!’ but they don’t all take. It’s a very strange 
thing. Embryos are not guarantees to make and turn into a baby. 
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Even though Kate knew that the odds of becoming pregnant were not in her favor, she felt the 
familiar pang of frustration that she had come to know through failed ovarian stimulations, 
intrauterine inseminations, and one prior IVF cycle. “I was mad at myself and mad at my body. 
Why can’t I carry a pregnancy? I was disappointed in myself.” At the time of our interview, she 
was in the process of being re-matched with another set of embryos for another try at pregnancy.  
Other adoptive women I spoke with felt the added pressure to have successful 
pregnancies for their donor families. Amanda, a married mother of two, “felt a certain degree of 
pressure to not let the [embryo] donor family down. They were giving us this gift,” she 
explained, which felt “more personal” to her than when she adopted her son Daniel from a 
Vietnamese orphanage. Amanda felt that not getting pregnant or miscarrying would let the 
embryo donor family down:  
They had waited so long for an adoptive family, and knowing they are Catholic and that 
the Church frowns on IVF to begin with, [embryo donation] was probably their way of 
dealing with that. I felt like I needed to have good pregnancies for us and for them too. 
 
Nearly every Blossom adopter, when asked to describe the ideal future for frozen embryos, 
wished that each frozen embryo would have the opportunity to be born. The prospect of birth for 
any embryo depends entirely on the gendered labors of the women into whose uteruses frozen 
embryos are transferred. Although social workers complete the traditional “home studies” for the 
adoptive Blossom applicants, adoptive women submit their bodies to other kinds of “home 
studies.” Diet and exercise, medical care, prayer, and emotional management represent the types 
of gendered bodily work that adoptive women perform in order to produce pregnancies for the 




‘Our job is to be obedient’: Donor Perspectives on Responsibilities to God 
Some Blossom donors described the decision-making processes for their remaining 
embryos as part of feeling responsible to God. Donors who feel in partnership with God and 
committed to carrying out God’s plan distinguish between their duties and those belonging to 
God. According to Erin, a married evangelical Christian and mother of two living in the 
Northwest, God is in charge of manifesting each embryo’s potential while her job is to obey.  
Every baby born has a purpose, a place, however God uniquely arranges this. God 
decides their potential and their part in this world. It is all up to God. He works out the 
details. I can see his hand throughout. My job is our small little part. God took it so much 
further; whatever he chooses to do is the potential and opportunity. Our job is to be 
obedient. God certainly could have done without me but He chose for me to be part of it. 
 
Embryo donor Annika, a white born-again Christian raising two sets of twins in the Midwest, 
similarly embraces her task of obedience. After two traumatic twin deliveries, Annika and her 
husband donated their five remaining embryos to a couple, who afterward gave birth to a son. 
Annika approaches the donation of her embryos as she did parenting her four children: as acts of 
stewardship toward the lives that came into her care by God’s design. She explained:  
I don’t look at it like they are my kids. I look at it like they are on loan to me. They are 
not my children. I mean they are my children, but they are God's children. I look at them 
like they are on loan to me and He’s entrusted me with four to raise. 
 
Annika enjoys telling her donation story not to be patted on the back for being a responsible 
steward of precious lives, but in order to reveal God’s handiwork to others who are willing to see 
it:  
It’s amazing how many people say, ‘Look what you’ve done!’ and ‘What a blessing 
you’ve been!’ They don’t get it. I emphasize it’s not what we’ve done. It’s what God’s 
done. We’re not a blessing, but we are being blessed. We are so blessed because God was 
able to use us to bring this little boy into the world because he was supposed to be here. 
And look at these people, the adoptive family. What have they done? They are sharing 
his [child born from embryo adoption] life with us and we are reaping the benefits of that.  
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Frozen IVF embryos are entangled in webs of kinship, ownership, as well as stewardship—or the 
temporary caretaking of something belonging to another. For some, frozen embryos and their 
potential belong to God. As donors like Annika think about how to talk to their children about 
the decision to donate embryos to another family, many agree with her conclusion that “it’s 
important for them to know that we wanted to be obedient to what God wanted us to do, and 
doing so allowed more lives to come into the world.”  
Scholars of many faith traditions acknowledge that the convictions of IVF patients with 
deeply held religious beliefs are often tested through the veritable rollercoasters of emotions, 
losses, and doubts entailed in creating family using reproductive technologies (Inhorn 2006; 
Kahn 2000; Roberts 2012). Among Blossom donors, God figures centrally in donation stories; in 
some cases, religious convictions were edified while they were called into doubt for others. 
Sharon Baker, for instance, continues to identify as a Christian though her once “black-and-
white” perspective shifted as a result of participating in the Blossom program. Now, as she 
identifies as pro-choice and participates in birth mother advocacy, Sharon believes that “God 
made the world more gray than we give it credit for.” 
   
‘God calls you to be his vessel’: Adopter Perspectives on Responsibilities to God 
One way that Blossom adopters express obedience to God is by submitting their 
reproductive bodies through embryo adoption for God’s sake. Regardless of pregnancy 
outcomes, some adoptive women feel peaceful relief because they offered their bodies wholly to 
giving embryos a chance to be born. Soon after Tiffany’s first child was born through embryo 
adoption, she began to think about the four embryos that remained in her clinic’s cryotank. “I 
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feel a big responsibility to go back to them like a good parent,” she explained. “I probably 
haven’t prayed for them specifically but for God’s wisdom. At the moment we are trying to 
figure out when the best time to do another transfer, when to give them the best chance.”  
After a series of unsuccessful frozen embryos transfers, Carla turned to God to help make 
sense of the overwhelming grief and loss she felt. She thawed and transferred eighteen adopted 
embryos without establishing pregnancy. Although each negative pregnancy test devastated 
Carla, she came to feel privileged to have been chosen by God to help “deliver the babies home 
to heaven.”  
I couldn’t believe God brought us to this point and didn’t bring us a child. Amy, the 
director of the Blossom program at the time, said to me that it’s hard to deal with now but 
sometimes God calls you to be his vessel for children to go home to him. It’s hard to 
accept but I feel incredibly blessed that God would use me to be a vessel to send babies 
home. I don’t want to say I felt like Mary but I felt incredibly chosen. It was so hard 
though that didn’t happen, that I didn’t get pregnant. I couldn’t understand it, but to be 
used by God for this was an incredible privilege.  
 
During her final embryo transfer, Carla became pregnant with her only daughter. Six years after 
her daughter’s birth, Carla felt that she had a role in God’s plan for her adopted embryos: “Out of 
19 babies, one survived. I was privileged to send 18 home.” For many embryo adopters, Blossom 
provides them a responsible way to solve their fertility problems, contribute to a laudable 
mission of saving lives, and obey God’s plan for them and their families. 
--- 
Blossom donors and adopters provide critical insight into the processes, limitations, and 
appeals of embryo orphanhood. In the view of donors and adopters, the erasure of embryo 
origins is risky and undermines the reason Blossom participants come to embryo adoption in the 
first place. Donors are propelled to place their embryos through Blossom due to feelings of 
responsibility toward their embryos, through their bodies, and with respect to God. Also, donors 
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want to give their IVF leftovers the best chance to be born as originally intended. The vast 
majority of adopters come to Blossom for the opportunity to “grow” their families and they 
appreciate that their family-making motivations can be in accord with responsibilities they feel to 
help embryos in need and obeying God’s wishes. For people with and wanting embryos, embryo 
humanitarianism may motivate them to walk through the agency door but, in practice, 
opportunities to act responsibly facilitate the transfer of leftover embryos into uteruses where 
their chances for birth may be realizable.  
 
The Frozen Unborn: Race and Gender Politics in Cultivating Cultural Innocents  
Race and gender politics in the United States figure centrally in cultivating cultural 
innocents worthy of rescue. The white child, for instance, served as a rich site for moral 
inscription and political mobilization within American controversies from abolitionist rhetoric, to 
immigration politics, to public education (Levander 2006). IVF embryos, now equated with a 
stage of human development described as “the beginning of conception,” are increasingly cast in 
debates as “the plausible innocent[s] in whose name moral claims can be made” (Comaroff 1997: 
15).  
Pacific Christian Adoption is a leading advocate for the rescue of the “frozen unborn” 
and one of the few places in the world where embryo rescue operates as the status quo. Blossom 
staff works passionately to find a receptive uterus for all adoptable embryos, especially the least 
desirable. The agency enshrines embryo personhood values in the organization’s mission by 
committing to “recognize and advocate for the personhood of pre-born children.” Blossom 
donors and adopters sign embryo transfer contracts that describe embryos as “entitled to the 
rights and protections accorded to all children, legally and morally.”  
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In this section, I discuss histories of personhood advocacy and Christian child-saving in 
the United States to illustrate how saving ethics and practices commingle in the making of 
cultural innocents. My review of historical, social, religious, and political factors beyond the 
agency door illuminates some conditions that make it possible to cast frozen embryos as 
innocents deserving of rescue from destructive, devaluing forces. Important to these 
considerations are the ways race and gender conspire in generating notions of innocence and 
social worth.  
  
Politics of Personhood 
Advocacy for embryo personhood is a historically recently social movement with roots 
dating to the 1776 drafting of the U.S. Constitution wherein the rights of persons as citizens were 
first detailed. From the beginning, race and gender logics pervaded legal categories of persons in 
the United States. Founders of the republic limited legal personhood to land-owning white males 
and many decades passed before personhood rights via citizenship included African Americans, 
women, and immigrants.57 Race and gender politics remain constitutive of contemporary battles 
over the definition of person in America within which frozen embryo rescue figures centrally. 
The Roe v. Wade58 decision legalizing abortion marks the most recent turning point in 
personhood advocacy on behalf of embryos. Justice Harry Blackmun, author of the majority Roe 
opinion, addressed the question of fetal personhood that arose during the case’s oral arguments. 
After finding no basis for attributing personhood status to fetuses, he observed in the court’s 
opinion a veritable loophole: “If this suggestion of personhood is established, [Roe’s] case, of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
57	  The 13th (1865), 14th (1868), and 15th (1870) Amendments to the U.S. Constitution abolished 
slavery and extended citizenship and voting rights to black males, followed by the 19th (1920) 
Amendment’s extension of voting rights to women.	  
58	  Roe v. Wade, 410 U.S. Supreme Court 113, (January 22, 1973)	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course, collapses, for the fetus’ right to life would then be guaranteed” (Martin 2014). 
Antiabortion strategists leapt to action in response to the legal Achilles’ heel that, in Blackmun’s 
words, could dismantle the legal right to abortion. Political activism to establish the personhood 
of embryos and fetuses launched a week after the Roe decision when a Maryland Congressman 
proposed the Human Life Amendment, which sought to amend the Constitutional definition of 
person as beginning at the moment of conception.59  
Antiabortion lawmakers have built their case and cause for personhood over the past four 
decades. Legislatures at the state and federal levels have seen more than 330 variations of 
personhood amendments proposed and introduced (Martin 2014). As of March 2015, thirty-eight 
states passed “fetal homicide” laws that create increased penalties for crimes, such as violence 
toward pregnant women or drunk driving, that result in the death of a fetus, based on their 
separate rights (National Conference of State Legislatures 2015). Additionally, pregnant women 
in most states are increasingly arrested, detained, and prosecuted for “child endangerment,” such 
as exposing their fetuses to illegal substances. Low-income women and women of color—
especially African American women—are disproportionately impacted by fetal homicide and 
endangerment policies. For example, twenty-six year old Regina McKnight, an African 
American woman in South Carolina, was arrested and charged with homicide after miscarrying 
her pregnancy based on allegations that her cocaine use caused the stillbirth. In North Dakota, 
the twelve-week pregnant and homeless Native American woman Martina Greywind, was 
arrested and charged with reckless endangerment based on the claim that she inhaled paint fumes 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
59	  The text of the first Human Life Amendment reads: “Neither the United States nor any State 
shall deprive any human being, from the moment of conception, of life without due process of 
law; nor deny to any human being, from the moment of conception, within its jurisdiction, the 




that were toxic to her fetus. Lynn Paltrow of the legal advocacy organization National Advocates 
for Pregnancy Women identified 413 cases in the United States like these that treat embryos and 
fetuses as separate legal entities at the expense of the personal liberties of women (Paltrow and 
Flavin 2013). As fetuses in utero gain legal protections of “personhood,” the rights of women 
who bear them wane.  
Race and gender politics are evident within fetal personhood activism in other ways, such 
as when strategists appropriate Black American history to forward a “civil rights” cause for the 
unborn. While antiabortion activism more commonly racializes the fetus as white to justify its 
rescue, intersecting race and gender politics also facilitate the making of a “minority unborn” 
(Mason 1999) as a cultural innocent. For decades, anti-abortion spokespersons have drawn links 
between slavery and abortion that call out black women, among whom abortion rates are highest 
in the nation, for being complicit with “black genocide”; the controversial billboard erected in 
New York City in 2011 stating “The Most Dangerous Place for an African American is in the 
Womb” is an exemplar (Kumeh 2011). Antiabortion campaigns also use tropes of personhood, 
rights, and freedom that echo the long struggle for racial justice in America. In 2010, Priests for 
Life began a  “Pro-Life Freedom Rides” campaign modeled on the anti-segregation bus rides led 
by black and white challengers to Jim Crow era oppressions. The goal of the pro-life freedom 
rides is to build a popular movement around freedom and justice for all, particularly fetuses at 
risk of being aborted.  
Similarly, embryo personhood proponents racialize frozen embryos as both white and 
black to strategically convey their cultural innocence and worthiness of rescue. Embryo 
personhood advocates represent a recent faction of the U.S. antiabortion movement who shifted 
political foci from in utero fetuses to ex utero embryos, and from the realm of lawmakers to 
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engage the public around the personhood cause. In 2008, twenty-one year old Kristi Burton took 
personhood to the voters of Colorado after galvanizing 1300 volunteers and 500 churches to 
collect 103,000 signatures that put the “Colorado Definition of Person” initiative on the ballot. 
Although voters defeated the constitutional amendment by a three to one margin, it inspired the 
formation of Personhood USA to continue grassroots advocacy for embryo and fetal personhood.  
Personhood USA became a go-to advocacy organization for embryo personhood whose 
mission is to “change the cultural mindset through action to respect the dignity of the human 
person” in ways that “glorify Jesus Christ.” In addition to trying to influence a “cultural shift,” 
their legal aspirations are in line with mainstream antiabortion legal strategists, suggested by the 
opening tagline on their website: “Don’t take Roe for an answer.” Personhood USA spearheaded 
efforts to bring personhood initiatives to ballots in Colorado again in 2010 and 2014, Mississippi 
in 2011, and North Dakota in 2014. They also supported activists internationally to challenge 
legal protections for abortion, such as supporting the ratification of the Dominican Republic’s 
pro-personhood constitution in 2009 and the passage of personhood amendments in eighteen 
Mexican states. Their work also inspired the formation of new U.S. groups, like the National 
Personhood Alliance.60  
Frozen embryos within the Blossom Embryo Adoption program are most often racialized 
as white. The face of embryo adoption in news media is predominantly white heterosexual 
couples, which is also true for promotional materials from the program’s website, brochures, and 
informational webinars. In 2008, Blossom created a “multi-ethnic” embryos page to highlight the 
small fraction of embryos from non-white donors available for adoption. Monica, the Blossom 
program manager, explained why:  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
60 Personhood USA’s website is www.personhood.com and the National Personhood Alliance’s 
website is www.personhood.org.  
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There was a point in time where the multi-ethnic page didn’t exist at all. We just had the 
embryos sitting here being passed over all the time. I felt badly because I started to do 
matching with Sarah and it was like, ‘Oh, can’t match them, they’re African American,’ 
or ‘Oh, can’t match them, they’re Asian.’ The embryos would just sit so I thought we 
have to do something. So a webpage was born. 
 
By featuring embryos from non-white donors on the multi-ethnic webpage, the Blossom program 
reinforces the idea that all other embryos available for adoption are from white donors. 
Representations of embryo adoption as a practice among predominantly white people are 
accurate, yet obscure how frozen embryos are also racialized as black, creating a frozen 
“minority unborn” worthy of rescue. In 2009, for example, Pacific Christian Adoption agency 
and two Blossom program couples signed on as plaintiffs in a suit filed against the Obama 
administration by the NAAPC, or National Association for the Advancement of Preborn 
Children. In their challenge federal funding for embryonic stem cell research, the filing party 
aligned itself with the well-known civil rights organization the National Association for the 
Advancement of Colored People and named the case’s chief plaintiff Mary Scott Doe. Doe is a 
frozen embryo named after the 1857 Dred Scott case, which denied citizenship to an enslaved 
black man suing for his freedom, and a “pseudonym to stand for children in vitro left behind in 
America’s frozen orphanages with their souls on ice.”    
Other personhood advocates promote a frozen minority unborn by likening the 
personhood cause to abolishing slavery and redressing social injustice. To announce the 
personhood ballot initiative in Colorado in 2010, Personhood USA devised a radio ad read by a 
fictional slave in support of the proposed personhood amendment remarking on the likeness 
between chattel slaves and embryos:  
I’m George Stevens and I am a person. I was held as property as a child. Even before my 
birth I was called a slave in an America you wouldn’t recognize… But today in Colorado, 
there are still people called property—children—just like I was. And that America you 
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thought you wouldn’t recognize is all around you and these children are being 
killed.  This November, vote “yes” on Amendment 62. Amendment 62 declares unborn 
children persons, not property.   
 
Recently in the state of Missouri, where the Black Lives Matter movement first erupted in 2014 
after the killing of Michael Brown, a state legislator introduced a personhood bill for 
consideration during the 2016 legislative session entitled the “All Lives Matter Bill.” In an effort 
to redress discrimination against embryos by according them legal status as persons, this bill 
directly appropriates and rejects the Black Lives Matter movement’s efforts to restore justice to 
black and other historically marginalized communities (Levintova 2016). Race and gender serve 
as tools within contemporary personhood politics to construct frozen embryos as cultural 
innocents worthy of rescue. 
 
Christian Child-Saving 
Race and gender politics also play a constitutive role within child-saving efforts, which 
began in the mid-nineteenth century in America. The first child-saving movement in the United 
States arose among Protestant social reformers during the antebellum era who sought to redress 
the effects of industrialism and urbanization upon the “dangerous classes” of poor, urban, and 
immigrant youth. Protestant minister and social work pioneer Charles Loring Brace was an early 
child-saving leader dedicated to identifying, as he titled his 1859 book, the “best method of 
disposing of our pauper and vagrant children” (Brace and Children's Aid Society of New York 
1859). Brace established the New York Children’s Aid Society to place “orphaned” youth from 
poor, immigrant, and urban households on Anglo Protestant family farms out West. Over the 
next eighty years (1854-1929), 250,000 children—many Catholic and Jewish—were transported 
on orphan trains from northeastern cities to rural western towns where Protestant families took in 
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urban youth as acts of charity. Brace’s broader vision for the trains was to mitigate social ills by 
transforming the children of the “dangerous classes” into productive citizens (Gordon 1994; 
O'Connor 2001). “Saving” the so-called orphans, who often had one or both living parents when 
placed out on western-bound trains, used Christian humanitarian logics to convert the perceived 
threats of marginalized races, religions, and classes into a social good (Gordon 1999). 
Other Christian child-saving projects gained prominence in the twentieth century after the 
orphan trains ended. Christian assimilation intensified around Native American families who had 
been broken apart from forced enrollment in Christian boarding schools since the nineteenth 
century. The Indian Adoption Project of the Child Welfare League of America (1957-1968) and 
subsequent Adoption Resource Exchange of North America (1966-1978) amplified efforts to 
save the future of Native American youth by relocating nearly a third of the children from 
reservations to white American homes and orphanages. Assimilation and missionizing practices 
collaborated for decades and did not slow until the 1978 passage of the Native American 
Adoption Act (Jacobs 2014), though the law has been challenged in numerous disputes over the 
adoption of indigenous youth.  
For instance, national controversy erupted in 2013 over the case of Baby Veronica, the 
daughter of a Cherokee man, who was adopted by the Capobianco family without his consent. 
The removal of Veronica from her adoptive family’s home inspired a “Save Veronica” campaign 
from Christian communities (www.saveveronica.org) where messages of support could be 
emailed to prayers@saveveronica.org. The assimilationist and missionizing child-saving 
practices that link Veronica’s case with embryo rescue is explicit: Pacific Christian Adoption 
agency’s South Carolina office staff facilitated Christina Maldonado’s placement of Veronica 
with the Capobianco family. The adoptive Capobianco family won custody of Veronica as a 
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result of further eroding of the laws established to protect Native Americans (Briggs 2013).  
Christian child-saving also became inextricably linked with the burgeoning international 
adoption industry and American war efforts. Following World War II, American families looked 
increasingly abroad to adopt children from war-torn and disaster-ridden countries. “Baby lift” 
missions, initially in postwar Germany and Japan and later Korea and Vietnam, mobilized the 
relocation of thousands of internationally-born children, many the children of American soldiers 
stationed abroad and left behind, into American families. The welcoming of foreign orphans into 
white American homes, while a seemingly progressive expression of racial liberalism, was 
inextricably linked with a Christian American patriotism that fueled Cold War politics (Oh 
2012). The rescue of Third World children cast American adopters as heroes and orphans as 
innocents whose American upbringing would confirm the U.S. victory in the Cold War.    
People like Bertha and Harry Holt, an evangelical family from rural Oregon who adopted 
eight children from Korean orphanages, established the legal and procedural groundwork that 
made international adoption now common in the United States. The Holts became a celebrity 
family when they convinced the U.S. Congress to change adoption law in 1955 to simplify the 
international placement of foreign-born children in American homes. They started Holt 
International Children Services, today one of the largest and longest lasting Christian 
international adoption programs in the world, by appealing to other Christian families to “assume 
the responsibility” of rescuing orphans from the “cold and misery and darkness of Korea into the 
warmth and love of your homes” (Joyce 2013: 49). Child-saving campaigns of the twentieth 
century, forged by Christian missionizing and Cold War patriotism, made the United States the 
largest adopter of foreign-born children worldwide.  
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  The rescue ethos that fueled postwar international adoption fell short domestically due to 
racial politics at home. Between World War II and Roe v. Wade, children born to black mothers 
in the United States were largely regarded as unadoptable and channeled into the foster care 
system (Roberts 2002). Newborns from unwed white mothers, by contrast, were “scooped” up by 
white adoptive families in vast numbers. By placing their illegitimate children into socially 
acceptable homes, the single white women who were sent away to maternity homes came back 
socially redeemed (Solinger 2000). Within the gendered and racial logics of rescue, mid-century 
adoption in the United States provided single white women a means to be socially saved while 
there existed no parallel recourse for single black women to redeem themselves or their children. 
Race continued to shape domestic and international adoption trends through the end of the 
twentieth century (Gailey 2009). For example, a wave of would-be adopters in the 1990s 
responded to the so-called “crack baby” epidemic by undertaking the expense and difficulty of 
adopting children from Romanian orphanages rather than caring for the predominantly black 
children within American domestic foster care (Ortiz and Briggs 2003).   
Christian saving values shaped the development of adoption as a practice in the United 
States, although adoption was not a focus of Christian works until the early twenty-first century 
when it became a cause among evangelical Christians. “Adoption is everywhere,” proclaimed an 
editorial headline in the July 2010 issue of Christianity Today, “and God is into it too.” Journalist 
Kathryn Joyce observed a “sea change” that followed a 2007 summit hosted by the Christian 
Alliance for Orphans, the umbrella organization for the growing movement for orphan care and 
adoption among American evangelicals. Key Christian leaders in attendance forged a plan that 
centralized adoption as a “signature issue” for Christians. They reasoned that by embracing 
adoption, Christians would be positioned to fight proactively for something considered good 
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rather than being known mainly for what they oppose, like homosexuality and abortion. In the 
years that followed the summit, evangelical leaders popularized adoption-related activities, such 
as establishing “Orphan Sundays” in congregations worldwide; publishing dozens of new books 
that espoused “orphan theology”; and seeking political opportunities to foreground the “orphan 
crisis” as the premier concern for evangelicals. By 2010, the nation’s largest adoption agency—
Bethany Christian Services—reported significant increases in adoption inquiries and placements, 
which they attributed to the increased mobilization of churches around adoption (Joyce 2013: 
56). Tim, reflecting on trends in Pacific’s adoption programs, told the Baptist Press in the same 
year, “I think the reason for the upswing in the number of home studies that are being done and 
the number of families that are applying is because of this increased awareness within the church 
of the need to take care of kids.”   
Decades before saving children via adoption became a “signature issue” for evangelical 
Christians, saving “unborn children” from abortion served as a cornerstone of Protestant politics. 
The 1973 Roe v. Wade decision marked a pivotal moment when born-again Christians became 
focused on the unborn. Treated as a declaration of war, legal abortion galvanized child-savers in 
defense fetal rights-to-life and the moral fabric of America itself. Following the Roe decision, 
evangelical preachers around the nation “biblicalized” what it meant to be antiabortion by 
locating absolute moral opposition at the heart of being Christian. The message “abortion is 
murder” became the part of the gospel being evangelized in the name of saving children 
(Harding 2000: 194). 
For Jerry Falwell, evangelical preacher and leader of the Moral Majority, Roe signaled 
that “this time preaching would not be enough,” leading him to “realize that there were other 
crises facing the nation that required immediate political action from men and women of 
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Christian faith” (Lugg 1996: 341). For James Dobson of the evangelical advocacy organization 
Focus on the Family, Roe incited a wave of grassroots militancy through a “new Civil War of 
values” (Diamond 1998: 2). Rescuing the unborn within the extreme ends of the right-to-life 
movement served a particular role for the white, middle-aged male activists drawn to militant 
antiabortion activist organizations like Operation Rescue. For them, “the embryo, the fetus, the 
unborn have served as proxy victims of the psychological and political abuses some men believe 
they have experienced in the wake of social change since the 1960s” (Mason 2002: 193). Randall 
Terry, founder of Operation Rescue, considered undermining legal abortion to be a means to a 
greater end: “When the Lord put the vision in my heart, it was not just to rescue babies and 
mothers but to rescue the country. This is the first domino to fall” (quoted in Ginsburg 1998: 
227).  
--- 
Logics of race and gender are foundational to discourses of personhood, innocence, and 
worth in the United States. Embryo rescue tropes are imbued with race and gender politics that 
guide how Blossom proponents promote their moral precepts about valuing life. Christian child-
savers, personhood advocates, and embryo adoption practitioners similarly mobilize racialized 
and gendered frameworks of rescue to fashion children, fetuses, and now embryos as valuable 
and deserving protection.  
 
Conclusion 
As historian Karen Dubinsky suggests, I directed my analysis of rescue in this chapter 
beneath its sentimental veneer to examine submerged political issues concerning notions of value 
and worth. I began in the flooded Louisiana delta with a story about rescued embryos from 
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Hurricane Katrina floodwaters. New Orleans served as a fitting place for beginning to explore 
the coincidence of rescue and abandonment within life-saving campaigns, which I argue are 
inextricably bound to logics of race and gender. Specifically, I demonstrated how race and 
gender are constitutive of embryo rescue practices that fashion the frozen embryos as cultural 
innocents deserving of social value and protection. I supported this conclusion by illustrating 
how the Blossom program deploys Christian rescue scripts that created an orphan embryo crisis 
as well as a moral solution. Blossom converts reproductive remainders into the adoptable frozen 
unborn, regarded by many staff—though critiqued by some donors and adopters—as orphans 
awaiting a uterine home and forever family.  
The lens of saving reveals the similar ways Christian adoption and stem cell science 
respond ethically and practically to the potentials of IVF leftovers. Like the stem cell researchers 
discussed in the previous chapter, Blossom proponents operate within a distinctive ethical 
landscape that informs their vision for saving life in American society. Evidence in this chapter 
shows how rescuing the frozen unborn articulates an ethic for preserving and creating “good 
family” premised on core Christian values of equality, dignity, and duty. As previously 
discussed, Christian rescue scripts are fundamentally discourses about family, and traditions of 
humanitarianism and responsibility align with Blossom’s core values around extending dignity 
and equality to all embryos by assuming the duty to find homes for the remainders. In their 
descriptive and critical stories, Blossom donors and adopters also value equality, dignity, and 
duty, which they locate within their white, heterosexual, and middle class experiences.  
The “good family” moralism that guides Blossom’s activities and advocacy for revering 
rather than cheapening human life echoes “Sunbelt” values established by migrant evangelicals 
who populated Orange County over the twentieth century. Similar to contemporary embryo 
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rescuers, the plain folk, preachers, and entrepreneurs of the 1930s-1960s “assumed responsibility 
for protecting their communities and country from those who would undermine them” (Dochuk 
2011: xx). Arguably, Blossom’s “good family” ethos cultivates in the twenty-first century what 
California’s Sunbelt evangelical visionaries sowed—“a religious culture of entrepreneurialism, 
experimentation, and engagement” (Dochuk 2011: xviii), with frozen embryos serving as an 
emblem of innocence and possibility within it.  
Saving offers a conceptual framework for examining what stem cell biologists and pro-
life Christian embryo adopters share. I have shown, for instance, that rescue and waste are 
kindred practices informed by their respective moral frameworks. In addition to sharing an 
ethical commitment to doing good today for the betterment of life in America tomorrow—one on 
behalf of science, the other on behalf of family—each alienates IVF remainders from their social 
ties and repurposes their potential for new futures. Saving also illuminates Blossom and 
REDEEM’s respective blind spots. Cross-cutting both scientific and Christian ideals about 
“doing good” are forces of race, class, and gender that stratify societies along variegated lines of 
social value and worth. In Chapters 2, 3, and 4, I have brought to the surface topics of inequality 
and injustice that challenge both stem cell and Christian ideals of what is meant by good science 
and good family. In doing so, I encourage champions and critics of each life-saving program to 
evaluate how their redemptive visions for tomorrow align with lived experiences today. 
--- 
Despite REDEEM and Blossom’s respective saving aspirations, each is challenged to 
sustain embryo potential for all donated leftovers. In the next chapter, I examine the valuation 
systems at play that differentially produce “hot commodities” and “special needs” embryos from 
donated IVF remainders. 
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CHAPTER 5 
Sorting: Archiving Embryos for Viable Futures 
 
“Hallelujah, 2PNs!” Wendy announced one afternoon as she flipped through a stack of 
embryology reports in a sun-filled office of Sutter University’s Stem Cell Institute.61 The reports 
accompanied a portable cryopreservation tank filled with donated frozen embryos that arrived at 
the REDEEM Biobank office via FedEx that day. “Those have to go to the bottom of the tank,” 
she said, where they would be immersed safely in liquid nitrogen. “I want to prioritize them.” 
Lucia, who utilizes early stage embryos in an ongoing research project, overheard the 
commotion. “Welcome, 2PNs!” she said as she walked into the office with a smile. After 
reviewing the donation documents confirming receipt of the rare early stage embryos, Wendy 
reached for a pair of blue oven-mitt-looking gloves. They protect her skin from the -196 degree 
liquid nitrogen filling the Biobank and preserving the thousands of embryos it contains. Standing 
atop a footstool with a hooked metal tool in her hand, she reached carefully into the tank’s liquid 
depths in search of a new place for the precious embryos that would serve invaluably in ongoing 
research projects within Sutter University’s thriving Stem Cell Institute. 
In Pacific Christian Adoptions agency, efforts to find homes for valuable frozen embryos 
were also underway. “Yes! Yes! Hallelujah!” Monica exclaimed to the good news Sarah shared 
with the Blossom Embryo Adoption team. A difficult-to-match embryo donated by the Crown 
family had finally been thawed and transferred into adoptive client Marsha’s uterus. Marsha, one 
of Blossom’s first single women adopters, drove five hours in a snowstorm to her fertility clinic 
for her much anticipated chance at pregnancy and first-time motherhood. “We prayed for this,” 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
61	  2PN, or two pronuclear, describes the first developmental stage of a fertilized egg. A 2PN 
embryo typically emerges 18-24 hours after fertilization on the first day of in vitro fertilization. 
Each pronuclei at the 2PN stage comes from the nucleus of the sperm and the egg.	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Monica explained before closing her eyes, saying a private prayer, and whispering to herself: 
“Keep growing, keep growing, keep growing.” The team recalled their tumultuous journey over 
many years trying to find a home for the Crowns’ less desirable, but still precious, embryo. 
“Risa, we saved this embryo.” 
As discussed in Chapters 3 and 4, embryos donated to REDEEM and Blossom contain 
“potencies” (Munn 1986) to become many different things. Once donated, program staff works 
to cultivate opportunities for their future use. Wendy manages the Biobank inventory in 
anticipation of transferring donated treasures to the warmed Petri dishes of researchers like 
Lucia. The Blossom team, on the other hand, works diligently to “find homes” for precious 
orphans by matching donors with adopters like Marsha, who are willing to thaw and transfer 
them into their uteruses.  
Yet in order for such transfers to be possible, Blossom and REDEEM have to sort 
embryos out. At the time of donation, neither organization sets limits for the kinds of embryos 
they will receive, a practice that is uncommon among other embryo donation programs in the 
United States. Dr. Dunn believes the REDEEM Biobank is an honorable method of disposition 
for fertility patients, which informs the staff’s sense that it is disrespectful and impractical to 
limit the kinds of embryos that fertility patients can donate. For the Blossom program, their 
welcoming of any embryo for adoption placement is a core value of the program’s mission to 
acknowledge the personhood of all embryos they regard as equally deserving of a chance to be 
born. As a result, numerous “kinds” of embryos are donated based on information extracted from 
IVF embryology reports. Embryos arrive representing different developmental stages, grades, 
and counts; frozen recently and long ago using different methods; made with egg and sperm 
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donors; commissioned by couples young and old; from donors with communicable diseases, 
etcetera.  
In response to the range of embryos for which the programs work to find a place, each 
developed sorting systems to organize their respective embryo “inventories.” Once sorted, 
circumstances beyond the cryotanks render donated embryos differently viable for particular 
futures. While some embryos become “hot commodities” with streamlined pathways from 
freezer to Petri dish or uterus, other embryos are stuck “waiting.” 
This chapter examines sorting practices as windows into the circumstances that make 
embryos differently viable. I describe the organizing practices within Blossom and REDEEM 
that ready embryos for new futures, the broader contexts for these systems, and some of their 
effects. Like Geoffrey Bowker and Susan Leigh Star, whose work on classification inspired this 
chapter (Bowker and Star 1999), I approach the ordering of things as creative processes, and thus 
pay attention to the ways embryo potentiality is created through them. First, I address the varying 
ways embryos are archived within each program in order to provide another lens through which 
to see how IVF leftovers become renewed treasures. Then I examine the stories of two embryo 
donations whose futures were put on hold due to forces active beyond the tank.  
 
Embryo Inventories 
Each program serves as a coordinating center for facilitating the futures of frozen 
embryos, but they manage their inventories in distinct ways. The following two sections describe 
the ordering systems created within the Blossom program and REDEEM Biobank for finding 
Petri dishes and uteruses for the once unwanted, still un-wastable frozen remains.   
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Blossom’s Adoption Files 
The Blossom program coordinates the matching of embryos between donors and 
recipients and, like contemporary adoption agencies in the United States, do so without 
managing an “orphanage.”62 Despite the faux cryotank they keep stored in the agency conference 
room, they specialize in handling embryos like social workers rather than lab technicians. Rather 
than keep a frozen inventory of adoptable embryos, they keep files—and a lot of them.  
Adoption files were a constant presence during my time in the Blossom program office. I 
regularly squeezed myself between blue and brown files stacked on the table at which I sat most 
days. Much of the daily work for Blossom staff involves creating and managing client files, 
which they use in various ways throughout the day. These hefty blue and brown ethnographic 
objects in my midst came to life in a new way when I was allowed to freely look through them 
starting in September 2011. I familiarized myself with the structure of the files and the amazing 
stories they contained. Such archiving systems are essential to the success of the program as well 
as instructive about how IVF embryos become frozen orphans. The history of their potentialities 
was literally at my fingertips.     
Donor and adopter clients each have a file, and all members of Blossom’s team play a 
role in developing them. Client files are comprised of key documents that begin when a donor or 
adopter applies to the program. Blossom’s program assistant Sarah works with new donors and 
adopters to help them complete their applications in preparation for matching. In 2008, 
application materials were organized on colored paper to help staff stay organized, but by the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
62	  The National Embryo Donation Center is an embryo adoption program based in a fertility 
clinic where they do receive and store frozen embryos awaiting placement with an adoptive 
couple.	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time I returned in 2011 the program shifted to organizing files digitally after making applications 
available online and accepting materials through email. 
While Sarah works with clients, Monica coordinates with their fertility clinics to preempt 
any issues that could disrupt a match. Blossom learned from past problems that matching 
embryos is not simply a matter of finding two couples to agree on each other. Since embryos are 
shipped from one fertility clinic to another, matching also includes making sure that the giving 
and receiving clinics are paired well too. For example, Monica implemented a system for making 
sure that donors with vitrified embryos would not be matched with adopters whose fertility 
clinics were not equipped to thaw embryos frozen by that method.63 Also, all donors are required 
to provide proof of testing for cytomegalovirus (CMV), a virus in the herpes family most 
frequently passed on to babies during pregnancy; adoptive clients need a letter from their doctor 
indicating whether or not they will transfer embryos from donors that are CMV+. Such types of 
information populate client files.      
A completed donor application includes: donor application with extensive medical 
history; donor family profile with a letter, autobiography, and pictures; health authorization 
release forms for obtaining embryology reports from their clinic; FDA risk assessment 
questionnaire; physical evaluation form from within 12 months of applying; copies of egg and/or 
sperm donor profile and consents; and blood work for infectious disease to comply with FDA 
regulations.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
63 Vitrification is a method of storing embryos through a fast-freeze process in which embryos 
achieve a “glass-like” solidification. This procedure reduces the risk of ice crystal formation 
common within slow-freeze methods, which can damage cells, and shows higher rates of cellular 
recovery after thaw. Although Basile Luyet, the father of cryobiology, theorized vitrification 
technology in the 1940s, the technique was not clinically available until 2008. 	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Once donors submit all of the requisite paperwork, Sarah passes their file to the 
program’s social worker, Kathy, who conducts an interview about their matching preferences 
before entering donors into the “matching pool.” In this conversation, Kathy asks donors about 
the preferences they rank on page 4 of the application for qualities they want in adopting parents. 
Donors are asked to number from 1-10 the importance of the following qualities in an adopting 
family, listed in the order it appears in on the application: religion; educational background; 
number of children in the family; prior marriages; length of current marriage; age; works full or 
part-time, or at home; ethnic background; and financial position. The Blossom application also 
asks donors to indicate if they are open to single women adopters, and how much contact they 
desire with the adoptive family: from none to email communication to in-person visits.  
During the pre-matching interview with the donor, Kathy fills out the “Fact Sheet for 
Embryo Placing Family,” which is a one-page summary of donor preferences that condenses 
client information from a dozen application pages to key criteria helpful for matching (See 
Figure 11). She also translates matching details into the program’s digital database for quick 
sorting of the donor pool by characteristics (e.g., Catholic, donor egg, slow-freeze embryos) and 
preferences (e.g., no single mother). Kathy also lets donors know what they can expect during 
the matching phase. She notifies donors by email when the team identifies a potential adoptive 
match, giving them the opportunity to review the profile and the first chance to approve or 
decline the match. If the donor approves, their profile is emailed to the adoptive client for 
consideration; if the donor declines, their file returns to the pool.    
Blossom adoptive clients are similarly required to submit personal materials to activate 
their file, including: adoption application, adoption family profile with a letter, autobiography, 
and pictures; adoption home study by a licensed adoption agency; letter from physician stating  
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Figure 11. Blossom embryo donor fact sheet64  
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
64 Photo by author. 
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no contraindications to pregnancy; signed agreement for adoption services detailing the fee 
schedule; and a $500 check to start the file. In the application, Blossom adopters describe 
matching preferences, including desired levels of contact with donors; the “racial and ethnic 
characteristics” of the gamete donors for the embryos; and whether or not they will accept 
embryos created by use of donor egg or sperm. Once the adoptive client’s file is completed, they 
are notified by phone of their entry into the matching pool, reminded that they will be contacted 
when a donor accepts their profile, and assured that they have the chance to approve or decline 
any proposed match. 
  
Matching Embryo Donors and Adopters 
 “Matching” is an old sorting practice within American adoption premised on finding a 
“good fit” for a child by assuming that his or her “best interest” involves placement in a family 
with similar racial, ethnic, and religious identities (Modell and Dambacher 1997). Matching 
practices maintain a biologically deterministic view that families need to be paired with 
phenotypically similar children to maintain the semblance of a naturally formed family unit. 
While racial matching ended within U.S. public adoption in the 1970s—with the exception of 
placing black children with black families that continues—matching still operates within 
international and private forms of adoption (Gailey 2009). Ethno-racial sorting is also active 
within the fertility industry. U.S. egg agencies recruit egg donors to meet client desires to 
resemble their donor-conceived children (Almeling 2007). The growing demand by white 
American fertility patients for affordable egg donors from Eastern Europe exemplifies these 
sorting trends in third-party reproduction (Bergmann 2011). As a “bridge” between traditional 
adoption and assisted reproduction, embryo adoption also sorts things out through matching 
practices designed to find homes for orphan embryos.  
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“Matching” within the Blossom program is a general term to describe their process for 
evaluating if donor and adopter families are suitably fit. Blossom staff explains that matches are 
based on three main factors: program rules, client preferences, and “a little bit of God.” Program 
rules established by the agency proscribe which types of clients end up in their piles. At the 
beginning of my field research in 2008, Blossom required that all adopters be heterosexually 
married for three years, plan to raise their children in a spiritual home, and, for the adoptive 
woman, be able to carry a pregnancy. During my last year with Blossom, program rules had 
shifted; they began placing embryos with single women as well as adopters who planned to use 
surrogates.  
During my last visits in 2013, I sensed tension between Blossom staff and Pacific agency 
leadership around the topic of placing embryos with gay and lesbian adopters. Increasing 
numbers of Blossom donors expressed openness to placing with queer clients, or who were gay 
or lesbian themselves. Although Blossom staff was open to matching embryos with gay and 
lesbian couples, Thomas’s response to my question about the idea was that Pacific adheres to 
Biblical principles that are not open to interpretation around homosexuality. Tim answered with 
respect to business; he explained that Pacific “decided on our niche” for addressing the orphan 
embryo crisis, and that placing with gay and lesbian couples “is not who we are… If I thought it 
would triple the numbers of babies being born, you know I’d have to rethink it, but that isn’t the 
case.” Pacific’s institutional policies, flexible in some regards and entrenched in others, are part 
of the broader rescuing infrastructure involved in sorting donors and adopters out.  
 Matches are also driven by client preferences. According to an embryo donor brochure, 
“safety and security” and “peace of mind” are benefits for donors being able to select which 
families adopt their embryos. Blossom encourages open adoptions, which means adopters benefit 
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from being able to turn down a match without penalty as well as to receive information about 
donors that is often not available within anonymous donation programs, like contact information. 
Staff compiles matching preferences from client applications and interviews onto cheat sheets 
and spreadsheets to make matching sessions more efficient. Oftentimes during matching 
sessions, staff refers to other items within the client files, like autobiographies, home studies, and 
photos, to help “get a feeling” about a possible match or to break a tie. Similar to Ken’s grading 
and ranking practices within Harrington’s IVF lab, Blossom clients make ranking and grading 
observations about their wishes for a match, which staff reconfigures into their own 
classificatory systems for narrowing down families who could help give embryos their chance to 
be born.  
Lastly, Blossom staff reminded me on many occasions that matching is a process aided 
by God. For this reason, they are known to begin matching sessions with a prayer. “Dear God,” 
Monica began one morning in 2008, 
Thank you for this beautiful day and for bringing us all here safely today and for putting 
desire in our hearts to do your work to find homes for these embryos. We thank you for 
the parents you’ve brought to this program who desire to give life. We pray that you put 
peace into their hearts for the matches that are going to be made and, God, that you be in 
control of bringing these embryos, these children, home to the parents they are meant to 
have. We pray that you will give them life and fulfill the desire of these parents’ hearts. 
In Jesus’s name, Amen. 
 
Although Blossom staff considers program rules, client preferences, and God to be the 
main drivers of matching, the matcher’s role in forging connections between donors and adopters 
is vital—much like the embryologist’s role in producing IVF embryo potential discussed in 
Chapter 2. For instance, I noticed on a few occasions that Kathy broke a tie between two or three 
possible matches for an adoptive client by selecting the donor whose embryos had been in the 
program the longest. Blossom does not have a policy for matching based on a “first come, first 
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serve” basis or length of time in the program, though Kathy’s matching decisions show a 
preference for moving old files toward contracts. She learned through experience that finding 
homes for all embryos becomes more challenging the “older” frozen embryos are, and therefore 
makes matches today in hopes of preventing future struggles tomorrow.  
As in traditional adoption and third-party reproduction, the racial and ethnic makeup of 
Blossom clients figures centrally within matching decisions. I discussed in Chapter 4 that most 
embryos in the Blossom program are racialized as white; this occurs discursively through visual 
representations of white people and children in program materials as well as by highlighting 
“multi-ethnic” embryos in ways that mark all other embryos as white. On the adopter 
application, clients are asked to describe three “Preferences Regarding Embryo,” including 
“which racial/ethnic characteristics you prefer in a genetic family (indicate ½ or ¼ where a mix 
is acceptable).” The application provides seven options: Any race or combination, Asian, Black, 
Caucasian, Hispanic, Middle Eastern, and Native American. Most Blossom adoptive clients 
mark a preference for Caucasian embryos, though I discovered in matching sessions that this 
category was not always agreed upon among staff. How Blossom staff decides which donors are 
and are not white illuminates one of many sorting practices within the Blossom program that 
facilitates and hinders the movement of embryos from frozen orphanages to warm uteruses.     
Monica and Vera, an early Blossom program assistant, came to different conclusions 
about whether the Whittakers were “Caucasian.” When the Whittakers applied to place their five 
embryos for adoption, they completed a medical history that begins with a “Physical 
Description” of the embryos’ genetic mother, father, and both sets of genetic grandparents. The 
Whittakers filled out a table with spaces for self-described information about each person’s 
ethnicity, religion, age, height, weight, eye color, hair color, and skin color. At the beginning of 
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the matching session, the Whittakers seemed like a good match for a new adoptive client based 
on compatible age preferences, number of embryos, and faith, but Monica decided to look more 
closely at the Whittakers’ application to be sure.  
When Monica came upon their “physical description,” she sought Vera’s help. “Ethnicity 
of embryos—Colombian and Anglo,” she read aloud. “Is that not Caucasian?” Vera was quick to 
clarify her view that “Colombian is not Caucasian.” Monica flipped to a page of the Whittakers’ 
file with pictures of their children, and said, “Well these babies look dang white to me.” Vera 
responded, “Well so does my brother-in-law, and he’s Cuban.” She chuckled and said, “He’s 
fairer than you are and has green eyes.” Monica flipped through other pictures. “Look at this 
little boy,” she said as she lifted the image for Vera to see. “Oh, I guess his hair’s beginning to 
turn brown. Uh-oh.” They both laughed. “Uh-oh. Not Caucasian enough.” Still looking at the 
donor profile, Monica replied with confusion “Well, I don’t understand. Mommy and the 
twins… Anglo and Colombian.” Vera said again, hoping it would sink in: “Not Caucasian.” 
Monica’s confusion over the Whittakers’ whiteness came to mind months later during 
another matching session involving the Figueiroas. This self-described “Portuguese-Caucasian” 
donor couple was being considered as a possible match for the Carrolls until Shannon, a Blossom 
intern, remembered that the Carrolls preferred Caucasian embryos. I asked why the Figueiroas 
were not considered Caucasian, which prompted Kathy to show me pictures of the Figueroa 
family compared to the Carrolls, the latter whom she described as “a normal looking white 
family.” “They look tan,” Shannon said about the Figueiroas, then reflected that she is not sure if 
the Carrolls would want her embryos either because of her mixed heritage with a Caucasian 
mother and Guatemalan father. Rather than ask the Figueiroas to clarify if they identify as 
“Caucasian,” Kathy decided to email the Carrolls to see if they were “open” to embryos from 
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“Portuguese-Caucasian” donors. Although the Carrolls were not interested in the Figueiroas’ 
embryos, Blossom staff decided to include the Figueiroas in future matching sessions for 
Caucasian embryos, rather than leave them out of the pool as “multi-ethnic.” As a result, the 
Figueiroas’ embryos were successfully matched with an adoptive couple seeking Caucasian 
embryos a few weeks later.   
 Disagreements, confusion, and decisions among Blossom matchers about categories like 
Caucasian are generative moments for understanding the intersecting social forces, institutional 
infrastructures, and individual worldviews that impact the viability of embryos’ futures. 
Matching practices in embryo adoption reveal the instability of sorting categories and highlight 
the fundamentally creative process of sorting things out.  
  
--- 
When matches are made, the donor file is merged into the adoptive client file and 
together they enter the next phase of contracts, followed by shipping. Each completed adoption 
file includes a contract that donors and adopters sign and notarize. The Blossom “Embryo 
Adoption Agreement” does not formalize the transfer of parental rights that is characteristic of 
adoption, but enacts the legal relinquishment and transfer of property between giving and 
receiving parties. The eleven-page contract was initially drafted by Tim, a lawyer by training, 
and has been refined periodically over the years. Client files also contain FedEx shipping records 
noting the pickup and delivery dates of embryos from donating to adopting client clinics; copies 
of significant email correspondence with Blossom staff; and pages of “Baby Steps,” which are 
handwritten notes tracking the various behind-the-scenes activities of staff that move each phase 
of the adoption process along.  
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The archive of embryo giver and receiver files that Blossom staff works with is organized 
primarily by a workflow that converts IVF extras to adoptable orphans. Sarah created a 
corkboard with the pictures of unmatched donors and adopters to help personalize the people for 
whom she works (See Figure 12). Once Monica gathers the information she needs from a clinic, 
she moves the file stacked on her desk to the matching table extending into the middle of the 
room where I sat. Problem files that troubled the whole team live in a drawer next to Kathy’s 
desk. Completed adoptions with embryos shipped are stored in sequential order from 001-919 
(the latter number was the newest file opened when I left the field) in large gray metal filing 
cabinets lining the walls outside the program office (See Figure 13). Closed files that did not 
result in pregnancy, as well as incomplete files of people dropping out of the program, are 
numbered and stored in paper boxes in a storage room alongside other documents that adoption 
agencies are legally required to keep.  
 
Figure 12. Active Blossom donor and adopter organization board65 
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Figure 13. Drawer of completed Blossom Adoption files66 
 
 
REDEEM Biobank’s Archives 
REDEEM Biobank staff maintains three main archives. A paper archive organizes 
donation consent forms into groups according to their different stages of development: in 
process; needing correction; in line for shipping; and in storage at Sutter University. The 
Biobank itself, the large stainless steel tank chained to the wall in Wendy’s office, is the physical 
archive of frozen embryos donated from patients all over the country. Lastly, an Excel 
spreadsheet digitally archives data from the received embryology reports as well as the Biobank 
“coordinates” that record where to locate the embryos in the Biobank.  
During Spring 2013, I assisted with inventorying the materials to make sure all three of 
the archives align. This was a hefty task, and unfinished by the time I left Sutter University in 
April. We started with the “A” files in the paper archive by reviewing donation consent forms 
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and embryology reports to make sure that information from them recorded in the electronic 
database is accurate. Specific information from embryology reports tracked in the database 
includes: patient’s clinic; female and male date of birth; embryo freeze date; number of embryos; 
embryo stage; use of egg and/or sperm donor; storage number on the frozen straw associated 
with the fertility clinic’s storage system. Information logged from the donation consent forms 
includes: approval for Class 1 (human development), Class 2 (stem cell derivation), or both 
classes of research; and approval for being contacted with genetic information or to give 
additional health information in the future.     
As a result of staff turnover and a series of multiple intern-coordinators, the database had 
significant holes. The goal of inventorying was to resolve the problem areas and start from as 
clean as slate as possible. Donna was hired as the Biobank coordinator to do exactly this, though 
she was only allocated a part-time position initially that, months later, was increased to .8 of a 
full-time appointment. Dr. Dunn, Dr. Moto, Wendy, and others have varying opinions about how 
many hours it should take to manage the Biobank each week. Those not working regularly with 
the files and clients presume that an efficient, part-time staffer can do the job. Donna and the two 
embryologists from Sutter’s IVF clinic tasked with helping her for a few months suggest 
otherwise. They conveyed stories discussed in Chapter 3 of struggling through logistical hiccups 
and unforeseen roadblocks. Having witnessed their challenges, experienced some of them 
myself, and known about the three-person team at work in the Blossom program, I felt sympathy 
for Donna and the coordinating task before her. By the time I left Sutter in April 2013, we had 
only made it through the “G” files in the paper archive; a year later, the inventory remained 
incomplete.   
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REDEEM’s physical embryo inventory is stored in a large cryopreservation bank in Dr. 
Moto’s lab. The inside of the tank is organized by seven pie-shaped quadrants: three in the top 
half of the tank, four in the bottom half. Each quadrant fits 14 boxes that are color coded and 
numbered (e.g., Upper Blue 10, Lower Red 7). Within each numbered box, up to 16 canes can be 
stored. Canes are long aluminum rods topped with a numbered tab and encased in a narrow 
plastic sheath. They are designed to hold an average of 3-5 straws or vials, inside of which 1-3 
embryos are frozen in each. Upon arrival at the Biobank, the tab at the top of a cane of donated 
embryos corresponds with the patient whose leftovers are stored. These tabs, marked according 
to the organizing system from a particular fertility clinic, are de-identified and replaced with 
neutral numbers 1-14 prior to storage in the tank. Patients with numerous embryos stored after 
IVF often have multiple canes. The Biobank has room for a lot of donated embryos: one full box 
can contain 240 frozen embryos, a full quadrant can contain 3360 embryos, and a full tank can 
hold over 23,000 embryos. (See Figure 14)  
The issue of greatest concern to Wendy and Caitlin while I was on site was the Biobank’s 
near full capacity and how to better organize the embryos according to “preciousness.” As 
described in this chapter’s opening vignette, Wendy and Caitlin periodically move boxes of Day 
6 blastocysts from the bottom quadrants, where materials are immersed in liquid nitrogen, to top 
racks surrounded by cold vapor. Their logic is to make room at the bottom for the most valuable 
of the donated embryos: Day 1 2PNs. Dr. Dunn thinks this is wasted effort based on an 
unnecessary worry about the safety of the embryos. Whether they are in liquid nitrogen or vapor, 
she conveyed that cryopreservation tanks are designed for all embryos to be equally safe. 
Embryo preciousness at REDEEM Biobank is determined primarily by research 
priorities. The story of Angela Stoll’s donation to the Biobank later in this chapter explains why  
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Figure 14. Inside the Biobank67 
 
some embryos, like 2PNs, are regarded as “hot commodities” in Dr. Moto’s lab while others, like 
blastocysts, are in abundant supply but not demand. 
During the same period that I assisted Biobank staff with the paper and digital archive, 
Wendy asked me to help with the Biobank’s physical inventory. The goal was to make sure that 
the coordinates in the physical archive matched the ones logged in the database. In Chapter 3, I 
described a time when Caitlin requested embryos for an experiment, thawed them, and found out 
that they were the wrong stage. This kind of mistake can occur at many points: wrongly stored 
embryos, incorrectly logged coordinates in the database, or wrongly pulled embryos right before 
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an experiment. Such incidents, in conjunction with the holes in the database, hinted at problems 
with the physical inventory that needed repair.  
For a few afternoons a week over multiple weeks I helped Wendy inventory the Biobank. 
I stationed myself at the desk across from the Biobank with the laptop and database opened; 
Wendy put on the blue protective gloves and wielded the hook for grabbing boxes (See Figure 
15). We started in a chosen quadrant by pulling Box 1 out of the bank and submerging it in a 
temporary liquid nitrogen bath in a Styrofoam box on the floor. Within each box we worked 
through each numbered cane, up to fourteen. Wendy called out the storage numbers on the 
frozen straws within each cane, which I searched for in the database and updated to make sure 
the digital coordinates corresponded with the physical location of the donated embryos. Many 
entries in the database did not have coordinates, leaving the promising embryos in the cool 
depths without any referent for finding them.  
Once embryos are in the Biobank, researchers are able to request them for use in 
experiments through a simple process. Dr. Moto first approves the use of embryo materials that 
the researcher then requests directly from Donna in an email indicating developmental stage of 
embryos, number of embryos needed, and class of research. Sometimes researchers include other 
criteria, such as Lucia’s request for embryos from younger donors or egg donors. Donna uses the 
criteria to sort the database according to the request criteria. Once she identifies one or multiple 
batches of embryos that meet the researcher’s needs, Donna forwards the physical coordinates to 
Caitlin, who collaborates with the researcher to schedule the experiment. On the day of the 
experiment, Caitlin retrieves the embryos located at the coordinates she is given, plunges them 
into a mobile box with liquid nitrogen, and walks across the hallway to the “embryo room” 
where she begins the embryo thaw process (See Figure 16). Embryo freezing protocols are not 
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uniform across fertility clinics, so Caitlin uses a generic method corresponding to whether the 
sample was stored via a slow-freeze or vitrification technique. 
 
Figure 15. Inventorying the Biobank68 
 
Figure 16. Embryo research room69 
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--- 
Inventorying embryos, whether within Blossom adoption files or REDEEM cryotank 
quadrants, involves sorting. Each program categorizes, gathers, and organizes information they 
consider pertinent to the embryo futures that they strive to realize. In doing so, their archival 
systems and flows show how new embryo potentialities are made, and the files and databases are 
“paper trails” of such processes.  
Classificatory systems are also windows into the organizations that develop them. 
Bowker and Star argue that categories are thoroughly steeped in the contexts within which they 
are found; they are “tied to the things that people do; to the worlds to which they belong” 
(Bowker and Star 283). I showed in Chapter 2 how embryos at the end of IVF are sorted into 
three main groups—transferable, savable, and discardable—based on the IVF goal of producing 
a “take home baby.” The goals of the embryo donation programs similarly infuse their mission 
into their sorting systems. Within the Blossom program, donor and adopter preferences for the 
kind of people and embryos they want to be matched with inform how Blossom staff develop 
aids, like the client applications and donor “Fact Sheet,” to help them find suitable homes for 
adoptable embryos. Similarly, REDEEM’s database reflects the political climate around human 
embryo research that translates into strict ethical protocols for consenting and experimentation. 
As a result, the embryo archives are divided into three types of embryos based on how they can 
be used in Petri dishes: Class 1 for non-stem cell human development research, Class 2 for stem 
cell research, or both. Whether embryos are filed away as precious person or precious 2PN, the 
categories that give meaning and movement to the activities within these programs are neither 
neutral nor abstract. Rather, they arise from work practices that make up their every ordering of 
these frozen things.   
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Sorting embryos out in the Blossom program and REDEEM Biobank involves interfacing 
with a kind of document discussed previously: embryology reports, those artifacts of clinical IVF 
processes introduced in Chapter 2. Embryology reports at Harrington Fertility are artifacts of the 
production IVF embryo potential through documentary practices, like grading. In the hands of 
embryo donation program staff, embryology reports are better understood as “boundary objects.” 
This concept was originally developed to make sense of the different interpretations and uses of 
dead birds in a museum. Susan Leigh Star and James Griesemer noticed that amateur 
birdwatchers and biologists impart different meanings and find various uses for “the same bird” 
in a natural museum archive (Star and Griesemer 1999). Boundary objects describe things that 
are flexible and robust, “inhabit[ing] several communities of practice and satisfy[ing] the 
informational requirements of each” (Bowker and Star 1999: 297). As the stories in the 
following section suggests, categories on embryology reports, like “blastocyst” and “2PN,” have 
afterlives beyond the IVF lab with constitutive effects on the viability of remainder embryos. 
Embryology reports, as I argued in Chapter 2, are artifacts of broader apparatuses that “culture” 
embryo potentials. The factors of interest in this chapter are those that render un-wastable 
remainders differently viable.  
 
Embryos Out of Sorts 
Unlike fertility clinics and long-term cryostorage facilities that are designed to save for 
near and distant futures, Blossom and REDEEM are in the redemption business; each endeavors 
to put frozen matter back in place, to use Douglas’s phrase, by finding people with uteruses and 
Petri dishes willing to receive them. In their respective ways, Blossom and REDEEM provide 
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avenues for transferring embryos from a remaindered to a repurposed state, from suspended 
potential into actualized value.  
Despite each program’s best-laid plans, problems arise when donated embryos 
accumulate in their respective “storehouses” with no place to go. Embryos unable to be matched 
with willing recipients challenge the goals of these saving programs trying to find new places for 
embryos after IVF. They also provoke important questions about the making of potentiality 
explored at length in this dissertation, namely what happens to the promise of the doubly 
unwanted embryos. In the following sections, I tell the stories of two donated embryos that 
became so-called problem cases: one placed for adoption through the Blossom program and one 
donated for research to REDEEM Biobank. Through them, I develop the notion of 
circumstantial viability, a concept that puts into relief conditions external to embryos that impact 
their possibilities for repurposement.  
 
The Bower Embryo 
“Dear Future Mom and Dad,” begins the introductory letter of the Blossom Embryo 
Adoption application packet. Answers to common questions about embryo adoption—from 
eligibility requirements to agency fees to statistical chances for pregnancy—are outlined in the 
twenty-nine pages that follow. “We know you’ve come through a lot to get to this day,” the letter 
continues. “The journey might have been frustrating, sorrowful, and intimidating. Maybe you’re 
not sure if this is the right adoption choice for you.” For lingering questions, applicants are 
encouraged to contact Monica, the Blossom program’s friendly manager. It is her job, the 
signatory explains, to “work diligently on our behalf.” The letter is signed: “Sincerely Yours, 
The Waiting Embryos.”   
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Waiting is a word common within international adoption efforts that seek to find homes 
for orphaned children. As analyzed in Chapter 4, international adoption programs often justify 
their mission to rescue children “waiting” for homes based on the humanitarian imperative to 
relieve human suffering. As such, waiting is a framework that helps to position orphaned 
children as legitimately deserving of care and resources (Briggs 2003). Waiting is not a neutral 
term for the Blossom program; it draws parallels between embryos and orphans, and is used 
intentionally and often to further their mission of revaluing life through the attribution of 
personhood to frozen IVF remains.  
The Blossom program advocates for treating all frozen embryos as awaiting a particular 
future, specifically the chance to be born, though within their program some wait longer than 
others. In Fall 2012 I received an email soliciting interest in one of the Blossom program’s 
“special circumstances” embryos. “Dear Risa, Are you ready to take a leap of faith? There is a 
single embryo waiting for its chance at life. Here is its story…” The email detailed Dennis and 
Jolene Bower’s journey with infertility and their desire to find a willing recipient for their single 
remaining embryo. The Bower story shows how frozen embryo viability hinges on factors 
beyond the cryotank that present obstacles to Blossom’s effort to find home in willing recipients’ 
uteruses. 
After several years of trying to become pregnant, Dennis and Jolene turned to IVF in 
1998 for assistance. By year’s end, they had given birth to one son and were paying storage for 
seventeen extra embryos. Nine years later, the Bowers decided they were done having children 
but wanted to help another become a parent. They completed the Blossom program application 
and ranked their top ten preferences for an adoptive family. They desired a religiously moderate, 
Caucasian, middle-to-upper class family that would be “college minded” for any resulting 
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children. They also preferred a stay-at-home parent but would accept adopters employed full or 
part-time. An ideal family would have no prior marriages and would be parenting fewer than 
three kids. The ideal adoptive family mirrored the Bowers almost exactly. With respect to 
contact with the adoptive family, the Bowers requested photos and letters at least once a year 
about any children born and were open to phone calls, emails, and visitations if the adoptive 
family would be too. 
Within months of applying to the Blossom program in 2007, the Bowers chose the 
Daniels to receive their entire batch of seventeen embryos. Once contracts transferring the legal 
ownership of the embryos were signed and notarized, FedEx delivered the embryos to the 
Daniels’ clinic, where they went quickly to work thawing and transferring embryos. The Daniels 
felt their family complete after giving birth to their only child. They had used five adopted 
embryos, so decided to “return” the remaining twelve embryos to the Bowers, in effect 
relinquishing their rights as the adoptive clients and new embryo owners. The Daniels continued 
to pay for storage of the embryos at their clinic while the Bowers reviewed adoptive family 
profiles in search of another match.  
By early 2008, the Bowers selected the Millers to be the second family to adopt their 
remaining twelve embryos. In the required adoption profile letter accompanying the Millers’ 
application, they explained how they felt when they first learned about embryo adoption: “The 
idea that we could share a pregnancy or childbirth was an idea that we had long given up. To 
think that we could have that together is priceless! We are ready to give birth to twins or triplets. 
We have the room in our house and our hearts, and if that is what we are blessed with, we 
believe that God will give us the energy and patience too.”  
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Despite their ready home and hearts, the Millers’ prayers to become parents were not 
answered. They thawed and transferred eleven embryos without ever becoming pregnant. At the 
end of the year, the Millers wrote to the Blossom program expressing their palpable grief and 
decision to be done:  
Unfortunately, we got the news yesterday that, once again, we are not pregnant. We were 
better prepared for that possibility this time. But, it doesn’t hurt any less. The hardest part 
is that we are finished. We are financially strapped, emotionally worn out, and just plain 
tired of this battle to become parents. Somehow, this is God’s plan for our lives… I have 
spent so many years dreaming of being a Mommy, I don’t know what else to dream. 
 
Monica expressed surprise at the Millers’ decision. She shared with me why:  
It was very sad to talk with [Ms. Miller] and hear her words which were full of ‘Why 
me?’ and ‘This isn't what I would choose.’ I found myself thinking that she didn’t have to 
stay this way. She had other options. She had another embryo, for goodness sakes! I don’t 
know why she felt she was just not meant to have children and she ‘couldn’t continue.’ I 
don't know. Hardly anyone who joins Blossom shares with me that they are just not 
meant to become parents. Usually they get pregnant with Blossom or they move on to 
other means. 
 
After adoption by two families, the Bowers’ original group of seventeen embryos had 
become a batch of one, and the Millers were done trying to become pregnant. Even though they 
were grieving the end of their embryo adoption journey, the Millers agreed—like the Daniels 
previous to them—to follow through on their commitment to pay storage for the “returned” 
embryo until it could be re-matched: “Of course we can store the little guy until you find a place 
for him,” the Millers assured in an email to Blossom staff. “We continue to try to tell people 
about you guys. We have nothing but positive things to say about our experience even though it 
didn't work out for us.”  
Finding a place for the single Bower embryo proved difficult and slow. The original 
seventeen embryos matched within months, but as the batch reduced in number and the freeze 
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date grew more distant, the single Bower embryo’s “special circumstances” became more 
pronounced. According to the embryology report, the remaining embryo was frozen in 1998 
using a slow-freeze method at Day 1 of development, or at the two pro-nuclear (2PN) stage. 
According to Ken and Zhao at Harrington Fertility, this is not a “slam dunk” embryo but one 
with questionable potential to establish pregnancy. Coupled with its solo status, the Bower 
embryo was rejected numerous times by potential adopters uninterested in the low-graded 
embryo.  
When a possible adoptive family applied to the Blossom program in 2011, Kathy 
contacted the Millers’ fertility clinic where the embryo was stored for an updated embryology 
report. She was surprised to learn from the clinic that in the span of a few years, the Millers had 
divorced, moved out of state, and left an unpaid $1500 storage bill for the Bower embryo. 
According to the fertility clinic, the Millers retained legal and financial rights and responsibilities 
as the intended parents that brought the donated embryo into their clinic for use. Before the clinic 
would agree to ship the embryo to another adoptive family, the bill needed payment and the 
Millers needed to sign paperwork approving its release for shipment. Unless Blossom staff could 
surmount these obstacles, the Bower embryo would wait indefinitely in legal, financial, and 
frozen limbo.  
Blossom staff consulted with Tim and came up with a plan: the Blossom program would 
pay the storage fee of $1500 to release the embryo for relocation to a long-term storage facility 
where Blossom was prepared to assume legal and financial responsibility as the storage account 
holders, if the Millers were not willing to, until the embryo could be matched with its “forever 
family.” Assuming such financial and legal burdens is atypical for the Blossom program, but 
from my field research observations, is also not unique. “Since the embryo was already in the 
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program,” Sarah explained, “we assumed responsibility. There were seventeen embryos to begin 
with. We don’t want to give up on one.”  
Overcoming the second obstacle depended on the cooperation of the Millers. Locating 
and convincing them to help was one challenge; obtaining signatures from a divorced couple on 
the clinic release forms posed another. Sarah vented to me one afternoon over the fax machine: 
“It is so frustrating because they are the adoptive family. They didn’t transfer the embryo and 
they are refusing to pay their storage fees. And now they’re not getting around to sign a simple 
form.” Kathy surmised that the Millers’ behavior might be because they do not consider the 
Bower embryo to be “theirs,” or to belong to them.  
In an effort to leave no stone unturned, Monica reached out to the first adoptive family—
the Daniels—to see if they were interested. They had a son who would be the genetic sibling to 
this embryo. When first asked, they did not initially say no. What they said was: “That’s a lot for 
one embryo.” Julie Daniel was not concerned about the singularity of the Bower embryo, or its 
stage. “Oh, that’s fine,” she told Monica. “All of my embryos were two cells.” The Daniels 
ultimately declined the offer, even though Blossom offered some concessions: they would not 
have to update their home study or pay an adoption fee. Monica had also reached out to a 
reproductive endocrinologist in the area that had a relationship with Blossom to ask if he would 
do the transfer for free. The process for Julie still involved too much to go forward. As Blossom 
staff worked diligently to maneuver the ever-changing circumstances that halt, slow, and ensnare 
the waiting Bower embryo’s chance to be born, they felt the pressure and frustrations of time. 
Time, though, was something alleged to be on the side of frozen embryos. When stored at 
-196 degrees Celsius, one embryologist explained to me: “You can keep them in there for the 
next twenty years, and nothing is going to happen.” But Blossom staff know from experience 
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that time does not stand still for waiting embryos. As the clock ticks outside the freezer, the 
viability of the leftovers suspended within is subject to countless factors that cause frozen 
embryos to “age,” as one said, and bear the social marks of time. The viability of the Bower 
embryo for adoption, like all donated embryos, is shaped by many variables beyond the 
cryotank. For instance, it remained unused by two adoptive families and abandoned in the wake 
of divorce. The Bower embryo’s chance to find a home was impacted by changing laws, political 
climates, clinical best practices, personal financial circumstances, fertility histories of potential 
adopters, etc. Cryopreservation might pause the effects of time at the cellular level, but frozen 
embryos are actively subject to forces and factors beyond the cryopreservation tank that render 
them circumstantially viable.  
The Blossom team expressed “very little hope that the [Bower] embryo will result in a 
pregnancy,” yet they invested time, energy, resources, and prayers into finding a place for it. 
After nearly a year of effort, Blossom received and forwarded all of the corresponding 
paperwork to release the Bower embryo from the Millers’ clinic. With the bill paid and forms 
signed, it was shipped from the Millers’ clinic to a long-term storage facility, “proving,” in 
Sarah’s view, “that miracles do happen.” Monica was so personally overjoyed with her staff’s 
efforts that her husband sent the team a “Hallelujah!” congratulations card that was displayed in 
the Blossom office. One week after the Bower embryo arrived to the new storage facility, 
Monica drafted the email sent to all prospective adopters advertising the readiness of this single 
embryo, waiting expectantly for its chance to be born. Who among them would be ready to take 
a leap of faith? 
Despite, or perhaps because of, the Bower embryo’s readiness for adoption, the embryo 
faced a different problem once it arrived at the storage facility. To whom did this embryo 
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belong? On paper, the storage facility legally recognized the Millers as the storing clients; 
meanwhile, Blossom paid the storage bill and the Bowers had the ultimate authority to decide 
when, where, and to whom their remaining embryo may be adopted. Without a clear steward, 
owner, parent, payer, or categorical place for understanding how frozen embryos relate to their 
many handlers, the Bower embryo—like all left over frozen embryos—defied easy 
categorization. As Blossom seeks to “place” frozen embryos with adoptive families, embryos 
like the Bowers’ provoke fundamental questions about belonging. Where do frozen embryos 
belong—materially, culturally, categorically?  
The Bower embryo, like all frozen embryos, lingers in anticipation as an unwanted yet 
un-wastable reproductive remainder. It waits, according to the Blossom program, like an 
orphaned child in need of a forever family. When corresponding with Sarah during a periodic 
phone date in November 2013, I asked for an update about the Bower embryo. With a sigh, she 
said: “We still own that sucker,” then clarified that she did not mean ownership but something 
like the feeling of responsibility to help it find a home. “I think everyone wishes the ‘difficult 
cases’ were on their way. I mean it gets so hairy with some of these cases.”  
The Bower story illustrates how embryos wait for many reasons beyond the potentialities 
presumed to inhere in them. They exist in frozen and categorical limbo, yet are touched by forces 
that span the gamut of legal, financial, relational, emotional, geographic, and clinical 
circumstance. Blossom’s sorting practices, informed by their moral obligations to find a home 
for this hard-to-match embryo, are chief among them. Circumstantial viability is not unique to 
the frozen unborn placed for adoption, but is also a common occurrence among embryos donated 
for scientific research. Angela Stoll’s donation to REDEEM reveals similar obstacles to fostering 
viable futures for leftover embryos. 
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The Stoll Embryo 
One embryo remained at the end of a series of unsuccessful IVF cycles for Angela Stoll. 
At the age of forty-two, she was motivated to start a fresh IVF cycle, and soon. Her fertility 
clinic would not begin a new IVF cycle for her until she decided what do to with the one frozen 
embryo in storage that she did not plan to use. Discarding the remaining embryo would have 
been the quickest and least expensive option, but she decided to donate it for research. Angela’s 
donation involved a logistically intensive coordination effort, significant expense to her, and an 
indeterminate future for her leftover embryo.  
Angela called REDEEM Biobank directly and reached Donna, who explained to her the 
process for donation. REDEEM follows inquiries like Angela’s by emailing an introductory 
letter, six-page informed consent form, and voluntary health questionnaire. Once patients review 
the materials at home and decided to donate, they mark their preferences for how researchers 
may use their embryos, sign the donation forms in the presence of a witness, and return the 
paperwork to REDEEM for review and final consenting over the phone. REDEEM considers 
embryo donations “complete” when patients submit their consent forms free of error to the 
Biobank office at Sutter University. The “completion” of donation for fertility patients marks the 
first step of many for REDEEM. With a consent for donation form on file, Donna then 
orchestrates the retrieval of the embryos from IVF clinics. Once they arrive to the Biobank, she 
prepares them through de-identification processes to anonymize the materials for use by research 
scientists. In practice, the process is rarely so streamlined. As a result of strict institutional 
protocols discussed in Chapter 3, which require the highest ethical standards and legal safeguards 
within the political pro-cure climate of human embryo research, the donation of left over, 
precious embryos is sometimes stalled.    
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Time was of the essence for Angela, and she could not afford a slow, bumpy donation 
process. She asked Donna for help and together they tackled the donation forms at Angela’s 
fertility clinic and the REDEEM Biobank with uncommon precision. Within a week’s time, 
Angela’s completed consent materials were in Donna’s hands, followed soon after by a “Thank 
You” card expressing Angela’s gratitude for the quick turnaround.  
Before she could move forward with her much anticipated next IVF cycle, Angela faced 
an additional hurdle. Her fertility clinic informed her that they would continue charging her for 
storing the embryo still at her clinic and would not cease until the Biobank physically retrieved 
the embryo. Fertility clinics that manage frozen embryo inventories assume all of the legal and 
financial liabilities that responsibility entails. As a result, many clinics consider embryo 
donations to be complete not merely when Biobank paperwork is signed but when embryos are 
physically removed from cryotanks. As REDEEM builds relationships with fertility clinics 
around the United States, they explain that it will likely take the Biobank a few months from the 
time a patient submits her donation consent forms to when her embryos will be fetched from the 
clinic because of shipping costs. It is more economical for REDEEM to send a $200 portable 
shipping container via FedEx to a clinic when there are enough embryos to fill it rather than 
sending a tank for each individual donor. In order to relieve patients of any financial burdens for 
donating their embryos, REDEEM asks clinics to discontinue charging patients cryostorage 
when they complete the Biobank paperwork rather than continue billing until when embryos 
physically left the clinic freezer. REDEEM also lets patients know that their embryos will be on 
hold for a period of time. The introductory letter to prospective donors explains: “We do not pick 
up materials when the consent process is completed, but wait until there are sufficient donations 
at one site to send a portable liquid nitrogen tank.” 
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Upon hearing the news about Angela’s storage bill, Dr. Dunn expressed frustration. She 
vented in a Biobank staff meeting: “To keep the patient’s one embryo is costing them nothing…I 
know they run a business but the patient has already paid them $25,000 and they want to 
continue charging her?” To avoid the expense of another year’s cryostorage bill, Angela decided 
to take matters into her own hands. She commissioned a private reproductive tissue shipping 
company to transport her single embryo across the country from her home clinic to REDEEM 
Biobank. Donna was touched by Angela’s determination, and was curious how much her 
donation to REDEEM Biobank cost her. This was the first time the Biobank had a donor willing 
to pay the shipping costs associated with donation.  
Prior to embryos arriving to REDEEM, staff do not know what kinds of materials they 
are receiving, which means that every tank is greeted with some level of anticipation. Because 
REDEEM accepts all embryos for donation, the range of possibility is wide: from Day 1 2PN 
stage embryos to Day 6 hatching blastocysts, in batches of any number, frozen using any variety 
of method, and made using the sperm and eggs of the intended parents or gamete donors. When 
Angela’s embryo arrived with a shipping receipt of $500, Donna and Wendy were shocked and 
even more interested to learn what kind of embryo she had given them. They flipped through 
seventeen pages of paperwork to come to the embryology report describing the left over treasure 
that lay inside: one vitrified grade 5AA Day 6 blastocyst made with donor egg and sperm.  
According to IVF clinic standards, Angela’s embryo received the highest grades for 
establishing pregnancy. Had she instead decided to donate her “slam dunk” embryo to the 
Blossom program for adoption, Kathy, Sarah, and Monica would have had little difficulty 
matching her embryo with the pool of adopters hoping for pregnancy and parenthood. But for 
REDEEM, Angela’s embryo joined a long line of donated remainders that had little use value to 
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researchers at the time. “Ninety percent of the embryos in the bank are blastocysts,” Wendy 
explained to me as she moved Angela’s embryo from the shipping container into the Biobank. 
“And they probably represent ten percent of the value.”  
The need for blastocysts to derive human embryonic stem cell lines, as discussed in 
Chapter 3, was the original impetus for the grant that established REDEEM Biobank. Since 
opening in 2008, research agendas within Sutter’s Stem Cell Institute labs shifted in new 
directions in response to developments within stem cell biology. The establishment of induced 
pluripotent stem cell technology (iPSC), for instance, allows researchers to derive pluripotent 
stem cells from easily obtained human skin cells rather than having to rely on the stem cells 
contained within hard to obtain and controversial human embryos. The Biobank originators 
could not know that the common blastocysts left over from IVF clinics would be less useful for 
Sutter University stem cell scientists than initially imagined. During my period of research, the 
most common users of donated embryos at Sutter were Class 1 researchers studying human 
development, for whom Day 1 2PNs were better than gold. Wendy chose a spot for Angela’s 
embryo in the top rack of the Biobank because the lower racks, deep in the liquid nitrogen, were 
reserved for the most valuable 2PNs embryos that aligned with the lab’s current research needs. 
Even though Angela’s embryo made it successfully to the Biobank, it remains in limbo 
slated for neither a researcher’s Petri dish nor the trash. Similar to the early twentieth century 
embryological specimens preserved in formaldehyde that Lynn Morgan discovered in the 
basement of Mount Holyoke College, frozen blastocysts like Angela’s become “specimens [that] 
proliferated not because anyone necessarily wanted many of them, but because it was awkward 
to refuse a well-intentioned gift” (Morgan 2009: 61). Wendy explained why receiving well-
intentioned gifts of frozen blastocysts poses real problems for the Biobank. “We can’t just keep 
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getting blasts from people who want to donate,” she told me. “It ends up being storage for them 
that they don’t have to pay for.” Right after saying this, she corrected herself. “It’s not that 
patients intend that when they donate.” I understood what she meant: People donate their 
embryos to REDEEM, as I discussed in Chapter 3, with hope that their extra materials will be 
used for good. But the reality of the situation for embryos like Angela’s is that they are not 
currently viable as research materials. Rather, their utility as a tool for research—for which they 
are newly intended—is determined by political, technical, and financial circumstances. Chances 
are high that the Stoll embryo will remain unused for an indefinite length of time until 
circumstances beyond the tank make them viable for use in research.  
“You never know down the road what you're going to need,” Caitlin remarked in 
response to the growing problem she perceived within the Biobank. “Blastocysts are not being 
used as quickly as they are coming in but I think things go full circle sometimes. I feel like 
science is like that.” At the same time, she questions if the resources being used to receive and 
store embryos like Angela’s “that aren’t going to be used, or at least not going to be used yet” 
make sense. She and other Biobank staff worry about the day in the near future when the tank 
reaches capacity—filled with embryos without present day purpose—and wonder what they 
would do next: Invest in a new tank? Limit the kinds of donations they receive? Close the bank 
altogether, as many other tissue banks in universities around the country have done? Caitlin 
believes that if REDEEM is going to continue receiving embryos like Angela’s, “we should be 
doing more collaborations with other researchers around the university to get the blastocysts 
used. I'm not really sure that's being done.” In the meantime, Wendy continued to monitor the 
tank’s liquid nitrogen levels on a weekly basis. Caitlin admitted to having nightmares about 
accidents that devastate their precious supply. Despite the burdens of caretaking embryos with no 
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current use, REDEEM staff continues to care for the frozen remainders for some future day when 
research needs may be otherwise.  
After I left Sutter in April 2013 and Caitlin moved out of state in the following August to 
start a faculty position, some of her questions about the future of the Biobank were answered. 
That fall, the Biobank launched a “soft close” by limiting the kinds of embryos they received for 
donation only to 2PNs and diseased embryos from PGD screening, like the Golds’ ML4 embryo. 
Since it was one of the only tissue banks in the United States that received embryos without 
restriction for donation, word spread quickly among fertility clinic staff; emails seeking 
clarification about the Biobank’s new policy circulated on EmbryoMail, a public embryology 
listserv. Dr. Dunn was opposed to saying anything publicly that sounded as if the bank was 
closed because, as Wendy relayed, “It takes a long time to turn around and get started again if 
they say they are closed.” But in Wendy’s view, the closure was necessary. “In reality, if we ever 
use these blastocysts up it will be astounding.” In October 2012, Donna sent notification to 
EmbryoMail explaining the new situation for Biobank donors: 
We want to update everyone about the recent change in the program policy here at Sutter 
University REDEEM Biobank in regards to acceptance of human embryo donation 
mentioned in a recent embryo mail. 
 
The Biobank has stopped accepting donation of embryos cryopreserved at the blastocyst 
stage, as we have reached our maximum capacity. At this time we are unable to predict 
when we will resume accepting blastocysts, as it depends on the need and usage of such 
embryos by the research teams. We will keep everyone posted of any changes. 
 
We are still accepting new consents for PGD and/ or PGS tested and affected embryos as 
well as 2PNs. Please refer patients who fit the above criteria and we will gladly help them 
complete our donation process. 
 
We cannot stress enough how valuable your efforts have been in making our program a 





The Biobank agreed to receive the blastocysts of donors who had already consented and were 
“still in the pipeline.” By the following spring, staff was still working on getting the pipeline 
embryos shipped to Sutter. Even though the bank had effectively closed six months prior, 
managing the remaining frozen remains seemed without end.  
The news of REDEEM’s closure might have been a story already foretold; other tissue 
banks at universities around the country opened, received embryos for research, and eventually 
shuttered, like banks at Harvard, Michigan, and University of Connecticut. The bank’s closure 
did not surprise me as much as the fact that the talented staff I worked alongside were unable to 
realize their vision of a functional and vibrant tissue bank to support Dr. Moto’s research. 
Finding adequate resources to staff the Biobank was a constant challenge, at the heart of which is 
the belief that managing the afterlives of IVF embryos is a straightforward process of deciding, 
signing, sending, and storing. But as I came to learn, spinning embryo trash into gold can be 
understood in one of two ways: the stuff of fairytales or, as staff on the ground at both REDEEM 
and Blossom claimed, alchemy that requires an intense amount of work.    
Coinciding with the whispered news of the Biobank’s closure was another stunning 
announcement: Dr. Moto was leaving Sutter University. In October 2013, she announced that in 
January of the next year, she would begin a new post as Vice President of Research at another 
university. She explained that in this new role, she planned to bring more scientists and 
researchers to a very small school in a rural state plagued by poverty to see if her efforts can 
foster growth in the region. The community she hoped to energize was the one from which she 
and her husband originated.  
Much like the speculative economies shaping the California frontier from the Gold Rush 
booms through the dot-com bust, Dr. Moto’s quick move to and from Sutter University 
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exemplifies twenty-first century science in myriad ways. In 2008, Dr. Moto had brought a few 
students with her from her previous university to join the faculty at Sutter, where she had played 
an instrumental role in securing grant funds to build the Stem Cell Institute. She recruited 
talented investigators, students, and postdocs from around the world to populate the dozens of 
Institute labs and initiated a novel doctoral program bridging stem cell biology with translational 
medicine. Her leadership encouraged new interdisciplinary collaborations unseen before at 
Sutter, earning her an endowed professorship that was announced during the Fall 2012 semester. 
In the spirit of mentoring stem cell leaders of the future, she made her lab an active training 
space for researchers worldwide to take courses in stem cell derivation. And, of course, Dr. Moto 
mobilized the funding necessary to start the REDEEM Biobank as a resource for her lab 
members, for Sutter investigators, and—had the vision panned out—for researchers across the 
state of California. Dr. Moto’s vision brought to Sutter millions of dollars and talent that 
cultivated the vibrant world I entered the year before she announced that she was leaving.  
Speaking with Uma, a second-year doctoral student who had come to Sutter specifically 
to work with Dr. Moto, helped clarify how Dr. Moto’s decision to leave Sutter behind is 
indicative of the speculative logics informing modern science today. Uma expressed admiration 
for Dr. Moto’s desire to help her community of origin. Herself a minority in the sciences as a 
woman with multi-ethnic Native American, Mexican-American, and white heritage, Uma has a 
strong desire to use her career path to help her communities too: “I want to do that someday for 
my community.” Uma also saw Dr. Moto’s shift to V.P. of Research in a poor community as an 
extension of what Dr. Moto does so well: conduct experiments. In a way, all that Dr. Moto 
developed at Sutter was similar to the everyday lab bench activity of cultivating a stem cell line 
and nurturing a regenerative colony that could sustain on its own. To extend the metaphor, Dr. 
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Moto’s move to the other university was like the passaging of a stem cell colony, which involved 
relocating good cells to another Petri dish where their growth could be nurtured. The stem cell 
experiment Dr. Moto carried out at the scale of Sutter University shifted to one much more 
ambitious: to the regenerative potential of an entire state’s economy. While such big visions have 
impacts on countless people at many levels, Uma understands such gambles as normal within the 
life sciences.  
I don’t think that things are going to fall apart in these people’s absence. I don’t think 
they are irreplaceable. That’s why we have grad students and postdocs so that we can 
keep recycling people into these positions. Life in general is like this. You have to deal 
with change all the time: people, the environment, refits and remodels, all are moving… 
You always hope that things will continue to evolve in positive direction when changes 
like this happen.  
 
 
Seasoned scientists and students alike responded quickly to the news of Dr. Moto’s 
departure. Doctoral students Eric and Jackie fast-forwarded their research to defend their 
dissertations sooner while Madison and Uma, graduate students in earlier stages toward their 
degree, found co-advisors and made homes in different labs. Luke, Jay, and other postdocs fast-
tracked their job search and moved manuscripts more quickly toward publication. Also, Dr. 
Moto used her professional network to help other mentees who were caught in limbo. Two 
postdocs decided to relocate with Dr. Moto to her new university in order to continue their 
research.    
The closure of the Biobank and dissolution of Dr. Moto’s lab brought urgency to 
questions of what would happen with the thousands of embryos like Angela’s in storage at Sutter 
University. I decided to visit what was left of Dr. Moto’s lab in April 2014 following a 
conference I attended nearby to see how people were negotiating the tides of change. Certainly, I 
was also curious about the future of the Biobank. On numerous occasions during field research, 
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staff, researchers, and I talked hypothetically about Dr. Moto’s leaving because it made for good 
conversation around the question, to whom does the Biobank belong? At the time, Lucia said the 
embryos belonged to Dr. Moto, Caitlin guessed Sutter University, and Luke laughed at them 
both stating that they clearly belonged to the donors.  
As I sat down to Wendy’s familiar desk within the old Biobank office, we discussed the 
tasks before her that involved closing up the lab and managing grant reports and budgets. She 
explained to me the particulars of what happens with capital equipment purchased through grant 
money, such as the physical Biobank tank. Factors like the value of the equipment and wishes of 
the home department, Dean’s office, and university determine what happens in a circumstance 
like this one. Our conversation turned to the challenge of applying these logics to the Biobank; 
while the tank itself could be claimed as Sutter University property, to whom the contents of the 
tank belong is murky. Wendy proffered an uncertain guess: “It’s a Sutter consent, so I imagine 
the embryos belong to Sutter? I don’t know…” 
I noticed that the Biobank was not in its usual spot by the door, and asked where it went. 
They had moved it down to a storage closet in the hallway in anticipation of rolling it over to the 
School of Medicine. “We’re trying to get the Biobank adopted by the OB/GYN department,” she 
said. “The bank is in need of a home.” When I remarked on her interesting choice of words, she 
clarified: “By adopted I mean paying to support it.” Dr. Moto did not want to take the Biobank 
with her to the next university, which left the precious materials—whose funding source would 
dry up in a few months—without a home. She mentioned a couple of names of people who might 
assume responsibility for the tank, but as we sat at her desk those decisions had not yet been 
made. Wendy seemed confident that the Biobank would find a home:  
Sutter is a big enough place. Before they let publicity out that the Biobank closed and 
discarded all of the donated embryos, I think the Dean would step in and pay a couple 
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hundred bucks a month for filling the tank. I can say that it will be taken care of but I 
don’t know for sure and the decision is above my pay grade. I think they are too valuable 
of a research asset to dispose of in that way, but I don’t know how exactly how it’s going 
to be done. 
 
 
Before leaving the remnants of Dr. Moto’s once vibrant lab, I asked Wendy if she thought it was 
worth it. Were all of the efforts she and others made to collect frozen embryos from around the 
country worth the hassle? In her view, human embryos are vital for “good, valid research” and 
“how things will progress” for treating human disease. “You have to make it worth it,” she said.  
 
Conclusion 
Sorting, according to anthropologist Anna Tsing, is an art of creating classes for 
specialized purposes (Tsing 2013). Tsing comes to this conclusion while musing about niche 
markets for matsutake mushrooms—the world’s most valuable fungi—that are hunted in Oregon 
forests. The creative art of sorting, as this chapter showed, proves to be salient for invaluable 
frozen embryos too. Sorting IVF leftovers into different categories and types is a process that 
contributes to transforming embryo potential into new forms: as adoptable orphans and 
laboratory treasures. I explored how the criteria used to organize the respective embryo 
inventories, archives, and databases within Blossom and REDEEM arise from significant work 
efforts and worldviews about the best use of reproductive remainders. In these ways, sorting 
practices also reveal why certain classes and categories are incorporated into the structure of a 
particular system and others are not. 
Sorting also provides a window into the circumstances that make embryos 
circumstantially viable. Read together, the Stoll and Bower stories offer a contrastive picture for 
why some embryos are quickly consumed as “hot commodities” while others are unviable for 
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any future prospect. Had the Bowers and Angela Stoll donated their respective embryos to the 
other embryo redemption program, their materials may have different stories to tell. The Bower 
embryo was passed over repeatedly by potential Blossom adopters, but if donated to REDEEM it 
would have been received with glee by Caitlin and Lucia, who consider rare 2PN stage embryos 
invaluable for their Class 1 human development experiments. Similarly, Angela’s embryo is 
stored high in the Biobank racks because it ranks low for research needs, and yet vitrified 
blastocysts made with donor eggs like hers are snatched up quickly in Blossom’s matching pool 
because of their desirable probabilities for establishing pregnancy. Neither embryo is more or 
less valuable inherently, but valuable because they are viable circumstantially. Potentiality in the 
embryo donation programs, as these cases show, is created through sorting processes and made 
intelligible through the idea that viability, like value, is dependent on context. 
Even though embryos like the Bowers’ and Stolls’ are circumstantially unviable, and 
despite all of the challenges associated with repurposing leftover frozen IVF embryos, their 
preservation still seemed to be “worth it,” as Wendy stated. The remaining remainders pose 
myriad problems as their newly redirected potential contextually bottoms out, yet they do not 
seem to lose their value for Blossom or REDEEM staff. Sarah continued to work with the 
Bowers to help them find their ideal match. Wendy accepted that the ultimate decision for the 
Biobank was out of her hands, but she helped the embryo consents “in the pipeline” get shipped 
to Sutter, monitored the bank’s liquid nitrogen levels every week, and held out hope for its 
“adoption.” Saving embryos with no place to go yet is a worthwhile effort common to both stem 
cell tissue bankers and embryo adoption proponents.  
But why were these doubly unwanted embryos still worth saving? Saving ethics and 
practices are actively at work within REDEEM and Blossom and most evident here as an 
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underlying moral obligation to “do good” today on behalf of tomorrow. The Blossom program 
“assumed responsibility,” as Sarah explained, for the original batch of seventeen donated by the 
Bowers and do not want “to give up on one.” To do otherwise undermines their familial notion 
of leaving none left in the cold. Similarly, Wendy’s remark that you have to “make” the banking 
of embryos worth it aligns with the ethos of doing good stem cell science; in a political 
maelstrom where human embryos for research are seemingly in short supply, saving embryos for 
future use is the sine qua non of protecting opportunities now and in the future for “good, valid 
research” and “progress.” Potential, as explored in this dissertation, is a powerful substance. The 
possibilities associated with potentiality articulate, across Christian adopters and stem cell 


























Redeeming: Claiming Potential Makes Moral Cents 
 
 
This chapter analyzes two experiments in redemption carried out by embryo givers and 
receivers claiming the potential of frozen embryos. First, I discuss the Darlings’ adoption of nine 
embryos through the Blossom program, and then I return to the Golds’ donation of the ML4 
embryo to the REDEEM Biobank. Common to each story is something that many embryo donors 
and recipients talk about but few have done: both families filed tax returns claiming credits and 
deductions based on their embryo saving activities. The Darlings and Golds illustrate how the 
moral drive to save that undergirds efforts “do good” operates among givers and receivers of 
frozen embryos. Their stories accentuate the role of fertility patients not only as commissioners 
of IVF embryos, but as makers, managers, and claimers of their potentials too. The Golds’ story 
in particular illuminates points of convergence between the contested embryo saving programs 
that inform their desires to contribute both to “good science” and foster “good family.”   
 
The Darlings: An Experiment with Adoption Tax Credit 
Ester and Dave Darling adopted nine embryos through the Blossom Embryo Adoption 
program in 2008. After their second biological child was diagnosed with an inheritable genetic 
condition, the Darlings decided to explore adoption: “Why not start with a different genetic base 
and not take the risk of bringing in another child that may have those sort of problems?” They 
first heard about the Blossom program from a Focus on the Family Christian radio broadcast that 
featured the story of the Drylers, the first Blossom family introduced in Chapter 4. Embryo 
adoption met their needs for growing their family and resonated with their evangelical values 
around protecting “life.”  
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“It’s a great way to save lives,” Ester explained during our first conversation in July 
2008. A few days prior, she had transferred the first two adopted embryos into her uterus. We 
reconnected in August 2012, when I learned that she had given birth to two sets of twins through 
embryo adoption and was planning for more. The Darlings found embryo adoption to be an ideal 
way to expand their family and welcomed the chance, as Ester explained, to “actually play a role 
in saving the life of a child. Life begins at conception and embryos are the smallest place that 
you can start with that.”  
The mission of the Blossom program aligns with Ester’s religious and political beliefs. 
She is a committed pro-life proponent who joins annual prayer chain activists in opposition to 
abortion and attends national right-to-life marches. When nine months pregnant in 2006, she 
traveled to Washington D.C. to attend the press conference where President Bush vetoed the 
Congressional bill for funding embryonic stem cell research. Her values inform how she relates 
to the nine adopted embryos in her charge.  
If you ask Ester, she is the proud parent of ten children: one biological child, five children 
adopted as Blossom embryos and born, three frozen embryos waiting to be transferred to her 
uterus, and one embryo that was thawed, transferred, and did not establish a pregnancy that, she 
says, “I won’t be able to hold until I’m in Heaven.” This latter statement is a more subtle form of 
her pro-life advocacy. Ester publicly grieves the loss of the one adopted embryo that was 
transferred into her uterus without establishing pregnancy. She named the embryo Rose and 
commemorates the loss she experienced annually on her Facebook wall. She also participates in 
online forums for grieving parents of miscarried pregnancies and early infant loss. This is not 
common among the embryo adopters I spoke to because, as many experienced, embryo attrition 
in IVF is quite common.  
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Adoption Tax Credit 
The U.S. adoption tax credit is an economic incentive that provides support to families 
who assume parental responsibilities through adoption for children in need of guardianship. U.S. 
Congressional law governs the adoption tax credit and the Internal Revenue Service determines 
eligibility. The Economic Recovery Tax of 1981 established an itemized deduction for expenses 
related to adoption, which was replaced by a tax credit in 1996.70 The U.S. Congress made the 
adoption tax credit permanent in 2013, allowing taxpayers six years to use the credit from the 
time the adopted child enters into their custody and home. The current credit, according to the 
United States Internal Revenue Service, “offsets qualified adoption expenses, making adoption 
possible for some families who could not otherwise afford it. Your tax liability may be reduced if 
you adopt an eligible child and qualify for the Adoption Credit.”71 In 2014, the nonrefundable 
tax credit capped at $13,190 per child. The Darlings were aware of the tax benefits available to 
traditional adoptive families who bring born children into their homes because they have adopted 
nieces and nephews in their extended family. After their first child’s birth from embryo adoption 
in 2009, the Darlings explored if and how they could apply for an adoption tax credit too. 
 Every year, Blossom staff receives inquiries from embryo adoptive clients like the Darlings 
about filing for the adoption tax credit with questions that are difficult for staff to answer: Does 
embryo adoption count as an adoption for the IRS? Does an embryo qualify as an “eligible 
child”? Which adoption expenses can Blossom families claim exemptions for (e.g., home study, 
agency fees, medical costs for frozen embryo transfer)? Which date is an embryo adoption 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
70	  One of the effects of this shift was that the relative cost of private adoption was decreased 
while families who adopted children through foster care did not receive benefits because they did 
not have any associated “costs” after federal matching funds that covered their up-front costs. 
The Adoption and Safe Families Act of 1997 brought reform to foster care and adoption. 
71 See the IRS website: http://www.irs.gov/Individuals/Adoption-Benefits-FAQs	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finalized – contract signing, shipment, embryo transfer, birth? Would the Blossom contract work 
in lieu of an adoption “certificate” or “decree”? The Blossom team is unable to provide 
conclusive answers for clients and typically refers people back to their tax preparer for advice. 
 Tim, the former Director of Pacific Christian Adoptions, is not discouraged by the fact that 
embryo adoption is not included explicitly in the IRS’s adoption credit literature: 
The language in the law and forms you have to file say it has to be legal adoption. It 
isn’t an illegal adoption. Does the federal government recognize it as an adoption? 
Well, they’ve spent 3-4 million dollars making the public aware of embryo 
adoption so I think that they believe it’s adoption. I just don’t think they’ve stopped 
to think if it’s the same as adoption that’s eligible for a tax credit.  
  
The issue of legality does not concern Kathy, the Blossom program social worker, as much as the 
financial risks that Blossom clients take when signing up for embryo adoption. The overall cost 
for Blossom adopters averages $12-15,000, which includes the $8000 program fee to be matched 
with a set of embryos, an adoption home study, and frozen embryo transfers with their fertility 
clinic. Within international and domestic adoption, Kathy explained: “The odds are very high 
that you’re going to get a child, eventually. There’s not a guarantee, but for the most part we’re 
going to have a child at some point in the future.” By contrast, the risks for adoptive clients in 
the Blossom program are not becoming pregnant or carrying a pregnancy to term. In Kathy’s 
view, embryo adoption “is a very costly thing to go through and not have a result.” She 
explained that families who adopt domestically or internationally “can wrap their head around 
[the tax credit] and make it financially okay,” but Blossom clients are in a different position. 
“People aren’t real sure if they can take any of that [embryo adoption expenses] off their taxes 
and we’re not even sure if they can. So, financially, they are just out the money and they may or 
may not have a baby.” I was surprised to hear critique of the tax credit from within the Blossom 
program, and specifically from the Blossom program manager, Monica. She is aware that some 
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of her personal opinions are not popularly held among adoptive clients and other staff, but in her 
view: “Being reasonable about who the adoption tax credit is intended for, I don’t think Blossom 
families fall under the category.” 
 In the absence of specific guidance or precedence about the adoption tax credit for 
Blossom clients, adoptive families share with each other various resources, tips, and experiences 
through the program’s client listserv. Some feel perplexed by the responses they receive from the 
IRS. “I am still very confused by the process,” shared one adoptive father, “and I’m an 
accountant; I can read tax code.” Some families reported successful filings for their first children 
born through embryo adoption, which were followed by confusing denials from the IRS when 
they submitted materials for their second and third born. Instead of the adoption decree requested 
by the IRS for the tax credit, Carol sent copies of her home study and the Blossom contract as 
supplementary materials in her adoption tax credit filing. “And they still think it is not an 
adoption?!” she posted to the Blossom listserv after being denied the adoption credit. “Perhaps I 
should have sent them a picture!”  
 Laura, a Blossom adoptive mother and Certified Professional Accountant, took the extra 
legal step of requesting a judge to provide an adoption decree. “It was a pain and it cost extra, 
but in the end it paid for itself,” Laura assured the Blossom listserv after receiving news that her 
tax credit was approved. Adopting her child in the courts provided Laura the adoption certificate 
that the IRS requests to be considered for the adoption tax credit. In many state courts, families 
like Laura’s are denied the request because she is already considered the legal mother as the 
bearer of her child. In the state of Missouri, though, some judges have granted adoption 
certificates to couples after they gave birth to embryos received through the Blossom program.  
 Recouping adoption expenses is only part of the motivation for some Blossom families to 
 256 
file for the credit. For instance, Martha expressed hope that efforts to obtain an adoption tax 
credit would encourage the U.S. government to acknowledge the practice of embryo adoption as 
adoption. In a note to the adoptive client listserv, she wrote: 
We are praying for guidance and direction - we feel so strongly about claiming 
this adoption tax credit. Receiving this credit would just give more affirmation to 
our 100% belief that she WAS a human being as an embryo, and share that 
message even further… My little girl WAS adopted, and it hurts to see it in 
writing that they don't consider her as a human life when we adopted her. I know 
you girls get it - why can't the rest of the world? 
   
Similarly, the Darlings were motivated to legitimize the saving of unborn lives.  
 When Ester’s family members questioned if embryo adoption was a “true” adoption, her 
response was prepared:  
For me, these embryos are children and they need someone to take care of them just 
as much. I know there are so many children out in the world and I’d love to help all 
of them if I could. But I feel that this is the way the Lord has led us to adopt 
children. I think all of them are in need of somebody to help them. 
 
When it came time to file the tax return with the adoption credit claimed, Ester was of the 
opinion that “whether they felt it was a ‘true’ adoption or not, it was. I was going to apply for 
[the tax credit] whether they liked it or not. We would just take it from there and see what 
happens.”  
Ultimately, the Darlings’ claim was accepted. The IRS audited their 2009 tax return in 
which they claimed their first child born through embryo adoption for the tax credit. The IRS 
asked them to provide a “certificate of adoption” for their daughter, which they did not have, so 
they sent copies of their home study and receipts for the Blossom agency fees. 
In terms of saving money, the Darlings used the $12,150 credit to offset their personal tax 
liabilities for 2009 and 2010. When it comes to the saving of lives, they feel that the IRS 
“accepted” embryo adoption as an eligible practice, which they interpret as a win for their pro-
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life Christian and political commitments. The approved adoption credit gives the Darlings a 
financial break as well as contributes to their long-standing commitment to valuing unborn lives 
morally, which in their case includes economic forms of valuation too.  
 
The Golds: An Experiment with Tax Exemption 
This section returns to the story from the opening pages of the dissertation involving the 
Gold family. Like the Darlings, Adam and Julie are a devoutly religious couple parenting a child 
with a genetic disorder. They also decided to experiment with their tax return to claim the 
potential of their ML4 embryo for their family and cause.  
 
A Sense of Responsibility 
The stakes felt high as the Golds reviewed Sutter’s informed consent form about research 
options for their single ML4 embryos. They chose Class 2 research, initialing next to the 
description on the consent form that read:  
This research will try to make new cell lines from embryos. Through genetic 
reprogramming, certain genes containing DNA could be put into the embryo to study 
how the cells can be changed, or reprogrammed, into embryonic-like cells. Donated 
embryos may be broken up into cells or cell clusters and researchers will try to grow 
cultures of new cells that come from the embryo. Cells multiply by dividing in two, and 
the genetic material is replicated every time a cell divides. These cells, which can live 
indefinitely, will contain your DNA. 
 
Once submitting their signed forms to REDEEM and their fertility clinic, the next steps involved 
shipping. The Golds were in touch with their fertility clinic liaison, who coordinated with Donna 
to have their single embryo shipped via FedEx across the country to Sutter University. Adam is a 
self-described “Type A personality” and “a CPA [Certified Professional Accountant] that likes to 
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dot all the I's and cross all the T's.” Signing and shipping their “one-shot deal” was stressful for 
him:  
I was just terrified that this one chance that we had to create stem cells for our 
daughter was going to get thawed out of mistake at the IVF doctor’s office or not 
shipped properly or not received properly at Sutter. My only anxiety was: is it 
going to get to the right hands and be able to start growing stem cells?  
 
 
The Golds’ donation of their ML4 embryo involved a mixture of hope, worry, and uncertainty. 
Giving up their precious embryo also provided a way for them to follow through on the sense of 
responsibility they felt since learning of Alice’s diagnosis. “We felt an obligation,” Julie 
explained, “to make sure this doesn’t happen again. I love Alice with every fiber of my 
being…but it is heartbreaking. I would never want this to happen to anyone else.”  
One way they approached their sense of responsibility was by addressing the lack of 
knowledge about genetic diseases within the Jewish community. With the support of the Atlanta-
based Marcus Foundation and Victor Center, the Golds launched Atlanta Jewish Gene Screen in 
2011, a non-profit organization that provided community genetic screening, counseling, and 
education for health care professionals, clergy, and individuals about pre-conception screening. 
The Golds were acknowledged as “Jewish Community Heroes of the Year” with a $25,000 
award for establishing the genetic screening program.  
Despite the recognition they received for their community project, the Golds felt that 
education was insufficient without affordable access to a full genetic screening test. To resolve 
this problem, Adam and Julie worked with community partners to raise $1.5 million to co-found 
JScreen, a non-profit public health initiative that provides affordable at-home education and 
carrier screening for all 19 known Jewish genetic diseases. During my first conversation with 
Adam in November 2012, JScreen was a few months away from going national.  
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For the Golds, as for the Darlings, advocacy plays a formative role in their everyday 
lives. “I don’t think Adam or I could have lived with ourselves if we didn’t do as much as 
possible to promote screening for all 19 known preventable Jewish Genetic Diseases, which 
includes sometimes having to educate your doctor about what you should be tested for,” Julie 
explained. “Our message is that you have the control if you are screened.” Proponents of 
standardized genetic screening like the Golds hope that pre-conception information can spare or 
prepare other couples interested in growing their family. From Adam’s perspective, Alice is the 
driving force behind his moral commitments.   
She is the catalyst behind everything I think about all day long. I run a company of 100 
people. I work really hard and probably always would but work even harder because of 
Alice. She is going to have medical needs and, because of her situation, I work harder to 
raise money to cure disease, work harder to make sure JScreen will be successful. 
Outside of work, I can't tell you how many hours I spend on ML4 and JScreen… Every 
piece of my life revolves around this little girl. I may be the voice she doesn't have. My 
legs might run to do work she can't do. She's the reason for it all. In her merit all of this is 
happening. 
 
Care in Dr. Blythe’s Lab 
Despite their clinical designation as medical waste, embryos that have undergone 
preimplantation genetic diagnosis (PGD) like the ML4 embryo are among the most highly prized 
materials available in stem cell science. PGD embryos reflect the “ultimate trash to treasure 
scenario” in moving from the IVF clinic, where they are nonviable options for establishing 
pregnancy, to the research lab. For these reasons, genetically abnormal embryos donated to 
Sutter receive special treatment. Donna typically collects completed consent forms in files 
organized by clinic until five to ten accrue. At that point, she calls FedEx to schedule the pickup 
and return of a portable cryopreservation tank to be delivered to the clinic for filling with the 
embryos slated for donation. Each round trip shipment costs the Biobank $300 regardless of 
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volume within the tank. Since the Biobank assumes the cost of shipment for donated embryos, 
they prefer to receive the frozen materials in batches from clinics rather than from each donor at 
the time of consenting. But when a consent form is received for PGD embryos, a tank is sent 
immediately to the donor’s IVF clinic, even to retrieve a single embryo like the Golds’. The 
Biobank also typically allows a brief waiting period after embryos are received before using 
them for research in case donors change their minds. PGD embryos, on the other hand, are 
transferred immediately to researchers for thawing, sometimes within hours of arrival. 
The Gold embryo was received at Sutter University by Dr. Judy Blythe’s lab, which was 
ready for its arrival. The goal of Dr. Blythe’s ongoing study of genetically abnormal human 
embryos is to derive new human embryonic stem cell lines that contain, as her lab website 
describes, “disease-associated mutations for the future disease research and therapies.” If Dr. 
Blythe’s lab were to successfully establish a cell line from a diseased embryo like the Golds’, it 
could mean opportunities for patents and in vitro models for screening drugs. A cell line could 
also attract the attention of investors wanting to produce and package marketable therapies. Even 
if these larger dreams are never realized, the establishment of a diseased stem cell line could 
result in publications, which are their own form of currency within the hard sciences that help 
secure real grant dollars and accelerate careers. As discussed in Chapter 3, the promised hopes of 
stem cell science to produce life-saving and extending therapies are inextricably tied to the 
politically volatile topic of funding streams for such work in the United States.  
In the Blythe lab, the work of establishing embryonic stem cell lines is the project of Lin 
Bao, a Taiwanese postdoc with a PhD in molecular and cell biology. Lin came to Sutter because 
she was attracted to working with human embryonic stem cells due to the novelty and 
opportunity to make an impact within the new field of stem cell biology. “Not many people have 
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touched it,” Lin explained, “so you can find the new… If I get a [stem cell] line, a paper will 
come out. It’s exciting and a lot of people would be interested. There is so much potential with 
this kind of opportunity.” Lin found that the “main hurdle about this project is how many 
embryos we can get; it’s not that much.” From 2009-2013, she recalled fewer than ten PGD 
donations, one of which was the Golds’: “This embryo is very precious. In a whole year we get 
less than ten embryos.” 
Trying to establish a human embryonic stem cell line is labor intensive and time-
consuming. Some cells are more forgiving than others in vitro, but human embryonic stem cells 
are among the hardest type to work with. Lin explained that is it important to “keep the pace… I 
think for several years you need to come weekends and holidays.” Once the inner cells from the 
embryo are extracted and plated in a Petri dish, Lin’s initial work involves watching and feeding. 
She uses her expert eyes, feelings, and judgments to make adjustments to the cell conditions and 
documents her decisions in a large lab journal. Living cells need warmth, nourishment and a safe 
place to grow in order to thrive. “If I feel a feeder is not that great, I will change the media or 
make a combined media. There’s really not that much that I can do but, still, I need to find a way 
to make them grow.” Some stem cells look robust in the beginning with cell growth patterns that 
appear tight, strong, and clear, which suggests they may grow quickly toward a line. “Sometimes 
you can feel that they grow stronger.” In other instances, for no discernible reason, the colony 
disappears and Lin “begins to lose hope.”  
Despite the sacrifices Lin makes personally and professionally to “keep the pace” by 
showing up at the lab every day and tending meticulously to finicky cells, she is clear that her 
work with human embryonic stem cells boils down to chance: “It’s kind of about luck, right? 
Sometimes weird things happen.” And when they do, Lin’s work becomes a mission of rescue 
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and recovery. “When unexpected things happen, it feels terrible. In the moment I have to come 
down and change my strategy, to rescue the cells. Most cell lines [I work with], I rescued them.” 
The variables of luck and chance are an accepted part of scientific inquiry that Lin and other 
stem cell scientists confront each day that they agonize over the microscopic activities in their 
Petri dishes. Even when hope may be lost, Lin feels that “we cannot give up. You don’t know 
what will happen. The cells could adjust themselves to the outside environment and they will… 
who knows? It’s hard to control and even hard to say.” Saving cells from the brink is the 
everyday task of stem cell biologists committed to doing good science. Like many at Sutter, Lin 
hopes her efforts may contribute to real world therapies that could, one day, save lives.  
 
Care at Home 
Lin’s lab work might be described as an ongoing “labor of love,” which Adam and Julie 
understand all too well. As full-time professionals and parents of three children, the Golds are 
familiar with the day-to-day sacrifices people make to care for a family. Like a new stem cell 
scientist working with embryos for the first time, new parents experience anxiety, restlessness, 
and stress around the intense time and energy involved in caring for a newborn. Stem cell 
scientists and parents similarly watch over, feed, nurture, and help grow their precious entities. In 
family and lab life, the unexpected can almost certainly be expected, as it was for the Golds 
when they learned about Alice’s rare genetic condition. Tending to Alice’s special needs has 
become full-time work for Adam and Julie, and their ongoing labors of love. 
Daily care for Alice requires a sophisticated coordination of skill, resources, time, and 
professional assistance. At five years old and 35lbs, Alice was just learning to crawl yet 
remained largely immobile. “We pick her up in the morning from her bed, bring her to the 
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breakfast table, back to her room, that kind of thing.” Adam and Julie do everything for Alice 
that a typical five year old could do for her self when it comes to bathing, being fed, and dressing 
for bed. Feeding her is an especially arduous task. “She can bring a spoon to her mouth—she’s 
got the mechanics down—but we basically have to feed her every meal.” Because she has a 
delayed reflex, Alice is at risk of choking. Adam has had to perform the Heimlich maneuver on 
her at least six times to dislodge food stuck in her airway.  
Beyond the daily challenges that Alice and her family surmount each day, the rareness of 
ML4 means that the Golds face many unknowns. Part of the reality of Alice’s surprising 
diagnosis involves addressing the uncertainties about her future health. By the age of twelve, 
doctors anticipate Alice to be blind; already her retinas are deteriorating and her corneas show 
signs of clouding. She has a very strong eyeglass prescription, but they cannot accurately tell the 
detail of what she sees or how far because she is not able to communicate typically. When Adam 
comes home, “she knows that I walked in. I think she can see me, but I don’t know if she sees 
my form, or if she hears my voice and that’s what tips her off. We just don’t know.” As Alice 
learns how to maneuver her world with degenerating eyesight, her family is figuring out how to 
respond without a clear vision about what the future entails.  “The way I see it,” Adam began, 
you really only have two choices in this situation. If you don’t keep moving 
forward, you just crumble under the weight of the emotion, stress, sadness, anger, 
grief, and all of that stuff. You can’t allow yourself to live in that moment. You 
can experience that moment from time to time, are entitled to and probably 
should, but you can’t live there forever. I focus on the fact that Alice is this 
gorgeous little girl, absolutely adorable…The work that I’m putting in to educate 
others so that they know what to do to avoid this kind of situation, or to find a 
cure for ML4, helps me focus my energy toward the goal that might otherwise be 
sort of misdirected toward the sadness. 
 
Alice attends school every day from 8 a.m. to 1 p.m. and works with various therapists 
each afternoon. The public school near her home integrates special needs kids and typical kids in 
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the same classroom and provides an assistant to Alice, who is with her at all times. For 2-3 hours 
after school, Alice works with physical, occupational, and speech therapists. “We give her more 
therapy than any other kid with ML4 has ever gotten,” Adam explained. “That’s really by choice 
because we are not willing to not give her therapies just because were are not sure that they are 
working. I’d rather give her therapies and learn that they didn’t work than not give her therapies 
and wish that we had.” Caring for Alice any other way is not worth the gamble for her parents.   
The issue of lifelong care for Alice is emotionally taxing and financially stressful for the 
Golds: “We can’t even address the question of where she would live if she wasn’t living in our 
house because it is a very difficult, emotional topic.” As children with ML4 age and grow, they 
become more challenging and costly to care for. For this reason, children like Alice typically do 
not live at home into their teens and twenties. The Golds’ objective has been to find a way for 
Alice to remain at home with her parents and siblings as opposed to in a facility. To this end, the 
Golds decided to invest in building a home around Alice’s care needs so that she can live out her 
days with her family. All of her anticipated needs, from a wheelchair accessible bathroom to a 
“ridiculously expensive” elevator, are structural cues in the house’s blueprint of their efforts to 
“plan for down the road.” Alice’s application for Medicaid assistance was approved through the 
Katie Beckett waiver, but according to Adam, “it’s still going to be financially difficult for us. 
Caring for Alice is clearly going to require a significant amount of money.”  
 
Pricing Potential 
With these financial obstacles in mind, the Golds initiated an embryo experiment of their 
own. Adam explained how they idea for a tax deduction arose: 
Subsequent to donating the embryo I realized that the embryo itself was 
incredibly unique and that the donation of the embryo might afford me and Julie a 
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tax deduction for IRS purposes. This was a wonderful revelation as we are 
currently trying to determine how we can fund the long-term healthcare and 
lifestyle costs of our 5-year-old daughter who will likely maintain the mental 
capacity of an 18-month-old into adulthood.  
 
When the idea of a tax deduction first came to mind, Adam contacted ML4 researchers around 
the country about the utility of such an embryo and asked accounting colleagues to research tax 
law for similar cases. No precedent could be found, but the Golds’ case seemed arguable, in their 
opinions. On October 15, 2012, Adam and Julie filed a tax exemption with the IRS for the 
charitable donation of their property to the non-profit organization, Sutter University. 
The IRS requires taxpayers who desire an exemption for donated property to fill out 
Form 8283 for “noncash charitable contributions.” Section B is reserved for property valued over 
$5000, which is where the Golds began filling in their information. Donors are first asked to 
describe the type of property being donated: Is it art, collectible, real estate, intellectual property, 
a vehicle, securities, or equipment? The Golds checked the box for “Other.” “Mucolipidosis 
Type IV embryo” is how they described their donated property. For the “brief summary of the 
physical condition of the property at the time of the gift,” the embryo was noted to be “Perfect.” 
They listed May 2011, the date of their last IVF cycle, as the date they acquired the property, 
which they claim to have gotten via “Purchase.” (See Figure 17) 
Section B donors are also required to include an appraisal of the property justifying its 
reasonable “fair market value” at the time of donation. The Golds compiled statements from a 
team of experts—a bioethicist, active ML4 researcher, venture capitalist in drug development,  
and value consultant—to compose their report. To convey that taking a tax exemption for this 
donation is ethical as well as to justify the classification of the ML4 embryo as “property” on the 
form, Adam contacted the Director of Emory University’s Center for Ethics, Dr. Peter Warner, 
for an expert opinion. Dr. Warner cited to Adam U.S. divorce cases, like Davis v. Davis, 
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Figure 17. The Golds’ embryo donation tax exemption form72  
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
72 Photo by author. 
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discussed in the Introduction, in which some courts regarded the frozen embryos in dispute as 
property. 
Adam took from his conversation with Dr. Warner confidence that he had a case to make 
for owning the ML4 embryo:  
If embryos are litigated over and the decisions are made about who has rights to them, 
clearly we’re talking about something that is property. As property, there is a value that 
can be assigned to [the embryo] like other types of property. If the embryo had no 
inherent value then Sutter wouldn’t want it for research purposes in the first place. 
 
The main value Adam saw in the ML4 was its potential to generate therapies, even a cure. “Here 
we were with the opportunity to produce something that could create a research opportunity,” he 
said. “It could create a drug opportunity and somewhere along the line could end up benefiting 
kids with ML4. There’s real value there. There’s no question that there is value behind that 
concept.” From the vantage point that the ML4 embryo contained the potential to cure, the 
challenge facing the Golds in their tax preparation was how to put a price on such a priceless 
embryo. 
Toward narrowing down a price in the appraisal report, the Golds first established the 
embryo’s value to laboratory researchers. Ruth Bargal, the geneticist who led the all-Israeli team 
that discovered the gene associated with ML4 in 2000, contributed a statement (Bargal, et al. 
2000). She explained how the embryo might benefit research on ML4 in addition to the broader 
group of inherited diseases known as lysosomal storage disorders. Central to Dr. Bargal’s 
statement was the point that stem cells will be one of the materials helpful in forwarding 
“breakthroughs.”  
The Golds assigned the task of estimating and substantiating the embryo’s monetary 
value at the time of donation to a value consultant and a venture capitalist with expertise in drug 
development, whom I describe as the estimators. In the absence of a market in the United States 
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that puts a dollar value on embryos themselves, the estimators turned to the speculative logics 
within the biotech industry for ideas. The estimators argued that the price of the ML4 embryo 
should be based on the prospective market value of a drug that could result from the derivation 
of a stem cell line. Specifically, they outlined a profitable pathway for the potential of the ML4 
embryo: if the donated embryo established a stem cell line, it could be used to test therapies that, 
if promising in in vitro and animal models, could translate to the clinical trial phases which, if 
successful, could undergo FDA review for approval to go to market. Adam uses the metaphor of 
steps to clarify the valuation process of the embryo: 
We tried to determine what the market was, or the value on the open market of a 
drug that might come about. If today we’re at Step 1 and there are 100 steps to get 
to the drug, we have to value the [embryo] material that we have at Step 1. We 
can’t value it at step 100 because we’re so far away from creating the drug. Tax 
law didn’t define how to value it; it just defined that it needs to have a value. We 
used an approach to the market value of the drug and backed it up to Step 1 of 
many, many steps to drug production to come up with the value. 
 
 
In other words, they regard the ML4 embryo as an invaluable resource—a spring of potential—
that was considered in biotech industry terms an “upstream” material that had potential to lead to 
sizable “downstream” profits.  
In the space for question 5C on the 8283 form, the Golds entered the settled on value for 
their embryo’s potential on the day it left their clinic’s freezer for the REDEEM Biobank: $3.124 
million dollars. When asked what he thought about the estimated value of the embryo, Adam 
stated:  
I don't really have a concept of what the value should be… If the value is $20 million it 
wouldn't have mattered to me because I’m limited to so much that I can deduct. For the 
purposes of what I’m trying to accomplish, which is to create an ability to fund Alice’s 
care, the value itself is really not important… That I get as much value as the tax law will 
allow is my only concern. 
 
 269 
He made a point to clarify that “the value of the embryo is in the donation, not in the result of the 
research.” This distinction is worth parsing out because it made their claim of property and the 
tax exemption experiment possible.  
The REDEEM Biobank’s informed consent materials state explicitly, as discussed in 
Chapter 3, that donors forfeit their claim to financial benefit from any commercial value that may 
result from products or patents derived from their materials. When Adam and Julie signed the 
Biobank’s consent form, they gave up their chance to receive compensation from possible future 
profits. At the time of their donation and before Lin’s laboratory experiment began, the Golds 
argue that the embryo’s potential was appraised to be worth three million dollars. They suggest 
that their embryo’s promise and the associated dollar value were independent of the actual 
outcome of Lin’s lab efforts. Coming to the three million dollar value involved freezing the 
frozen embryo’s potential in time, fixing it at the moment of donation per IRS rules, and then 
calculating its “upstream” value by projecting “downstream” into the future. In a letter to Sutter 
explaining their request for Dr. Dunn’s signature on the Golds’ tax form certifying receipt of the 
donation, Adam makes his case for why it is reasonable for Sutter to sign:  
Julie and I freely signed the consent forms that you provided prior to our donation and 
those forms clearly state that we cannot be paid for or induced to provide the embryo, 
have no future right to the embryo, and no right to any commercial benefit created by 
Sutter University from use of the embryo. This is an important and relevant consent in 
that had we intended to receive any benefit from Sutter at all, the charitable deduction 
would be disallowed by the IRS. So the consent form that we signed actually supports our 
position that this donation is reasonable. 
 
Sutter’s team of lawyers reviewed the request and approved it. Dr. Dunn’s signature on the 
Golds’ form was like the receipt given by staff at Goodwill to a donor in acknowledgment of 
their donation. Sutter’s lawyers knew that the burden of justifying the value of the gift to the 
IRS—whether a couch to Goodwill or a diseased embryo to the Biobank—is on the donor.  
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With the tax experiment underway and in the hands of the IRS, what happened with the 
stem cell experiment? The ML4 embryo shipped directly to the Blythe lab where Lin took over. 
Some early successes provided hope: the embryo survived the thaw and its inner cell mass 
containing the stem cells was successfully isolated. During the first three weeks after plating 
when Lin feeds, observes, and rescues the cells from the brink, she hopes to see a particular kind 
of cellular activity that indicates a budding stem cell colony, at which point she will do a 
“passage.” Passaging is a technique common among stem cell biologists that involves isolating 
the best looking cells in a dish, dividing them into sections, and transferring the pieces to new 
plates where it is hoped they will thrive and grow. The Gold embryo was passaged successfully 
five times, yet the cells ultimately did not remain “robust” enough to stay in their pluripotent 
state. The time came for Lin to give up hope and summarize her results in a post-experiment 
report:  
The initially formed stem cell colony associated with ML4 was not robust, 
containing a lot of differentiated cells (Fig 1F). We split cells to more than 5 
passages, however, every time some pieces of cells failed to attach, and the 
attached cells couldn’t proliferate well. Usually differentiated cells have lower 
capability of self-renewal and proliferation. Probably that’s [the] reason why stem 
cell colonies couldn’t attach and expand well. 
 
Unsurprisingly, Adam and Julie were disappointed with the results, shared with them by Dr. 
Dunn. “We were really hoping that this could be a breakthrough in the disease for our daughter,” 
Adam said. “It was really disappointing that it didn’t take but we knew ahead of time that the 
odds were very, very slim that we were going to get stem cells out of it.” By the time the Golds 
filed their tax exemption, the ML4 embryo’s future had already been foreclosed; its three million 
dollar value concerned not what could still be but what could have been. 
 271 
I first learned about the Gold embryo when Dr. Dunn received Adam’s letter requesting 
his signature on the 8382 form. I spoke with Adam a few weeks later in November 2012 soon 
after they filed the tax exemption, and have followed up with him two more times since. During 
our first conversation, Adam expected the IRS to respond with an audit, and had no idea what 
would follow.  
I don’t know if they are going to allow the deduction, or disallow it. Say it's 
reasonable or unreasonable. I don’t know if they are going to fight me on the legal 
concepts, if they are going to fight me on the value, if they are going to fight me 
on the deductibility. We’ll just have to wait and see.  
 
Despite the disappointing laboratory experiment with the three million dollar embryo, Adam and 
Julie remain hopeful that their ongoing tax experiment will pan out. As of my last 
correspondence with the Golds in July 2014, no tax audit has occurred. As a professional 
accountant who is familiar with IRS behavior, Adam considers no news from the IRS to be good 
news. In November 2015, the IRS’s window to audit lapsed. “If it works, it will be a real game 
changer in Alice’s life,” said Adam. “Not just for me and Julie, but really for Alice’s life, and 
that's the only reason that any of this matters to me.” 
 
Conclusion: Lively Potentials 
The adoption and donation stories of the Darlings and Golds describe two attempts to 
claim the potential of frozen embryos as a way to express and generate values. Both stories 
showed forms of “moral pioneering” (Rapp 1987) within even newer saving frontiers that 
characterize the afterlives of reproductive remainders. The redemption that both sought was not 
the capitalized value of their priceless possessions but acknowledgement of their contributions to 
the greater good: through child saving, child rearing, and sacrificing for scientific progress. 
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Each family expressed saving values that they enacted through their respective claims to the state 
via income taxes as parents and property owners.  
Together, the Golds’ and Darlings’ stories exemplify sociologist Viviana Zelizer’s 
perspective on the relationship between money and morality, which is that the priceless child 
often has a price and intimate relations are not beyond purchase (Zelizer 1979; Zelizer 1985). For 
the Christian embryo adoptive couple the Darlings, seeking recognition for their embryos to 
count as adoptable children was affirmed with the receipt of a tax credit from the IRS. They may 
not consider life to be “cheaper by the dozen,” but the receipt of dollars makes moral sense for 
their religious opposition to abortion and for recouping some of the costs of adopting embryos. 
The Golds’ story of embryo donation introduced concerned parents who are propelled by 
feelings of responsibility for the well being of their daughter Alice and the broader Jewish 
community. Each year that passes with IRS approval of their tax exemption is like a stem cell 
passage that establishes a new colony of hope that the Golds plan to harness toward the care of 
their sick daughter. The lens of saving foregrounds their shared ethic of responsibility for 
preserving and advancing the kind of society within which each wants to live. 
Their stories also contribute to the extended discussion in this dissertation about the 
production of potential. Each offers a nuanced case that I examine in turn. The Darlings seem to 
have successfully claimed their daughter’s birth to the state as evidence of the potential 
contained within their adopted embryos. But, while the IRS “accepted” the tax filing for their 
first born through embryo adoption, the other eight embryos they adopted from Blossom were 
not included or counted (Hacking 1986). This was not a point that Ester dwelled on in our 
conversations, nor did the Darlings submit a tax filing for the four additional children born from 
their adopted embryos. Rather, she emphasized how excited their accepted tax filing made them 
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feel because it suggested that the U.S. government acknowledged the value of all frozen embryos 
awaiting their chances to be born. The Darlings’ tax credit affirmed for Ester the inherent value 
of the potential she knows to exist within frozen embryos, and is a story she is inclined to share 
“with anyone who will listen.”   
Claiming the ML4 embryo’s potential reveals other mechanisms through which potential 
is produced. The estimators who the Golds hired to appraise the value of their ML4 embryo 
approached it as a resource. In the fullest meaning of the word resource, the value estimators 
considered it a natural wellspring of possibility. It was positioned upstream, in “Step 1” of a 
linear, multi-stage progression toward the development of a drug therapy that could come to 
fruition downstream in the future. The perceived generativity of embryos like the Golds’ and 
other biological materials is increasingly common within the decades following the biotech 
revolution, which I reviewed in Chapter 3. Within this era of expanding efforts to prospect 
biological matters for new forms of biowealth, the Golds are proving to be ahead of the curve.  
The Golds learned from cases that came before theirs, like the use of property in the 
Davis divorce trials and the denial of John Moore’s claim to ownership and profit from the Mo 
line derived from his spleen cells. With these lessons in mind, they freely signed Sutter’s consent 
form giving up their ownership rights to future commercialized products that they hoped to see 
produced by Sutter researchers. But in signing, they did not fully give up their claim of property 
or their stake in the promises of the future.  
The Golds argued that in donating their embryo to the REDEEM Biobank, they forfeited 
their property, a point that Sutter’s entire legal team did not dispute. On the tax exemption form, 
the limbo legal status of embryos in the United States allowed them to fit their ML4 embryo into 
the “Other” category at the same time that they claimed their ownership of it as an item they 
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“Purchased” the day of their IVF cycle. Owning their embryo at the time of donation was the 
stake they needed to collect on the future.  
The embryo appraisal report paints a picture of their vision for the future and valuation of 
it, a gesture not so different from other entrepreneurs in speculative markets (Peterson 2014). 
The three million dollar value of the ML4 embryo was a number plucked from a particular slice 
in time: at the moment of donation before the lab experiment commenced. In that instance, the 
ML4 embryo contained myriad potentialities, not least of which was promising cells that could 
be derived as a stem cell line. This kind of potential is certainly one that many recognize as such 
moments of possibility come and go in our lives, yet the Golds found a way to take this narrow 
span of time and put it to work. The tax exemption materials they submitted to the IRS were the 
means for the kind of end they hoped would pan out, which is to have sufficient resources to care 
for Alice for the duration of her life.  
I have shared this story with diverse groups, from stem cell biologists and social 
scientists to abortion policy researchers, and the three million dollar number has elicited a broad 
range of reactions. At one end of the spectrum, some wish that the IRS looks kindly upon the 
Golds’ tax return so that Alice gets quality care; at the other end, some express disgust with the 
“shrewd” way this family is “in it for the money” in tones that sound anti-Semitic to my ear. My 
interest in the number is not its size but in the unprecedented kind of potential it represents. It is a 
kind unseen in the examples discussed in this dissertation, and provokes some questions about 
the basic premises of my argument, which I review in brief.  
I have argued throughout that potential is a naturalizing concept that imparts inherent 
possibility and power to things. Important to my argument is laying bare the circumstances that 
produce and impact what are the presumably inherent, unchanging capacities of an embryo. For 
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this reason, I talk about viability as circumstantial and take interest not in how frozen embryos 
are categorized but in the saving ethics and practices deployed to figure out where they belong. 
In all of these ways, I show the potentials of embryos—and values they generate—to be 
completely cultured and vibrantly alive.  
The ML4 embryo enshrined in the Golds’ tax return suggests that potentiality need not be 
lively to be generative. Instead, the case of the ML4 embryo introduces petrified and ghostly 
potentials. Like a fossil, the three million dollar embryo was fixed in a moment, yet petrified 
beyond the reach of its material and contextual referents. While the ML4 embryo and its cells 
perished in Lin’s Petri dish in 2012, its promissory value lives on. Like the undead, the ML4 
embryo haunts the Golds’ tax return with the ghosts of cells that were not immortalized and 
hopes of a cure now extinguished. The new colonies of hope that are cultivated each year that the 
IRS “accepts” the Golds’ tax return are shadowed by the remains of a past future. These ghostly 















Saving is a topic that features regularly in news headlines in the United States. “Save 
Fetal Tissue Remains, and Save Lives” featured on the New York Times editorial page in 
response to a national controversy about aborted fetuses—another kind of reproductive remain—
in which both science researchers and abortion foes claim to be on the side of saving lives for the 
greater good. Activists fighting to stop the Keystone XL oil pipeline appeal to saving ecosystems 
for future generations while pipeline proponents fight for saving jobs and economies. 
Breastfeeding advocates counter outcries about nursing in public with news reports citing studies 
about how “Breastfeeding Could Save More than 800,000 Lives a Year.” Meanwhile, 
commercial breast milk banks that sell “white gold” to neonatal intensive care units appeal to 
mothers with surplus breast milk to “help save the country’s most fragile infants.” After 
reviewing the financials, Fortune magazine declared, “Yes, Premature Babies are Worth 
Saving,” though the underlying causes for the high rates of premature deliveries among black 
women continue to receive little attention. Diverse invocations of saving can be expected in a 
country that is home to cutting-edge medical fields and scientific research, a vibrant Christian 
political movement, and a deeply entrenched capitalist economy.  
In this dissertation, I explore the saving in America that happens beyond headlines and in 
the hands of people and programs striving to do their best in the face of life’s uncertainties. I 
cohere my questions and conclusions around a central question: how and why are America’s 
frozen embryos saved at the turn of the twenty-first century? I traveled within the frontier lands 
of California to two pioneering organizations on the vanguard of embryo saving: a Christian 
embryo adoption program, and stem cell institute tissue bank. Both solutions for America’s 
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embryo surplus express agreement on what makes embryos valuable, which is their potential. 
Whether embryos contain promise as a precious resource for research or a couple’s hoped-for 
child, embryo savers regard potential as something inherent to the frozen remainder. I took this 
idea that frozen embryos are naturally potent, and therefore valuable, as a starting place for 
exploring how and why these remainders are saved.  
 
Saving: Ethics, Practices, Infrastructures 
I entered the U.S. frozen embryo debate with an ethnographer’s interest in the processes 
through which frozen IVF embryo potential is produced and valued. Rather than fix my attention 
on the novel ethnographic object in my midst, or the polarizing forces common to life politics, I 
focused on understanding the dynamics of saving—the active realms of moral orientations, daily 
practices, and structural environs that collaborate in making things matter to particular people 
and in specific places. By holding simultaneous its multiple significances in medicine, 
Christianity, and capitalism, saving provides a framework that puts into relief points of 
convergence among different approaches to life’s uncertainties. Convergences are sites of 
mixture and tension that I examine in three main ways: ethics, practices, and infrastructures. 
Through the lens of saving, stem cell tissue bankers and embryo adoption proponents 
converge around a shared commitment to “do good.” On the one hand, Sutter University Stem 
Cell Institute researchers try to adhere to and model the principles of “good science,” at the heart 
of which is the responsibility to not be wasteful. Blossom proponents, on the other hand, strive to 
live according to Christian values of equality, dignity, and duty by modeling social forms of 
inclusion through “good family.” Embryo savers demonstrate their respective commitments in 
diverse ways via ethical pronouncements and practical activities. Saving also puts into relief 
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underlying structures that prop up their meaningful activities through which frozen embryos 
come to matter. In this study, property and personhood are key organizing logics that suffuse the 
everyday within each program. In what follows, I discuss how I identified these convergences as 
I explored how and why frozen embryos are valued for their potential.  
How frozen embryos come to contain potential and how that potential is deemed valuable 
are the topics of Chapter 2. Embryologists Ken and Zhao at Harrington Fertility Clinic in 
Southern California proved to be useful guides for illuminating how potentiality is “cultured” in 
the IVF lab. I used culturing as a concept to help reveal connections between what happens 
cellularly in Petri dishes and the forces beyond the dish—e.g., stratified reproductions, histories 
of modern standards, school report cards, etcetera—that inform how clinics and patients “make 
babies.” Ken and Zhao’s bench-top and desktop tasks in Harrington’s IVF lab showed how Petri 
dishes, paperwork, and standards collaborate in making IVF embryos contain potential.  
I took particular interest in the grades marked on embryology reports, which sort out 
which embryos are thought to have the best chance to establish pregnancy. Ken described his 
grades as letting embryos “speak” what their destinies may be, which was my first ethnographic 
encounter of the naturalizing presumption that potential is linear and inherent to not-yet-entities, 
an idea that was first articulated by Aristotle. Rather than see it as he did—as an objective 
discovery of embryo potentiality—I suggested that Ken’s tracking techniques, report 
compilations, and expert interpretations actively brought embryo potentiality into being. These 
potentials are then directed toward different futures through scales of value established by 
fertility clinics that categorize embryos as transferrable, savable, or discardable. In a fertility 
clinic, savable IVF embryos are plunged into liquid nitrogen for possible use another day. 
Although unwanted today, they are also un-wastable because their potential is considered 
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valuable. This chapter established that embryo potential is made through various culturing 
forces, which laid the foundation for examining how their mutable, contingent potentials are re-
valued within post-IVF embryo saving programs.  
Chapters 3 and 4 enter into the embryo saving worlds of the REDEEM Biobank in Sutter 
University’s Stem Cell Institute and the Blossom Embryo Adoption program of Pacific Christian 
Adoption agency where IVF leftovers become precious treasures and adoptable orphans. Saving 
ethics, practices, and infrastructures are fundamental to the daily rigors of stem cell tissue 
banking as well as Christian embryo adoption. Each saving program’s commitment to doing 
good for the betterment of life in America—preventing waste on behalf of science, for one, and 
rescuing in the name of family, for the other—involves alienating IVF remainders from their 
social ties in order to repurpose their potential for new futures. Through the lens of saving, I 
found many points of convergence between these two programs, some of which I revisit here.  
Dr. Moto’s lab at Sutter University was an ideal place to learn about waste, which I 
explored in depth in Chapter 3. Attitudes of responsibility on behalf of the future were strongly 
felt among researchers, who planned careful experiments and maximized the use of cells. Peter’s 
efforts to “freeze down” extra cells and Luke’s conservative requests for 2PN embryos expressed 
a widely shared value around preventing the waste of precious embryo resources. For them, 
embryos were made more precious by the contentious environment in the U.S. around stem cell 
research, yet their anxieties about resource scarcity sounded odd coming from inside one of the 
biggest, best funded labs in the largest stem cell research building in the world located in a state 
with unprecedented funding dedicated to stem cell research. Caitlin’s worry about the near-full 
reserve in the Biobank inventory exemplified for me the pressures of doing good science in 
uncertain times where the boom can become a bust at anytime. Although the blastocysts in the 
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REDEEM Biobank were considered burdensome to caretakers like Wendy, Caitlin rested assured 
knowing they were there because science, as she explained, sometimes circles back around.  
Despite common regard for frozen embryos as un-wastable, the Biobank’s procurement 
strategies “trashed” clinical embryos in order to transform them into precious research materials. 
These transformations involved the work of property, or the cutting of ownership ties between 
donors and embryos so that researchers may establish new property relations through them, like 
patents. The lens of saving brought Sutter into view as both a responsible redeemer and rubbish 
collector within a global reproductive waste sector that transforms biological potentialities into 
new valuable forms. The story of potential at Sutter is about turning trash into treasure.   
Life in the Blossom Embryo Adoption program tells a similar story. The first program of 
its kind in the world, Blossom puts pro-life Christian values into practice by striving to find 
homes for adoptable embryos cast through humanitarian rhetoric as orphans in the midst of 
crisis. Tim and the Drylers launched the program in response to a perceived “cheapening of life” 
within the United States; they sought to reaffirm the value of embryonic life—and by extension, 
Christian family values of equality, dignity, and inclusion—by facilitating their chances to be 
born.  
Blossom is one of the few places where embryo personhood operates as the status quo, 
which they integrate into their mission, materials, and everyday practices. Over 450 “blossoms” 
have been born to date through the giving and receiving of embryos among people who are 
compelled by feelings of responsibility. Donors like Annika want to be good stewards of their 
embryos by giving them to others who can bring them in from the cold. Adopters like Maria care 
for their bodies—the first homes for embryos—and submit to God’s plan for their reproductive 
futures. Blossom staff commits whole-heartedly to finding adopters for even the most taxing of 
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cases, like the Bower embryo discussed in Chapter 6. Yet in order to make orphans of embryos, 
Blossom has to strip IVF leftovers of their kinship ties of with donors. Embryo humanitarianism 
casts embryos as at risk and in need, but Blossom donors like the Bakers were clear that their 
frozen remainders were never without parents. The lens of saving illuminates the racial and 
gendered logics involved in cultivating frozen embryos as cultural innocents, which sheds a 
different light on Blossom’s expressed values of equality, dignity, and inclusion. Although 
committed to rescuing all embryos toward a societal embrace of family values, the families into 
which the Blossom program invests their energies are predominantly white, middle class, 
heterosexual, and Christian.  Stories from Chapters 3 and 4 reveal synergies and alignments 
across the hard line drawn between pro-science and pro-Christian answers to life’s problems. 
Blossom emerged, like the REDEEM Biobank, as a program in the business of salvaging 
reproductive leftovers and repurposing frozen treasures for future use. Christian strategists as 
well as stem cell scientists mobilize IVF surpluses to forward moral agendas about doing good.  
Once frozen embryos are donated and undergoing transformation into orphans and 
treasures, each program’s staff works hard to cultivate futures for them. In order for such futures 
to be possible, Blossom and REDEEM have to sort embryos out. The sorting practices I examine 
in Chapter 5 served as windows into the circumstances beyond the cryotank that make embryos 
differently and circumstantially viable. Some embryos become “hot commodities” with 
streamlined pathways from freezer to Petri dish or uterus, while other embryos are stuck 
“waiting.” Had the Bowers donated their single 2PN embryo to the REDEEM Biobank, 
researchers would have shouted “Hallelujah!” for their good fortune, but it proved unviable as an 
adoptable orphan in the Blossom program. Similarly, Angela Stoll’s “slam dunk” blastocyst 
would have had a strong case for adoption in the Blossom program, but joined ranks in the top 
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racks of the Biobank with other embryo types in oversupply. The futures of these two embryos 
were put on hold due to myriad forces beyond the tank. Their cases illustrate how neither embryo 
was more or less valuable inherently, but viable circumstantially. The lens of saving helps 
explain why, despite the hardships of continuing to care for unviable embryos, staff at Blossom 
and REDEEM are driven by a moral obligation to save, or to “do good” today on behalf of 
possible tomorrow. In Caitlin’s view, blastocysts might not be a usable research material in the 
Stem Cell Institute today, but shifting trends in scientific innovations might make it invaluable in 
the future. Even with the dissolution of Dr. Moto’s lab, I am confident the orphaned Biobank 
will undoubtedly find a home because preparing for unknown futures is so strongly felt to be 
worth it among stem cell researchers. A similar belief is true for embryo adoption advocates. The 
possibilities associated with potentiality articulated across Christian adopters and stem cell 
researchers a shared faith in the promise of the future based on the good efforts of today.  
Although I focused on the managers of embryo afterlives based in institutions like 
Blossom and REDEEM, fertility patients are also active makers, managers, and claimers of their 
potentials whose perspectives are easily lost in the mix of embryo saving middlemen making 
their own claims on frozen futures. For this reason, it is imperative to hear from donors and 
adopters, and consider the kinds of claims they also make on their frozen remainders. In Chapter 
6, I examine two experiments carried out by the Darlings and Golds that introduce other ways of 
claiming the potential of frozen embryos. I discuss the Darlings’ adoption of nine embryos 
through the Blossom program as well as the Golds’ donation of their ML4 embryo to the 
REDEEM Biobank. Common to each story is something few have done: both families filed tax 
returns claiming credits and deductions based on their embryo saving activities. Despite the 
many differences between the Darlings and Golds, both couples are religiously devout parents to 
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children with genetic disabilities with passionate commitments to life-saving advocacy in their 
respective communities. In filing their tax returns, neither was solely driven by the capitalized 
value of their priceless possessions but sought acknowledgement for their contributions to the 
greater good: through child saving, child rearing, and sacrificing for scientific progress. Their 
stories provoke questions about how making such claims—in their cases, to the state—as parents 
and property owners articulates a stake in a different notion of good: in the collective goods of 
society, available to those who can verify their do-gooding efforts.  
“Good,” as should now be clear, figured centrally within my explorations of embryo 
saving. First and foremost, good is a concept discovered ethnographically to be active in the lives 
of the embryo savers with whom I spent time during research in California. They cued me to see 
“good” as a centrifugal force for the morals, actions, and conditions that propel them to do good 
for science and family today in hopes of a better tomorrow. In my analysis thus far, I have 
discussed good in ways that my interlocutors will recognize and, in doing so, contribute to an 
“anthropology of the good” called for by Joel Robbins. “To study the good as anthropologist,” he 
argues:  
…we need to be attentive to the way people orientate to and act in a world that outstrips 
the one most concretely present to them, and…avoid dismissing their ideals as 
unimportant or, worse, as bad-faith alibis for the worlds they actually create (Robbins 
2013: 457). 
 
What my interlocutors might not recognize are the parallels I discern between their 
respective life-saving campaigns. I arrive at this conclusion by approaching “good” in different 
way: as an analytical pivot point between two ethico-political formations that champion saving 
in order to make the best use of the privately held and valuable frozen goods of today for the so-
called collective good of tomorrow. Between stem cell research and embryo adoption, I highlight 
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many sites of convergence and alignment that challenge the way America’s embryo savers are 
often antagonistically polarized. Among these convergences, none go further than the Golds’ 
story to disrupt presumptions that doing “good family” and “good science” are distinct projects. 
As a result of this research, I am convinced that they are not. Rather, the colonies of hope 
cultivated by the Golds’ tax return that may generate resources for their daughter’s care dissolve 
false dichotomies characterizing how embryo saving efforts are often cast, such as cure versus 
dignity, profit versus morals, and progress versus conservatism. Instead, what comes into relief 
through their particular story is how saving—as ethical practice, political claim, and condition of 




Saving provides an intersectional framework for understanding the politics of 
regenerating value when “life” is in surplus (Cooper 2008) and capital is in crisis—both of which 
are increasingly commonplace within speculative markets and societies. Through this lens, 
Blossom and REDEEM come into view as intermediary organizations—similar to traditional 
banks—at the forefront of managing unwanted but un-wastable forms of “frozen capital.” In this 
dissertation, I argue that the opposing missions of stem cell researchers and Christian adopters 
belie common saving efforts within capital crises that transform frozen, or illiquid, forms of 
capital from devalued trash into potent treasure. In addition to offering a revision to scholarly 
understandings of biocapital from the perspectives of evangelical Christians, IVF patients, and 
stem cell scientists, this dissertation extends theories about the generation and valuation of 
potential. While potentiality is the subject of growing theoretical and ethnographic interest, this 
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project addresses critical lacunae by demonstrating how potentiality operates in tissue economies 
as a discourse about reproduction. At the confluence of feminist theories on reproductive 
technologies, politics, and economies, I argue that IVF and cryopreservation function not just as 
reproductive, but also speculative, technologies in the contemporary United States. As a result, 
they provide a critical lens for understanding reproductive remains as novel forms of 
“cryocapital” and explaining why speculative financial practices are attracted to the value of 
reproductive potential.  
Theoretically and methodologically, this dissertation builds on efforts that began four 
decades ago when feminist scholars started systematically dragging reproduction to the center of 
social theory, expanding its definition beyond biological procreation, and demonstrating the 
invisible centrality of reproduction to social life (cf. Ginsburg and Rapp 1995). Stories from 
embryo savers speak to recent feminist literatures that theorize labor and value with respect to 
growing global hungers for “biovalue” presumed to be latent within reproductive tissue 
economies, such as donated eggs and surplus embryos (Cooper and Waldby 2014). By bringing 
ethnographic attention to the lived experiences of American savers with and wanting leftover 
embryos, this research revises how we may understand implosions between the life sciences and 
finance capital by illuminating the foundational role of evangelical Christianity in generating 
values within U.S. reproductive economies. The new species of speculative biocapital 
exemplified by surplus IVF embryos cannot be adequately understood by only attending to the 
imbrications between biomedicine and capitalism. Rather, this dissertation makes a case for 
polysemy, or analyses that account for multiple intersecting frameworks and realities, as 
demonstrated by the concept of saving. Previous chapters show how religious moralities and 
laboratory ethics shape rescue and waste prevention practices in embryo saving programs, as 
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well as highlight the financial logics infused within evangelical Christian adoption. Such 
intersectional analyses are indebted to feminist scholars of color (Collins 2000; Crenshaw 1989; 
Dill and Zambrana 2009) who first articulated the necessity of scholarship that accounts for the 
simultaneous forces of race, class, and gender. Intersectional analysis informs the next 
generations of feminist research, like this one, that develop polysemous theories to address 
twenty-first century reproductive politics.   
This research also contributes to feminist interrogations of binary thinking, or as 
Haraway describes it, the “antagonistic dualisms” that organize Western discourse and ideas 
about modernity. Saving, as the sampling of headlines at the opening of this chapter indicates, 
serves as a compelling framework in American politics for “doing good” when futures are felt to 
be uncertain. The seeming imperative to save in the twenty-first century—evident across stem 
cell research labs, IVF clinics, Christian adoption agencies, and may other political formations—
may ultimately be complicit in emptying saving of its ethical and political meaning. At the time 
of writing this dissertation, calls to save still rally people into moral action, though it may soon 
join the ranks of other fetishized concepts—like “life”—as a four-letter word that declares war 
but means little at all.  
More importantly, by questioning polarizing logics within saving discourses, this 
dissertation makes space for the quieted politics and remaindered ideas that have not fit neatly 
within the dominant trope of saving in the United States. The false binaries proffered by saving 
campaigns have elbowed out alternative formulations to doing good. Although alternative 
political articulations to embryo saving campaigns were not the focus of my research, some 
marginalized perspectives to the saving tropes I studied found their way into the edges of my 
chapters. For instance, I highlighted frameworks for doing good in the midst of California’s 
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struggling economy, like redistributive and restorative justice for historically marginalized 
communities and addressing the underlying causes of health disparities. I asked how our 
communities might redress stratified reproductive potentials if our collective charge was to make 
babies thrive rather than just make babies. And in contrast to the saving logics informing the 
“politics of disposability” during Hurricane Katrina and the appropriations of Black histories in 
creating savable innocents in America, I am interested in the alternative framings posed by the 
Black Lives Matter movement to the imperative to save. These and other remaindered topics on 
the political terrains dominated by saving provide useful directions for future research.  
 
Future Directions for Research 
Race 
Race, as Dorothy Roberts argues, is inextricably bound to politics of reproduction in the 
United States (Roberts 1997). This dissertation demonstrates that leftover IVF embryos provide a 
new locus for understanding the imbrications between race and reproduction. Examples 
discussed in this dissertation, ranging from the racialization of rescuable embryos to the 
underlying grammars shaping how embryos are sorted out, reveal that race operates as a 
structuring logic for contemporary embryo saving practices. But many questions remain about 
the particular role of race in producing cultural notions of value and worth in the United States. 
One avenue for exploring these questions involves examining the role racial sciences and other 
racialized knowledges about “prisms of heritability” (Duster 1990) play within IVF, human 
embryonic stem cell research, and embryo adoption. Critical race scholars of science and 
technology (Fullwiley 2007; Kowal 2013; Nelson 2016; TallBear 2013; Wailoo, et al. 2012) 
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offer foundational frameworks for pursuing such topics in the aftermaths of IVF and other 
cryopolitical domains.  
Future research on the relationship between race and value may also direct attention to 
the legal realm, where race and reproductive science actively intermix within disputes over the 
definition of personhood in the United States. Critical race and feminist theories, and historical 
and ethnographic methods, may be used fruitfully to examine legal claims about the moral and 
material worth of frozen embryos, which use embryological science and Black American 
histories of slavery to forward a civil rights cause for the “frozen unborn.” By analyzing legal 
activism over the status of frozen embryos—championed by Christian pro-life law firms like the 
Thomas More Society—these studies could shed light on the interconnecting roles of 
reproductive science, race, law, and Christianity in constructing notions of value in America.  
 
Disability 
Anthropologists Faye Ginsburg and Rayna Rapp describe tensions around two cultural 
values in the United States—one focused on perfection and enhancement, and the other on 
expanding the rights and inclusion of people living with disabilities—or what they call the 
“double telos of modernity and technology” (Rapp and Ginsburg 2001). These tensions are 
constitutive of intersections between disability and reproductive technologies in the United 
States where achieving perfectibility in pregnancy comes into conflict with a growing acceptance 
of individuals and groups with screenable disabilities. For instance, disability subtends prenatal 
care in the U.S. through the availability of screening and diagnostic tests, like amniocentesis and 
newer forms of non-invasive prenatal testing, used to assess risk for genetic abnormalities in 
pregnancy. Also, since the 1990s, IVF patients desiring a “take home baby” have had access to 
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preimplantation genetic screening (PGS) or diagnosis (PGD) for in vitro embryos prior to 
transfer (Franklin and Roberts 2006). PGS/PGD are also used for “family balancing,” a practice 
of selecting the sex of the embryos transferred. Recently, the Francis Crick Institute in the U.K. 
received approval to use gene-editing technology on human embryos, a controversial technique 
exemplifying tensions between eradicating genetic disease and the embrace of human diversities.  
Suffusing such reprogenetic technologies are notions of normalcy and desirability that shape how 
patients decide to proceed with pregnancy, including decisions to transfer as well as to terminate.   
Within stem cell research advocacy, discourse about disability also features prominently, 
For instance, individual members of affected communities are often included in media to raise 
resources for finding cures for disease and debilitating conditions. Yet, the scripting of 
disabilities as having or needing a cure casts disability as a medical phenomenon rather than a 
complex social condition shaped by dis-abling circumstances, such as prevailing notions of what 
is “normal” (Ginsburg and Rapp 2013a). Possible directions for future research include 
understanding alternative perspectives about “cure” and “disease” from people living with 
various kinds of disabilities or diseases targeted for cure by science. While their lives are often 
marked by biomedical knowledge, their lived experiences are not often integrated into scientific 
developments involving their bodies, capacities, and futures (Ginsburg and Rapp 2013b; Taussig, 
et al. 2003). 
Embryo adoption, as a type of third-party reproduction, also provides a promising venue 
for exploring how disability is conceived and managed. The Blossom Embryo Adoption program 
treats all embryos as deserving a chance to be born, though staff expressed disappointment when 
embryo adoptive clients appeared to be “shopping” for embryos. In response to embryos leftover 
from “picky” client criteria, Blossom staff created an advertising webpage for “special case” 
 290 
embryos that listed embryos requiring “more advocacy,” according to the program manager, 
Monica, to help them find a home. Included on the list were embryos from donors with 
conditions ranging from multiple sclerosis, 21-hydroxylase deficiency, and Hepatitis A to 
embryos with full genetic siblings diagnosed with neurofibromatosis, autism, and a non-specified 
developmental disability. Future research may examine how disability is constructed and 
negotiated among embryo savers, and how rescuing logics operate within the interplay between 
wishes to become pregnant and living in accordance with religious values.   
 
Kinship and Ownership in Third-Party Reproduction 
Critical feedback from adult adoptees about their experiences has had significant impacts 
on the field of adoption, such as the monumental shift of norms from closed records to open 
adoptions. Similar trends are underway within the newer field of assisted reproduction, and 
especially forms of third-party reproduction that include sperm, egg, and embryo donation and 
surrogacy. Donor conceived children, many of whom are born with closed records without 
access to information about their biological heritage, are increasingly voicing critique about 
anonymity within third-party reproduction and creating new mediums for connection, such as the 
online Donor Sibling Registry.  
Embryo adoption is one of the newer forms of third-party reproduction available to 
prospective parents, with the oldest “blossom” now 16 years old. Many of the Blossom donor 
and adopter families in my study felt challenged to talk about their particular family formations 
due to inadequate language, children’s books, grieving spaces, and other systems to support their 
novel family forms. In response to these lacunae, many created their own. Future scholarship on 
the perspectives of children born through embryo adoption, including kinship narratives among 
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participants in embryo adoption, would find an eager audience among contemporary adoption 
and fertility clinic professionals.  
Another area for exploration is how embryo adoption enacts forms of “rent” common 
within financialized capitalism. The Blossom contract signed by embryo donors and adopters is 
modeled on legal transfers of property that includes a clause about relinquishment and renewal 
sustaining donor rights to embryos for a designated period of time. These clauses, as 
demonstrated by the conflict between the Bakers and Channings, open up rather than resolve the 
question of embryo ownership within adoption economies. How this form of “embryo renting” 
parallels trends within financialized markets may elucidate other ways in which excess embryos 
operate as lively forms of frozen capital (Sunder Rajan 2012). 
 
Beyond the United States  
California, as a frontier land for prospecting new biovaluables, offers a compelling site 
for understanding embryo saving projects, though this case may benefit from comparative 
international studies that put into relief how reproductive remainders are handled in other 
settings. For example, the United Arab Emirates offers a possible location for examining the 
savability of frozen embryos in the context of cross-border reproductive care and shifting 
national law. In 2010, the UAE banned embryo freezing, which left international fertility patients 
who traveled there for services not offered in their home countries wondering about the fates 
their frozen remainders stored abroad (Inhorn 2015). The shifting policies and cultural norms 
regulating assisted reproductive technologies, embryo cryopreservation, and embryonic stem cell 
research will continue to offer generative sites for comparatively exploring the meanings and 
flows of frozen reproductive remains.   
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Small Things Considered 
“Scientists and artists know that the way to handle an immense topic is often through 
close attention to a small aspect of it, revealing the whole through the part.”  
- Ursula le Guin, in review of Anna Tsing’s book The Mushroom at the End of the World: 
On the Possibility of Life in Capitalist Ruins 
 
Akin to the way the shape of a finch’s beak gives insight into the whole of evolution, 
frozen embryos are small things through which big stories can be told. In the United States, 
efforts to save frozen embryos illuminate widely felt obligations among Americans to do good 
during uncertain times. These unwanted but un-wastable remainders prove to be cultural 
touchstones constitutive of new thresholds between kinship and property, Christianity and 
science, and presents and futures. The value of their potentiality implicates the global human 
tissue trade, expanding property regimes, national economies, reproductive tourisms, etcetera. 
All told, saving frozen embryos is never simply a matter of economic crisis, heroic medicine, or 
religious salvation. Rather, keeping these knotty things around suggests an unshakable faith in 
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